Document:

Exhibit 4.1

Exhibit 4.1

EXECUTION VERSION

IASIS HEALTHCARE LLC

IASIS CAPITAL CORPORATION

and each of the Guarantors party hereto

8.375% SENIOR NOTES DUE 2019

INDENTURE

Dated as of May 3, 2011

The Bank of New York Mellon Trust Company, N.A.

Trustee

 

 

 

CROSS-REFERENCE TABLE*

	 	 	 	 	 
	Trust Indenture	 	 	 
	Act Section	 	Indenture Section	 
	310(a)(1)
	 	 	7.10	 
	(a)(2)
	 	 	7.10	 
	(a)(3)
	 	 	N.A.	 
	(a)(4)
	 	 	N.A.	 
	(a)(5)
	 	 	7.10	 
	(b)
	 	 	7.10	 
	(c)
	 	 	N.A.	 
	311(a)
	 	 	7.11	 
	(b)
	 	 	7.11	 
	(c)
	 	 	N.A.	 
	312(a)
	 	 	2.05	 
	(b)
	 	 	12.03	 
	(c)
	 	 	12.03	 
	313(a)
	 	 	7.06	 
	(b)(1)
	 	 	N.A.	 
	(b)(2)
	 	 	7.06; 7.07	 
	(c)
	 	 	7.06; 12.02	 
	(d)
	 	 	7.06	 
	314(a)
	 	 	4.03; 12.02; 12.05	 
	(b)
	 	 	N.A.	 
	(c)(1)
	 	 	N.A.	 
	(c)(2)
	 	 	N.A.	 
	(c)(3)
	 	 	N.A.	 
	(d)
	 	 	N.A.	 
	(e)
	 	 	12.05	 
	(f)
	 	 	N.A.	 
	315(a)
	 	 	7.01	 
	(b)
	 	 	7.05	 
	(c)
	 	 	7.01	 
	(d)
	 	 	7.01	 
	(e)
	 	 	6.11	 
	316(a) (last sentence)
	 	 	2.09	 
	(a)(1)(A)
	 	 	6.05	 
	(a)(1)(B)
	 	 	6.04	 
	(a)(2)
	 	 	N.A.	 
	(b)
	 	 	6.07	 
	(c)
	 	 	2.12	 
	317(a)(1)
	 	 	6.08	 
	(a)(2)
	 	 	6.09	 
	(b)
	 	 	2.04	 
	318(a)
	 	 	12.01	 
	(b)
	 	 	N.A.	 
	(c)
	 	 	12.01	 

	 	 	 
	N.A. means not applicable.
	 
	*	 	This Cross Reference Table is not part of the Indenture.

 

 

 

TABLE OF CONTENTS

	 	 	 	 	 
	 	 	Page	 
	 
	 
	ARTICLE 1.

	DEFINITIONS AND INCORPORATION

	BY REFERENCE

	 
	 	 	 	 
	Section 1.01 Definitions
	 	 	1	 
	Section 1.02 Other Definitions
	 	 	39	 
	Section 1.03 Incorporation by Reference of Trust Indenture Act
	 	 	39	 
	Section 1.04 Rules of Construction and Calculation
	 	 	40	 
	 
	 	 	 	 
	ARTICLE 2.

	THE NOTES

	 
	 	 	 	 
	Section 2.01 Form and Dating
	 	 	41	 
	Section 2.02 Execution and Authentication
	 	 	42	 
	Section 2.03 Registrar and Paying Agent
	 	 	43	 
	Section 2.04 Paying Agent to Hold Money in Trust
	 	 	43	 
	Section 2.05 Holder Lists
	 	 	44	 
	Section 2.06 Transfer and Exchange
	 	 	44	 
	Section 2.07 Replacement Notes
	 	 	59	 
	Section 2.08 Outstanding Notes
	 	 	59	 
	Section 2.09 Treasury Notes
	 	 	60	 
	Section 2.10 Temporary Notes
	 	 	60	 
	Section 2.11 Cancellation
	 	 	60	 
	Section 2.12 Defaulted Interest
	 	 	61	 
	Section 2.13 CUSIP Numbers
	 	 	61	 
	Section 2.14 Issuance of Additional Notes
	 	 	61	 
	 
	 	 	 	 
	ARTICLE 3.

	REDEMPTION AND PREPAYMENT

	 
	 	 	 	 
	Section 3.01 Notices to Trustee
	 	 	62	 
	Section 3.02 Selection of Notes to Be Redeemed or Purchased
	 	 	62	 
	Section 3.03 Notice of Redemption
	 	 	63	 
	Section 3.04 Effect of Notice of Redemption
	 	 	64	 
	Section 3.05 Deposit of Redemption or Purchase Price
	 	 	64	 
	Section 3.06 Notes Redeemed or Purchased in Part
	 	 	64	 
	Section 3.07 Optional Redemption
	 	 	65	 
	Section 3.08 Mandatory Redemption
	 	 	65	 
	Section 3.09 Offer to Purchase by Application of Excess Proceeds
	 	 	65	 

 

- i -

 

	 	 	 	 	 
	 	 	Page	 
	 
	 
	ARTICLE 4.

	COVENANTS

	 
	 	 	 	 
	Section 4.01 Payment of Notes
	 	 	68	 
	Section 4.02 Maintenance of Office or Agency
	 	 	68	 
	Section 4.03 Reports
	 	 	69	 
	Section 4.04 Compliance Certificate
	 	 	70	 
	Section 4.05 Taxes
	 	 	71	 
	Section 4.06 Stay, Extension and Usury Laws
	 	 	71	 
	Section 4.07 Restricted Payments
	 	 	72	 
	Section 4.08 Dividend and Other Payment Restrictions Affecting Restricted Subsidiaries
	 	 	77	 
	Section 4.09 Incurrence of Indebtedness and Issuance of Disqualified Stock and Preferred Stock
	 	 	80	 
	Section 4.10 Asset Sales
	 	 	85	 
	Section 4.11 Transactions with Affiliates
	 	 	88	 
	Section 4.12 Liens
	 	 	91	 
	Section 4.13 Business Activities
	 	 	91	 
	Section 4.14 Corporate Existence
	 	 	91	 
	Section 4.15 Offer to Repurchase Upon Change of Control
	 	 	92	 
	Section 4.16 Specified Change of Control
	 	 	94	 
	Section 4.17 Designation of Restricted and Unrestricted Subsidiaries
	 	 	94	 
	Section 4.18 Existence of Corporate Co-Issuer
	 	 	95	 
	Section 4.19 Payments for Consent
	 	 	95	 
	Section 4.20 Additional Subsidiary Guarantees
	 	 	96	 
	Section 4.21 Covenant Termination
	 	 	96	 
	 
	 	 	 	 
	ARTICLE 5.

	SUCCESSORS

	 
	 	 	 	 
	Section 5.01 Merger, Consolidation, or Sale of Assets
	 	 	97	 
	Section 5.02 Successor Corporation Substituted
	 	 	98	 
	 
	 	 	 	 
	ARTICLE 6.

	DEFAULTS AND REMEDIES

	 
	 	 	 	 
	Section 6.01 Events of Default
	 	 	99	 
	Section 6.02 Acceleration
	 	 	101	 
	Section 6.03 Other Remedies
	 	 	101	 
	Section 6.04 Waiver of Past Defaults
	 	 	101	 
	Section 6.05 Control by Majority
	 	 	102	 
	Section 6.06 Limitation on Suits
	 	 	102	 
	Section 6.07 Rights of Holders to Receive Payment
	 	 	102	 
	Section 6.08 Collection Suit by Trustee
	 	 	102	 
	Section 6.09 Trustee May File Proofs of Claim
	 	 	103	 
	Section 6.10 Priorities
	 	 	103	 
	Section 6.11 Undertaking for Costs
	 	 	104	 
	 
	 	 	 	 
	ARTICLE 7.

	TRUSTEE

	 
	 	 	 	 
	Section 7.01 Duties of Trustee
	 	 	104	 
	Section 7.02 Rights of Trustee
	 	 	105	 
	Section 7.03 Individual Rights of Trustee
	 	 	106	 

 

- ii -

 

	 	 	 	 	 
	 	 	Page	 
	 
	 
	Section 7.04 Trustee’s Disclaimer
	 	 	107	 
	Section 7.05 Notice of Defaults
	 	 	107	 
	Section 7.06 Reports by Trustee to Holders of the Notes
	 	 	107	 
	Section 7.07 Compensation and Indemnity
	 	 	107	 
	Section 7.08 Replacement of Trustee
	 	 	108	 
	Section 7.09 Successor Trustee by Merger, etc
	 	 	109	 
	Section 7.10 Eligibility; Disqualification
	 	 	109	 
	Section 7.11 Preferential Collection of Claims Against Company
	 	 	110	 
	 
	 	 	 	 
	ARTICLE 8.

	LEGAL DEFEASANCE AND COVENANT DEFEASANCE

	 
	 	 	 	 
	Section 8.01 Option to Effect Legal Defeasance or Covenant Defeasance
	 	 	110	 
	Section 8.02 Legal Defeasance and Discharge
	 	 	110	 
	Section 8.03 Covenant Defeasance
	 	 	111	 
	Section 8.04 Conditions to Legal or Covenant Defeasance
	 	 	111	 
	Section 8.05 Deposited Money and Government Securities to be Held in Trust; Other Miscellaneous Provisions
	 	 	112	 
	Section 8.06 Repayment to Issuers
	 	 	113	 
	Section 8.07 Reinstatement
	 	 	113	 
	 
	 	 	 	 
	ARTICLE 9.

	AMENDMENT, SUPPLEMENT AND WAIVER

	 
	 	 	 	 
	Section 9.01 Without Consent of Holders
	 	 	114	 
	Section 9.02 With Consent of Holders
	 	 	115	 
	Section 9.03 Compliance with Trust Indenture Act
	 	 	116	 
	Section 9.04 Revocation and Effect of Consents
	 	 	117	 
	Section 9.05 Notation on or Exchange of Notes
	 	 	117	 
	Section 9.06 Trustee to Sign Amendments, etc
	 	 	117	 
	 
	 	 	 	 
	ARTICLE 10.

	SUBSIDIARY GUARANTEES

	 
	 	 	 	 
	Section 10.01 Guarantee
	 	 	117	 
	Section 10.02 Limitation on Guarantor Liability
	 	 	119	 
	Section 10.03 Execution and Delivery of Subsidiary Guarantee
	 	 	119	 
	Section 10.04 Guarantors May Consolidate, etc., on Certain Terms
	 	 	120	 
	Section 10.05 Releases
	 	 	121	 
	 
	 	 	 	 
	ARTICLE 11.

	SATISFACTION AND DISCHARGE

	 
	 	 	 	 
	Section 11.01 Satisfaction and Discharge
	 	 	121	 
	Section 11.02 Application of Trust Money
	 	 	123	 
	 
	 	 	 	 
	ARTICLE 12.

	MISCELLANEOUS

	 
	 	 	 	 
	Section 12.01 Trust Indenture Act Controls
	 	 	123	 
	Section 12.02 Notices
	 	 	123	 

 

- iii -

 

	 	 	 	 	 
	 	 	Page	 
	Section 12.03 Communication by Holders with Other Holders
	 	 	124	 
	Section 12.04 Certificate and Opinion as to Conditions Precedent
	 	 	124	 
	Section 12.05 Statements Required in Certificate or Opinion
	 	 	125	 
	Section 12.06 Rules by Trustee and Agents
	 	 	125	 
	Section 12.07 No Personal Liability of Directors, Officers, Employees and Stockholders
	 	 	125	 
	Section 12.08 Governing Law
	 	 	125	 
	Section 12.09 No Adverse Interpretation of Other Agreements
	 	 	126	 
	Section 12.10 Successors
	 	 	126	 
	Section 12.11 Severability
	 	 	126	 
	Section 12.12 Counterpart Originals
	 	 	126	 
	Section 12.13 Table of Contents, Headings, etc
	 	 	126	 
	Section 12.14 Waiver of Jury Trial
	 	 	126	 
	Section 12.15 Force Majeure
	 	 	127	 

EXHIBITS

	 	 	 
	Exhibit A1

	 	FORM OF NOTE
	Exhibit A2

	 	FORM OF REGULATION S TEMPORARY GLOBAL NOTE
	Exhibit B

	 	FORM OF CERTIFICATE OF TRANSFER
	Exhibit C

	 	FORM OF CERTIFICATE OF EXCHANGE
	Exhibit D

	 	FORM OF NOTATION OF SUBSIDIARY GUARANTEE
	Exhibit E

	 	FORM OF SUPPLEMENTAL INDENTURE

 

- iv -

 

INDENTURE dated as of May 3, 2011 among IASIS Healthcare LLC, a Delaware limited liability
company (“the Company”), IASIS Capital Corporation, a Delaware corporation (“IASIS Capital” and,
together with the Company, the “Issuers”), the Guarantors (as defined) and The Bank of New York
Mellon Trust Company, N.A., as trustee (the “Trustee”).

The Issuers, the Guarantors and the Trustee agree as follows for the benefit of each other and
for the equal and ratable benefit of the Holders (as defined) of the 8.375% Senior Notes due 2019
(the “Notes”):

ARTICLE 1.

DEFINITIONS AND INCORPORATION

BY REFERENCE

Section 1.01 Definitions.

“144A Global Note” means a Global Note substantially in the form of Exhibit A1 hereto bearing
the Global Note Legend and the Private Placement Legend and deposited with or on behalf of, and
registered in the name of, the Depositary or its nominee, issued in a denomination equal to the
outstanding principal amount of the Notes sold in reliance on Rule 144A.

“2004 Transactions” means the acquisition in 2004 by the Permitted Holders of the business
then being conducted by a predecessor of the Company, including the financing of the acquisition,
the refinancing of Indebtedness then existing, and all financings, contributions and other
transactions related thereto.

“Acquired Debt” means, with respect to any specified Person:

(1) Indebtedness of any other Person existing at the time such other Person is merged
with or into or became a Restricted Subsidiary of such specified Person, whether or not such
Indebtedness is incurred in connection with, or in contemplation of, such other Person
merging with or into, or becoming a Restricted Subsidiary of, such specified Person; and

(2) Indebtedness secured by a Lien encumbering any asset acquired by such specified
Person.

“Additional Assets” means any property or assets (other than Indebtedness and Capital Stock)
to be used by the Company or a Restricted Subsidiary of the Company in a Permitted Business.

“Additional Notes” means any Notes (other than the Initial Notes), if any, issued under this
Indenture in accordance with Sections 2.02, 2.14 and 4.09 hereof.

 

 

 

“Affiliate” of any specified Person means any other Person directly or indirectly controlling
or controlled by or under direct or indirect common control with such specified Person. For
purposes of this definition, “control,” as used with respect to any Person, means the possession,
directly or indirectly, of the power to direct or cause the direction of the management or policies
of such Person, whether through the ownership of voting securities, by agreement or otherwise. For
purposes of this definition, the terms “controlling,” “controlled by” and “under common control
with” have correlative meanings. No Person in whom a Receivables Subsidiary makes an Investment in
connection with a Qualified Receivables Transaction will be deemed to be an Affiliate of the
Company or any of its Subsidiaries solely by reason of such Investment.

“Agent” means any Registrar, co-registrar, Paying Agent or additional paying agent.

“Applicable Premium” means, with respect to any Note on any Redemption Date, the greater of:

(1) 1.0% of the principal amount of such Note; and

(2) the excess, if any, of (a) the present value at such redemption date of (i) the redemption
price (such redemption price being set forth in the table appearing in Section 3.07 of this
Indenture) of such Note at May 15, 2014, plus (ii) all required interest payments due on such Note
(excluding accrued but unpaid interest to the Redemption Date) to but excluding May 15, 2014,
computed using a discount rate equal to the Treasury Rate as of such Redemption Date plus 50 basis
points; over (b) the principal amount of such Note.

“Applicable Procedures” means, with respect to any transfer or exchange of or for beneficial
interests in any Global Note, the rules and procedures of the Depositary, Euroclear and Clearstream
that apply to such transfer or exchange.

“Asset Sale” means:

(1) the sale, lease (other than operating leases), conveyance or other disposition of
any assets or rights outside of the ordinary course of business; provided that the sale,
lease, conveyance or other disposition of all or substantially all of the assets of the
Company and its Restricted Subsidiaries taken as a whole shall be governed by Sections 4.15
and 5.01 of this Indenture and not by Section 4.10 of this Indenture; and

(2) the issuance of Equity Interests in any of the Company’s Restricted Subsidiaries or
the sale of Equity Interests in any of its Subsidiaries (other than directors’ qualifying
Equity Interests or Equity Interests required by applicable law to be held by a Person other
than the Company or a Restricted Subsidiary).

 

-2-

 

Notwithstanding the preceding, none of the following items shall be deemed to be an Asset Sale:

(1) any single transaction or series of related transactions that involves assets
having a Fair Market Value of less than $10.0 million;

(2) a transfer of assets between or among the Company and its Restricted Subsidiaries;

(3) an issuance of Equity Interests by a Restricted Subsidiary of the Company to the
Company or to a Restricted Subsidiary of the Company;

(4) the sale or lease of products, services or accounts receivable (including at a
discount) in the ordinary course of business and any sale or other disposition of damaged,
worn-out, negligible, surplus or obsolete assets in the ordinary course of business;

(5) the sale or other disposition of Cash Equivalents;

(6) a Restricted Payment that does not violate Section 4.07 of this Indenture or is a
Permitted Investment;

(7) a sale and leaseback transaction with respect to any assets within 180 days of the
acquisition of such assets;

(8) any exchange of like-kind property of the type described in Section 1031 of the
Internal Revenue Code of 1986 for use in a Permitted Business;

(9) the sale or disposition of any assets or property received as a result of a
foreclosure by the Company or any of its Restricted Subsidiaries on any secured Investment
or any other transfer of title with respect to any secured Investment in default;

(10) the licensing of intellectual property in the ordinary course of business or in
accordance with industry practice;

(11) the sale, lease, conveyance, disposition or other transfer of (a) the Capital
Stock of, or any Investment in, any Unrestricted Subsidiary or (b) Permitted Investments
made pursuant to clause (15) of the definition of “Permitted Investments”;

(12) surrender or waiver of contract rights or the settlement, release or surrender of
contract, tort or other claims of any kind;

(13) leases or subleases to third persons in the ordinary course of business that do
not interfere in any material respect with the business of the Company or any of its
Restricted Subsidiaries;

 

-3-

 

(14) sales of accounts receivable and related assets of the type specified in the
definition of Qualified Receivables Transaction to a Receivables Subsidiary for the
Fair Market Value thereof, less amounts required to be established as reserves and
customary discounts pursuant to contractual agreements with entities that are not Affiliates
of the Company entered into as part of a Qualified Receivables Transactions; and

(15) transfers of accounts receivable and related assets of the type specified in the
definition of Qualified Receivables Transaction (or a fractional undivided interest therein)
by a Receivables Subsidiary in a Qualified Receivables Transaction.

“Bankruptcy Law” means Title 11, U.S. Code or any similar federal or state law for the relief
of debtors.

“Beneficial Owner” has the meaning assigned to such term in Rule 13d-3 and Rule 13d-5 under
the Exchange Act, except that in calculating the beneficial ownership of any particular “person”
(as that term is used in Section 13(d)(3) of the Exchange Act), such “person” will be deemed to
have beneficial ownership of all securities that such “person” has the right to acquire by
conversion or exercise of other securities, whether such right is currently exercisable or is
exercisable only after the passage of time.

“Board of Directors” means:

(1) with respect to a corporation, the board of directors of the corporation or any
committee thereof duly authorized to act on behalf of such board;

(2) with respect to a partnership, the Board of Directors of the general partner of the
partnership;

(3) with respect to a limited liability company, the managing member or members or any
controlling committee of managing members thereof; and

(4) with respect to any other Person, the board or committee of such Person serving a
similar function.

“Broker-Dealer” has the meaning set forth in the Registration Rights Agreement.

“Business Day” means any day other than a Legal Holiday.

“Capital Lease Obligation” means, at the time any determination is to be made, the amount of
the liability in respect of a capital lease that would at that time be required to be capitalized
on a balance sheet prepared in accordance with GAAP, and the Stated Maturity thereof shall be the
date of the last payment of rent or any other amount due under such lease prior to the first date
upon which such lease may be prepaid by the lessee without payment of a penalty.

 

-4-

 

“Capital Stock” means:

(1) in the case of a corporation, corporate stock;

(2) in the case of an association or business entity, any and all shares, interests,
participations, rights or other equivalents (however designated) of corporate stock;

(3) in the case of a partnership or limited liability company, partnership interests
(whether general or limited) or membership interests; and

(4) any other interest or participation that confers on a Person the right to receive a
share of the profits and losses of, or distributions of assets of, the issuing Person, but
excluding from all of the foregoing any debt securities convertible into Capital Stock,
whether or not such debt securities include any right of participation with Capital Stock.

“Cash Equivalents” means:

(1) United States dollars or any other currencies held from time to time in the
ordinary course of business;

(2) securities issued or directly and fully and unconditionally guaranteed or insured
by the United States government or any agency or instrumentality thereof the securities of
which are unconditionally guaranteed as a full faith and credit obligation of such
government with maturities of 24 months or less from the date of acquisition;

(3) certificates of deposit, time deposits and eurodollar time deposits with maturities
of two years or less from the date of acquisition, bankers’ acceptances with maturities not
exceeding two years and overnight bank deposits, in each case with any domestic commercial
bank having capital and surplus of not less than $250.0 million;

(4) repurchase obligations for underlying securities of the types described in clauses
(2), (3) and (7) entered into with any financial institution meeting the qualifications
specified in clause (3) above;

(5) commercial paper rated at least P-1 by Moody’s or at least A-1 by S&P (or, if at
any time neither Moody’s nor S&P shall be rating such obligations, an equivalent rating from
another nationally recognized statistical rating agency selected by the Company) and in each
case maturing within 24 months after the date of creation thereof and Indebtedness or
preferred stock issued by Persons with a rating of “A” or higher from S&P or “A2” or higher
from Moody’s with maturities of 24 months or less from the date of acquisition;

(6) marketable short-term money market and similar funds either having (A) assets in
excess of $250.0 million or (B) a rating of at least P-2 or A-2 from either Moody’s or S&P,
respectively (or, if at any time neither Moody’s nor S&P shall be
rating such obligations, an equivalent rating from another nationally recognized
statistical rating agency selected by the Company);

 

-5-

 

(7) readily marketable direct obligations issued by any state, commonwealth or
territory of the United States or any political subdivision or taxing authority thereof
having an Investment Grade Rating from either Moody’s or S&P (or, if at any time neither
Moody’s nor S&P shall be rating such obligations, an equivalent rating from another
nationally recognized statistical rating agency selected by the Company) with maturities of
24 months or less from the date of acquisition;

(8) readily marketable direct obligations issued by any foreign government or any
political subdivision or public instrumentality thereof, in each case having an Investment
Grade Rating from either Moody’s or S&P (or, if at any time neither Moody’s nor S&P shall be
rating such obligations, an equivalent rating from another nationally recognized statistical
rating agency selected by the Company) with maturities of 24 months or less from the date of
acquisition; and

(9) investment funds investing at least 90% of their assets in securities of the types
described in clauses (1) through (8) above.

“Change of Control” means the occurrence of any of the following:

(1) the direct or indirect sale, lease, transfer, conveyance or other disposition
(other than by way of merger or consolidation), in one or a series of related transactions,
of all or substantially all of the properties or assets of the Company and its Subsidiaries
taken as a whole to any “person” (as that term is used in Section 13(d) of the Exchange Act)
other than Permitted Holders;

(2) the adoption of a plan relating to the liquidation or dissolution of the Company
(other than a plan with respect to the Company adopted solely for the purpose of
reorganizing the Company as a corporation); or

(3) the Issuers become aware of (by way of a report or any other filing pursuant to
Section 13(d) of the Exchange Act, proxy, vote, written notice or otherwise) the acquisition
by (A) any Person (other than any Permitted Holder) or (B) Persons (other than any Permitted
Holder) that are together a group (within the meaning of Section 13(d)(3) or Section
14(d)(2) of the Exchange Act, or any successor provision), including any such group acting
for the purpose of acquiring, holding or disposing of securities (within the meaning of Rule
13d-5(b)(1) under the Exchange Act), in a single transaction or in a related series of
transactions, by way of merger, consolidation or other business combination or purchase of
beneficial ownership (within the meaning of Rule 13d-3 under the Exchange Act, or any
successor provision) of more than 50.0% of the total voting power of the Voting Stock of the
Company directly or indirectly through any of its direct or indirect parent holding
companies; provided that a Change of Control shall not be deemed to have occurred solely as
a result of the Issuers becoming Subsidiaries of any direct or indirect parent holding companies so long as
no Person or Persons that are together a group (within the meaning of Section 13(d)(3) or
Section 14(d)(2) of the Exchange Act, or any successor provision), including any such group
acting for the purpose of acquiring, holding or disposing of securities (within the meaning
of Rule 13d-5(b)(1) under the Exchange Act), in a single transaction or in a related series
of transactions, by way of merger, consolidation or other business combination or purchase
of beneficial ownership (within the meaning of Rule 13d-3 under the Exchange Act, or any
successor provision), in each case other than the Permitted Holders owns or holds, directly
or indirectly, more than 50.0% of the total voting power of the ultimate parent holding
company.

 

-6-

 

“Clearstream” means Clearstream Banking, S.A.

“Company” shall have the meaning assigned to such term in the introductory statement of this
Indenture.

“Consolidated Adjusted EBITDA” means, with respect to any specified Person for any period (the
“Measurement Period”), the Consolidated Net Income of such Person for such period plus, without
duplication and to the extent deducted in determining such Consolidated Net Income, the amounts for
such period of:

(1) the Fixed Charges of such Person and its Restricted Subsidiaries for the
Measurement Period; plus

(2) the consolidated income tax expense of such Person and its Restricted Subsidiaries
for the Measurement Period; plus

(3) the consolidated depreciation expense of such Person and its Restricted
Subsidiaries for the Measurement Period; plus

(4) the consolidated amortization expense of such Person and its Restricted
Subsidiaries for the Measurement Period; plus

(5) Subordinated Management Fees paid and permitted to be paid under the terms of this
Indenture plus reasonable out-of-pocket expenses incurred, in each case, during the
Measurement Period pursuant to the Management Services Agreement as described under the
caption “Certain Relationships and Related Party Transactions” in the Offering Memorandum;
plus

(6) fees, costs and expenses paid or payable in cash by the Company or any of its
Subsidiaries during the Measurement Period in connection with the Transactions; plus

 

-7-

 

(7) other non-cash expenses and charges for the Measurement Period reducing
Consolidated Net Income (excluding any such non-cash item to the extent representing an accrual or reserve for potential cash items in any future period or
amortization of a prepaid cash item that was paid in a prior period); plus

(8) any non-recurring out-of-pocket expenses or charges for the Measurement Period
relating to any offering of Equity Interests by the Company or any direct or indirect parent
of the Company, any Asset Sale, Investment or merger, recapitalization or acquisition or
disposition transactions made by the Company or any of its Restricted Subsidiaries, or any
Indebtedness incurred, repaid, refinanced or amended by the Company or any of its Restricted
Subsidiaries (in each case, whether or not successful and whether before or after the
issuance of the Notes); plus

(9) Consolidated Net Income attributable to minority interests of a Restricted
Subsidiary that is not a Wholly Owned Subsidiary; plus

(10) to the extent deducted from the calculation of Consolidated Net Income, payments
made pursuant to clause (1) of the definition of “Permitted Payments to Parent”; minus

(11) without duplication, other non-cash items (other than the accrual of revenue in
accordance with GAAP consistently applied in the ordinary course of business) increasing
Consolidated Net Income for the Measurement Period (excluding any such non-cash item to the
extent it represents the reversal of an accrual or reserve for potential cash item in any
prior period).

“Consolidated Net Income” means, with respect to any specified Person for any period, the
aggregate of the Net Income of such Person and its Restricted Subsidiaries for such period, on a
consolidated basis, determined in accordance with GAAP; provided that:

(1) the Net Income (but not loss) of any Person that is not a Restricted Subsidiary or
that is accounted for by the equity method of accounting will be included only to the extent
of the amount of dividends or similar distributions paid in cash to the specified Person or
a Restricted Subsidiary of the Person;

(2) solely for the purpose of determining the amount available for Restricted Payments
under Section 4.07(a)(D)(3)(a), the Net Income of any Restricted Subsidiary will be excluded
to the extent that the declaration or payment of dividends or other distributions by that
Restricted Subsidiary of that Net Income is not at the date of determination permitted
without any prior governmental approval (that has not been obtained) or, directly or
indirectly, by operation of the terms of its charter or any agreement, instrument, judgment,
decree, order, statute, rule or governmental regulation applicable to that Restricted
Subsidiary or its stockholders;

(3) the cumulative effect of a change in accounting principles will be excluded;

 

-8-

 

(4) the amortization of any premiums, fees or expenses incurred in connection with the
2004 Transactions or subsequent acquisition transactions or the Transactions or any amounts
required or permitted by Accounting Principles Board Opinions Nos. 16 (including non-cash
write-ups and non-cash charges relating to inventory and fixed assets, in each case arising
in connection with the 2004 Transactions or subsequent acquisition transactions or the
Transactions) and 17 (including non-cash charges relating to intangibles and goodwill) and
any net after-tax income or loss (less fees and expenses or charges relating thereto
attributable to the early extinguishment of Indebtedness, in each case in connection with
the 2004 Transactions or subsequent acquisition transactions or the Transactions, will be
excluded;

(5) any increase in amortization or depreciation or any one-time non-cash charges
resulting from purchase accounting in connection with any acquisition that is consummated
after the Issue Date shall be excluded;

(6) any gain or loss, together with any related provision for taxes on such gain or
loss, realized in connection with: (a) any Asset Sale; or (b) the disposition of any
securities by such Person or any of its Restricted Subsidiaries or the extinguishment of any
Indebtedness of such Person or any of its Restricted Subsidiaries will be excluded;

(7) any extraordinary gain or loss, together with any related provision for taxes on
such extraordinary gain or loss will be excluded;

(8) income or losses attributable to discontinued operations (including, without
limitation, operations disposed during such period whether or not such operations were
classified as discontinued) will be excluded;

(9) all non-recurring or unusual gains and losses and all restructuring charges will be
excluded;

(10) any non-cash charges attributable to applying the purchase method of accounting in
accordance with GAAP will be excluded;

(11) an amount equal to the payments actually made to Holdings pursuant to clause (1)
of the definition of Permitted Payments to Parent in respect of the net taxable income
allocated by the Company to Holdings for such period shall be excluded as though such
amounts had been paid as income taxes directly by the Company; and

(12) all non-cash charges relating to employee benefit or other management or stock
compensation plans of the Company or a Restricted Subsidiary (excluding any such non-cash
charge to the extent that it represents an accrual of or reserve for cash expenses in any
future period or amortization of a prepaid cash expense incurred in a prior period) will be
excluded to the extent that such non-cash charges are deducted in computing such
Consolidated Net Income; provided, further that if the
Company or any Restricted Subsidiary of the Company makes a cash payment in respect of
such non-cash charge in any period, such cash payment will (without duplication) be deducted
from the Consolidated Net Income of the Company for such period.

 

-9-

 

“Consolidated Secured Debt Ratio” means, as of the date of determination, the ratio of (a) the
Consolidated Total Indebtedness of the Issuers and their Restricted Subsidiaries as of the end of
the most recent fiscal quarter for which internal financial statements are available that is
secured by a Lien to (b) Consolidated Adjusted EBITDA of the Issuers and their Restricted
Subsidiaries for the most recently ended four fiscal quarters ending immediately prior to such date
for which internal financial statements are available, in each case with such pro forma adjustments
to Consolidated Total Indebtedness and Consolidated Adjusted EBITDA as are appropriate and
consistent with the pro forma adjustment provisions set forth in the definition of “Fixed Charge
Coverage Ratio.”

“Consolidated Total Indebtedness” means, as at any date of determination, an amount equal to
(a) the sum of (1) the aggregate amount of all outstanding Indebtedness of the Issuers and their
Restricted Subsidiaries on a consolidated basis consisting of Indebtedness for borrowed money,
Obligations in respect of Capital Lease Obligations and debt obligations evidenced by promissory
notes and similar instruments, as determined in accordance with GAAP (but excluding the effects of
any discounting of Indebtedness resulting from the application of purchase accounting in connection
with the 2004 Transactions or any permitted acquisition under this Indenture) and (2) the aggregate
amount of all outstanding Disqualified Stock of the Issuers and all Preferred Stock of its
Restricted Subsidiaries on a consolidated basis, with the amount of such Disqualified Stock and
preferred stock equal to the greater of their respective voluntary or involuntary liquidation
preferences and maximum fixed repurchase prices, in each case determined on a consolidated basis in
accordance with GAAP minus (b) the lesser of (x) the aggregate amount of cash and Cash Equivalents
(in each case, free and clear of all Liens, other than nonconsensual Liens permitted by Section
4.12) included in the consolidated balance sheet of the Issuers and the Restricted Subsidiaries as
of such date and (y) $100.0 million; provided that Consolidated Total Indebtedness shall not
include Indebtedness in respect of (i) any Qualified Receivables Transaction, (ii) letters of
credit, except to the extent of unreimbursed amounts thereunder, (iii) Unrestricted Subsidiaries
and (iv) Hedging Obligations. For purposes hereof, the “maximum fixed repurchase price” of any
Disqualified Stock or Preferred Stock that does not have a fixed repurchase price shall be
calculated in accordance with the terms of such Disqualified Stock or preferred stock as if such
Disqualified Stock or preferred stock were purchased on any date on which Consolidated Total
Indebtedness shall be required to be determined pursuant to this Indenture, and if such price is
based upon, or measured by, the fair market value of such Disqualified Stock or preferred stock,
such fair market value shall be determined reasonably and in good faith by the Issuers.

“Corporate Trust Office of the Trustee” shall be at the address of the Trustee specified in
Section 12.02 hereof or such other address as to which the Trustee may give notice to the Company.

 

-10-

 

“Credit Agreement” means that certain Amended and Restated Credit Agreement, dated as of the
Issue Date, by and among the Company, as borrower, Holdings, certain subsidiaries of the Company,
Bank of America, N.A., as administrative agent, and various lenders providing for up to $1,025.0
million of term loan to be drawn on the Issue Date and $300.0 million of revolving credit
borrowings, including any related notes, Guarantees, collateral documents, instruments and
agreements executed in connection therewith, and, in each case, as amended, restated, modified,
renewed, refunded, replaced (whether upon or after termination or otherwise) or refinanced by any
other Indebtedness (including by means of sales of debt securities and including any amendment,
restatement, modification, renewal, refunding, replacement or refinancing that increases the amount
borrowed thereunder or extends the maturity thereof) in whole or in part from time to time.

“Credit Facilities” means, one or more debt facilities (including, without limitation, the
Credit Agreement) or commercial paper facilities, in each case, with banks or other institutional
lenders providing for revolving credit loans, term loans, receivables financing (including through
the sale of receivables to such lenders or to special purpose entities formed to borrow from such
lenders against such receivables) or letters of credit or any other Indebtedness, in each case, as
amended, restated, modified, renewed, refunded, replaced (whether upon or after termination or
otherwise) or refinanced (including by means of sales of debt securities and including any
amendment, restatement, modification, renewal, refunding, replacement or refinancing that increases
the amount borrowed thereunder or extends the maturity thereof) in whole or in part from time to
time.

“Custodian” means the Trustee, as custodian with respect to the Notes in global form, or any
successor entity thereto.

“Default” means any event that is, or with the passage of time or the giving of notice or both
would be, an Event of Default.

“Definitive Note” means a certificated Note registered in the name of the Holder thereof and
issued in accordance with Section 2.06 hereof, substantially in the form of Exhibit A1 hereto
except that such Note shall not bear the Global Note Legend and shall not have the “Schedule of
Exchanges of Interests in the Global Note” attached thereto.

“Depositary” means, with respect to the Notes issuable or issued in whole or in part in global
form, the Person specified in Section 2.03 hereof as the Depositary with respect to the Notes, and
any and all successors thereto appointed as depositary hereunder and having become such pursuant to
the applicable provision of this Indenture.

“Designated Noncash Consideration” means any non-cash consideration received by the Company or
a Restricted Subsidiary in connection with an Asset Sale that is designated as Designated Noncash
Consideration pursuant to an Officer’s Certificate, executed by the president and the principal
financial officer of the Company.

 

-11-

 

“Designated Preferred Stock” means preferred stock of the Company (other than Disqualified
Stock), that is issued for cash (other than to a Restricted Subsidiary) and is so designated as
Designated Preferred Stock, pursuant to an Officer’s Certificate executed on the date of such
issuance.

“Disqualified Stock” means any Capital Stock that, by its terms (or by the terms of any
security into which it is convertible, or for which it is exchangeable, in each case, at the option
of the holder of the Capital Stock), or upon the happening of any event, matures or is mandatorily
redeemable, pursuant to a sinking fund obligation or otherwise, or redeemable at the option of the
holder of the Capital Stock, in whole or in part, on or prior to the date that is 90 days after the
date on which the Notes mature. Notwithstanding the preceding sentence, (x) any Capital Stock that
would constitute Disqualified Stock solely because the holders of the Capital Stock have the right
to require the Company or its Subsidiary that issued such Capital Stock to repurchase such Capital
Stock upon the occurrence of a change of control or an asset sale will not constitute Disqualified
Stock, (y) any Capital Stock that would constitute Disqualified Stock solely as a result of any
redemption feature that is conditioned upon, and subject to, compliance with Section 4.07 hereof
will not constitute Disqualified Stock and (z) any Capital Stock issued to any plan for the benefit
of employees will not constitute Disqualified Stock solely because it may be required to be
repurchased by the Company or the Subsidiary that issued such Capital Stock in order to satisfy
applicable statutory or regulatory obligations. The amount of Disqualified Stock deemed to be
outstanding at any time for purposes of this Indenture will be the maximum amount that the Company
and its Restricted Subsidiaries may become obligated to pay upon the maturity of, or pursuant to
any mandatory redemption provisions of, such Disqualified Stock, exclusive of accrued dividends.

“Domestic Subsidiary” means any Restricted Subsidiary of the Company that was formed under the
laws of the United States or any state of the United States or the District of Columbia or that
guarantees any Indebtedness of the Company under the Credit Agreement.

“Equity Interests” means Capital Stock and all warrants, options or other rights to acquire
Capital Stock (but excluding any debt security that is convertible into, or exchangeable for,
Capital Stock).

“Equity Offering” means a public or private offering of Qualified Capital Stock of the Company
or a direct or indirect parent of the Company.

“Euroclear” means Euroclear Bank, S.A./N.V., as operator of the Euroclear system.

“Exchange Act” means the Securities Exchange Act of 1934, as amended.

“Exchange Notes” means the Notes issued in the Exchange Offer pursuant to the Registration
Rights Agreement.

 

-12-

 

“Exchange Offer” has the meaning set forth in the Registration Rights Agreement.

“Exchange Offer Registration Statement” has the meaning set forth in the Registration Rights
Agreement.

“Excluded Contributions” means net cash proceeds, marketable securities or Qualified Proceeds
received by the Company from (i) contributions to its common equity capital and (ii) the sale
(other than to a Subsidiary of the Company or to any management equity plan or stock option plan or
any other management or employee benefit plan or agreement of the Company) of Equity Interests
(other than Disqualified Stock and Designated Preferred Stock) of the Company, in each case
designated as Excluded Contributions pursuant to an Officer’s Certificate on the date such capital
contributions are made or the date such Equity Interests are sold, as the case may be, that are
excluded from the calculation set forth in clause (3) of Section 4.07(a) hereof.

“Existing Indebtedness” means Indebtedness existing on the Issue Date, plus interest accruing
thereon.

“Fair Market Value” means the value that would be paid by a willing buyer to an unaffiliated
willing seller in a transaction not involving distress or necessity of either party, determined in
good faith by the Board of Directors, chief executive officer or chief financial officer of the
Company (unless otherwise provided in this Indenture).

“Fixed Charge Coverage Ratio” means with respect to any specified Person for any period, the
ratio of the Consolidated Adjusted EBITDA of such Person for such period to the Fixed Charges of
such Person for such period. In the event that the specified Person or any of its Restricted
Subsidiaries incurs, assumes, guarantees, repays, repurchases, redeems, defeases or otherwise
discharges any Indebtedness (other than ordinary working capital borrowings) or issues, repurchases
or redeems preferred stock or Disqualified Stock subsequent to the commencement of the period for
which the Fixed Charge Coverage Ratio is being calculated and on or prior to the date on which the
event for which the calculation of the Fixed Charge Coverage Ratio is made (the “Calculation
Date”), then the Fixed Charge Coverage Ratio will be calculated giving pro forma effect to such
incurrence, assumption, Guarantee, repayment, repurchase, redemption, defeasance or other discharge
of Indebtedness, or such issuance, repurchase or redemption of preferred stock or Disqualified
Stock, and the use of the proceeds therefrom, as if the same had occurred at the beginning of the
applicable four-quarter reference period.

In addition, for purposes of calculating the Fixed Charge Coverage Ratio:

(1) Investments, acquisitions, mergers, consolidations and dispositions that have been
made by the specified Person or any of its Restricted Subsidiaries, or any Person or any of
its Restricted Subsidiaries acquired by, merged or consolidated with the specified Person or
any of its Restricted Subsidiaries, and including any related financing transactions and including increases in ownership of Restricted Subsidiaries,
during the four-quarter reference period or subsequent to such reference period and on or
prior to the Calculation Date will be given pro forma effect, including giving effect to Pro
Forma Cost Savings, as if they had occurred on the first day of the four-quarter reference
period;

 

-13-

 

(2) the Consolidated Adjusted EBITDA attributable to discontinued operations, as
determined in accordance with GAAP, and operations or businesses (and ownership interests
therein) disposed of prior to the Calculation Date, will be excluded;

(3) the Fixed Charges attributable to discontinued operations, as determined in
accordance with GAAP, and operations or businesses (and ownership interests therein)
disposed of prior to the Calculation Date, will be excluded, but only to the extent that the
obligations giving rise to such Fixed Charges will not be obligations of the specified
Person or any of its Restricted Subsidiaries following the Calculation Date;

(4) any Person that is a Restricted Subsidiary on the Calculation Date will be deemed
to have been a Restricted Subsidiary at all times during such four-quarter period;

(5) any Person that is not a Restricted Subsidiary on the Calculation Date will be
deemed not to have been a Restricted Subsidiary at any time during such four-quarter period;
and

(6) if any Indebtedness bears a floating rate of interest, the interest expense on such
Indebtedness will be calculated as if the rate in effect on the Calculation Date had been
the applicable rate for the entire period (taking into account any Hedging Obligation
applicable to such Indebtedness).

For purposes of this definition, whenever pro forma effect is given to a transaction, the pro
forma calculations shall be made in good faith by a responsible financial or accounting officer of
the Company. For purposes of determining whether any Indebtedness constituting a Guarantee may be
incurred, the interest on the Indebtedness to be guaranteed shall be included in calculating the
Fixed Charge Coverage Ratio on a pro forma basis. Interest on a Capitalized Lease Obligation shall
be deemed to accrue at an interest rate reasonably determined by a responsible financial or
accounting officer of the Company to be the rate of interest implicit in such Capitalized Lease
Obligation in accordance with GAAP. For purposes of making the computation referred to above,
interest on any Indebtedness under a revolving credit facility computed on a pro forma basis shall
be computed based upon the average daily balance of such Indebtedness during the applicable period.
Interest on Indebtedness that may optionally be determined at an interest rate based upon a factor
of a prime or similar rate, a eurocurrency interbank offered rate, or other rate, shall be deemed
to have been based upon
the rate actually chosen, or, if none, then based upon such optional rate chosen as the
Company may designate.

 

-14-

 

“Fixed Charges” means, with respect to any specified Person for any period, the sum, without
duplication, of:

(1) the consolidated interest expense of such Person and its Restricted Subsidiaries
for such period, net of interest income, whether paid or accrued, including, without
limitation, original issue discount, non-cash interest payments, the interest component of
any deferred payment obligations, the interest component of all payments associated with
Capital Lease Obligations, commissions, discounts and other fees and charges incurred in
respect of letter of credit or bankers’ acceptance financings, and net of the effect of all
cash payments made or received pursuant to Hedging Obligations in respect of interest rates,
and excluding amortization of deferred financing costs; plus

(2) any interest on Indebtedness of another Person that is guaranteed by such Person or
one of its Restricted Subsidiaries or secured by a Lien on assets of such Person or one of
its Restricted Subsidiaries, but only to the extent that such Guarantee or Lien is called
upon; plus

(3) all cash dividends, paid on any series of preferred stock of such Person or any of
its Restricted Subsidiaries (other than to the Company or a Restricted Subsidiary of the
Company), in each case, determined on a consolidated basis in accordance with GAAP.

“GAAP” means generally accepted accounting principles set forth in the opinions and
pronouncements of the Accounting Principles Board of the American Institute of Certified Public
Accountants and statements and pronouncements of the Financial Accounting Standards Board or in
such other statements by such other entity as have been approved by a significant segment of the
accounting profession, which are in effect on the Issue Date.

“Global Note Legend” means the legend set forth in Section 2.06(g)(2), which is required to be
placed on all Global Notes issued under this Indenture.

“Global Notes” means, individually and collectively, each of the Restricted Global Notes and
the Unrestricted Global Notes deposited with or on behalf of and registered in the name of the
Depository or its nominee, substantially in the form of Exhibit A1 and A2 hereto and that bears the
Global Note Legend and that has the “Schedule of Exchanges of Interests in the Global Note”
attached thereto, issued in accordance with Section 2.01, 2.06(b)(3), 2.06(b)(4), 2.06(d)(2) or
2.06(f) hereof.

“Government Securities” means direct obligations of, or obligations guaranteed by, the United
States of America (including any agency or instrumentality thereof) and the payment for which the
United States pledges its full faith and credit.

 

-15-

 

“Guarantee” means a guarantee other than by endorsement of negotiable instruments for
collection in the ordinary course of business, direct or indirect, in any manner including, without
limitation, by way of a pledge of assets or through letters of credit or reimbursement agreements
in respect thereof, of all or any part of any Indebtedness (whether arising by virtue of
partnership arrangements, or by agreements to keep-well, to purchase assets, goods, securities or
services, to take or pay or to maintain financial statement conditions or otherwise).

“Guarantors” means each Restricted Subsidiary of the Company that executes a Subsidiary
Guarantee in accordance with the provisions of this Indenture, and their respective successors and
assigns, in each case, until the Subsidiary Guarantee of such Person has been released in
accordance with the provisions of this Indenture.

“Hedging Obligations” means, with respect to any specified Person, the obligations of such
Person under:

(1) interest rate swap agreements (whether from fixed to floating or from floating to
fixed), interest rate cap agreements and interest rate collar agreements;

(2) other agreements or arrangements designed to manage interest rates or interest rate
risk; and

(3) other agreements or arrangements designed to protect such Person against
fluctuations in currency exchange rates or commodity prices.

“Holder” means a Person in whose name a Note is registered.

“Holdings” means IASIS Healthcare Corporation, a Delaware corporation.

“Holdings Loans” means the senior unsecured payment-in-kind loans borrowed by Holdings on
April 27, 2007 pursuant to that certain credit agreement dated as of April 27, 2007, among
Holdings, the lenders party thereto and Banc of America Bridge LLC, as administrative agent, and
including any additional loans outstanding thereunder as a result of the payment-in-kind of
interest.

“Hospital” means a hospital, outpatient clinic, long-term care facility, medical office
building or other facility, business or other asset that is used or useful in or related to the
provision of healthcare services.

 

-16-

 

“Hospital Investment Program” means, with respect to any Subsidiary of the Company,
substantially all of the assets of which consist of one or more Hospitals, an offering by such
Subsidiary for the sale or issuance of Equity Interests in such Subsidiary to any Hospital
Investment Program Participants; provided that (i) after giving effect to such sale or issuance
with respect to any Subsidiary, the Company directly or indirectly controls such Subsidiary and
owns at least 65% of the economic interests of such Subsidiary, (ii) each such sale
or issuance shall be for an amount at least equal to the Fair Market Value thereof, (iii) each
such sale results in consideration at least 75% of which shall be in the form of cash (for such
purpose, taking into account the amount of cash, the principal amount of any promissory notes and
the Fair Market Value of any other consideration), (iv) the cash and Cash Equivalents received in
connection therewith are treated as aggregate cash proceeds in respect of an Asset Sale, and (v)
each Hospital Investment Program Participant acknowledges in writing that the documentation
governing the Notes restricts the ability of such Subsidiary to make distributions to such Hospital
Investment Program Participant.

“Hospital Investment Program Participants” means, with respect to any Hospital, Persons
interested in such Hospital including physicians, administrators and other Persons in the community
in which such Hospital is located.

“Hospital Swap” means an exchange of assets by the Company or a Restricted Subsidiary for one
or more Hospitals and/or one or more Related Businesses or for 100% of the Capital Stock of any
Person owning or operating one or more Hospitals and/or one or more Related Businesses and, to the
extent necessary to equalize the value of the assets being exchanged, the receipt or payment of
cash by the Company or a Restricted Subsidiary; provided that cash received by the Company or a
Restricted Subsidiary does not exceed 20% of the sum of the amount of the cash and the Fair Market
Value of the Capital Stock or assets received by the Company or a Restricted Subsidiary in such
transaction, unless such excess cash over the aforementioned 20% threshold is treated as aggregate
cash proceeds in respect of an Asset Sale.

“Indebtedness” means, with respect to any specified Person, the principal and premium (if any)
of any indebtedness of such Person (excluding accrued expenses and trade payables), whether or not
contingent:

(1) in respect of borrowed money;

(2) evidenced by bonds, notes, debentures or similar instruments or letters of credit
(or reimbursement agreements in respect thereof) (other than letters of credit issued in
respect of trade payables);

(3) in respect of banker’s acceptances;

(4) representing Capital Lease Obligations;

(5) representing the balance deferred and unpaid of the purchase price of any property
or services due more than twelve months after such property is acquired or such services are
completed (except any such balance that constitutes a trade payable or similar obligation to
a trade creditor); or

 

-17-

 

(6) representing the net obligations under any Hedging Obligations,
if and to the extent any of the preceding items (other than letters of credit, and Hedging
Obligations) would appear as a liability upon a balance sheet of the specified Person prepared in
accordance with GAAP. In addition, the term “Indebtedness” includes all Indebtedness of others
secured by a Lien on any asset of the specified Person (whether or not such Indebtedness is assumed
by the specified Person) and, to the extent not otherwise included, the Guarantee by the specified
Person of any Indebtedness of any other Person.

“Indenture” means this Indenture, as amended or supplemented from time to time.

“Indirect Participant” means a Person who holds a beneficial interest in a Global Note through
a Participant.

“Initial Notes” means the first $850.0 million aggregate principal amount of Notes issued
under this Indenture.

“Initial Purchasers” means Merrill Lynch, Pierce, Fenner & Smith Incorporated, Barclays
Capital Inc., Citigroup Global Markets Inc., Goldman, Sachs & Co., J.P. Morgan Securities LLC,
Deutsche Bank Securities Inc. and SunTrust Robinson Humphrey, Inc.

“Insurance Subsidiary” means a Subsidiary of the Company or a Restricted Subsidiary
established for the purpose of insuring (1) the healthcare businesses or facilities owned or
operated by the Company or any Subsidiary of the Company or (2) any physician employed by or on the
medical staff of any such business or facility.

“Investment Grade Rating” means a rating equal to or higher than Baa3 (or the equivalent) by
Moody’s and BBB- (or the equivalent) by S&P, or an equivalent rating by any other Rating Agency.

“Investments” means, with respect to any Person, all direct or indirect investments by such
Person in other Persons (including Affiliates) in the forms of loans (including Guarantees or other
obligations), advances or capital contributions (excluding commission, travel, relocation and
similar advances to officers and employees made in the ordinary course of business), purchases or
other acquisitions for consideration of Indebtedness, Equity Interests or other securities,
together with all items that are or would be classified as investments on a balance sheet prepared
in accordance with GAAP. If the Company or any Restricted Subsidiary of the Company sells or
otherwise disposes of any Equity Interests of any direct or indirect Restricted Subsidiary of the
Company such that, after giving effect to any such sale or disposition, such Person is no longer a
Subsidiary of the Company, the Company will be deemed to have made an Investment on the date of any
such sale or disposition equal to the Fair Market Value of the Company’s Investments in such
Subsidiary that were not sold or disposed of in an amount determined as provided in Section 4.07(c)
hereof. The acquisition by the Company or any Restricted Subsidiary of the Company of a Person
that holds an Investment in a third Person will be deemed to be an Investment by the Company or
such Restricted Subsidiary in such third Person in an amount equal to the Fair Market Value of the
Investments held by the acquired Person in such third Person in an amount determined as provided in
Section 4.07(c) hereof. The outstanding amount of any Investment shall be the original cost
thereof, reduced by all returns on such Investment (including dividends, interest, distributions,
returns of principal and profits on sale).

 

-18-

 

“Issue Date” means the date on which the Initial Notes were issued under this Indenture.

“Issuers” shall have the meaning assigned to such term in the introductory statement to this
Indenture.

“Legal Holiday” means a Saturday, a Sunday or a day on which banking institutions in the City
of New York or at a place of payment are authorized by law, regulation or executive order to remain
closed. If a payment date is a Legal Holiday at a place of payment, payment may be made at that
place on the next succeeding day that is not a Legal Holiday, and no interest shall accrue on such
payment for the intervening period.

“Letter of Transmittal” means the letter of transmittal to be prepared by the Company and sent
to all Holders of the Notes for use by such Holders in connection with the Exchange Offer.

“Lien” means, with respect to any asset, any mortgage, lien, pledge, charge, security interest
or encumbrance of any kind in respect of such asset, whether or not filed, recorded or otherwise
perfected under applicable law, including any conditional sale or other title retention agreement,
any lease in the nature thereof, any option or other agreement to sell or give a security interest
in and any filing of or agreement to give any financing statement under the Uniform Commercial Code
(or equivalent statutes) of any jurisdiction, except in connection with any Qualified Receivables
Transaction.

“Management Services Agreement” means the Management Services Agreement as in effect on June
22, 2004, as described under the caption “Certain Relationships and Related Party Transactions” in
the Offering Memorandum.

“Moody’s” means Moody’s Investors Service, Inc. or any successor to its rating agency
business.

“Net Income” means, with respect to any specified Person, the net income (loss) of such
Person, determined in accordance with GAAP and before any reduction in respect of preferred stock
dividends.

 

-19-

 

“Net Proceeds” means the aggregate cash proceeds received by the Company or any of its
Restricted Subsidiaries in respect of any Asset Sale (including, without limitation, any cash
received upon the sale or other disposition of any non-cash consideration received in any Asset
Sale), net of the direct costs relating to such Asset Sale, including, without limitation, legal, accounting and investment banking fees, payments made in order to
obtain a necessary consent or required by applicable law, and sales commissions, and any relocation
expenses incurred as a result of the Asset Sale, taxes paid or payable as a result of the Asset
Sale, including taxes resulting from the transfer of the proceeds of such Asset Sale to the
Company, in each case, after taking into account:

(1) any available tax credits or deductions and any tax sharing arrangements;

(2) amounts required to be applied to the repayment of Indebtedness secured by a Lien
on the asset or assets that were the subject of such Asset Sale;

(3) any reserve for adjustment in respect of the sale price of such asset or assets
established in accordance with GAAP;

(4) any reserve for adjustment in respect of any liabilities associated with the asset
disposed of in such transaction and retained by the Company or any Restricted Subsidiary
after such sale or other disposition thereof;

(5) any distributions and other payments required to be made to minority interest
holders in Subsidiaries or joint ventures as a result of such Asset Sale; and

(6) in the event that a Restricted Subsidiary consummates an Asset Sale and makes a pro
rata payment of dividends to all of its stockholders from any cash proceeds of such Asset
Sale, the amount of dividends paid to any stockholder other than the Company or any other
Restricted Subsidiary,

provided that any net proceeds of an Asset Sale by a Non-Guarantor Subsidiary that are subject to
restrictions on repatriation to the Company will not be considered Net Proceeds for so long as such
proceeds are subject to such restrictions.

“New York Office of the Trustee” means 101 Barclay Street, New York, New York 10286.

“Non-Guarantor Subsidiaries” means (v) any Unrestricted Subsidiary, (w) Health Choice Arizona,
Inc., Brim Healthcare of Texas, LLC (d/b/a Wadley Regional Medical Center), Texarkana Regional
Healthcare Network, Harpeth Insurance Limited, NLV Healthcare Development, LP, Permian Premier
Health Services, Inc., Permian Basin Clinical Services, Inc., Indigent Care Services of Permian
Basin, Inc., IASIS Healthcare Foundation, SET Physicians, Southwest Physicians of San Antonio,
Odessa Regional Hospital, LP, The Medical Center of Southeast Texas, LP, Southwest General
Hospital, LP, Mountain Vista Medical Center, LP, Jordan Valley Medical Center, LP, Davis Hospital &
Medical Center, LP and Salt Lake Regional Medical Center, LP, (x) any Receivables Subsidiary, (y)
any Subsidiary of the Company that does not guarantee the Company’s Obligations under the Credit
Agreement and

 

-20-

 

(z) in addition to the foregoing, any other non-Wholly-Owned Subsidiary of
the Company.  The Board of Directors of the Company may designate any Restricted Subsidiary as
a Non-Guarantor Subsidiary by filing with the trustee a certified copy of a resolution of such
Board of Directors giving effect to such designation and an officers’ certificate certifying as to
the applicable clause of the definition of Non-Guarantor Subsidiaries that warrants such
designation. In addition, if a Guarantor that is a guarantor under the Credit Agreement is
released from its guarantee of the Credit Agreement, it will be automatically released from its
guarantee of the Notes and will be a Non-Guarantor Subsidiary.

“Non-Recourse Debt” means Indebtedness:

(1) as to which neither the Company nor any of its Restricted Subsidiaries (a) provides
credit support of any kind (including any undertaking, agreement or instrument that would
constitute Indebtedness), (b) is directly or indirectly liable as a guarantor or otherwise,
or (c) constitutes the lender;

(2) no default with respect to which (including any rights that the holders of the
Indebtedness may have to take enforcement action against an Unrestricted Subsidiary) would
permit upon notice, lapse of time or both any holder of any other Indebtedness of the
Company or any of its Restricted Subsidiaries to declare a default on such other
Indebtedness or cause the payment of such other Indebtedness to be accelerated or payable
prior to its Stated Maturity; and

(3) as to which the lenders have been notified in writing or have agreed in writing (in
the agreement relating thereto or otherwise) that they will not have any recourse to the
stock or assets of the Company or any of its Restricted Subsidiaries.

“Non-U.S. Person” means a Person who is not a U.S. Person.

“Notes” has the meaning assigned to it in the preamble to this Indenture.

“Obligations” means any principal, interest, penalties, fees, indemnifications,
reimbursements, damages and other liabilities payable under the documentation governing any
Indebtedness.

“Offering Memorandum” means the Issuers’ offering memorandum, dated April 27, 2011 related to
the issuance and sale of the Initial Notes.

“Officer” means, with respect to any Person, the Chairman of the Board, the Chief Executive
Officer, the President, the Chief Operating Officer, the Chief Financial Officer, the Treasurer,
any Assistant Treasurer, the Controller, the Secretary or any Vice-President of such Person.

“Officer’s Certificate” means a certificate signed on behalf of the Company by one Officer of
the Company, who must be the principal executive officer, the principal financial officer, the treasurer or the principal accounting officer of the Company, that meets the
requirements of Section 12.05 hereof.

 

-21-

 

“Opinion of Counsel” means an opinion from legal counsel that meets the requirements of
Section 12.05 hereof. The counsel may be an employee of or counsel to the Company or any
Subsidiary of the Company.

“Pari Passu Indebtedness” means:

(1) all Indebtedness of the Issuers or any Guarantor outstanding under the Credit
Agreement or under any other Credit Facilities (including post-petition interest at the rate
provided in the documentation with respect thereto, whether or not allowed as a claim in any
bankruptcy proceeding), and all Hedging Obligations and Treasury Management Obligations with
respect thereto;

(2) any other Indebtedness of the Issuers or any Guarantor permitted to be incurred
under the terms of this Indenture, unless the instrument under which such Indebtedness is
incurred expressly provides that it is subordinated in right of payment to the Notes or any
Subsidiary Guarantee; and

(3) all Obligations with respect to the items listed in the preceding clauses (1) and
(2).

Notwithstanding anything to the contrary in the preceding, Pari Passu Indebtedness will not
include:

(1) any intercompany Indebtedness of the Issuers or any of their Subsidiaries to the
Company or any of its Affiliates;

(2) any trade payables;

(3) the portion of any Indebtedness that is incurred in violation of this Indenture
(but only to the extent so incurred); provided that Indebtedness outstanding under Credit
Facilities will not cease to be Pari Passu Indebtedness as a result of this clause (4) if
the lenders or agents thereunder obtained a representation from the Company or any of its
Subsidiaries on the date such Indebtedness was incurred to the effect that such Indebtedness
was not prohibited by this Indenture; or

(4) Indebtedness which is classified as non-recourse in accordance with GAAP or any
unsecured claim arising in respect thereof by reason of the application of Section
1111(b)(1) of the Bankruptcy Code.

“Participant” means, with respect to the Depositary, Euroclear or Clearstream, a Person who
has an account with the Depositary, Euroclear or Clearstream, respectively (and, with respect to
DTC, shall include Euroclear and Clearstream).

 

-22-

 

“Permitted Business” means (i) any business engaged in by the Company or any of its Restricted
Subsidiaries on the Issue Date, (ii) any business or other activities that are reasonably similar,
ancillary, complementary or related to, or a reasonable extension, development or expansion of, the
businesses in which the Company and its Restricted Subsidiaries are engaged on the Issue Date and
(iii) any business in the healthcare industry.

“Permitted Holders” means (i) TPG Partners IV, L.P., JLL Partners Fund IV, L.P., Trimaran Fund
Management, L.L.C. and their respective Affiliates, but not including any portfolio companies of
any of the foregoing and (ii) any group (within the meaning of Section 13(d)(3) or Section 14(d)(2)
of the Exchange Act or any successor provision) of which any of the foregoing beneficially own more
than 50.0% of the total voting power of the aggregate Voting Stock of the Company held by such
group.

“Permitted Investments” means:

(1) any Investment in the Company or in a Restricted Subsidiary of the Company;
provided that any Investment in a Non-Guarantor Subsidiary by either Issuer or a Guarantor
shall be evidenced by (A) a certificate, or other evidence of equity, in the case of any
Investment in the form of equity or (B) a note, or other evidence of Indebtedness, in the
case of any Investment in the form of Indebtedness, in each case, issued to and held by such
Issuer or Guarantor, as applicable, except to the extent of the Fair Market Value of assets
received by such Issuer or Guarantor, as applicable, in respect of such Investment;

(2) any Investment in Cash Equivalents;

(3) any Investment by the Company or any Restricted Subsidiary of the Company in a
Person, if as a result of such Investment:

(a) such Person becomes a Restricted Subsidiary of the Company; or

(b) such Person, in one transaction or a series of transactions, is merged,
consolidated or amalgamated with or into, or transfers or conveys substantially all
of its assets to, or is liquidated into, the Company or a Restricted Subsidiary of
the Company;

(4) any Investment made as a result of the receipt of non-cash consideration from an
Asset Sale that was made pursuant to and in compliance with Section 4.10 hereof;

(5) any Investment solely in exchange for the issuance of Equity Interests (other than
Disqualified Stock) of the Company;

 

-23-

 

(6) any Investments received in compromise, settlement or resolution of (A) obligations
of trade creditors or customers that were incurred in the ordinary course of business of the
Company or any of its Restricted Subsidiaries, including pursuant to any plan of
reorganization or similar arrangement upon the bankruptcy or insolvency of any trade
creditor or customer, (B) litigation, arbitration or other disputes with Persons who are not
Affiliates or (C) as a result of a foreclosure by the Company or any Restricted Subsidiary
with respect to any secured Investment or other transfer of title with respect to any
secured Investment in default;

(7) Investments represented by Hedging Obligations;

(8) any Investment in payroll, travel and similar advances to cover business-related
travel expenses, moving expenses or other similar expenses, in each case incurred in the
ordinary course of business;

(9) Investments in receivables owing to the Company or any Restricted Subsidiary if
created or acquired in the ordinary course of business and payable or dischargeable in
accordance with customary trade terms; provided, however, that such trade terms may include
such concessionary trade terms as the Company or any such Restricted Subsidiary deems
reasonable under the circumstances;

(10) Investments in prepaid expenses, negotiable instruments held for collection and
lease, utility and workers compensation, performance and similar deposits entered into as a
result of the operations of the business in the ordinary course of business;

(11) obligations of one or more officers or other employees of the Company or any of
its Restricted Subsidiaries in connection with such officer’s or employee’s acquisition of
 shares of common stock of the Company so long as no cash or other assets are paid by the
Company or any of its Restricted Subsidiaries to such officers or employees in connection
with the acquisition of any such obligations;

(12) loans or advances to and guarantees provided for the benefit of employees made in
the ordinary course of business of the Company or the Restricted Subsidiary of the Company
in an aggregate principal amount not to exceed $12.5 million at any one time outstanding;

(13) Investments existing as of the Issue Date or made pursuant to a binding commitment
existing on the date of the Offering Memorandum or an Investment consisting of any
extension, modification or renewal of any Investment existing as of the Issue Date
(excluding any such extension, modification or renewal involving additional advances,
contributions or other investments of cash or property or other increases thereof unless it
is a result of the accrual or accretion of interest or original issue discount or
payment-in-kind pursuant to the terms, as of the Issue Date, of the original Investment so
extended, modified or renewed);

 

-24-

 

(14) repurchases of the Notes;

(15) other Investments in any Person having an aggregate Fair Market Value (measured on
the date each such Investment was made and without giving effect to subsequent changes in
value), when taken together with all other Investments made pursuant to this clause (15)
that are at the time outstanding not to exceed the greater of $125.0 million and 5% of Total
Assets; provided, however, that if any Investment pursuant to this clause (15) is made in
any Person that is not a Restricted Subsidiary of the Company at the date of the making of
such Investment and such Person becomes a Restricted Subsidiary after such date, such
Investment shall thereafter be deemed to have been made pursuant to clause (1) above and
shall cease to have been made pursuant to this clause (15) for so long as such Person
continues to be a Restricted Subsidiary of the Company (it being understood that if such
Person thereafter ceases to be a Restricted Subsidiary of the Company, such Investment will
again be deemed to have been made pursuant to this clause (15));

(16) the acquisition by a Receivables Subsidiary in connection with a Qualified
Receivables Transaction of Equity Interests of a trust or other Person established by such
Receivables Subsidiary to effect such Qualified Receivables Transaction; and any other
Investment by the Company or a Subsidiary of the Company in a Receivables Subsidiary or any
Investment by a Receivables Subsidiary in any other Person in connection with a Qualified
Receivables Transaction customary for such transactions;

(17) Investments in connection with Hospital Swaps;

(18) Physician Support Obligations;

(19) Investments in an Insurance Subsidiary in an amount that does not exceed the
minimum amount of capital required under the laws of the jurisdiction in which the Insurance
Subsidiary is formed plus the amount of any reasonable general corporate and overhead
expenses of such Insurance Subsidiary, and any Investment by such Insurance Subsidiary that
is a legal investment for an insurance company under the laws of the jurisdiction in which
the Insurance Subsidiary is formed and made in the ordinary course of business and rated in
one of the four highest rating categories;

(20) Investments in Health Choice Arizona, Inc. required to be made under applicable
laws, rules and regulations or pursuant to contractual obligations of the Company or a
Subsidiary with the Arizona Health Care Cost Containment System as in effect on the Issue
Date;

(21) Investments consisting of repurchase or redemptions of Capital Stock of
Subsidiaries sold or issued in connection with the Company’s Hospital Investment Program and
(ii) Investments in joint ventures to the extent required by, or made pursuant to, customary
buy/sell arrangements between the joint venture parties set forth in the joint venture
arrangements and similar binding arrangements; and

 

-25-

 

(22) additional investments in Unrestricted Subsidiaries and/or joint ventures of the
Company or any Restricted Subsidiary existing on the Issue Date in an aggregate amount not
to exceed $50.0 million.

“Permitted Liens” means:

(1) Liens in favor of the Issuers or the Guarantors;

(2) Liens on property or assets of a Person, plus renewals and extensions of such
Liens, existing at the time such Person is merged with or into, consolidated with or
acquired by the Company or any Subsidiary of the Company; provided that such Liens were in
existence prior to the contemplation of such merger, consolidation or acquisition and do not
extend to any assets other than those of the Person merged into, consolidated with or
acquired by the Company or such Subsidiary, and other than pursuant to customary
after-acquired property clauses;

(3) Liens on property (including Capital Stock) existing at the time of acquisition of
the property by the Company or any Restricted Subsidiary of the Company; provided that such
Liens were in existence prior to, such acquisition, and not incurred in contemplation of,
such acquisition;

(4) Liens (including deposits and pledges) to secure the performance of public or
statutory obligations, progress payments, surety or appeal bonds, performance bonds or other
obligations of a like nature incurred in the ordinary course of business;

(5) Liens to secure Indebtedness (including Capital Lease Obligations) permitted by
Section 4.09(b)(4) hereof covering only the assets acquired, constructed or improved with or
financed by such Indebtedness, and additions, accessions, improvements and replacements and
customary deposits in connection therewith; provided that individual financings of equipment
provided by one lender may be cross collateralized to other financings of equipment provided
by such lender;

(6) Liens existing on the Issue Date (other than Liens securing the Credit Agreement),
plus renewals and extensions of such Liens;

(7) Liens for taxes, assessments or governmental charges or claims that are not yet
delinquent or that are being contested in good faith by appropriate proceedings promptly
instituted and diligently concluded; provided that any reserve or other appropriate
provision as is required in conformity with GAAP has been made therefor;

 

-26-

 

(8) Liens imposed by law, such as carriers’, warehousemen’s, landlord’s, materialmen’s,
laborers’, employees’, suppliers’ and mechanics’ Liens, in each case, incurred in the
ordinary course of business;

(9) survey exceptions, title defects, encumbrances, easements or reservations of, or
rights of others for, licenses, rights-of-way, sewers, electric lines, telegraph and
telephone lines and other similar purposes, or zoning or other restrictions as to the use of
real property that do not materially interfere with the ordinary conduct of the business of
the Company and its Subsidiaries, taken as a whole;

(10) Liens created for the benefit of (or to secure) the Notes (or the Subsidiary
Guarantees);

(11) Liens to secure any Permitted Refinancing Indebtedness permitted to be incurred
under this Indenture; provided, however, that:

(a) the new Lien shall be limited to all or part of the same property and
assets that secured or, under the written agreements pursuant to which the original
Lien arose, could secure the original Indebtedness (plus improvements and accessions
to, such property or proceeds or distributions thereof); and

(b) the Indebtedness secured by the new Lien is not increased to any amount
greater than the sum of (x) the outstanding principal amount, or, if greater,
committed amount, of the Permitted Refinancing Indebtedness and (y) an amount
necessary to pay any fees and expenses, including premiums, related to such renewal,
refunding, refinancing, replacement, defeasance or discharge;

(12) Liens incurred in connection with a Qualified Receivables Transaction (which, in
the case of the Company and its Restricted Subsidiaries (other than Receivables
Subsidiaries) shall be limited to receivables and related assets referred to in the
definition of Qualified Receivables Transaction);

(13) Liens incurred in the ordinary course of business of the Company or any Subsidiary
of the Company with respect to obligations that do not exceed $75.0 million at any one time
outstanding;

(14) security for the payment of workers’ compensation, unemployment insurance, other
social security benefits or other insurance-related obligations (including, but not limited
to, in respect of deductibles, self-insured retention amounts and premiums and adjustments
thereto) entered into in the ordinary course of business;

(15) deposits or pledges in connection with bids, tenders, leases and contracts (other
than contracts for the payment of money), and Liens arising from conditional sale, title
retention, consignment and similar arrangements, in each case entered into in the ordinary
course of business;

 

-27-

 

(16) zoning restrictions, easements, licenses, reservations, provisions, encroachments,
encumbrances, protrusion permits, servitudes, covenants, conditions,
waivers, restrictions on the use of property or minor irregularities of title (and with
respect to leasehold interests, mortgages, obligations, liens and other encumbrances
incurred, created, assumed or permitted to exist and arising by, through or under a landlord
or owner of the leased property, with or without consent of the lessee), in each case, not
materially interfering with the ordinary conduct of the business of the Company and its
Subsidiaries, taken as a whole;

(17) leases, subleases, licenses or sublicenses to third parties entered into in the
ordinary course of business;

(18) Liens securing Hedging Obligations and cash management obligations;

(19) Liens arising out of judgments, decrees, orders or awards in respect of which the
Company shall in good faith be prosecuting an appeal or proceedings for review which appeal
or proceedings shall not have been finally terminated, or if the period within which such
appeal or proceedings may be initiated shall not have expired;

(20) Liens on Capital Stock of an Unrestricted Subsidiary that secure Indebtedness or
other obligation of such Unrestricted Subsidiary;

(21) Liens on assets of Restricted Subsidiaries that are not Guarantors securing
Indebtedness in an aggregate principal amount not to exceed $50.0 million;

(22) Liens on the assets of Non-Guarantor Subsidiaries securing Indebtedness of the
Company or the Restricted Subsidiaries that were permitted by the terms of this Indenture to
be incurred; and

(23) Liens securing Indebtedness under one or more Credit Facilities or other pari
passu Indebtedness permitted to be incurred pursuant to Section 4.09 in an amount not to
exceed the greater of (i) the amount of Indebtedness permitted to be incurred pursuant to
Section 4.09(b)(1) and (ii) the amount of Indebtedness such that the Consolidated Secured
Debt Ratio (at the time of incurrence of such Indebtedness after giving pro forma effect
thereto in a manner consistent with the calculation of the Fixed Charge Coverage Ratio)
would not be greater than 3.75 to 1.00.

 

-28-

 

“Permitted Payments to Parent” means

(1) payments, directly or indirectly, to Holdings to be used by Holdings to pay (x)
consolidated, combined or similar Federal, state and local taxes payable by Holdings and
directly attributable to (or arising as a result of) the operations of the Company and its
Subsidiaries and (y) franchise or similar taxes and fees of Holdings required to maintain
Holdings’ corporate existence and other taxes; provided, that:

(a) the amount of such dividends, distributions or advances paid shall not
exceed the amount (x) that would be due with respect to a consolidated, combined or
similar Federal, state or local tax return that included the Company and its
Subsidiaries if the Company were a corporation for Federal, state and local tax
purposes plus (y) the actual amount of such franchise or similar taxes and fees of
Holdings required to maintain Holdings’ corporate existence and other taxes, each as
applicable; and

(b) such payments are used by Holdings for such purposes within 90 days of the
receipt of such payments; and

(2) payments, directly or indirectly, to Holdings if the proceeds thereof are used to
pay general corporate and overhead expenses (including salaries and other compensation of
employees) incurred in the ordinary course of its business or of the business of its parent
holding company as a direct or indirect holding company for the Company.

“Permitted Refinancing Indebtedness” means any Indebtedness of the Company or any of its
Restricted Subsidiaries issued in exchange for, or the net proceeds of which are used to extend,
renew, refund, refinance, replace, defease or discharge other Indebtedness of the Company or any of
its Restricted Subsidiaries (other than intercompany Indebtedness); provided that:

(1) the principal amount (or accreted value, if applicable) of such Permitted
Refinancing Indebtedness does not exceed the principal amount (or accreted value, if
applicable) of the Indebtedness extended, renewed, refunded, refinanced, replaced, defeased
or discharged (plus all accrued interest on the Indebtedness and the amount of all fees,
commissions, discounts and expenses, including premiums, incurred in connection therewith);

(2) either (a) such Permitted Refinancing Indebtedness has a final maturity date later
than the final maturity date of, and has a Weighted Average Life to Maturity equal to or
greater than the Weighted Average Life to Maturity of, the Indebtedness being extended,
renewed, refunded, refinanced, replaced, defeased or discharged or (b) all scheduled
payments on or in respect of such Permitted Refinancing Indebtedness (other than interest
payments) shall be at least 91 days following the final scheduled maturity of the Notes; and
if such Indebtedness is Pari Passu Indebtedness and has a final stated maturity later than
the final stated maturity of the Notes, such Permitted Refinancing Indebtedness has a final
stated maturity later than the final maturity of the Notes;

 

-29-

 

(3) if the Indebtedness being extended, renewed, refunded, refinanced, replaced,
defeased or discharged is subordinated in right of payment to the Notes, such Permitted
Refinancing Indebtedness is subordinated in right of payment to the Notes on terms at least
as favorable to the Holders as those contained in the documentation
governing the Indebtedness being extended, renewed, refunded, refinanced, replaced,
defeased or discharged; and

(4) such Indebtedness is incurred

(a) by the Company or by the Restricted Subsidiary who is the obligor on the
Indebtedness being renewed, refunded, refinanced, replaced, defeased or discharged;

(b) by any Guarantor if the obligor on the Indebtedness being renewed,
refunded, refinanced, replaced, defeased or discharged is a Guarantor; or

(c) by any Non-Guarantor Subsidiary if the obligor on the Indebtedness being
renewed, refunded, refinanced, replaced, defeased or discharged is a Non-Guarantor
Subsidiary.

“Person” means any individual, corporation, partnership, joint venture, association,
joint-stock company, trust, unincorporated organization, limited liability company or government or
other entity.

“Physician Support Obligation” means a loan to or on behalf of, or a guarantee of Indebtedness
of, a physician or healthcare professional providing service to patients in the service area of a
Hospital or other health care facility operated by the Company or any of its Restricted
Subsidiaries made or given by the Company or any Subsidiary of the Company (a) in the ordinary
course of its business and (b) pursuant to a written agreement having a period not to exceed five
years.

“Private Placement Legend” means the legend set forth in Section 2.06(g)(1) to be placed on
all Notes issued under this Indenture except where otherwise permitted by the provisions of this
Indenture.

“Pro Forma Cost Savings” means, with respect to any period, the reduction in net costs and
related adjustments that (i) were directly attributable to an acquisition, merger, consolidation or
disposition that occurred during the four-quarter reference period or subsequent to the
four-quarter reference period and on or prior to the Calculation Date and calculated on a basis
that is consistent with Regulation S-X under the Securities Act as in effect and applied as of the
Issue Date or (ii) have been realized or for which the steps necessary for realization have been
taken or are reasonably expected to be taken within 12 months following any such acquisition and,
in the case of each of (i) and (ii), are described, as provided below, in an Officer’s Certificate,
as if all such reductions in costs had been effected as of the beginning of such period. Pro Forma
Cost Savings described above shall be accompanied by an Officer’s Certificate delivered to the
Trustee from the Company’s chief financial officer that outlines the specific actions taken or to
be taken, the net cost savings achieved or to be achieved from each such action.

 

-30-

 

“QIB” means a “qualified institutional buyer” as defined in Rule 144A.

“Qualified Capital Stock” means any Capital Stock that is not Disqualified Stock.

“Qualified Proceeds” means any of the following or any combination of the following:

(1) Cash Equivalents;

(2) the Fair Market Value of assets that are used or useful in the Permitted Business;
and

(3) the Fair Market Value of the Capital Stock of any Person engaged primarily in a
Permitted Business if, in connection with the receipt by the Company or any of its
Restricted Subsidiaries of such Capital Stock, such Person becomes a Restricted Subsidiary
or such Person is merged or consolidated into the Company or any Restricted Subsidiary;

provided that Qualified Proceeds shall not include Excluded Contributions.

“Qualified Receivables Transaction” means any transaction or series of transactions entered
into by the Company or any of its Subsidiaries pursuant to which the Company or any of its
Subsidiaries sells, conveys or otherwise transfers, or grants a security interest, to:

(1) a Receivables Subsidiary (in the case of a transfer by the Company or any of its
Subsidiaries, which transfer may be effected through the Company or one or more of its
Subsidiaries); and

(2) if applicable, any other Person (in the case of a transfer by a Receivables
Subsidiary),

in each case, in any accounts receivable (including health care insurance receivables),
instruments, chattel paper, general intangibles and similar assets (whether now existing or arising
in the future, the “Receivables”) of the Company or any of its Subsidiaries, and any assets related
thereto, including, without limitation, all collateral securing such Receivables, all contracts,
contract rights and all guarantees or other obligations in respect of such Receivables, proceeds of
such Receivables and any other assets, which are customarily transferred or in respect of which
security interests are customarily granted in connection with receivables financings and asset
securitization transactions of such type, together with any related transactions customarily
entered into in a receivables financings and asset securitizations, including servicing
arrangements.

 

-31-

 

“Rating Agencies” means Moody’s and S&P or if Moody’s or S&P or both shall not make a rating
on the Notes publicly available, a nationally recognized statistical rating agency or agencies, as
the case may be, selected by the Company (as certified by a Board Resolution) which shall be
substituted for Moody’s or S&P or both, as the case may be.

“Receivables Fees” means distributions or payments made directly or by means of discounts with
respect to any participation interest issued or sold in connection with, and other fees paid to a
Person that is not a Restricted Subsidiary in connection with, any Qualified Receivables
Transaction.

“Receivables Subsidiary” means a Subsidiary of the Company which engages in no activities
other than in connection with the financing of accounts receivable and in businesses related or
ancillary thereto and that is designated by the Board of Directors of the Company (as provided
below) as a Receivables Subsidiary (A) no portion of the Indebtedness or any other Obligations
(contingent or otherwise) of which:

(1) is guaranteed by the Company or any Subsidiary of the Company (excluding guarantees
of Obligations (other than the principal of, and interest on, Indebtedness) pursuant to
representations, warranties, covenants and indemnities entered into in the ordinary course
of business in connection with a Qualified Receivables Transaction);

(2) is recourse to or obligates the Company or any Subsidiary of the Company in any way
other than pursuant to representations, warranties, covenants and indemnities customarily
entered into in connection with a Qualified Receivables Transaction; or

(3) subjects any property or asset of the Company or any Subsidiary of the Company
(other than accounts receivable and related assets as provided in the definition of
Qualified Receivables Transaction), directly or indirectly, contingently or otherwise, to
the satisfaction thereof, other than pursuant to representations, warranties, covenants and
indemnities customarily entered into in connection with a Qualified Receivables Transaction;

(B) with which neither the Company nor any Subsidiary of the Company has any material
contract, agreement, arrangement or understanding other than on terms no less favorable to the
Company or such Subsidiary than those that might be obtained at the time from Persons who are not
Affiliates of the Company, other than as may be customary in a Qualified Receivables Transaction
including for fees payable in the ordinary course of business in connection with servicing accounts
receivable; and

 

-32-

 

(C) with which neither the Company nor any Subsidiary of the Company has any obligation to
maintain or preserve such Subsidiary’s financial condition or cause such Subsidiary to achieve
certain levels of operating results. Any such designation by the Board of Directors of the Company
will be evidenced to the Trustee by filing with the Trustee a certified copy of the resolution of the Board of Directors of the Company giving effect to such
designation and an Officer’s Certificate certifying that such designation complied with the
foregoing conditions.

“Registration Rights Agreement” means (i) the Registration Rights Agreement, dated as of May
3, 2011 among the Company, IASIS Capital, the Guarantors and the other parties named on the
signature pages thereof, as such agreement may be amended, modified or supplemented from time to
time and (ii) with respect to any Additional Notes, one or more registration rights agreements
among the Company, IASIS Capital and the other parties thereto, as such agreement(s) may be
amended, modified or supplemented from time to time, relating to rights given by the Company to the
purchasers of Additional Notes to register such Additional Notes under the Securities Act.

“Regulation S” means Regulation S promulgated under the Securities Act.

“Regulation S Global Note” means a Regulation S Temporary Global Note or Regulation S
Permanent Global Note, as appropriate.

“Regulation S Permanent Global Note” means a permanent Global Note in the form of Exhibit A1
hereto bearing the Global Note Legend and the Private Placement Legend and deposited with or on
behalf of and registered in the name of the Depositary or its nominee, issued in a denomination
equal to the outstanding principal amount of the Regulation S Temporary Global Note upon expiration
of the Restricted Period.

“Regulation S Temporary Global Note” means a temporary Global Note in the form of Exhibit A2
hereto deposited with or on behalf of and registered in the name of the Depositary or its nominee,
issued in a denomination equal to the outstanding principal amount of the Notes initially sold in
reliance on Rule 903 of Regulation S.

“Related Business” means a healthcare business affiliated or associated with a Hospital or any
business related or ancillary to the provision of healthcare services or information or the
investment in, or the management, leasing or operation of, a Hospital.

“Replacement Preferred Stock” means any Disqualified Stock or preferred stock of the Company
or any of its Restricted Subsidiaries issued in exchange for, or the net proceeds of which are used
to renew, refund, refinance, replace or discharge any other preferred stock of the Company or any
of its Restricted Subsidiaries (other than intercompany preferred stock); provided that such
Replacement Preferred Stock is issued by the Company or by the Restricted Subsidiary who is the
issuer of the preferred stock being renewed, refunded, refinanced, replaced or discharged.

 

-33-

 

“Responsible Officer” when used with respect to the Trustee, means any officer within the
corporate trust administration of the Trustee (or any successor group of the Trustee) or any other
officer of the Trustee customarily performing functions similar to those performed by any of the
above designated officers and also means, with respect to a particular
corporate trust matter, any other officer to whom such matter is referred because of his
knowledge of and familiarity with the particular subject and who shall have responsibility for the
administration of this Indenture.

“Restricted Definitive Note” means a Definitive Note bearing the Private Placement Legend.

“Restricted Global Note” means a Global Note bearing the Private Placement Legend.

“Restricted Investment” means an Investment other than a Permitted Investment.

“Restricted Period” means the 40-day distribution compliance period as defined in Regulation
S.

“Restricted Subsidiary” of a Person means any Subsidiary of the referent Person that is not an
Unrestricted Subsidiary. In the event of a Specified Change of Control Parent Assumption, the
Company shall be a Restricted Subsidiary.

“Rule 144” means Rule 144 promulgated under the Securities Act.

“Rule 144A” means Rule 144A promulgated under the Securities Act.

“Rule 903” means Rule 903 promulgated under the Securities Act.

“Rule 904” means Rule 904 promulgated under the Securities Act.

“S&P” means Standard & Poor’s Ratings Services, a division of The McGraw-Hill Companies, Inc.,
or any successor to its rating agency business.

“SEC” means the Securities and Exchange Commission.

“Securities Act” means the Securities Act of 1933, as amended.

“Shelf Registration Statement” means the Shelf Registration Statement as defined in the
Registration Rights Agreement.

“Significant Subsidiary” means any Subsidiary that would be a “significant subsidiary” as
defined in Article 1, Rule 1-02 of Regulation S-X, promulgated pursuant to the Securities Act, as
such Regulation is in effect on the Issue Date.

 

-34-

 

“Special Interest” means all special interest then owing pursuant to the Registration Rights
Agreement.

“Specified Change of Control” means a Change of Control transaction in which the following
conditions are satisfied: (i) the Issuers shall comply with the provisions of this Indenture
applicable to a Change of Control, including the making of a Change of Control Offer except as
otherwise provided pursuant to Section 4.15, (ii) to the extent such transaction involves a merger
with or the acquisition by another Person with ongoing material operations, such person is a
Permitted Business or a Related Business, (iii) after giving pro forma effect to the Specified
Change of Control and any related financing transactions (including any incurrence of Indebtedness
with respect thereto), with such pro forma adjustments to Consolidated Total Indebtedness and
Consolidated Adjusted EBITDA as are appropriate and consistent with the pro forma adjustment
provisions set forth in the definition of “Fixed Charge Coverage Ratio”, the Total Leverage Ratio
of the Company and its Restricted Subsidiaries would not exceed 5.75 to 1.0, (iv) no Default or
Event of Default is continuing or would result from the Specified Change of Control and (v) such
transaction is designated as a Specified Change of Control pursuant to an officers’ certificate on
or prior to the date such Specified Change of Control occurs certifying as to the applicable
conditions set forth in clauses (i) through (iv) of this definition; provided, however that no more
than one Change of Control transaction may be designated and treated as a Specified Change of
Control under this Indenture.

“Specified Change of Control Parent” means any person as to which the Company is a Restricted
Subsidiary as a result of a Specified Change of Control.

“Specified Change of Control Parent Assumption” means the irrevocable assumption by a
Specified Change of Control Parent of all of the obligations of the Company in this Indenture in
connection with and upon the consummation of a Specified Change of Control; provided, however, that
such assumption may only be made if, after giving pro forma effect to the Specified Change of
Control and any related financing transactions, the Specified Change of Control Parent would meet
the conditions described in clause (1)(b), (2), (3) and (4) of Section 5.01(a) (assuming for this
purpose that the Specified Change of Control Parent were the surviving corporation in a merger with
the Company).

“Specified Change of Control Parent Assumption Date” means the date of occurrence of a
Specified Change of Control Parent Assumption, as designated by the Company; provided, however,
that such date may not be later than 180 days after the occurrence of the Specified Change of
Control.

“Stated Maturity” means, with respect to any installment of interest or principal on any
series of Indebtedness, the date on which the payment of interest or principal was scheduled to be
paid in the documentation governing such Indebtedness as of the Issue Date, and will not include
any contingent obligations to repay, redeem or repurchase any such interest or principal prior to
the date originally scheduled for the payment thereof.

 

-35-

 

“Subordinated Indebtedness” means

(a) with respect to the Issuers, any Indebtedness of such Issuer which is by its terms
subordinated in right of payment to the Notes, and

(b) with respect to any Guarantor, any Indebtedness of such Guarantor which is by its
terms subordinated in right of payment to the Guarantee of such Guarantor under this
Indenture.

“Subordinated Management Fees” means the management fees payable pursuant to the Management
Services Agreement which in the event of a bankruptcy of the Company shall be subordinated to the
prior payment in full, in cash, of all Obligations due in respect of the Notes (including interest
after the commencement of any bankruptcy proceeding at the rate specified in the Notes) and payment
of which shall be suspended during the continuance of a payment default in respect of the Notes.

“Subsidiary” means, with respect to any specified Person:

(1) any corporation, association or other business entity of which more than 50% of the
total voting power of shares of Capital Stock entitled (without regard to the occurrence of
any contingency and after giving effect to any voting agreement or stockholders’ agreement
that effectively transfers voting power) to vote in the election of directors, managers or
trustees of the corporation, association or other business entity is at the time owned or
controlled, directly or indirectly, by that Person or one or more of the other Subsidiaries
of that Person (or a combination thereof); and

(2) any partnership (a) the sole general partner or the managing general partner of
which is such Person or a Subsidiary of such Person or (b) the only general partners of
which are that Person or one or more Subsidiaries of that Person (or any combination
thereof).

“Subsidiary Guarantee” means the Guarantee by each Guarantor of the Issuers’ Obligations under
this Indenture and the Notes, executed pursuant to the provisions of this Indenture.

“TIA” means the Trust Indenture Act of 1939 (15 U.S.C. §§ 77aaa-77bbbb) as in effect on the
date on which this Indenture is qualified thereunder.

“Total Assets” means the total consolidated assets of the Company and its Restricted
Subsidiaries as set forth on the most recent consolidated balance sheet of the Company and its
Restricted Subsidiaries.

 

-36-

 

“Total Leverage Ratio” means, as of the date of determination, the ratio of (a) Consolidated
Total Indebtedness of the Issuers and their Restricted Subsidiaries as of the end of the most
recent fiscal quarter for which internal financial statements are available to (b) Consolidated
Adjusted EBITDA of the Issuers and their Restricted Subsidiaries for the most recently ended four
fiscal quarters ending immediately prior to such date for which internal
financial statements are available, in each case with such pro forma adjustments to
Consolidated Total Indebtedness and Consolidated Adjusted EBITDA as are appropriate and consistent
with the pro forma adjustment provisions set forth in the definition of “Fixed Charge Coverage
Ratio.”

“Transactions” means, collectively, the transactions contemplated by this Indenture and the
Credit Agreement, including the borrowings under the Credit Agreement and the offering of the
Notes, the consummation of a cash tender offer for or redemption of all outstanding 83/4% Senior
Subordinated Notes due 2014 of the Issuers, the Restricted Payment to Holdings to fund the
repayment of the Holdings Loans, other Restricted Payments to Holdings in an amount not to exceed
$233.0 million, the consummation of any other transactions in connection with the foregoing and the
payment of the fees and expenses incurred in connection with any of the foregoing.

“Treasury Management Obligations” means obligations under any agreement governing the
provision of treasury or cash management services, including deposit accounts, funds transfer,
automated clearinghouse, zero balance accounts, returned check concentration, controlled
disbursement, lockbox, account reconciliation and reporting and trade finance services. Treasury
Management Obligations shall not constitute Indebtedness.

“Treasury Rate” means, as of any redemption date, the yield to maturity as of such redemption
date of United States Treasury securities with a constant maturity (as compiled and published in
the most recent Federal Reserve Statistical Release H.15 (519) that has become publicly available
at least two Business Days prior to the redemption date (or, if such Statistical Release is no
longer published, any publicly available source of similar market data)) most nearly equal to the
period from the redemption date to May 15, 2014; provided that if the period from the redemption
date to May 15, 2014 is less than one year, the weekly average yield on actively traded United
States Treasury securities adjusted to a constant maturity of one year will be used.

“Trustee” means the party named as such in the preamble to this Indenture until a successor
replaces it in accordance with the applicable provisions of this Indenture and thereafter means the
successor serving hereunder.

“Unrestricted Global Note” means a Global Note that does not bear and is not required to bear
the Private Placement Legend.

“Unrestricted Definitive Note” means a Definitive Note that does not bear and is not required
to bear the Private Placement Legend.

 

-37-

 

“Unrestricted Subsidiary” means any Subsidiary of the Company and any Subsidiary of an
Unrestricted Subsidiary that is designated by the Board of Directors of the Company as an
Unrestricted Subsidiary pursuant to a resolution of the Board of Directors, but only to the extent
that such Subsidiary:

(1) has no Indebtedness other than Non-Recourse Debt;

(2) except as permitted by Section 4.11 hereof, is not party to any agreement,
contract, arrangement or understanding with the Company or any Restricted Subsidiary of the
Company unless the terms of any such agreement, contract, arrangement or understanding are
no less favorable to the Company or such Restricted Subsidiary than those that might be
obtained at the time from Persons who are not Affiliates of the Company;

(3) is a Person with respect to which neither the Company nor any of its Restricted
Subsidiaries has any direct or indirect obligation (a) to subscribe for additional Equity
Interests or (b) to maintain or preserve such Person’s financial condition or to cause such
Person to achieve any specified levels of operating results; and

(4) has not guaranteed or otherwise directly or indirectly provided credit support for
any Indebtedness of the Company or any of its Restricted Subsidiaries, except in the case of
clauses (3) and (4), to the extent:

(A) that the Company or such Restricted Subsidiary could otherwise provide such
a guarantee or incur such Indebtedness (other than as Permitted Debt) pursuant to
Section 4.09 hereof, and

(B) the provision of such guarantee and the incurrence of such Indebtedness
otherwise would be permitted by Section 4.07 hereof.

“U.S. Person” means a U.S. Person as defined in Rule 902(k) promulgated under the Securities
Act.

“Voting Stock” of any specified Person as of any date means the Capital Stock of such Person
that is at the time entitled to vote in the election of the Board of Directors of such Person.

“Weighted Average Life to Maturity” means, when applied to any Indebtedness at any date, the
number of years obtained by dividing:

(1) the sum of the products obtained by multiplying (a) the amount of each then
remaining installment, sinking fund, serial maturity or other required payments of
principal, including payment at final maturity, in respect of the Indebtedness, by (b) the
number of years (calculated to the nearest one-twelfth) that will elapse between such date
and the making of such payment; by

(2) the then outstanding principal amount of such Indebtedness.

 

-38-

 

“Wholly-Owned Domestic Subsidiary” means a Domestic Subsidiary that is a Wholly-Owned
Subsidiary of the Company.

“Wholly Owned Subsidiary” of any specified Person means a Subsidiary of such Person all of the
outstanding Capital Stock or other ownership interest of which (other than directors’ qualifying
shares) will as that time be owned by such Person or by one or more Wholly Owned Subsidiaries of
such person.

Section 1.02 Other Definitions.

	 	 	 	 	 
	Term	 	Defined in Section	 
	“Affiliate Transaction”
	 	 	4.11	 
	“Asset Sale Offer”
	 	 	4.10	 
	“Authentication Order”
	 	 	2.02	 
	“Calculation Date”
	 	1.01 (Definition of “Fixed Charge Coverage Ratio”)	 
	“Change of Control Offer”
	 	 	4.15	 
	“Change of Control Payment”
	 	 	4.15	 
	“Change of Control Payment Date”
	 	 	4.15	 
	“Covenant Defeasance”
	 	 	8.03	 
	“Covenant Termination Event”
	 	 	4.21	 
	“Covenant Termination Event Notice”
	 	 	4.21	 
	“Cumulative Buildup Basket”
	 	 	4.07	 
	“DTC”
	 	 	2.03	 
	“Event of Default”
	 	 	6.01	 
	“Excess Proceeds”
	 	 	4.10	 
	“Financial Reports”
	 	 	4.03	 
	“incur”
	 	 	4.09	 
	“Legal Defeasance”
	 	 	8.02	 
	“Offer Amount”
	 	 	3.09	 
	“Offer Period”
	 	 	3.09	 
	“Paying Agent”
	 	 	2.03	 
	“Payment Default”
	 	 	6.01	 
	“Permitted Debt”
	 	 	4.09	 
	“Purchase Date”
	 	 	3.09	 
	“Registrar”
	 	 	2.03	 
	“Restricted Payments”
	 	 	4.07	 

Section 1.03 Incorporation by Reference of Trust Indenture Act.

Whenever this Indenture refers to a provision of the TIA, the provision is incorporated by
reference in and made a part of this Indenture.

 

-39-

 

The following TIA terms used in this Indenture have the following meanings:

“indenture securities” means the Notes;

“indenture security Holder” means a Holder of a Note;

“indenture to be qualified” means this Indenture;

“indenture trustee” or “institutional trustee” means the Trustee; and

“obligor” on the Notes and the Subsidiary Guarantees means the Issuers and the Guarantors,
respectively, and any successor obligor upon the Notes and the Subsidiary Guarantees, respectively.

All other terms used in this Indenture that are defined by the TIA, defined by TIA reference
to another statute or defined by SEC rule under the TIA have the meanings so assigned to them.

Section 1.04 Rules of Construction and Calculation.

(a) Unless the context otherwise requires:

(1) a term has the meaning assigned to it;

(2) an accounting term not otherwise defined has the meaning assigned to it in
accordance with GAAP;

(3) “or” is not exclusive;

(4) words in the singular include the plural, and in the plural include the singular;

(5) “will” shall be interpreted to express a command;

(6) provisions apply to successive events and transactions;

(7) references to sections of or rules under the Securities Act will be deemed to
include substitute, replacement or successor sections or rules adopted by the SEC from time
to time; and

(8) “including” shall be interpreted to mean “including without limitation.”

(b) All financial calculations regarding the Company and its Subsidiaries for periods prior to
the Issue Date shall be based upon the consolidated financial statements of Holdings and its
Subsidiaries.

 

-40-

 

ARTICLE 2.

THE NOTES

Section 2.01 Form and Dating.

(a) General. The Notes and the Trustee’s certificate of authentication shall be substantially
in the form of Exhibits A1 or A2 attached hereto. The Notes may have notations, legends or
endorsements required by law, stock exchange rule or usage (provided that any such notation, legend
or endorsement required by usage is in a form reasonably acceptable to the Company). Each Note
shall be dated the date of its authentication. The Notes shall be in denominations of $2,000 and
integral multiples of $1,000.

The terms and provisions contained in the Notes shall constitute, and are hereby expressly
made, a part of this Indenture and the Issuers, the Guarantors and the Trustee, by their execution
and delivery of this Indenture, expressly agree to such terms and provisions and to be bound
thereby. However, to the extent any provision of any Note conflicts with the express provisions of
this Indenture, the provisions of this Indenture shall govern and be controlling.

(b) Global Notes. Notes issued in global form shall be substantially in the form of Exhibits
A1 or A2 attached hereto (including the Global Note Legend thereon and the “Schedule of Exchanges
of Interests in the Global Note” attached thereto). Notes issued in definitive form shall be
substantially in the form of Exhibit A1 attached hereto (but without the Global Note Legend thereon
and without the “Schedule of Exchanges of Interests in the Global Note” attached thereto). Each
Global Note shall represent such of the outstanding Notes as shall be specified therein and each
shall provide that it represents the aggregate principal amount of outstanding Notes from time to
time endorsed thereon and that the aggregate principal amount of outstanding Notes represented
thereby may from time to time be reduced or increased, as appropriate, to reflect exchanges,
repurchases, and redemptions. Any endorsement of a Global Note to reflect the amount of any
increase or decrease in the aggregate principal amount of outstanding Notes represented thereby
shall be made by the Trustee or the Custodian, at the direction of the Trustee, in accordance with
instructions given by the Holder thereof as required by Section 2.06 hereof and shall be made on
the records of the Trustee and the Depositary.

 

-41-

 

(c) Temporary Global Notes. Notes offered and sold in reliance on Regulation S shall be
issued initially in the form of the Regulation S Temporary Global Note, which shall be deposited on
behalf of the purchasers of the Notes represented thereby with the Trustee, at its New York office,
as custodian for the Depositary, and registered in the name of the Depositary or the nominee of the
Depositary for the accounts of designated agents holding on behalf of Euroclear or Clearstream,
duly executed by the Issuers and authenticated by the Trustee as hereinafter provided. The
Restricted Period shall be terminated upon the receipt by the Trustee of:

(1) a written certificate from the Depositary, together with copies of certificates
from Euroclear and Clearstream certifying that they have received certification of
non-United States beneficial ownership of 100% of the aggregate principal amount of the
Regulation S Temporary Global Note (except to the extent of any beneficial owners thereof
who acquired an interest therein during the Restricted Period pursuant to another exemption
from registration under the Securities Act and who shall take delivery of a beneficial
ownership interest in a 144A Global Note bearing a Private Placement Legend, all as
contemplated by Section 2.06(b) hereof); and

(2) an Officer’s Certificate from the Issuers.

Following the termination of the Restricted Period, beneficial interests in the Regulation S
Temporary Global Note shall be exchanged for beneficial interests in Regulation S Permanent Global
Note pursuant to the Applicable Procedures. Simultaneously with the authentication of Regulation S
Permanent Global Note, the Trustee shall cancel the Regulation S Temporary Global Note. The
aggregate principal amount of the Regulation S Temporary Global Note and the Regulation S Permanent
Global Note may from time to time be increased or decreased by adjustments made on the records of
the Trustee and the Depositary or its nominee, as the case may be, in connection with transfers of
interest as hereinafter provided.

(d) Euroclear and Clearstream Procedures Applicable. The provisions of the “Operating
Procedures of the Euroclear System” and “Terms and Conditions Governing Use of Euroclear” and the
“General Terms and Conditions of Clearstream Banking” and “Customer Handbook” of Clearstream shall
be applicable to transfers of beneficial interests in the Regulation S Temporary Global Note and
the Regulation S Permanent Global Notes that are held by Participants through Euroclear or
Clearstream.

Section 2.02 Execution and Authentication.

At least one Officer must sign the Notes for the Issuers by manual or facsimile signature.

If an Officer whose signature is on a Note no longer holds that office at the time a Note is
authenticated, the Note shall nevertheless be valid.

A Note shall not be valid until authenticated by the manual signature of the Trustee. The
signature shall be conclusive evidence that the Note has been duly authenticated under this
Indenture.

The Trustee shall authenticate and deliver: (i) on the Issue Date, an aggregate principal
amount of $850.0 million 8.375% Senior Notes due 2019, (ii) Additional Notes for an original issue
in an aggregate principal amount specified in an Authentication Order pursuant to this Section 2.02
and (iii) Exchange Notes for issue only in an Exchange Offer pursuant to the Registration Rights
Agreement, for a like principal amount of Initial Notes or Additional Notes, in each case upon a written order of the Issuers signed by one Officer (an
“Authentication Order”). Such Authentication Order shall specify the amount of the Notes to be
authenticated and the date on which the original issue of the Notes is to be authenticated.

 

-42-

 

The Trustee may appoint an authenticating agent acceptable to the Company to authenticate
Notes. An authenticating agent may authenticate Notes whenever the Trustee may do so. Each
reference in this Indenture to authentication by the Trustee includes authentication by such agent.
An authenticating agent has the same rights as an Agent to deal with Holders or an Affiliate of
the Issuers.

Section 2.03 Registrar and Paying Agent.

The Issuers shall maintain an office or agency where Notes may be presented for registration
of transfer or for exchange (“Registrar”) and an office or agency where Notes may be presented for
payment (“Paying Agent”). The Registrar shall keep a register of the Notes and of their transfer
and exchange. The Issuers may appoint one or more co-registrars and one or more additional paying
agents. The term “Registrar” includes any co-registrar and the term “Paying Agent” includes any
additional paying agent. The Issuers may change any Paying Agent or Registrar without notice to
any Holder. The Issuers shall notify the Trustee in writing of the name and address of any Agent
not a party to this Indenture. If the Issuers fail to appoint or maintain another entity as
Registrar or Paying Agent, the Trustee shall act as such. The Company or any of its Subsidiaries
may act as Paying Agent or Registrar.

The Issuers initially appoint The Depository Trust Company (“DTC”) to act as Depositary with
respect to the Global Notes.

The Issuers initially appoint the Trustee to act as the Registrar and Paying Agent and to act
as Custodian with respect to the Global Notes.

Section 2.04 Paying Agent to Hold Money in Trust.

The Issuers shall require each Paying Agent other than the Trustee to agree in writing that
the Paying Agent shall hold in trust for the benefit of Holders or the Trustee all money held by
the Paying Agent for the payment of principal, premium or Special Interest, if any, or interest on
the Notes, and shall notify the Trustee of any default by the Issuers in making any such payment.
While any such default continues, the Trustee may require in writing a Paying Agent to pay all
money held by it in trust to the Trustee. The Issuers at any time may require in writing a Paying
Agent to pay all money held by it in trust to the Trustee. Upon payment over to the Trustee, the
Paying Agent (if other than the Company or a Subsidiary) shall have no further liability for the
money. If the Company or a Subsidiary acts as Paying Agent, it shall segregate and hold in a
separate trust fund for the benefit of the Holders all money held by it as Paying Agent. Upon any
bankruptcy or reorganization proceedings relating to the Issuers, the Trustee shall serve as Paying
Agent for the Notes.

 

-43-

 

Section 2.05 Holder Lists.

The Trustee shall preserve in as current a form as is reasonably practicable the most recent
list available to it of the names and addresses of all Holders and shall otherwise comply with TIA
§ 312(a). If the Trustee is not the Registrar, the Issuers shall furnish to the Trustee at least
seven Business Days before each interest payment date and at such other times as the Trustee may
request in writing, a list in such form and as of such date as the Trustee may reasonably require
of the names and addresses of the Holders and the Issuers shall otherwise comply with TIA § 312(a).

Section 2.06 Transfer and Exchange.

(a) Transfer and Exchange of Global Notes. A Global Note may not be transferred except in
whole (but not in part) by the Depositary to a nominee of the Depositary, by a nominee of the
Depositary to the Depositary or to another nominee of the Depositary, or by the Depositary or any
such nominee to a successor Depositary or a nominee of such successor Depositary. All Global Notes
shall be exchanged by the Issuers for Definitive Notes if:

(1) the Depository (a) notifies the Issuers that it is unwilling or unable to continue
as Depositary for the Global Notes or (b) has ceased to be a clearing agency registered
under the Exchange Act and, in either case, a successor Depositary is not appointed by the
Issuers within 120 days after the date of such notice from the Depositary;

(2) the Issuers in their sole discretion determine that the Global Notes (in whole but
not in part) should be exchanged for Definitive Notes and deliver a written notice to such
effect to the Trustee; provided that in no event shall the Regulation S Temporary Global
Note be exchanged by the Issuers for Definitive Notes prior to (x) the expiration of the
Restricted Period and (y) the receipt by the Registrar of any certificates required pursuant
to Rule 903(b)(3)(ii)(B) under the Securities Act; or

(3) there has occurred and is continuing an Event of Default with respect to the Notes.

Upon the occurrence of any of the preceding events in (1), (2) or (3) above, Definitive Notes
shall be issued in such names as the Depositary shall instruct the Trustee. Global Notes also may
be exchanged or replaced, in whole or in part, as provided in Sections 2.07 and 2.10 hereof. Every
Note authenticated and delivered in exchange for, or in lieu of, a Global Note or any portion
thereof, pursuant to this Section 2.06 or Section 2.07 or 2.10 hereof, shall be authenticated and
delivered in the form of, and shall be, a Global Note. A Global Note may not be exchanged for
another Note other than as provided in this Section 2.06(a); however, beneficial interests in a
Global Note may be transferred and exchanged as provided in Section 2.06(b), (c) or (f) hereof.

 

-44-

 

(b) Transfer and Exchange of Beneficial Interests in the Global Notes. The transfer and
exchange of beneficial interests in the Global Notes shall be effected through the Depositary, in
accordance with the provisions of this Indenture and the Applicable Procedures. Beneficial
interests in the Restricted Global Notes shall be subject to restrictions on transfer comparable to
those set forth herein to the extent required by the Securities Act. Transfers of beneficial
interests in the Global Notes also shall require compliance with either subparagraph (1) or (2)
below, as applicable, as well as one or more of the other following subparagraphs, as applicable:

(1) Transfer of Beneficial Interests in the Same Global Note. Beneficial interests in
any Restricted Global Note may be transferred to Persons who take delivery thereof in the
form of a beneficial interest in the same Restricted Global Note in accordance with the
transfer restrictions set forth in the Private Placement Legend; provided, however, that
prior to the expiration of the Restricted Period, transfers of beneficial interests in the
Regulation S Temporary Global Note may not be made to a U.S. Person or for the account or
benefit of a U.S. Person (other than an Initial Purchaser). Beneficial interests in any
Unrestricted Global Note may be transferred to Persons who take delivery thereof in the form
of a beneficial interest in an Unrestricted Global Note. No written orders or instructions
shall be required to be delivered to the Registrar to effect the transfers described in this
Section 2.06(b)(1).

(2) All Other Transfers and Exchanges of Beneficial Interests in Global Notes. In
connection with all transfers and exchanges of beneficial interests that are not subject to
Section 2.06(b)(1) above, the transferor of such beneficial interest must deliver to the
Registrar either:

(A) both:

(i) a written order from a Participant or an Indirect Participant given
to the Depositary in accordance with the Applicable Procedures directing the
Depositary to credit or cause to be credited a beneficial interest in
another Global Note in an amount equal to the beneficial interest to be
transferred or exchanged; and

(ii) instructions given in accordance with the Applicable Procedures
containing information regarding the Participant account to be credited with
such increase; or

(B) both:

(i) a written order from a Participant or an Indirect Participant given
to the Depositary in accordance with the Applicable Procedures directing the
Depositary to cause to be issued a Definitive Note in an amount equal to the
beneficial interest to be transferred or exchanged; and

 

-45-

 

(ii) instructions given by the Depositary to the Registrar containing
information regarding the Person in whose name such Definitive Note shall be
registered to effect the transfer or exchange referred to in clause (i)
above; provided that in no event shall Definitive Notes be issued upon the
transfer or exchange of beneficial interests in the Regulation S Temporary
Global Note prior to (A) the expiration of the Restricted Period and (B) the
receipt by the Registrar of any certificates required pursuant to Rule 903
under the Securities Act.

Upon consummation of an Exchange Offer by the Issuers in accordance with Section
2.06(f) hereof, the requirements of this Section 2.06(b)(2) shall be deemed to have
been satisfied upon receipt by the Registrar of the instructions contained in the
Letter of Transmittal delivered by the holder of such beneficial interests in the
Restricted Global Notes.

Upon satisfaction of all of the requirements for transfer or exchange of beneficial
interests in Global Notes contained in this Indenture and the Notes or otherwise
applicable under the Securities Act, the Trustee shall adjust the principal amount
of the relevant Global Note(s) pursuant to Section 2.06(h) hereof.

(3) Transfer of Beneficial Interests to Another Restricted Global Note. A beneficial
interest in any Restricted Global Note may be transferred to a Person who takes delivery
thereof in the form of a beneficial interest in another Restricted Global Note if the
transfer complies with the requirements of Section 2.06(b)(2) above and the Registrar
receives the following:

(A) if the transferee shall take delivery in the form of a beneficial interest
in the 144A Global Note, then the transferor must deliver a certificate in the form
of Exhibit B hereto, including the certifications in item (1) thereof; and

(B) if the transferee shall take delivery in the form of a beneficial interest
in the Regulation S Global Note then the transferor must deliver a certificate in
the form of Exhibit B hereto, including the certifications in item (2) thereof.

(4) Transfer and Exchange of Beneficial Interests in a Restricted Global Note for
Beneficial Interests in an Unrestricted Global Note. A beneficial interest in any
Restricted Global Note may be exchanged by any holder thereof for a beneficial interest in
an Unrestricted Global Note or transferred to a Person who takes delivery thereof in the
form of a beneficial interest in an Unrestricted Global Note if the exchange or transfer
complies with the requirements of Section 2.06(b)(2) above and:

 

-46-

 

(A) such exchange or transfer is effected pursuant to the Exchange Offer in
accordance with the Registration Rights Agreement and the holder of
the beneficial interest to be transferred, in the case of an exchange, or the
transferee, in the case of a transfer, certifies in the applicable Letter of
Transmittal that it is not (i) a Broker-Dealer, (ii) a Person participating in the
distribution of the Exchange Notes or (iii) a Person who is an affiliate (as defined
in Rule 144) of the Company;

(B) such transfer is effected pursuant to the Shelf Registration Statement in
accordance with the Registration Rights Agreement;

(C) such transfer is effected by a Broker-Dealer pursuant to the Exchange Offer
Registration Statement in accordance with the Registration Rights Agreement; or

(D) the Registrar receives the following:

(i) if the holder of such beneficial interest in a Restricted Global
Note proposes to exchange such beneficial interest for a beneficial interest
in an Unrestricted Global Note, a certificate from such holder in the form
of Exhibit C hereto, including the certifications in item (1)(a) thereof; or

(ii) if the holder of such beneficial interest in a Restricted Global
Note proposes to transfer such beneficial interest to a Person who shall
take delivery thereof in the form of a beneficial interest in an
Unrestricted Global Note, a certificate from such holder in the form of
Exhibit B hereto, including the certifications in item (4) thereof;

and, in each such case set forth in this subparagraph (D), if the Registrar so
requests or if the Applicable Procedures so require, an Opinion of Counsel in form
reasonably acceptable to the Registrar to the effect that such exchange or transfer
is in compliance with the Securities Act and that the restrictions on transfer
contained herein and in the Private Placement Legend are no longer required in order
to maintain compliance with the Securities Act.

If any such transfer is effected pursuant to subparagraph (B) or (D) above at a time when an
Unrestricted Global Note has not yet been issued, the Issuers shall issue and, upon receipt of an
Authentication Order in accordance with Section 2.02 hereof, the Trustee shall authenticate one or
more Unrestricted Global Notes in an aggregate principal amount equal to the aggregate principal
amount of beneficial interests transferred pursuant to subparagraph (B) or (D) above.

Beneficial interests in an Unrestricted Global Note cannot be exchanged for, or transferred to
Persons who take delivery thereof in the form of, a beneficial interest in a Restricted Global
Note.

 

-47-

 

(c) Transfer or Exchange of Beneficial Interests for Definitive Notes.

(1) Beneficial Interests in Restricted Global Notes to Restricted Definitive Notes. If
any holder of a beneficial interest in a Restricted Global Note proposes to exchange such
beneficial interest for a Restricted Definitive Note or to transfer such beneficial interest
to a Person who takes delivery thereof in the form of a Restricted Definitive Note, then,
upon receipt by the Registrar of the following documentation:

(A) if the holder of such beneficial interest in a Restricted Global Note
proposes to exchange such beneficial interest for a Restricted Definitive Note, a
certificate from such holder in the form of Exhibit C hereto, including the
certifications in item (2)(a) thereof;

(B) if such beneficial interest is being transferred to a QIB in accordance
with Rule 144A, a certificate to the effect set forth in Exhibit B hereto, including
the certifications in item (1) thereof;

(C) if such beneficial interest is being transferred to a Non-U.S. Person in an
offshore transaction in accordance with Rule 903 or Rule 904, a certificate to the
effect set forth in Exhibit B hereto, including the certifications in item (2)
thereof;

(D) if such beneficial interest is being transferred pursuant to an exemption
from the registration requirements of the Securities Act in accordance with Rule
144, a certificate to the effect set forth in Exhibit B hereto, including the
certifications in item (3)(a) thereof;

(E) if such beneficial interest is being transferred to the Company or any of
its Subsidiaries, a certificate to the effect set forth in Exhibit B hereto,
including the certifications in item (3)(b) thereof; or

(F) if such beneficial interest is being transferred pursuant to an effective
registration statement under the Securities Act, a certificate to the effect set
forth in Exhibit B hereto, including the certifications in item (3)(c) thereof,

the Trustee shall cause the aggregate principal amount of the applicable Global Note to be
reduced accordingly pursuant to Section 2.06(h) hereof, and the Issuers shall execute and
the Trustee shall authenticate and deliver to the Person designated in the instructions a
Definitive Note in the appropriate principal amount. Any Definitive Note issued in exchange
for a beneficial interest in a Restricted Global Note pursuant to this Section 2.06(c) shall
be registered in such name or names and in such authorized denomination or denominations as
the holder of such beneficial interest shall instruct the Registrar through instructions
from the Depositary and the Participant or Indirect Participant. The Trustee shall deliver
such Definitive Notes to the Persons in whose names such Notes are so registered. Any
Definitive Note issued in exchange for a
beneficial interest in a Restricted Global Note pursuant to this Section 2.06(c)(1) shall
bear the Private Placement Legend and shall be subject to all restrictions on transfer
contained therein.

 

-48-

 

(2) Beneficial Interests in Regulation S Temporary Global Note to Definitive Notes.
Notwithstanding Sections 2.06(c)(1)(A) and (C) hereof, a beneficial interest in the
Regulation S Temporary Global Note may not be exchanged for a Definitive Note or transferred
to a Person who takes delivery thereof in the form of a Definitive Note prior to (A) the
expiration of the Restricted Period and (B) the receipt by the Registrar of any certificates
required pursuant to Rule 903(b)(3)(ii)(B) under the Securities Act, except in the case of a
transfer pursuant to an exemption from the registration requirements of the Securities Act
other than Rule 903 or Rule 904.

(3) Beneficial Interests in Restricted Global Notes to Unrestricted Definitive Notes.
A holder of a beneficial interest in a Restricted Global Note may exchange such beneficial
interest for an Unrestricted Definitive Note or may transfer such beneficial interest to a
Person who takes delivery thereof in the form of an Unrestricted Definitive Note only if:

(A) such exchange or transfer is effected pursuant to the Exchange Offer in
accordance with the Registration Rights Agreement and the holder of such beneficial
interest, in the case of an exchange, or the transferee, in the case of a transfer,
certifies in the applicable Letter of Transmittal that it is not (i) a
Broker-Dealer, (ii) a Person participating in the distribution of the Exchange Notes
or (iii) a Person who is an affiliate (as defined in Rule 144) of the Company;

(B) such transfer is effected pursuant to the Shelf Registration Statement in
accordance with the Registration Rights Agreement;

(C) such transfer is effected by a Broker-Dealer pursuant to the Exchange Offer
Registration Statement in accordance with the Registration Rights Agreement; or

(D) the Registrar receives the following:

(i) if the holder of such beneficial interest in a Restricted Global
Note proposes to exchange such beneficial interest for an Unrestricted
Definitive Note, a certificate from such holder in the form of Exhibit C
hereto, including the certifications in item (1)(b) thereof; or

(ii) if the holder of such beneficial interest in a Restricted Global
Note proposes to transfer such beneficial interest to a Person who shall
take delivery thereof in the form of an Unrestricted Definitive Note, a certificate from such holder in the form of Exhibit B
hereto, including the certifications in item (4) thereof;

 

-49-

 

(iii) and, in each such case set forth in this subparagraph (D), if the
Registrar so requests or if the Applicable Procedures so require, an Opinion
of Counsel in form reasonably acceptable to the Registrar to the effect that
such exchange or transfer is in compliance with the Securities Act and that
the restrictions on transfer contained herein and in the Private Placement
Legend are no longer required in order to maintain compliance with the
Securities Act.

(4) Beneficial Interests in Unrestricted Global Notes to Unrestricted Definitive Notes.
If any holder of a beneficial interest in an Unrestricted Global Note proposes to exchange
such beneficial interest for a Definitive Note or to transfer such beneficial interest to a
Person who takes delivery thereof in the form of a Definitive Note, then, upon satisfaction
of the conditions set forth in Section 2.06(b)(2) hereof, the Trustee shall cause the
aggregate principal amount of the applicable Global Note to be reduced accordingly pursuant
to Section 2.06(h) hereof, and the Company shall execute and the Trustee shall authenticate
and deliver to the Person designated in the instructions a Definitive Note in the
appropriate principal amount. Any Definitive Note issued in exchange for a beneficial
interest pursuant to this Section 2.06(c)(4) shall be registered in such name or names and
in such authorized denomination or denominations as the holder of such beneficial interest
requests through instructions to the Registrar from or through the Depositary and the
Participant or Indirect Participant. The Trustee shall deliver such Definitive Notes to the
Persons in whose names such Notes are so registered. Any Definitive Note issued in exchange
for a beneficial interest pursuant to this Section 2.06(c)(4) shall not bear the Private
Placement Legend.

(d) Transfer and Exchange of Definitive Notes for Beneficial Interests.

(1) Restricted Definitive Notes to Beneficial Interests in Restricted Global Notes. If
any Holder of a Restricted Definitive Note proposes to exchange such Note for a beneficial
interest in a Restricted Global Note or to transfer such Restricted Definitive Notes to a
Person who takes delivery thereof in the form of a beneficial interest in a Restricted
Global Note, then, upon receipt by the Registrar of the following documentation:

(A) if the Holder of such Restricted Definitive Note proposes to exchange such
Note for a beneficial interest in a Restricted Global Note, a certificate from such
Holder in the form of Exhibit C hereto, including the certifications in item (2)(b)
thereof;

 

-50-

 

(B) if such Restricted Definitive Note is being transferred to a QIB in
accordance with Rule 144A, a certificate to the effect set forth in Exhibit B
hereto, including the certifications in item (1) thereof;

(C) if such Restricted Definitive Note is being transferred to a Non-U.S.
Person in an offshore transaction in accordance with Rule 903 or Rule 904, a
certificate to the effect set forth in Exhibit B hereto, including the
certifications in item (2) thereof;

(D) if such Restricted Definitive Note is being transferred pursuant to an
exemption from the registration requirements of the Securities Act in accordance
with Rule 144, a certificate to the effect set forth in Exhibit B hereto, including
the certifications in item (3)(a) thereof;

(E) if such Restricted Definitive Note is being transferred to the Company or
any of its Subsidiaries, a certificate to the effect set forth in Exhibit B hereto,
including the certifications in item (3)(b) thereof; or

(F) if such Restricted Definitive Note is being transferred pursuant to an
effective registration statement under the Securities Act, a certificate to the
effect set forth in Exhibit B hereto, including the certifications in item (3)(c)
thereof,

the Trustee shall cancel the Restricted Definitive Note and increase or cause to be
increased the aggregate principal amount of the applicable Global Note.

(2) Restricted Definitive Notes to Beneficial Interests in Unrestricted Global Notes.
A Holder of a Restricted Definitive Note may exchange such Note for a beneficial interest in
an Unrestricted Global Note or transfer such Restricted Definitive Note to a Person who
takes delivery thereof in the form of a beneficial interest in an Unrestricted Global Note
only if:

(A) such exchange or transfer is effected pursuant to the Exchange Offer in
accordance with the Registration Rights Agreement and the Holder, in the case of an
exchange, or the transferee, in the case of a transfer, certifies in the applicable
Letter of Transmittal that it is not (i) a Broker-Dealer, (ii) a Person
participating in the distribution of the Exchange Notes or (iii) a Person who is an
affiliate (as defined in Rule 144) of the Company;

(B) such transfer is effected pursuant to the Shelf Registration Statement in
accordance with the Registration Rights Agreement;

(C) such transfer is effected by a Broker-Dealer pursuant to the Exchange Offer
Registration Statement in accordance with the Registration Rights Agreement; or

 

-51-

 

(D) the Registrar receives the following:

(i) if the Holder of such Definitive Notes proposes to exchange such
Notes for a beneficial interest in the Unrestricted Global Note, a
certificate from such Holder in the form of Exhibit C hereto, including the
certifications in item (1)(c) thereof; or

(ii) if the Holder of such Definitive Notes proposes to transfer such
Notes to a Person who shall take delivery thereof in the form of a
beneficial interest in the Unrestricted Global Note, a certificate from such
Holder in the form of Exhibit B hereto, including the certifications in item
(4) thereof;

and, in each such case set forth in this subparagraph (D), if the Registrar so
requests or if the Applicable Procedures so require, an Opinion of Counsel in form
reasonably acceptable to the Registrar to the effect that such exchange or transfer
is in compliance with the Securities Act and that the restrictions on transfer
contained herein and in the Private Placement Legend are no longer required in order
to maintain compliance with the Securities Act.

Upon satisfaction of the conditions of any of the subparagraphs in this Section
2.06(d)(2), the Trustee shall cancel the Definitive Notes and increase or cause to be
increased the aggregate principal amount of the Unrestricted Global Note.

(3) Unrestricted Definitive Notes to Beneficial Interests in Unrestricted Global Notes.
A Holder of an Unrestricted Definitive Note may exchange such Note for a beneficial
interest in an Unrestricted Global Note or transfer such Definitive Notes to a Person who
takes delivery thereof in the form of a beneficial interest in an Unrestricted Global Note
at any time. Upon receipt of a request for such an exchange or transfer, the Trustee shall
cancel the applicable Unrestricted Definitive Note and increase or cause to be increased the
aggregate principal amount of one of the Unrestricted Global Notes.

If any such exchange or transfer from a Definitive Note to a beneficial interest is effected
pursuant to subparagraphs (2)(B), (2)(D) or (3) above at a time when an Unrestricted Global Note
has not yet been issued, the Issuers shall issue and, upon receipt of an Authentication Order in
accordance with Section 2.02 hereof, the Trustee shall authenticate one or more Unrestricted Global
Notes in an aggregate principal amount equal to the principal amount of Definitive Notes
transferred or exchanged pursuant to subparagraph (2)(B), (2)(D) or (3) above.

 

-52-

 

(e) Transfer and Exchange of Definitive Notes for Definitive Notes. Upon request by a Holder
of Definitive Notes and such Holder’s compliance with the provisions of this Section 2.06(e), the
Registrar shall register the transfer or exchange of Definitive Notes. Prior to such registration
of transfer or exchange, the requesting Holder must present or surrender to the Registrar the Definitive Notes duly endorsed or accompanied by a written
instruction of transfer in form satisfactory to the Registrar duly executed by such Holder or by
its attorney, duly authorized in writing. In addition, the requesting Holder must provide any
additional certifications, documents and information, as applicable, required pursuant to the
following provisions of this Section 2.06(e).

(1) Restricted Definitive Notes to Restricted Definitive Notes. Any Restricted
Definitive Note may be transferred to and registered in the name of Persons who take
delivery thereof in the form of a Restricted Definitive Note if the Registrar receives the
following:

(A) if the transfer shall be made pursuant to Rule 144A, then the transferor
must deliver a certificate in the form of Exhibit B hereto, including the
certifications in item (1) thereof;

(B) if the transfer shall be made pursuant to Rule 903 or Rule 904, then the
transferor must deliver a certificate in the form of Exhibit B hereto, including the
certifications in item (2) thereof; and

(C) if the transfer shall be made pursuant to any other exemption from the
registration requirements of the Securities Act, then the transferor must deliver a
certificate in the form of Exhibit B hereto, including the certifications required
by item (3) thereof, if applicable.

(2) Restricted Definitive Notes to Unrestricted Definitive Notes. Any Restricted
Definitive Note may be exchanged by the Holder thereof for an Unrestricted Definitive Note
or transferred to a Person or Persons who take delivery thereof in the form of an
Unrestricted Definitive Note if:

(A) such exchange or transfer is effected pursuant to the Exchange Offer in
accordance with the Registration Rights Agreement and the Holder, in the case of an
exchange, or the transferee, in the case of a transfer, certifies in the applicable
Letter of Transmittal that it is not (i) a broker-dealer, (ii) a Person
participating in the distribution of the Exchange Notes or (iii) a Person who is an
affiliate (as defined in Rule 144) of the Company;

(B) any such transfer is effected pursuant to the Shelf Registration Statement
in accordance with the Registration Rights Agreement;

(C) any such transfer is effected by a Broker-Dealer pursuant to the Exchange
Offer Registration Statement in accordance with the Registration Rights Agreement;
or

 

-53-

 

(D) the Registrar receives the following:

(i) if the Holder of such Restricted Definitive Notes proposes to
exchange such Notes for an Unrestricted Definitive Note, a certificate from
such Holder in the form of Exhibit C hereto, including the certifications in
item (1)(d) thereof; or

(ii) if the Holder of such Restricted Definitive Notes proposes to
transfer such Notes to a Person who shall take delivery thereof in the form
of an Unrestricted Definitive Note, a certificate from such Holder in the
form of Exhibit B hereto, including the certifications in item (4) thereof;

and, in each such case set forth in this subparagraph (D), if the Registrar so
requests, an Opinion of Counsel in form reasonably acceptable to the Registrar to
the effect that such exchange or transfer is in compliance with the Securities Act
and that the restrictions on transfer contained herein and in the Private Placement
Legend are no longer required in order to maintain compliance with the Securities
Act.

(3) Unrestricted Definitive Notes to Unrestricted Definitive Notes. A Holder of
Unrestricted Definitive Notes may transfer such Notes to a Person who takes delivery thereof
in the form of an Unrestricted Definitive Note. Upon receipt of a request to register such
a transfer, the Registrar shall register the Unrestricted Definitive Notes pursuant to the
instructions from the Holder thereof.

(f) Exchange Offer. Upon the occurrence of the Exchange Offer in accordance with the
Registration Rights Agreement, the Issuers shall issue and, upon receipt of an Authentication Order
in accordance with Section 2.02 hereof, the Trustee shall authenticate:

(1) one or more Unrestricted Global Notes in an aggregate principal amount equal to the
principal amount of the beneficial interests in the Restricted Global Notes accepted for
exchange in the Exchange Offer by Persons that certify in the applicable Letters of
Transmittal that (A) they are not Broker-Dealers, (B) they are not participating in a
distribution of the Exchange Notes and (C) they are not affiliates (as defined in Rule 144)
of the Company; and

(2) Unrestricted Definitive Notes in an aggregate principal amount equal to the
principal amount of the Restricted Definitive Notes accepted for exchange in the Exchange
Offer.

(3) Concurrently with the issuance of such Notes, the Trustee shall cause the aggregate
principal amount of the applicable Restricted Global Notes to be reduced accordingly, and
the Issuers shall execute and the Trustee shall authenticate and deliver to the Persons
designated by the Holders of Restricted Definitive Notes so accepted Unrestricted Definitive
Notes in the appropriate principal amount.

 

-54-

 

(g) Legends. The following legends shall appear on the face of all Global Notes and
Definitive Notes issued under this Indenture unless specifically stated otherwise in the applicable
provisions of this Indenture.

(1) Private Placement Legend.

(A) Except as permitted by subparagraph (B) below, each Global Note and each
Definitive Note (and all Notes issued in exchange therefor or substitution thereof)
shall bear the legend in substantially the following form.

“THE SECURITY (OR ITS PREDECESSOR) EVIDENCED HEREBY WAS ORIGINALLY ISSUED IN A
TRANSACTION EXEMPT FROM REGISTRATION UNDER SECTION 5 OF THE U.S. SECURITIES ACT OF
1933, AS AMENDED (THE “SECURITIES ACT”), AND THE SECURITY EVIDENCED HEREBY MAY NOT
BE OFFERED, SOLD OR OTHERWISE TRANSFERRED EXCEPT IN ACCORDANCE WITH THE FOLLOWING
SENTENCE. BY ITS ACQUISITION HEREOF OR OF A BENEFICIAL INTEREST HEREIN, THE
ACQUIRER:

(1) REPRESENTS THAT IT, AND ANY ACCOUNT FOR WHICH IT IS ACTING, (A) IS A
“QUALIFIED INSTITUTIONAL BUYER” (WITHIN THE MEANING OF RULE 144A UNDER THE
SECURITIES ACT) OR (B) IS NOT A “U.S. PERSON” (WITHIN THE MEANING OF RULE 902
OF REGULATION S UNDER THE SECURITIES ACT), AND THAT IT EXERCISES SOLE
INVESTMENT DISCRETION WITH RESPECT TO EACH SUCH ACCOUNT, AND

(2) AGREES FOR THE BENEFIT OF THE ISSUERS THAT IT WILL NOT OFFER, SELL,
PLEDGE OR OTHERWISE TRANSFER THIS SECURITY OR ANY BENEFICIAL INTEREST HEREIN
PRIOR TO THE RESALE RESTRICTION TERMINATION DATE (AS DEFINED IN THE NEXT
PARAGRAPH), EXCEPT:

(A) TO THE PARENT OR ANY SUBSIDIARY THEREOF; OR

(B) PURSUANT TO A REGISTRATION STATEMENT THAT HAS BECOME
EFFECTIVE UNDER THE SECURITIES ACT; OR

(C) TO A QUALIFIED INSTITUTIONAL BUYER IN COMPLIANCE WITH RULE
144A UNDER THE SECURITIES ACT; OR

(D) IN AN OFFSHORE TRANSACTION IN COMPLIANCE WITH RULE 903 OR
RULE 904 OF REGULATION S UNDER THE SECURITIES ACT; OR

 

-55-

 

(E) PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED BY RULE
144 UNDER THE SECURITIES ACT OR ANY OTHER AVAILABLE EXEMPTION FROM
THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT.

THE RESALE RESTRICTION TERMINATION DATE WILL BE THE DATE (1) THAT IS AT LEAST
ONE YEAR AFTER THE ORIGINAL ISSUE DATE HEREOF AND (2) ON WHICH THE ISSUERS INSTRUCT
THE TRUSTEE THAT THIS LEGEND SHALL BE DEEMED REMOVED FROM THIS SECURITY, IN
ACCORDANCE WITH THE PROCEDURES DESCRIBED IN THE INDENTURE RELATED TO THIS SECURITY.

PRIOR TO THE REGISTRATION OF ANY TRANSFER IN ACCORDANCE WITH 2(B) ABOVE, THE
ISSUERS AND THE TRUSTEE RESERVE THE RIGHT TO REQUIRE THE DELIVERY OF SUCH LEGAL
OPINIONS, CERTIFICATIONS OR OTHER EVIDENCE AS MAY REASONABLY BE REQUIRED IN ORDER TO
DETERMINE THAT THE PROPOSED TRANSFER IS BEING MADE IN COMPLIANCE WITH THE SECURITIES
ACT AND APPLICABLE STATE SECURITIES LAWS. NO REPRESENTATION IS MADE AS TO THE
AVAILABILITY OF ANY EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES
ACT.”

(B) Notwithstanding the foregoing, any Global Note or Definitive Note issued
pursuant to subparagraphs (b)(4), (c)(3), (c)(4), (d)(2), (d)(3), (e)(2), (e)(3) or
(f) of this Section 2.06 (and all Notes issued in exchange therefor or substitution
thereof) shall not bear the Private Placement Legend.

(2) Global Note Legend. Each Global Note shall bear a legend in substantially the
following form:

“THIS GLOBAL NOTE IS HELD BY THE DEPOSITARY (AS DEFINED IN THE INDENTURE GOVERNING
THIS NOTE) OR ITS NOMINEE IN CUSTODY FOR THE BENEFIT OF THE BENEFICIAL OWNERS
HEREOF, AND IS NOT TRANSFERABLE TO ANY PERSON UNDER ANY CIRCUMSTANCES EXCEPT THAT
(1) THE TRUSTEE MAY MAKE SUCH NOTATIONS HEREON AS MAY BE REQUIRED PURSUANT TO
SECTION 2.01 AND SECTION 2.06 OF THE INDENTURE, (2) THIS GLOBAL NOTE MAY BE
EXCHANGED IN WHOLE BUT NOT IN PART PURSUANT TO SECTION 2.06(a) OF THE INDENTURE, (3)
THIS GLOBAL NOTE MAY BE DELIVERED TO THE TRUSTEE FOR CANCELLATION PURSUANT TO
SECTION 2.11 OF THE INDENTURE AND (4) THIS GLOBAL NOTE MAY BE TRANSFERRED TO A
SUCCESSOR DEPOSITARY WITH THE PRIOR WRITTEN CONSENT OF THE ISSUERS.

 

-56-

 

UNLESS AND UNTIL IT IS EXCHANGED IN WHOLE OR IN PART FOR NOTES IN DEFINITIVE FORM,
THIS NOTE MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY THE DEPOSITARY TO A NOMINEE OF
THE DEPOSITARY OR BY A NOMINEE OF THE DEPOSITARY TO THE DEPOSITARY OR ANOTHER
NOMINEE OF THE DEPOSITARY OR BY THE DEPOSITARY OR ANY SUCH NOMINEE TO A SUCCESSOR
DEPOSITARY OR A NOMINEE OF SUCH SUCCESSOR DEPOSITARY. UNLESS THIS CERTIFICATE IS
PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY (55 WATER
STREET, NEW YORK, NEW YORK) (“DTC”), TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF
TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME
OF CEDE & CO. OR SUCH OTHER NAME AS MAY BE REQUESTED BY AN AUTHORIZED REPRESENTATIVE
OF DTC (AND ANY PAYMENT IS MADE TO CEDE & CO. OR SUCH OTHER ENTITY AS MAY BE
REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE
HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE
REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN.”

(3) Regulation S Temporary Global Note Legend.

“THE RIGHTS ATTACHING TO THIS REGULATION S TEMPORARY GLOBAL NOTE, AND THE CONDITIONS
AND PROCEDURES GOVERNING ITS EXCHANGE FOR CERTIFICATED NOTES, ARE AS SPECIFIED IN
THE INDENTURE (AS DEFINED HEREIN). NEITHER THE HOLDER NOR THE BENEFICIAL OWNERS OF
THIS REGULATION S TEMPORARY GLOBAL NOTE SHALL BE ENTITLED TO RECEIVE PAYMENT OF
PRINCIPAL HEREOF OR INTEREST HEREON.”

(h) Cancellation and/or Adjustment of Global Notes. At such time as all beneficial interests
in a particular Global Note have been exchanged for Definitive Notes or a particular Global Note
has been redeemed, repurchased or canceled in whole and not in part, each such Global Note shall be
returned to or retained and canceled by the Trustee in accordance with Section 2.11 hereof. At any
time prior to such cancellation, if any beneficial interest in a Global Note is exchanged for or
transferred to a Person who shall take delivery thereof in the form of a beneficial interest in
another Global Note or for Definitive Notes, the principal amount of Notes represented by such
Global Note shall be reduced accordingly and an endorsement shall be made on such Global Note by
the Trustee or by the Depositary at the direction of the Trustee to reflect such reduction; and if
the beneficial interest is being exchanged for or transferred to a Person who shall take delivery thereof in the form of a
beneficial interest in another Global Note, such other Global Note shall be increased accordingly
and an endorsement shall be made on such Global Note by the Trustee or by the Depositary at the
direction of the Trustee to reflect such increase.

 

-57-

 

(i) General Provisions Relating to Transfers and Exchanges.

(1) To permit registrations of transfers and exchanges, the Issuers shall execute and
the Trustee shall authenticate Global Notes and Definitive Notes upon receipt of an
Authentication Order in accordance with Section 2.02 or at the Registrar’s request.

(2) No service charge shall be made to a Holder of a beneficial interest in a Global
Note or to a Holder of a Definitive Note for any registration of transfer or exchange, but
the Issuers may require payment of a sum sufficient to cover any transfer tax or similar
governmental charge payable in connection therewith (other than any such transfer taxes or
similar governmental charge payable upon exchange or transfer pursuant to Sections 2.10,
3.06, 3.09, 4.10, 4.15 and 9.05 hereof).

(3) The Registrar shall not be required to register the transfer of or exchange of any
Note selected for redemption in whole or in part, except the unredeemed portion of any Note
being redeemed in part.

(4) All Global Notes and Definitive Notes issued upon any registration of transfer or
exchange of Global Notes or Definitive Notes shall be the valid obligations of the Issuers,
evidencing the same debt, and entitled to the same benefits under this Indenture, as the
Global Notes or Definitive Notes surrendered upon such registration of transfer or exchange.

(5) The Issuers shall not be required:

(A) to issue, to register the transfer of or to exchange any Notes during a
period beginning at the opening of business 15 days before the day of any selection
of Notes for redemption under Section 3.02 hereof and ending at the close of
business on the day of selection;

(B) to register the transfer of or to exchange any Note selected for redemption
in whole or in part, except the unredeemed portion of any Note being redeemed in
part; or

(C) to register the transfer of or to exchange a Note between a record date and
the next succeeding interest payment date.

(6) Prior to due presentment for the registration of a transfer of any Note, the
Trustee, any Agent and the Issuers may deem and treat the Person in whose name
any Note is registered as the absolute owner of such Note for the purpose of receiving
payment of principal of and interest on such Notes and for all other purposes, and none of
the Trustee, any Agent or the Issuers shall be affected by notice to the contrary.

 

-58-

 

(7) The Trustee shall authenticate Global Notes and Definitive Notes in accordance with
the provisions of Section 2.02 hereof.

(8) All certifications, certificates and Opinions of Counsel required to be submitted
to the Registrar pursuant to this Section 2.06 to effect a registration of transfer or
exchange may be submitted by facsimile.

(9) The Trustee shall have no obligation or duty to monitor, determine or inquire as to
compliance with any restrictions on transfer imposed under this Indenture or under
applicable law with respect to any transfer of any interest in any Security (including any
transfers between or among Depositary Participants or beneficial owners of interests in any
Global Security) other than to require delivery of such certificates and other documentation
or evidence as are expressly required by, and to do so if and when expressly required by the
terms of, this Indenture, and to examine the same to determine substantial compliance as to
form with the express requirements hereof.

Section 2.07 Replacement Notes.

If any mutilated Note is surrendered to the Trustee or the Issuers and the Trustee receives
evidence to its satisfaction of the destruction, loss or theft of any Note, the Issuers shall issue
and the Trustee, upon receipt of an Authentication Order, shall authenticate a replacement Note if
the Trustee’s requirements are met. If required by the Trustee or the Issuers, an indemnity bond
must be supplied by the Holder that is sufficient in the judgment of the Trustee and the Issuers to
protect the Issuers, the Trustee, any Agent and any authenticating agent from any loss that any of
them may suffer if a Note is replaced. The Issuers may charge for their expenses in replacing a
Note.

Every replacement Note is an additional obligation of the Issuers and shall be entitled to all
of the benefits of this Indenture equally and proportionately with all other Notes duly issued
hereunder.

Section 2.08 Outstanding Notes.

The Notes outstanding at any time are all the Notes authenticated by the Trustee except for
those canceled by it, those delivered to it for cancellation, those reductions in the interest in a
Global Note effected by the Trustee in accordance with the provisions hereof, and those described
in this Section as not outstanding. Except as set forth in Section 2.09 hereof, a Note does not
cease to be outstanding because the Company or an Affiliate of the Company holds the Note; however,
Notes held by the Company or a Subsidiary of the Company shall not be deemed to be outstanding for
purposes of Section 3.07(a) hereof.

 

-59-

 

If a Note is replaced pursuant to Section 2.07 hereof, it ceases to be outstanding unless the
Trustee receives proof satisfactory to it that the replaced Note is held by a protected purchaser.

If the principal amount of any Note is considered paid under Section 4.01 hereof, it ceases to
be outstanding and interest on it ceases to accrue.

If the Paying Agent (other than the Company, a Subsidiary or an Affiliate of any thereof)
holds, on a redemption date or maturity date, money sufficient to pay Notes payable on that date,
then on and after that date such Notes shall be deemed to be no longer outstanding and shall cease
to accrue interest.

Section 2.09 Treasury Notes.

In determining whether the Holders of the required principal amount of Notes have concurred in
any direction, waiver or consent, Notes owned by the Company or any Guarantor, or by any Person
directly or indirectly controlling or controlled by or under direct or indirect common control with
the Company or any Guarantor, shall be considered as though not outstanding, except that for the
purposes of determining whether the Trustee shall be protected in relying on any such direction,
waiver or consent, only Notes that a Responsible Officer of the Trustee actually knows are so owned
shall be so disregarded.

Section 2.10 Temporary Notes.

Until certificates representing Notes are ready for delivery, the Issuers may prepare and the
Trustee, upon receipt of an Authentication Order, shall authenticate temporary Notes. Temporary
Notes shall be substantially in the form of certificated Notes but may have variations that the
Issuers consider appropriate for temporary Notes and as may be reasonably acceptable to the
Trustee. Without unreasonable delay, the Issuers shall prepare and the Trustee shall authenticate
definitive Notes in exchange for temporary Notes.

Holders of temporary Notes shall be entitled to all of the benefits of this Indenture.

Section 2.11 Cancellation.

The Issuers at any time may deliver Notes to the Trustee for cancellation. The Registrar and
Paying Agent shall forward to the Trustee any Notes surrendered to them for registration of
transfer, exchange or payment. The Trustee and no one else shall cancel all Notes surrendered for
registration of transfer, exchange, payment, replacement or cancellation and shall dispose of such
canceled Notes (subject to the record retention requirement of the Exchange Act). Certification of
the disposal of all canceled Notes shall be delivered to the Issuers upon their request therefor.
The Issuers may not issue new Notes to replace Notes that it has paid or that have been delivered
to the Trustee for cancellation.

 

-60-

 

Section 2.12 Defaulted Interest.

If the Issuers default in a payment of interest on the Notes, they shall pay the defaulted
interest in any lawful manner plus, to the extent lawful, interest payable on the defaulted
interest, to the Persons who are Holders on a subsequent special record date, in each case at the
rate provided in the Notes and in Section 4.01 hereof. The Issuers shall notify the Trustee in
writing of the amount of defaulted interest proposed to be paid on each Note and the date of the
proposed payment. The Issuers shall fix or cause to be fixed each such special record date and
payment date; provided that no such special record date may be less than 10 days prior to the
related payment date for such defaulted interest. At least 15 days before the special record date,
the Issuers (or, upon the written request of the Issuers, the Trustee in the name and at the
expense of the Issuers) shall mail or cause to be mailed to Holders a notice that states the
special record date, the related payment date and the amount of such interest to be paid.

Section 2.13 CUSIP Numbers.

The Issuers in issuing the Notes may use CUSIP numbers (if then generally in use), and, if so,
the Trustee will use CUSIP numbers in notices of redemption as a convenience to Holders; provided
that any such notice may state that no representation is made as to the correctness of such numbers
either as printed on the Notes or as contained in any notice of a redemption and that reliance may
be placed only on the other identification numbers printed on the Notes, and any such redemption
will not be affected by any defect in or omission of such numbers. The Issuers will promptly
notify the Trustee of any change in the CUSIP numbers.

Section 2.14 Issuance of Additional Notes.

The Issuers will be entitled, from time to time, subject to its compliance with Section 4.09
hereof, without consent of the Holders, to issue Additional Notes under this Indenture with
identical terms as the Initial Notes issued on the Issue Date other than with respect to (i) the
date of issuance, (ii) the issue price, (iii) the amount of interest payable on the first interest
payment date and (iv) any adjustments in order to conform to and ensure compliance with the
Securities Act (or other applicable securities laws). The Initial Notes issued on the Issue Date,
any Additional Notes and all Exchange Notes issued in exchange therefor will be treated as a single
class for all purposes under this Indenture.

With respect to any Additional Notes, the Issuers will set forth in an Officer’s Certificate
pursuant to a resolution of the Board of Directors of the Issuers, copies of which will be
delivered to the Trustee, the following information:

(1) the aggregate principal amount of such Additional Notes to be authenticated and
delivered pursuant to this Indenture;

 

-61-

 

(2) the issue price, the issue date and the CUSIP number of such Additional Notes;
provided, however, that no Additional Notes may be issued at a price that would cause such
Additional Notes to have “original issue discount” within the meaning of Section 1273 of the
Internal Revenue Code of 1986, as amended; and

(3) whether such Additional Notes will be subject to transfer restrictions or will be
issued in the form of Exchange Notes.

ARTICLE 3.

REDEMPTION AND PREPAYMENT

Section 3.01 Notices to Trustee.

If the Issuers elect to redeem Notes pursuant to the optional redemption provisions of Section
3.07 hereof, they must furnish to the Trustee, at least 30 days but not more than 60 days before
the redemption date, an Officer’s Certificate setting forth:

(1) the clause of this Indenture pursuant to which the redemption shall occur;

(2) the redemption date;

(3) the principal amount of Notes to be redeemed; and

(4) the redemption price.

Section 3.02 Selection of Notes to Be Redeemed or Purchased.

If less than all of the Notes are to be redeemed or purchased in an offer to purchase at any
time, the Trustee shall select Notes for redemption or purchase on a pro rata basis except:

(1) if the Notes are listed on any national securities exchange, in compliance with the
requirements of the principal national securities exchange on which the Notes are listed; or

(2) if otherwise required by law.

In the event of partial redemption or purchase by lot, the particular Notes to be redeemed or
purchased shall be selected, unless otherwise provided herein, not less than 30 nor more than 60
days prior to the redemption or purchase date by the Trustee from the outstanding Notes not
previously called for redemption or purchase.

 

-62-

 

The Trustee shall promptly notify the Issuers in writing of the Notes selected for redemption
or purchase and, in the case of any Note selected for partial redemption or purchase, the principal
amount thereof to be redeemed or purchased. Notes and portions of
Notes selected shall be in amounts of $2,000 or integral multiples of $1,000; except that if
all of the Notes of a Holder are to be redeemed or purchased, the entire outstanding amount of
Notes held by such Holder, even if not a multiple of $1,000, shall be redeemed or purchased.
Except as provided in the preceding sentence, provisions of this Indenture that apply to Notes
called for redemption or purchase also apply to portions of Notes called for redemption or
purchase.

Section 3.03 Notice of Redemption.

Subject to the provisions of Section 3.09 hereof, at least 30 days but not more than 60 days
before a redemption date, the Issuers shall mail or cause to be mailed, by first class mail, a
notice of redemption to each Holder whose Notes are to be redeemed at its registered address,
except that redemption notices may be mailed more than 60 days prior to a redemption date if the
notice is issued in connection with a defeasance of the Notes or a satisfaction and discharge of
this Indenture pursuant to Articles 8 or 11 of this Indenture.

The notice shall identify the Notes to be redeemed (including CUSIP Number(s)) and shall
state:

(1) the redemption date;

(2) the redemption price;

(3) if any Note is being redeemed in part, the portion of the principal amount of such
Note to be redeemed and that, after the redemption date upon surrender of such Note, a new
Note or Notes in principal amount equal to the unredeemed portion shall be issued upon
cancellation of the original Note;

(4) the name and address of the Paying Agent;

(5) that Notes called for redemption must be surrendered to the Paying Agent to collect
the redemption price;

(6) that, unless the Issuers default in making such redemption payment, interest and
Special Interest, if any, on Notes called for redemption ceases to accrue on and after the
redemption date;

(7) the paragraph of the Notes and/or Section of this Indenture pursuant to which the
Notes called for redemption are being redeemed; and

(8) that no representation is made as to the correctness or accuracy of the CUSIP
number, if any, listed in such notice or printed on the Notes.

At the Issuers’ request, the Trustee shall give the notice of redemption in the Issuers’ name
and at its expense; provided, however, that the Issuers have delivered to the Trustee, at least 45
days prior to the redemption date, an Officer’s Certificate requesting that
the Trustee give such notice and setting forth the information to be stated in such notice as
provided in the preceding paragraph.

 

-63-

 

Section 3.04 Effect of Notice of Redemption.

Once notice of redemption is mailed in accordance with Section 3.03 hereof, Notes called for
redemption become irrevocably due and payable on the redemption date at the redemption price. A
notice of redemption may not be conditional.

Section 3.05 Deposit of Redemption or Purchase Price.

Prior to 10:00 a.m. New York City time on the relevant redemption or purchase date, the
Issuers shall deposit with the Trustee or with the Paying Agent money sufficient to pay the
redemption or purchase price of and accrued interest and Special Interest, if any, on all Notes to
be redeemed or purchased on that date. The Trustee or the Paying Agent shall promptly return to
the Issuers any money deposited with the Trustee or the Paying Agent by the Issuers in excess of
the amounts necessary to pay the redemption or purchase price of, and accrued interest and Special
Interest, if any, on, all Notes to be redeemed or purchased.

If the Issuers comply with the provisions of the preceding paragraph, on and after the
redemption or purchase date, interest shall cease to accrue on the Notes or the portions of Notes
called for redemption or purchase. If a Note is redeemed or purchased on or after an interest
record date but on or prior to the related interest payment date, then any accrued and unpaid
interest shall be paid to the Person in whose name such Note was registered at the close of
business on such record date. If any Note called for redemption or purchase is not so paid upon
surrender for redemption or purchase because of the failure of the Issuers to comply with the
preceding paragraph, interest shall be paid on the unpaid principal, from the redemption or
purchase date until such principal is paid, and to the extent lawful on any interest not paid on
such unpaid principal, in each case at the rate provided in the Notes and in Section 4.01 hereof.

Section 3.06 Notes Redeemed or Purchased in Part.

Upon surrender of a Note that is redeemed or purchased in part, the Issuers shall issue and,
upon receipt of an Authentication Order, the Trustee shall authenticate for the Holder at the
expense of the Issuers a new Note equal in principal amount to the unredeemed or unpurchased
portion of the Note surrendered.

 

-64-

 

Section 3.07 Optional Redemption.

(a) At any time prior to May 15, 2014, the Issuers may on any one or more occasions redeem up
to 35% of the aggregate principal amount of Notes issued under this Indenture at a redemption price
of 108.375% of the principal amount thereof, plus accrued and unpaid interest and Special Interest,
if any, to the redemption date, with the net cash proceeds of one or more Equity Offerings by the
Issuers or a contribution to the common equity capital
of the Company from the net proceeds of one or more Equity Offerings by a direct or indirect
parent of the Company (in each case, other than Excluded Contributions and the net proceeds of a
sale of Designated Preferred Stock); provided that:

(1) at least 65% of the aggregate principal amount of Notes originally issued under
this Indenture (excluding Notes held by the Company and its Subsidiaries) remains
outstanding immediately after the occurrence of such redemption; and

(2) the redemption occurs within 90 days of the date of the closing of such Equity
Offering or equity contribution.

(b) At any time prior to May 15, 2014, the Issuers may redeem all or a part of the Notes, at a
redemption price equal to 100% of the principal amount of the Notes redeemed plus the Applicable
Premium as of, and accrued and unpaid interest and Special Interest, if any to, but excluding, the
date of redemption (the “Redemption Date”), subject to the rights of Holders of record of Notes on
the relevant record date to receive interest due on the relevant interest payment date.

(c) On or after May 15, 2014, the Issuers may redeem all or a part of the Notes upon not less
than 30 nor more than 60 days’ notice, at the redemption prices (expressed as percentages of
principal amount) set forth below plus accrued and unpaid interest and Special Interest, if any, on
the Notes redeemed, to but excluding the applicable redemption date, if redeemed during the
twelve-month period beginning on May 15 of the years indicated below, subject to the rights of
Holders on the relevant record date to receive interest on the relevant interest payment date:

	 	 	 	 	 
	Year	 	Percentage	 
	2014 
	 	 	106.281	%
	2015 
	 	 	104.188	%
	2016 
	 	 	102.094	%
	2017 and thereafter 
	 	 	100.000	%

(d) Any redemption pursuant to this Section 3.07 shall be made pursuant to the provisions of
Section 3.01 through 3.06 hereof.

Section 3.08 Mandatory Redemption.

The Issuers are not required to make mandatory redemption or sinking fund payments with
respect to the Notes.

Section 3.09 Offer to Purchase by Application of Excess Proceeds.

In the event that, pursuant to Section 4.10 hereof, the Company is required to commence an
Asset Sale Offer, it shall follow the procedures specified below.

 

-65-

 

The Asset Sale Offer shall be made to all Holders and if the Company elects (or is required by
the terms of other pari passu Indebtedness), all holders of other Indebtedness that is Pari Passu
with the Notes. The Asset Sale Offer shall remain open for a period of at least 20 Business Days
following its commencement and not more than 30 Business Days, except to the extent that a longer
period is required by applicable law (the “Offer Period”). No later than five Business Days after
the termination of the Offer Period (the “Purchase Date”), the Company shall apply all Excess
Proceeds (the “Offer Amount”) to the purchase of Notes and such other pari passu Indebtedness, if
any, (on a pro rata basis, if applicable) or, if less than the Offer Amount has been tendered, all
Notes and other Indebtedness tendered in response to the Asset Sale Offer. Payment for any Notes
so purchased shall be made pursuant to Section 4.01 hereof.

If the Purchase Date is on or after an interest record date and on or before the related
interest payment date, any accrued and unpaid interest and Special Interest, if any, shall be paid
to the Person in whose name a Note is registered at the close of business on such record date, and
no additional interest shall be payable to Holders who tender Notes pursuant to the Asset Sale
Offer.

Upon the commencement of an Asset Sale Offer, the Company shall send, by first class mail, a
notice to the Trustee and each of the Holders, with a copy to the Trustee. The notice shall
contain all instructions and materials necessary to enable such Holders to tender Notes pursuant to
the Asset Sale Offer. The notice, which shall govern the terms of the Asset Sale Offer, shall
state:

(1) that the Asset Sale Offer is being made pursuant to this Section 3.09 and Section
4.10 hereof and the length of time the Asset Sale Offer shall remain open;

(2) the Offer Amount, the purchase price and the Purchase Date;

(3) that any Note not tendered or accepted for payment shall continue to accrue
interest;

(4) that, unless the Company defaults in making such payment, any Note accepted for
payment pursuant to the Asset Sale Offer shall cease to accrue interest after the Purchase
Date;

(5) that Holders electing to have a Note purchased pursuant to an Asset Sale Offer may
elect to have Notes purchased in denominations of $2,000 or integral multiples of $1,000
only;

(6) that Holders electing to have Notes purchased pursuant to any Asset Sale Offer
shall be required to surrender the Note, with the form entitled “Option of Holder to Elect
Purchase” attached to the Notes completed, or transfer by book-entry transfer, to the
Company, a Depositary, if appointed by the Company, or a Paying
Agent at the address specified in the notice at least three days before the Purchase
Date;

 

-66-

 

(7) that Holders shall be entitled to withdraw their election if the Company, the
Depositary or the Paying Agent, as the case may be, receives, not later than on the
expiration of the Offer Period, a telegram, telex, facsimile transmission or letter setting
forth the name of the Holder, the principal amount of the Note the Holder delivered for
purchase and a statement that such Holder is withdrawing his election to have such Note
purchased;

(8) that, if the aggregate principal amount of Notes and other pari passu Indebtedness
surrendered by holders thereof exceeds the Offer Amount, the Company shall select the Notes
and other pari passu Indebtedness to be purchased on a pro rata basis based on the principal
amount of Notes and such other pari passu Indebtedness surrendered (with such adjustments as
may be deemed appropriate by the Company so that only Notes in denominations of $2,000, or
integral multiples of $1,000, shall be purchased); and

(9) that Holders whose Notes were purchased only in part shall be issued new Notes
equal in principal amount to the unpurchased portion of the Notes surrendered (or
transferred by book-entry transfer).

On or before the Purchase Date, the Company shall, to the extent lawful, accept for payment,
on a pro rata basis to the extent necessary, the Offer Amount of Notes or portions thereof tendered
pursuant to the Asset Sale Offer, or if less than the Offer Amount has been tendered, all Notes
tendered, and shall deliver or cause to be delivered to the Trustee the Notes properly accepted
together with an Officer’s Certificate stating that such Notes or portions thereof were accepted
for payment by the Company in accordance with the terms of this Section 3.09. The Company, the
Depositary or the Paying Agent, as the case may be, shall promptly (but in any case not later than
five days after the Purchase Date) mail or deliver to each tendering Holder an amount equal to the
purchase price of the Notes tendered by such Holder and accepted by the Company for purchase, and
the Company, shall promptly issue a new Note, and the Trustee, upon written request from the
Company shall authenticate and mail or deliver (or cause to be transferred by book entry) such new
Note to such Holder, in a principal amount equal to any unpurchased portion of the Note
surrendered. Any Note not so accepted shall be promptly mailed or delivered by the Company to the
Holder thereof. The Company shall publicly announce the results of the Asset Sale Offer on the
Purchase Date.

Other than as specifically provided in this Section 3.09, any purchase pursuant to this
Section 3.09 shall be made pursuant to the provisions of Sections 3.01 through 3.06 hereof.

 

-67-

 

ARTICLE 4.

COVENANTS

Section 4.01 Payment of Notes.

The Issuers shall pay or cause to be paid the principal of, premium, if any, and interest and
Special Interest, if any, on the Notes on the dates and in the manner provided in the Notes.
Principal, premium, if any, and interest and Special Interest, if any, shall be considered paid on
the date due if the Paying Agent, if other than the Company or a Subsidiary thereof, holds as of
10:00 a.m. New York City time on the due date money deposited by or on behalf of the Issuers in
immediately available funds and designated for and sufficient to pay all principal, premium, if
any, and interest then due. The Issuers shall pay all Special Interest, if any, in the same manner
on the dates and in the amounts set forth in the Registration Rights Agreement.

The Issuers shall pay interest (including post-petition interest in any proceeding under any
Bankruptcy Law) on overdue principal at the rate equal to 1% per annum in excess of the then
applicable interest rate on the Notes to the extent lawful; it shall pay interest (including
post-petition interest in any proceeding under any Bankruptcy Law) on overdue installments of
interest and Special Interest (without regard to any applicable grace period) at the same rate to
the extent lawful. Interest on the Notes shall accrue from the date of original issuance or, if
interest has already been paid, from the date it was most recently paid. Interest shall be computed
on the basis of a 360-day year comprised of twelve 30-day months.

Section 4.02 Maintenance of Office or Agency.

The Issuers shall maintain in the Borough of Manhattan, the City of New York, an office or
agency (which may be an office of the Trustee or an affiliate of the Trustee, Registrar or
co-registrar) where Notes may be surrendered for registration of transfer or for exchange and where
notices and demands to or upon the Issuers in respect of the Notes and this Indenture may be
served. The Issuers shall give prompt written notice to the Trustee of the location, and any
change in the location, of such office or agency. If at any time the Issuers fail to maintain any
such required office or agency or fail to furnish the Trustee with the address thereof, such
presentations, surrenders, notices and demands may be made or served at the Corporate Trust Office
of the Trustee.

The Issuers may also from time to time designate one or more other offices or agencies where
the Notes may be presented or surrendered for any or all such purposes and may from time to time
rescind such designations; provided, however, that no such designation or rescission shall in any
manner relieve the Issuers of their obligation to maintain an office or agency in the Borough of
Manhattan, the City of New York for such purposes. The Issuers shall give prompt written notice to
the Trustee of any such designation or rescission and of any change in the location of any such
other office or agency.

The Issuers hereby designate the New York Office of the Trustee as one such office or agency
of the Issuers in accordance with Section 2.03 hereof.

 

-68-

 

Section 4.03 Reports.

(a) Whether or not required by the rules and regulations of the SEC, so long as any Notes are
outstanding, the Company shall furnish to the Holders or to the Trustee with instructions to
furnish to the Holders, within 45 days after the end of each of the first three fiscal quarters of
each fiscal year commencing with the fiscal quarter ended March 31, 2011 or (in the case of annual
financial information) within 90 days after the end of each fiscal year, all quarterly and annual
financial information that would be required to be contained in a filing with the SEC on Forms 10-Q
and 10-K if the Company were required to file such Forms, including a “Management’s Discussion and
Analysis of Financial Condition and Results of Operations” and, with respect to the annual
information only, a report on the annual financial statements by the Company’s certified
independent accountants.

(b) Whether or not required by the SEC, the Company will file a copy of all of the information
and reports referred to above with the SEC for public availability within the time periods
specified above (unless the SEC will not accept such a filing) and make such information available
to securities analysts and prospective investors upon request.

(c) If in the event of a Specified Change of Control Parent Assumption, the Specified Change
of Control Parent assuming the Company’s obligations hereunder does not regularly file reports with
the SEC at the time of the Specified Change of Control Assumption Date and has ongoing material
operations, the Specified Change of Control Parent shall not be required to file reports with the
SEC until the date that is 180 days after the Specified Change of Control Parent Assumption, but
shall otherwise be required during such 180-day period to comply with the reporting obligations
contained in the prior paragraphs by posting any such reports on information on a website made
available to all Holders.

(d) In addition, Company will:

(1) hold a quarterly conference call to discuss the information contained in the annual
and quarterly reports required under Section 4.03(a) (the “Financial Reports”) not later
than five business days from the time the Company furnishes such reports to the Trustee; and

(2) no fewer than three Business Days prior to the date of the conference call required
to be held in accordance with clause (1) above, issue a press release to the appropriate
U.S. wire services announcing the time and date of such conference call and directing the
beneficial owners of, and prospective investors in, the Notes and securities analysts to
contact an individual at the Company (for whom contact information shall be provided in such
press release) to obtain the Financial Reports and information on how to access such
conference call.

 

-69-

 

(e) If, at any time after consummation of the Exchange Offer contemplated by the Registration
Rights Agreement, the Company is no longer subject to the periodic reporting requirements of the
Exchange Act for any reason, the Company shall nevertheless continue filing the Financial Reports
with the SEC within the time periods specified above unless the SEC will not accept such a filing.
The Company shall not take any action for the purpose of causing the SEC not to accept any such
filings. If, notwithstanding the foregoing, the SEC shall not accept the Company’s filings for any
reason, the Company shall post the reports referred to in the preceding paragraphs on its website
within the time periods that would apply if the Company were required to file those reports with
the SEC.

(f) In addition, the Company and the Guarantors agree that, for so long as any Notes remain
outstanding, if at any time they are not required to file with the SEC the reports required by the
preceding paragraphs, they shall furnish to the Holders and to securities analysts and prospective
investors, upon their request, the information required to be delivered pursuant to Rule 144A(d)(4)
under the Securities Act.

(g) Delivery of such reports, information and documents to the Trustee is for informational
purposes only and the Trustee’s receipt of such shall not constitute constructive notice of any
information contained therein or determinable from information contained therein, including the
Issuers’ compliance with any of their covenants hereunder (as to which the Trustee is entitled to
rely exclusively on Officer’s Certificates).

(h) The Issuers may satisfy their obligations under this Section 4.03 by furnishing financial
information relating to any direct or indirect parent company of the Company (which shall be
permitted, subject to compliance with this Indenture, at any time, at the Issuers’ sole
discretion); provided that either (x) a Covenant Termination Event has occurred; or (y) such parent
company is a Guarantor of the Notes and, if such parent company has material operations other than
through its ownership of the Company, such reports shall be accompanied by consolidating
information that explains in reasonable detail the differences between the information relating to
such parent and its subsidiaries that are not guarantors of the Notes, on the one hand, and the
information relating to the Issuers and their Restricted Subsidiaries on the other hand.

Section 4.04 Compliance Certificate.

(a) The Issuers and each Guarantor (to the extent that such Guarantor is so required under the
TIA) shall deliver to the Trustee, within 105 days after the end of each fiscal year of the
Company, an Officer’s Certificate stating that a review of the activities of the Issuers and their
Subsidiaries during the preceding fiscal year has been made under the supervision of the signing
Officers with a view to determining whether the Issuers have kept, observed, performed and
fulfilled their obligations under this Indenture, and further stating, as to each such Officer
signing such certificate, that to his or her knowledge the Issuers have kept, observed, performed
and fulfilled each and every covenant contained in this Indenture and are not in default in the
performance or observance of any of the terms, provisions and conditions of this Indenture (or, if
a Default or Event of Default has occurred, describing all such Defaults or Events of Default of which he or she may have knowledge and what action the Issuers
are taking or propose to take with respect thereto) and that to his or her knowledge no event has
occurred and remains in existence by reason of which payments on account of the principal of or
interest, if any, on the Notes is prohibited or if such event has occurred, a description of the
event and what action the Issuers are taking or propose to take with respect thereto.

 

-70-

 

(b) So long as not contrary to the then current recommendations of the American Institute of
Certified Public Accountants, the year-end financial statements delivered pursuant to Section 4.03
above shall be accompanied by a written statement of the Issuers’ independent public accountants
(who shall be a firm of established national reputation) that in making the examination necessary
for certification of such financial statements, nothing has come to their attention that would lead
them to believe that the Issuers have violated any provisions of Article 4 or Article 5 hereof or,
if any such violation has occurred, specifying the nature and period of existence thereof, it being
understood that such accountants shall not be liable directly or indirectly to any Person for any
failure to obtain knowledge of any such violation.

(c) So long as any of the Notes are outstanding, the Issuers shall deliver to the Trustee,
within 30 days upon any Officer becoming aware of any Default or Event of Default, an Officer’s
Certificate specifying such Default or Event of Default and what action the Issuers are taking or
propose to take with respect thereto.

Section 4.05 Taxes.

The Issuers shall pay, and shall cause each of its Subsidiaries to pay, prior to delinquency,
all material taxes, assessments, and governmental levies except such as are contested in good faith
and by appropriate proceedings or where the failure to effect such payment is not adverse in any
material respect to the Holders.

Section 4.06 Stay, Extension and Usury Laws.

The Issuers and each of the Guarantors covenant (to the extent that they may lawfully do so)
that they shall not at any time insist upon, plead, or in any manner whatsoever claim or take the
benefit or advantage of, any stay, extension or usury law wherever enacted, now or at any time
hereafter in force, that may affect the covenants or the performance of this Indenture; and the
Issuers and each of the Guarantors (to the extent that they may lawfully do so) hereby expressly
waive all benefit or advantage of any such law, and covenant that they shall not, by resort to any
such law, hinder, delay or impede the execution of any power herein granted to the Trustee, but
shall suffer and permit the execution of every such power as though no such law has been enacted.

 

-71-

 

Section 4.07 Restricted Payments.

(a) The Company shall not, and shall not permit any of its Restricted Subsidiaries to,
directly or indirectly:

(A) declare or pay any dividend or make any other payment or distribution on account of
the Company’s or any of its Restricted Subsidiaries’ Equity Interests (including, without
limitation, any payment in connection with any merger or consolidation involving the Company
or any of its Restricted Subsidiaries) or to the direct or indirect holders of the Company’s
or any of its Restricted Subsidiaries’ Equity Interests in their capacity as such (other
than dividends or distributions payable in Equity Interests (other than Disqualified Stock)
of the Company); provided that the repurchase, redemption or other acquisition or retirement
for value of any Equity Interests of a Restricted Subsidiary of the Company shall not
constitute a Restricted Payment;

(B) purchase, redeem or otherwise acquire or retire for value (including, without
limitation, in connection with any merger or consolidation involving the Company) any Equity
Interests of the Company or any direct or indirect parent of the Company;

(C) make any payment on or with respect to, or purchase, redeem, defease or otherwise
acquire or retire for value any Subordinated Indebtedness of the Company or any Guarantor
(excluding any intercompany Indebtedness between or among the Company and any of its
Restricted Subsidiaries), except (i) a payment of interest or principal at the Stated
Maturity thereof or (ii) the purchase, repurchase or other acquisition of any such
Subordinated Indebtedness purchased in anticipation of satisfying a sinking fund obligation,
principal installment or payment at final maturity, in each case within one year of the date
of acquisition; or

(D) make any Restricted Investment;

(all such payments and other actions set forth in these clauses (A) through (D) above being
collectively referred to as “Restricted Payments”), unless, at the time of and after giving effect
to such Restricted Payment:

(1) no Default or Event of Default has occurred and is continuing or would occur as a
consequence of such Restricted Payment;

(2) the Company would, at the time of such Restricted Payment and after giving pro
forma effect thereto as if such Restricted Payment had been made at the beginning of the
applicable four-quarter period, have been permitted to incur at least $1.00 of additional
Indebtedness pursuant to the Fixed Charge Coverage Ratio test set forth in Section 4.09(a)
of this Indenture; and

 

-72-

 

(3) such Restricted Payment, together with the aggregate amount of all other Restricted
Payments made by the Company and its Restricted Subsidiaries since the Issue Date (excluding
Restricted Payments permitted by clauses (2), (3), (4), (5), (6), (7), (8), (9), (10), (12),
(13), (14), (15), (16) and (17) of the next succeeding paragraph), is less than the sum,
without duplication, of:

(A) 50% of the Consolidated Net Income of the Company for the period (taken as
one accounting period) from April 1, 2011 to the end of the Company’s most recently
ended fiscal quarter for which internal financial statements are available at the
time of such Restricted Payment (or, if such Consolidated Net Income for such period
is a deficit, less 100% of such deficit); plus

(B) 100% of the aggregate Qualified Proceeds received by the Company since the
Issue Date as a contribution to its common equity capital or from the issue or sale
of Equity Interests of the Company (other than Disqualified Stock, Excluded
Contributions and the net proceeds from a sale of Designated Preferred Stock) or
from the issue or sale of convertible or exchangeable Disqualified Stock or
convertible or exchangeable debt securities of the Company that have been converted
into or exchanged for such Equity Interests (other than Equity Interests (or
Disqualified Stock or debt securities) sold to a Subsidiary of the Company); plus

(C) to the extent not already included in Consolidated Net Income, 100% of the
aggregate Qualified Proceeds from (x) the sale or other disposition (other than to
the Company or a Restricted Subsidiary of the Company) of any Restricted Investment
that was made after the Issue Date and (y) repurchases, redemptions and repayments
of such Restricted Investments and the receipt of any dividends or distributions
from such Restricted Investments; plus

(D) to the extent that any Unrestricted Subsidiary of the Company designated as
such after the Issue Date is redesignated as a Restricted Subsidiary of the Company
after the Issue Date, the Fair Market Value of the Company’s Investment in such
Subsidiary as of the date of such redesignation; plus

(E) in the event the Company and/or any Restricted Subsidiary of the Company
makes any Investment in a Person that, as a result of or in connection with such
Investment, becomes a Restricted Subsidiary of the Company, an amount equal to the
existing Investment of the Company and/or any of its Restricted Subsidiaries in such
Person that was previously treated as a Restricted Payment.

 

-73-

 

The sum of all amounts under clauses (a) through (e) above are hereinafter referred to as the
“Cumulative Buildup Basket.” Upon consummation of a Specified Change of Control transaction
pursuant to which a Restricted Payment is made pursuant to clause (19) of
the immediately succeeding paragraph, the Cumulative Buildup Basket, if positive immediately
prior to such Specified Change of Control transaction, shall be reset to zero. In the event of a
Specified Change of Control Parent Assumption, the Cumulative Buildup Basket shall be calculated on
a consolidated basis as to the Specified Change of Control Parent and its Restricted Subsidiaries;
provided, however that the Cumulative Buildup Basket shall not give effect to any amounts
attributable to the Specified Change of Control Parent and its subsidiaries (other than the Company
and its Restricted Subsidiaries) prior to the date of such Specified Change of Control transaction.

(b) The preceding provisions of Section 4.07(a) shall not prohibit:

(1) the payment of any dividend or other distribution or the consummation of any
irrevocable redemption within 60 days after the date of declaration of the dividend or
giving of the redemption notice, as the case may be, if at the date of declaration or
notice, the dividend or redemption payment would have complied with the provisions of this
Indenture;

(2) the making of any Restricted Payment in exchange for, or out of the net cash
proceeds of the substantially concurrent sale (other than to a Restricted Subsidiary of the
Company) of, Equity Interests of the Company (other than Disqualified Stock) or from the
substantially concurrent contribution of common equity capital to the Company; provided that
the amount of any such net cash proceeds that are utilized for any such Restricted Payment
shall be excluded from clause (3)(B) of Section 4.07(a);

(3) the repurchase, redemption, defeasance or other acquisition or retirement for value
of Subordinated Indebtedness of the Company or any Guarantor with the net cash proceeds from
a substantially concurrent incurrence of Permitted Refinancing Indebtedness;

(4) the declaration and payment of regularly scheduled or accrued dividends to holders
of any class or series of Disqualified Stock of the Company or any Restricted Subsidiary of
the Company issued on or after the Issue Date in accordance with Section 4.09;

(5) the repurchase, redemption or other acquisition or retirement for value of
Disqualified Stock of the Company or any Restricted Subsidiary of the Company made by
exchange for, or out of the proceeds of the substantially concurrent sale of Replacement
Preferred Stock that is permitted to be incurred pursuant to Section 4.09;

(6) the payment of any dividend or other distributions to holders of any class or
series of Designated Preferred Stock (other than Disqualified Stock) issued by the Company
after the Issue Date;

 

-74-

 

(7) the payment of any dividend (or any similar distribution) by a Restricted
Subsidiary of the Company to the holders of its Equity Interests on a pro rata basis;

(8) the repurchase, redemption or other acquisition or retirement for value of any
Equity Interests of the Company or any Restricted Subsidiary of the Company held by any
current or former officer, director, employee or consultant of the Company or any of its
Restricted Subsidiaries, and any dividend payment or other distribution by the Company or a
Restricted Subsidiary of the Company to a direct or indirect parent holding company of the
Company utilized for the repurchase, redemption or other acquisition or retirement for value
of any Equity Interests of such direct or indirect parent holding company held by any
current or former officer, director, employee or consultant of the Company or any of its
Restricted Subsidiaries, in each case, pursuant to any equity subscription agreement, stock
option agreement, shareholders’ agreement or similar agreement or benefit plan of any kind;
provided that the aggregate price paid for all such repurchased, redeemed, acquired or
retired Equity Interests may not exceed $15.0 million in any fiscal year (it being
understood, however, that unused amounts permitted to be paid pursuant to this proviso are
available to be carried over to subsequent fiscal years); provided further that such amount
in any fiscal year may be increased by an amount not to exceed:

(A) the cash proceeds from the sale of Equity Interests of the Company and, to
the extent contributed to the Company as common equity capital, Equity Interests of
the Company’s direct or indirect parent entities, in each case to members of
management, directors or consultants of the Company, any of its Subsidiaries or any
of its direct or indirect parent entities that occurs after the Issue Date, to the
extent the cash proceeds from the sale of such Equity Interests have not otherwise
been applied to the payment of Restricted Payments by virtue of clause (3)(B) of
Section 4.07(a), and excluding Excluded Contributions, plus

(B) the cash proceeds of key man life insurance policies received by the
Company and its Restricted Subsidiaries after the Issue Date, less

(C) the amount of any Restricted Payments previously made pursuant to clauses
(A) and (B) of this clause (8);

and provided, further, that cancellation of Indebtedness owing to the Company from members of
management, directors or consultants of the Company or any of its Restricted Subsidiaries, or any
direct or indirect parent holding company of the Company, in connection with a repurchase of Equity
Interests of the Company or any direct or indirect parent holding company of the Company shall not
be deemed to constitute a Restricted Payment for purposes of this covenant or any other provision
of this Indenture;

 

-75-

 

(9) the repurchase of Equity Interests deemed to occur upon the exercise of options,
rights or warrants to the extent such Equity Interests represent a portion of the exercise
price of those options, rights or warrants;

(10) the repurchase, redemption, defeasance or other acquisition or retirement for
value of Subordinated Indebtedness of the Company or any Guarantor with any Excess Proceeds
that remain after consummation of an Asset Sale Offer;

(11) so long as no Default has occurred and is continuing or would be caused thereby,
after the occurrence of a Change of Control and within 60 days after the completion of the
offer to repurchase the Notes pursuant to Section 4.15 of this Indenture (including the
purchase of the Notes tendered), any purchase or redemption of Subordinated Indebtedness
required pursuant to the terms thereof as a result of such Change of Control at a purchase
or redemption price not to exceed 101% of the outstanding principal amount thereof, plus any
accrued and unpaid interest; provided, however, the Company would be able to incur at least
$1.00 of additional Indebtedness pursuant to the Fixed Charge Coverage Ratio test set forth
in Section 4.09(a) after giving pro forma effect to such Restricted Payment;

(12) cash payments in lieu of fractional shares issuable as dividends on preferred
stock or upon the conversion of any convertible debt securities of the Company or any of its
Restricted Subsidiaries;

(13) Permitted Payments to Parent;

(14) so long as no Default has occurred and is continuing or would be caused thereby,
the payment:

(A) by the Company or any Restricted Subsidiary of the Company to any direct or
indirect parent of the Company, which payment is used by the Person receiving such
payment, following the first initial public offering of common Equity Interests by
such Person, to pay dividends of up to 6% per annum of the net proceeds received by
such Person in such public offering that are contributed to the Company as common
equity capital; or

(B) by the Company, following the first initial public offering of common
Equity Interests by the Company, to pay dividends of up to 6% per annum of the net
proceeds received by the Company in such public offering;

(excluding, in the case of both clause (A) and clause (B), public offerings of common Equity
Interests registered on Form S-8 and any other public sale to the extent the proceeds
thereof are Excluded Contributions);

(15) Investments that are made with Excluded Contributions;

 

-76-

 

(16) distributions or payments of Receivables Fees;

(17) all payments made or to be made in connection with the application of proceeds of
this offering and the related Transactions as described in the Offering Memorandum under the
caption “Use of Proceeds” and payments made as described under the caption “Certain
Relationships and Related Party Transactions,” including all payments contemplated by the
definition of Transactions;

(18) so long as no Default has occurred and is continuing or would be caused thereby,
other Restricted Payments in an aggregate amount not to exceed $100.0 million since the
Issue Date; and

(19) dividends or other payments or distributions on account of Equity Interests of the
Company or any of its Restricted Subsidiaries or of any counterparty to a Specified Change
of Control transaction, or the purchase, redemption or other acquisition or retirement for
value of any Equity Interests of the Company or any of its Restricted Subsidiaries or of any
counterparty to a Specified Change of Control transaction, in each case, made as part of a
Specified Change of Control transaction.

(c) The amount of all Restricted Payments (other than cash) shall be the Fair Market Value on
the date of the Restricted Payment of the asset(s) or securities proposed to be transferred or
issued by the Company or such Restricted Subsidiary, as the case may be, pursuant to the Restricted
Payment. The Fair Market Value of any assets or securities that are required to be valued by this
Section 4.07 shall be determined by the Board of Directors of the Company whose resolution with
respect thereto shall be delivered to the Trustee.

For purposes of determining compliance with the provisions set forth above, in the event that
a Restricted Payment meets the criteria of more than one of the types of Restricted Payments
described in the above clauses, the Company, in its sole discretion, may order and classify, and
from time to time may reorder and reclassify, such Restricted Payment, if it would have been
permitted at the time such Restricted Payment was made and at the time of any such
reclassification.

Section 4.08 Dividend and Other Payment Restrictions Affecting Restricted Subsidiaries.

(a) The Company shall not, and shall not permit any of its Restricted Subsidiaries to,
directly or indirectly, create or permit to exist or become effective any consensual encumbrance or
restriction on the ability of any Restricted Subsidiary of the Company to:

(1) pay dividends or make any other distributions on its Capital Stock to the Company
or any of its Restricted Subsidiaries, or with respect to any other interest or
participation in, or measured by, its profits, or pay any Indebtedness owed to the Company
or any of its Restricted Subsidiaries;

 

-77-

 

(2) make loans or advances to the Company or any of its Restricted Subsidiaries; or

(3) sell, lease or transfer any of its properties or assets to the Company or any of
its Restricted Subsidiaries.

(b) The preceding restrictions in Section 4.08(a) shall not apply to encumbrances or
restrictions existing under or by reason of:

(1) agreements governing Existing Indebtedness and Credit Facilities as in effect on
the Issue Date and any amendments, restatements, modifications, renewals, increases,
supplements, refundings, replacements or refinancings of those agreements; provided that the
amendments, restatements, modifications, renewals, increases, supplements, refundings,
replacements or refinancings are not materially more restrictive, taken as a whole, with
respect to such dividend and other payment restrictions than those contained in those
agreements on the Issue Date;

(2) this Indenture, the Notes and the Subsidiary Guarantees;

(3) applicable law, rule, regulation or order;

(4) any instrument governing Indebtedness or Capital Stock of a Restricted Subsidiary
of the Company acquired by the Company or any of its Restricted Subsidiaries as in effect at
the time of such acquisition (except to the extent such Indebtedness or Capital Stock was
incurred in connection with or in contemplation of such acquisition), which encumbrance or
restriction is not applicable to any Person, or the properties or assets of any Person,
other than the Person or any of its Subsidiaries, or the property or assets of the Person or
any of its Subsidiaries, so acquired; provided that, in the case of Indebtedness, such
Indebtedness was permitted by the terms of this Indenture to be incurred;

(5) customary non-assignment provisions in contracts and licenses entered into in the
ordinary course of business;

(6) customary restrictions in leases (including capital leases), security agreements or
mortgages or other purchase money obligations for property acquired in the ordinary course
of business that impose restrictions on the property purchased or leased of the nature
described in clause (3) of Section 4.08(a);

(7) any agreement for the sale or other disposition of all or substantially all the
Capital Stock or the assets of a Restricted Subsidiary that restricts distributions by that
Restricted Subsidiary pending the sale or other disposition;

(8) Permitted Refinancing Indebtedness; provided that the restrictions contained in the
agreements governing such Permitted Refinancing Indebtedness are not
materially more restrictive, taken as a whole, than those contained in the agreements
governing the Indebtedness being refinanced;

 

-78-

 

(9) Liens permitted to be incurred under Section 4.12 of this Indenture that limit the
right of the debtor to dispose of the assets subject to such Liens;

(10) provisions limiting the disposition or distribution of assets or property in joint
venture agreements, asset sale agreements, sale-leaseback agreements, stock sale agreements
and other similar agreements, which limitation is applicable only to the assets that are the
subject of such agreements;

(11) restrictions on cash or other deposits or net worth imposed by customers under
contracts entered into in the ordinary course of business;

(12) customary provisions imposed on the transfer of copyrighted or patented materials;

(13) customary provisions restricting dispositions of real property interests set forth
in any reciprocal easement agreements of the Company or any Restricted Subsidiary of the
Company;

(14) Indebtedness or other contractual requirements of a Receivables Subsidiary in
connection with a Qualified Receivables Transaction; provided that such restrictions apply
only to such Receivables Subsidiary;

(15) contracts entered into in the ordinary course of business, not relating to any
Indebtedness, and that do not, individually or in the aggregate, detract from the value of
property or assets of the Company or any Restricted Subsidiary of the Company in any manner
material to the Company or any Restricted Subsidiary of the Company;

(16) restrictions on the transfer of property or assets required by any regulatory
authority having jurisdiction over the Company or any Restricted Subsidiary of the Company
or any of their businesses;

(17) restrictions arising in connection with Indebtedness permitted under this
Indenture of a Restricted Subsidiary that is not a Guarantor;

(18) restrictions arising in connection with Permitted Liens; and

(19) in the event of a Specified Change of Control Parent Assumption, any instrument
governing Indebtedness or Capital Stock of the Specified Change of Control Parent or any of
its Restricted Subsidiaries (as in effect at the time of such Specified Change of Control
transaction) except to the extent such Indebtedness or Capital
Stock was incurred in connection with or in contemplation of such Specified Change of
Control transaction.

 

-79-

 

Section 4.09 Incurrence of Indebtedness and Issuance of Disqualified Stock and Preferred
Stock.

(a) The Company shall not, and shall not permit any of its Restricted Subsidiaries to,
directly or indirectly, create, incur, issue, assume, guarantee or otherwise become directly or
indirectly liable, contingently or otherwise, with respect to (collectively, “incur”) any
Indebtedness (including Acquired Debt), and the Company shall not issue any Disqualified Stock and
shall not permit any of its Restricted Subsidiaries to issue any shares of preferred stock;
provided, however, that the Issuers and the Guarantors may incur Indebtedness (including Acquired
Debt) or issue Disqualified Stock or preferred stock, if the Fixed Charge Coverage Ratio for the
Company’s most recently ended four full fiscal quarters for which internal financial statements are
available immediately preceding the date on which such additional Indebtedness is incurred or such
Disqualified Stock or such preferred stock is issued, as the case may be, would have been at least
2.0 to 1, determined on a pro forma basis (including a pro forma application of the net proceeds
therefrom), as if the additional Indebtedness had been incurred or the Disqualified Stock or the
preferred stock had been issued, as the case may be, at the beginning of such four-quarter period.

(b) The provisions of Section 4.09(a) shall not prohibit the incurrence of any of the
following items of Indebtedness or the issuance of any of the following items of Disqualified Stock
or preferred stock (collectively, “Permitted Debt”):

(1) the incurrence by the Company, IASIS Capital and/or any Restricted Subsidiary (and
the Guarantee thereof by the Guarantors, IASIS Capital and the Non-Guarantor Subsidiaries)
of Indebtedness under the Credit Agreement and other Credit Facilities entered into after
the date of the Credit Agreement in an aggregate principal amount at any one time
outstanding under this clause (1) (with letters of credit being deemed to have a principal
amount equal to the maximum potential liability of the Company and its Restricted
Subsidiaries thereunder) not to exceed the greater of (x) $1,325 million and (y) the
aggregate principal amount of Indebtedness that may be incurred such that (i) the
Consolidated Secured Debt Ratio (at the time of incurrence and after giving pro forma effect
thereto with such pro forma adjustments to Consolidated Total Indebtedness and Consolidated
Adjusted EBITDA as are appropriate and consistent with the pro forma adjustment provisions
set forth in the definition of “Fixed Charge Coverage Ratio”) would not exceed 3.75 to 1.00
and (ii) the Fixed Charge Coverage Ratio for the Company’s most recently ended four full
fiscal quarters for which internal financial statements are available immediately preceding
the date on which such additional Indebtedness is incurred would have been at least 2.0 to
1, determined on a pro forma basis (including a pro forma application of the net proceeds
therefrom), as if the additional Indebtedness had been incurred at the beginning of such
four-quarter period, less the aggregate amount of all Net Proceeds of Asset Sales applied by
the Company or any of its Restricted Subsidiaries since the Issue Date to
repay any term Indebtedness under a Credit Facility or to repay any revolving credit
Indebtedness under a Credit Facility and effect a corresponding commitment reduction
thereunder pursuant to the Section 4.10 of this Indenture; provided that any amount of
Indebtedness incurred pursuant to this clause (1) in excess of $1,325 million may be
incurred only under the Credit Agreement;

 

-80-

 

(2) the incurrence by the Company and its Restricted Subsidiaries of the Existing
Indebtedness (other than Indebtedness described in clauses (1) and (3));

(3) the incurrence by the Issuers and the Guarantors of Indebtedness represented by the
Notes to be issued on the Issue Date, replacement Notes in respect thereof, if any, and the
related Subsidiary Guarantees and the Exchange Notes and related Subsidiary Guarantees to be
issued pursuant to the Registration Rights Agreement;

(4) the incurrence or issuance by the Company or any of its Restricted Subsidiaries of
Indebtedness (including Capital Lease Obligations), Disqualified Stock or preferred stock,
in each case, incurred or issued for the purpose of financing all or any part of the
purchase price or cost of design, construction, lease, installation or improvement of
property, plant or equipment used or useful in a Permitted Business, in an aggregate
principal amount, including all Permitted Refinancing Indebtedness and Replacement Preferred
Stock incurred to renew, refund, refinance, replace, defease or discharge any Indebtedness
incurred pursuant to this clause (4), not to exceed the greater of $75.0 million and 3% of
Total Assets at any time outstanding;

(5) the incurrence by the Company or any of its Restricted Subsidiaries of Permitted
Refinancing Indebtedness or Replacement Preferred Stock in exchange for, or the net proceeds
of which are used to renew, refund, refinance, replace, defease or discharge any
Indebtedness (other than intercompany Indebtedness) or any Disqualified Stock or preferred
stock that was permitted by this Indenture to be incurred under Section 4.09(a) or clauses
(2), (3), (4), (5), (13), (15), (18), (19) or (21) of this Section 4.09(b);

(6) the incurrence by the Company or any of its Restricted Subsidiaries of intercompany
Indebtedness between or among the Company and any of its Restricted Subsidiaries; provided,
however, that:

(A) if the Company or any Guarantor is the obligor on such Indebtedness and the
payee is not the Company or a Guarantor, such Indebtedness must be unsecured and
expressly subordinated to the prior payment in full in cash of all Obligations then
due with respect to the Notes, in the case of the Company or the Subsidiary
Guarantee, in the case of a Guarantor, except to the extent such subordination would
violate a material contract as in effect on the Issue Date or is not permitted
pursuant to applicable laws, rules or regulations; and

 

-81-

 

(B) (i) any subsequent issuance or transfer of Equity Interests that results in
any such Indebtedness being held by a Person other than the Company or a Restricted
Subsidiary of the Company and (ii) any sale or other transfer of any such
Indebtedness to a Person that is not either the Company or a Restricted Subsidiary
of the Company, shall be deemed, in each case, to constitute a new incurrence of
such Indebtedness by the Company or such Restricted Subsidiary, as the case may be,
which new incurrence is not permitted by this clause (6);

(7) the issuance by any of the Company’s Restricted Subsidiaries to the Company or to
any of its Restricted Subsidiaries of shares of preferred stock; provided, however, that:

(A) any subsequent issuance or transfer of Equity Interests that results in any
such preferred stock being held by a Person other than the Company or a Restricted
Subsidiary of the Company; and

(B) any sale or other transfer of any such preferred stock to a Person that is
not either the Company or a Restricted Subsidiary of the Company,

will be deemed, in each case, to constitute a new issuance of such preferred stock
by such Restricted Subsidiary which new issuance is not permitted by this clause
(7);

(8) the incurrence by the Company or any of its Restricted Subsidiaries of Hedging
Obligations in the ordinary course of business;

(9) the guarantee:

(A) by the Issuers or any of the Guarantors of Indebtedness of the Company or a
Restricted Subsidiary of the Company that was permitted to be incurred by another
provision of this Section 4.09; provided that if the Indebtedness being guaranteed
is subordinated to or pari passu with the Notes, then the guarantee shall be
subordinated or pari passu, as applicable, to the same extent as the Indebtedness
guaranteed;

(B) by any Restricted Subsidiary that is not a Guarantor of Indebtedness of a
Restricted Subsidiary that is not a Guarantor; and

(C) by the Issuers or any Restricted Subsidiary of Indebtedness of the
Specified Change of Control Parent or its Subsidiaries (other than debt securities
issued in a capital markets transaction); provided that the Fixed Charge Coverage
Ratio for the Company’s most recently ended four full fiscal quarters for which
internal financial statements are available immediately preceding the date on which
such guarantee is incurred would have been at least 2.0 to 1, determined on a pro forma basis (including a pro forma application of the net
proceeds therefrom), as if such guarantee had been incurred at the beginning of such
four-quarter period;

 

-82-

 

(10) the incurrence by the Company or any of its Restricted Subsidiaries of
Indebtedness in respect of workers’ compensation claims, self-insurance obligations,
bankers’ acceptances, letters of credit, performance bonds, surety bonds, appeal bonds or
other similar bonds in the ordinary course of business; provided, however, that upon the
drawing of letters of credit for reimbursement obligations, including with respect to
workers’ compensation claims, or the incurrence of other Indebtedness with respect to
reimbursement type obligations regarding workers’ compensation claims, such obligations are
reimbursed within 30 days following such drawing or incurrence;

(11) the incurrence by the Company or any of its Restricted Subsidiaries of
Indebtedness arising from the honoring by a bank or other financial institution of a check,
draft or similar instrument inadvertently (except in the case of daylight overdrafts) drawn
against insufficient funds in the ordinary course of business, so long as such Indebtedness
is extinguished within five Business Days;

(12) the incurrence of Indebtedness arising from agreements of the Company or a
Restricted Subsidiary of the Company providing for indemnification, adjustment of purchase
price, holdback, contingency payment obligations or similar obligations, in each case,
incurred or assumed in connection with the disposition or acquisition of any business,
assets or Capital Stock of the Company or any Restricted Subsidiary;

(13) the incurrence of Indebtedness or the issuance of any Disqualified Stock or
preferred stock by any Non-Guarantor Subsidiary of the Company, in an amount not to exceed
$30.0 million at any time outstanding; provided that after giving effect to such incurrence
or issuance, the Company would be permitted to incur at least $1.00 of additional
Indebtedness pursuant to the Fixed Charge Coverage Ratio test set forth in Section 4.09(a);

(14) the incurrence of Indebtedness resulting from endorsements of negotiable
instruments for collection in the ordinary course of business;

(15) Indebtedness, Disqualified Stock or preferred stock of Persons that are acquired
by the Company or any Restricted Subsidiary (including by way of merger or consolidation) in
accordance with the terms of this Indenture; provided that such Indebtedness, Disqualified
Stock or preferred stock is not incurred in contemplation of such acquisition or merger; and
provided, further, that after giving effect to such acquisition or merger, either

 

-83-

 

(A) the Company would be permitted to incur at least $1.00 of additional
Indebtedness pursuant to the Fixed Charge Coverage Ratio; or

(B) the Company’s Fixed Charge Coverage Ratio after giving pro forma effect to
such acquisition or merger would be greater than the Company’s actual Fixed Charge
Coverage Ratio immediately prior to such acquisition or merger;

(16) Indebtedness of the Company or a Restricted Subsidiary in respect of netting
services, overdraft protection and otherwise in connection with deposit accounts; provided
that such Indebtedness remains outstanding for ten Business Days or less;

(17) Physician Support Obligations incurred by the Company or any of its Restricted
Subsidiaries;

(18) the incurrence by a Receivables Subsidiary of Indebtedness in a Qualified
Receivables Transaction;

(19) the incurrence or issuance by the Company or any of its Restricted Subsidiaries of
additional Indebtedness, Disqualified Stock or preferred stock in an aggregate principal
amount (or accreted value or liquidation preference, as applicable) at any time outstanding,
including all Permitted Refinancing Indebtedness and all Replacement Preferred Stock
incurred to renew, refund, refinance, replace, defease or discharge any Indebtedness,
Disqualified Stock and preferred stock incurred or issued pursuant to this clause (19), not
to exceed the greater of $125.0 million and 5% of Total Assets;

(20) Indebtedness incurred on behalf of or representing Guarantees of Indebtedness of
joint ventures of the Company or any Restricted Subsidiaries not in excess of $50.0 million
at any time outstanding; and

(21) in the event of a Specified Change of Control Parent Assumption, Indebtedness,
Disqualified Stock or preferred stock of the Specified Change of Control Parent or any of
its Restricted Subsidiaries (except to the extent incurred in connection with such Specified
Change of Control Transaction); provided that the Specified Change of Control Parent would,
on the date of such transaction after giving pro forma effect thereto and any related
financing, be permitted to incur at least $1.00 of additional Indebtedness pursuant to the
Fixed Charge Coverage Ratio test set forth in Section 4.09(a) or have a Fixed Charge
Coverage Ratio that is greater than the actual Fixed Charge Coverage Ratio of the Company
immediately prior to such transaction.

 

-84-

 

For purposes of determining compliance with this Section 4.09, in the event that an item of
proposed Indebtedness meets the criteria of more than one of the categories of Permitted Debt
described in clauses (1) through (21) above, or is entitled to be incurred pursuant to Section
4.09(a), the Company shall be permitted to classify such item of Indebtedness on the date of its
incurrence, or later reclassify all or a portion of such item of Indebtedness, in any manner that
complies with this Section 4.09. Indebtedness under the Credit Agreement
outstanding on the date on which Notes are first issued and authenticated under this Indenture
shall be deemed to have been incurred on such date in reliance on the exception provided by clause
(1) of this Section 4.09(b). The accrual of interest, the accretion or amortization of original
issue discount, the payment of interest on any Indebtedness in the form of additional Indebtedness
with the same terms, the reclassification of preferred stock as Indebtedness due to a change in
accounting principles, and the payment of dividends on Disqualified Stock or preferred stock in the
form of additional shares of the same class of Disqualified Stock or preferred stock shall not be
deemed to be an incurrence of Indebtedness or an issuance of Disqualified Stock or preferred stock
for purposes of this Section 4.09; provided, in each such case, that the amount thereof is included
in Fixed Charges of the Company as accrued (other than the reclassification of preferred stock as
Indebtedness due to a change in accounting principles).

The amount of any Indebtedness outstanding as of any date will be:

(1) the accreted value of the Indebtedness, in the case of any Indebtedness issued with
original issue discount;

(2) the principal amount of the Indebtedness, in the case of any other Indebtedness;
and

(3) in respect of Indebtedness of another Person secured by a Lien on the assets of the
specified Person, the lesser of:

(A) the Fair Market Value of such assets at the date of determination; and

(B) the amount of the Indebtedness of the other Person.

Section 4.10 Asset Sales.

(a) The Company shall not, and shall not permit any of its Restricted Subsidiaries to,
consummate an Asset Sale unless:

(1) the Company (or the Restricted Subsidiary, as the case may be) receives
consideration at the time of the Asset Sale at least equal to the Fair Market Value of the
assets or Equity Interests issued or sold or otherwise disposed of; and

(2) at least 75% of the consideration received in the Asset Sale by the Company or such
Restricted Subsidiary is in the form of cash other than in the case where the Company or
such Restricted Subsidiary is undertaking a Hospital Swap. For purposes of this provision,
each of the following shall be deemed to be cash:

(A) Cash Equivalents;

 

-85-

 

(B) any liabilities, as shown on the Company’s most recent consolidated balance
sheet, of the Company or any Restricted Subsidiary of the Company (other than
contingent liabilities and liabilities that are by their terms subordinated to the
Notes or any Subsidiary Guarantee) that are assumed by the transferee of any such
assets pursuant to a customary novation agreement that releases the Company or such
Restricted Subsidiary from further liability;

(C) any securities, notes or other obligations received by the Company or any
such Restricted Subsidiary from such transferee that are converted by the Company or
such Restricted Subsidiary into cash within 180 days of receipt, to the extent of
the cash received in that conversion;

(D) any Designated Noncash Consideration the Fair Market Value of which, when
taken together with all other Designated Noncash Consideration received pursuant to
this clause (d) (and not subsequently converted into Cash Equivalents that are
treated as Net Proceeds of an Asset Sale) does not exceed $40.0 million since the
Issue Date, with the Fair Market Value of each item of Designated Noncash
Consideration being measured at the time received and without giving effect to
subsequent changes in value; and

(E) any stock or assets of the kind referred to in clauses (2) or (4) of
Section 4.10(b) hereof.

Notwithstanding the foregoing, the 75% limitation referred to in clause (2) above shall not
apply to any Asset Sale in which the cash or Cash Equivalent portion of the consideration received
therefrom, determined in accordance with the foregoing provision, is equal to or greater than what
the after-tax proceeds would have been had such Asset Sale complied with the aforementioned 75%
limitation.

(b) Within 365 days after the receipt of any Net Proceeds from an Asset Sale, the Company (or
the applicable Restricted Subsidiary, as the case may be) may apply such Net Proceeds at its
option:

(1) to permanently repay:

(x) Obligations under a Credit Facility to the extent such Obligations were
incurred under paragraph (1) of the definition of “Permitted Debt” and to
correspondingly reduce any outstanding commitments with respect thereto or
other Indebtedness secured by the assets subject to such Asset Sale;

 

-86-

 

(y) Obligations under the Notes or any other Pari Passu Indebtedness of the
Issuers or any Restricted Subsidiary (and, in the case of other Pari Passu
Indebtedness, to correspondingly reduce any outstanding commitments with
respect thereto if applicable); provided that if the Issuers or any Restricted Subsidiary shall so repay any other Pari Passu
Indebtedness, the Issuers will reduce Obligations under the Notes on a pro
rata basis by, at its option, (A) redeeming Notes as described in Section
3.07, (B) making an offer (in accordance with the procedures set forth in
Section 3.09 for an Asset Sale Offer) to all Holders to purchase their Notes
at 100% of the principal amount thereof, plus the amount of accrued but
unpaid interest, if any, thereon up to the principal amount of Notes to be
repurchased or (C) purchasing Notes through privately negotiated
transactions or open market purchases, at a price equal to or higher than
100% of the principal amount thereof, in a manner that complies with this
Indenture and applicable securities law; or

(z) Indebtedness of a Restricted Subsidiary that is not a Guarantor, other
than Indebtedness owed to the Issuers or another Restricted Subsidiary;

(2) to acquire all or substantially all of the assets of, or any Capital Stock of,
another Permitted Business, if, after giving effect to any such acquisition of Capital
Stock, the Permitted Business is or becomes a Restricted Subsidiary of the Company;

(3) to make a capital expenditure; or

(4) (4) to acquire Additional Assets;

provided that the requirements of clauses (2) through (4) above shall be extended by an additional
180 days if an agreement (including a lease, whether a capital lease or an operating lease)
committing to make the acquisitions or expenditures referred to therein is entered into by the
Company or its Restricted Subsidiary within 365 days after the receipt of such Net Proceeds and
such Net Proceeds are applied in accordance with such agreement.

Pending the final application of any Net Proceeds, the Company may temporarily reduce
revolving credit borrowings or otherwise invest such Net Proceeds in any manner that is not
prohibited by this Indenture.

(c) Any Net Proceeds from Asset Sales that are not applied or invested as provided in Section
4.10(b) hereof shall constitute “Excess Proceeds.” When the aggregate amount of Excess Proceeds
exceeds $25.0 million, within ten Business Days thereof, the Company shall make an Asset Sale Offer
to all Holders and if the Company elects (or is required by the terms of such other pari passu
Indebtedness), all holders of other Indebtedness that is pari passu with the Notes (an “Asset Sale
Offer”) to purchase the maximum aggregate principal amount of Notes and such pari passu
Indebtedness, in denominations of $2,000 initial principal amount and multiples of $1,000
thereafter, that may be purchased out of the Excess Proceeds at an offer price in cash in an amount
equal to 100% of the principal amount thereof, or, in the case of Pari Passu Indebtedness
represented by securities sold at a discount, the amount of the accreted value thereof at such
time, plus accrued and unpaid interest and
Special Interest, if any, to the date fixed

 

-87-

 

for the closing of such offer, in accordance with
the procedures set forth in this Indenture.  In the event that the Company or a Restricted
Subsidiary prepays any Pari Passu Indebtedness that is outstanding under a revolving credit or
other committed loan facility pursuant to an Asset Sale Offer, the Company or such Restricted
Subsidiary shall cause the related loan commitment to be reduced in an amount equal to the
principal amount so prepaid. If any Excess Proceeds remain after consummation of an Asset Sale
Offer, the Company may use such Excess Proceeds for any purpose not otherwise prohibited by this
Indenture. If the aggregate principal amount of Notes and such other pari passu Indebtedness
tendered into such Asset Sale Offer exceeds the amount of Excess Proceeds, the Trustee shall select
the Notes and such other pari passu Indebtedness to be purchased on a pro rata basis. Upon
completion of each Asset Sale Offer, the amount of Excess Proceeds shall be reset at zero.

(d) The Company will comply with the requirements of Rule 14e-1 under the Exchange Act and any
other securities laws and regulations thereunder to the extent such laws and regulations are
applicable in connection with each repurchase of Notes pursuant to an Asset Sale Offer. To the
extent that the provisions of any securities laws or regulations conflict with the provisions of
Sections 3.09 or 4.10 of this Indenture, the Company shall comply with the applicable securities
laws and regulations and shall not be deemed to have breached its obligations under Section 3.09 or
this Section 4.10 by virtue of such compliance.

Section 4.11 Transactions with Affiliates.

(a) The Company shall not, and shall not permit any of its Restricted Subsidiaries to, make
any payment to, or sell, lease, transfer or otherwise dispose of any of its properties or assets
to, or purchase any property or assets from, or enter into or make or amend any transaction,
contract, agreement, understanding, loan, advance or guarantee with, or for the benefit of, any
Affiliate of the Company involving aggregate consideration in excess of $10.0 million (each, an
“Affiliate Transaction”), unless:

(1) the Affiliate Transaction is on terms that, taken as a whole, are not materially
less favorable to the Company or the relevant Restricted Subsidiary than those that would
have been obtained in a comparable transaction by the Company or such Restricted Subsidiary
with an unrelated Person; and

(2) the Company delivers to the Trustee, with respect to any Affiliate Transaction or
series of related Affiliate Transactions involving aggregate consideration in excess of
$20.0 million, a resolution of the Board of Directors of the Company set forth in an
Officer’s Certificate certifying that such Affiliate Transaction complies with clause (1) of
this Section 4.11(a) and that such Affiliate Transaction has been approved by a majority of
the members of the Board of Directors of the Company.

 

-88-

 

(b) The following items shall not be deemed to be Affiliate Transactions and, therefore, shall
not be subject to the provisions of Section 4.11(a):

(1) any employment agreement, employee benefit plan, officer or director
indemnification agreement or any similar arrangement entered into by the Company or any of
its Restricted Subsidiaries in the ordinary course of business and payments pursuant
thereto;

(2) transactions between or among the Company and/or its Restricted Subsidiaries or any
entity that becomes a Restricted Subsidiary as a result of such transaction;

(3) transactions with a Person (other than an Unrestricted Subsidiary of the Company)
that is an Affiliate of the Company solely because the Company owns, directly or through a
Restricted Subsidiary of the Company, an Equity Interest in, or controls, such Person;

(4) payment of reasonable directors’ fees;

(5) any issuance of Equity Interests (other than Disqualified Stock) of the Company to
Affiliates of the Company;

(6) Permitted Investments or Restricted Payments that do not violate Section 4.07
hereof;

(7) payment of fees and the reimbursement of other expenses to the Permitted Holders in
connection with the Transactions on the terms as described in the Offering Memorandum under
the caption “Certain Relationships and Related Party Transactions”;

(8) payment of Subordinated Management Fees in each fiscal year not in excess of the
lesser of (x) 0.25% of the Company’s net revenue as reflected on the budget prepared for
such fiscal year by the management of the Company and approved by the Board of Directors of
the Company and (y) $5.0 million, pursuant to the Management Services Agreement as in effect
on the Issue Date and the reimbursement of all other expenses;

(9) loans (or cancellation of loans) or advances to employees in the ordinary course of
business;

(10) transactions with customers, suppliers, contractors, joint venture partners or
purchasers or sellers of goods or services, in each case which are in the ordinary course of
business (including, without limitation, pursuant to joint venture agreements) and otherwise
in compliance with the terms of this Indenture, and which are fair to the Company or its
Restricted Subsidiaries, as applicable, in the reasonable determination of the Board of
Directors, chief executive officer or chief financial officer of the Company or its
Restricted Subsidiaries, as applicable, or are on terms at
least as favorable as might reasonably have been obtained at such time from an
unaffiliated party;

 

-89-

 

(11) the existence of, or the performance by the Company or any Restricted Subsidiary
of their obligations under the terms of, any stockholders agreement, partnership agreement
or limited liability company agreement (including any registration rights agreement or
purchase agreement related thereto) to which it is a party as of the Issue Date as described
in the Offering Memorandum under the caption “Certain Relationships and Related Party
Transactions” and any similar agreements which it may enter into thereafter; provided,
however, that the existence of, or the performance by the Company or any Restricted
Subsidiary of obligations under any future amendment to any such existing agreement or under
any similar agreement entered into after the Issue Date will only be permitted by this
clause to the extent that the terms of any such amendment or new agreement, taken as a
whole, are not materially disadvantageous to the holders of the Notes, as determined in good
faith by the Board of Directors, chief executive officer or chief financial officer of the
Company;

(12) the Transactions, including all payments made or to be made in connection with the
Transactions as described in the Offering Memorandum under the captions “Use of Proceeds”
and “Certain Relationships and Related Party Transactions”;

(13) any Qualified Receivables Transaction;

(14) Permitted Payments to Parent;

(15) any management, financial advisory, financing, underwriting or placement services
or any other investment banking, banking or similar services involving the Company and any
of its Restricted Subsidiaries (including without limitation any payments in cash, Equity
Interests or other consideration made by the Company or any of its Restricted Subsidiaries
in connection therewith) on the one hand and the Permitted Holders on the other hand, which
services (and payments and other transactions in connection therewith) are approved by a
majority of the members of the Board of Directors of the Company in good faith;

(16) the issuance of Equity Interests (other than Disqualified Stock) in the Company or
any Restricted Subsidiary of the Company for compensation purposes;

(17) intellectual property licenses in the ordinary course of business;

(18) Existing Indebtedness and any other obligations pursuant to an agreement existing
on the Issue Date, including any amendment thereto (so long as such amendment is not
disadvantageous to the Holders in any material respect);

 

-90-

 

(19) payments by the Company or any of its Restricted Subsidiaries of reasonable
insurance premiums to, and any borrowings from, any Insurance Subsidiary,
in each case on terms that are no less favorable to the Company or such Restricted
Subsidiary than those that would have been obtained in a comparable arm’s-length transaction
by the Company or such Restricted Subsidiary with a Person that is not an Affiliate of the
Company; and

(20) (x) the guarantee by the Company or any of its Restricted Subsidiaries of the
Indebtedness of any parent company of the Company that becomes the parent company of the
Company in a Change of Control transaction consummated in accordance with this Indenture, or
of any Indebtedness of Subsidiaries of such parent company; provided that such guarantee was
permitted by the terms of this Indenture to be incurred and (y) the granting by the Company
or any of its Restricted Subsidiaries of any Liens to secure such Indebtedness or such
guarantee; provided that such Liens are permitted to be incurred under this Indenture.

Section 4.12 Liens.

The Company shall not, and shall not permit any of its Restricted Subsidiaries to create,
incur, assume or otherwise cause or suffer to exist or become effective any Lien of any kind (other
than Permitted Liens) securing Indebtedness upon any of their property or assets, now owned or
hereafter acquired, or any income or profits therefrom unless all payments due under this Indenture
and the Notes (or a Guarantee in the case of Liens of a Guarantor) are secured on an equal and
ratable basis with the obligations so secured until such time as such obligations are no longer
secured by a Lien.

Section 4.13 Business Activities.

The Company shall not, and shall not permit any of its Restricted Subsidiaries to, engage in
any business other than Permitted Businesses, except to such extent as would not be material to the
Company and its Restricted Subsidiaries taken as a whole.

Section 4.14 Corporate Existence.

Subject to Article 5 hereof, the Company shall do or cause to be done all things necessary to
preserve and keep in full force and effect:

(1) its limited liability company existence, and the corporate, limited liability
company, partnership or other existence of each of its Restricted Subsidiaries, in
accordance with the respective organizational documents (as the same may be amended from
time to time) of the Company or any such Restricted Subsidiary; and

(2) the rights (charter and statutory), licenses and franchises of the Company and its
Restricted Subsidiaries;

provided, however, that the Company shall not be required to preserve any such right, license or
franchise, or the corporate, limited liability company, partnership or other existence of any
of its Restricted Subsidiaries, if the Board of Directors of the Company determines that the
preservation thereof is no longer desirable in the conduct of the business of the Company and its
Restricted Subsidiaries, taken as a whole, and that the loss thereof is not adverse in any material
respect to the Holders.

 

-91-

 

Section 4.15 Offer to Repurchase Upon Change of Control.

(a) If a Change of Control occurs after the date hereof, unless the Issuers have previously or
concurrently mailed a redemption notice with respect to all the outstanding Notes as described
under Sections 3.07 or 12.01 of this Indenture, the Issuers will make an offer to purchase all of
the Notes pursuant to the offer described below (the “Change of Control Offer”) at a price in cash
(the “Change of Control Payment”) equal to 101% of the aggregate principal amount thereof plus
accrued and unpaid interest and Special Interest, if any, to, but excluding, the date of purchase
subject to the right of Holders on the relevant record date to receive interest due on the relevant
interest payment date. Within 30 days following any Change of Control, the Issuers will send notice
of such Change of Control Offer by first class mail, with a copy to the Trustee, to each Holder of
Notes to the address of such Holder appearing in the security register with a copy to the Trustee
or otherwise in accordance with the procedures of DTC, with the following information:

(1) that the Change of Control Offer is being made pursuant to this Section 4.15 and
that all Notes tendered pursuant to such Change of Control Offer will be accepted for
payment by the Issuers;

(2) the purchase price and the purchase date, which shall be no earlier than 30 days
nor later than 60 days from the date such notice is mailed (the “Change of Control Payment
Date”);

(3) that any Note not tendered will remain outstanding and continue to accrue interest;

(4) that, unless the Issuers default in the payment of the Change of Control Payment,
all Notes accepted for payment pursuant to the Change of Control Offer will cease to accrue
interest on the Change of Control Payment Date;

(5) that Holders electing to have any Notes purchased pursuant to a Change of Control
Offer will be required to surrender such Notes, with the form entitled “Option of Holder to
Elect Purchase” on the reverse of such Notes completed, to the Paying Agent specified in the
notice at the address specified in the notice prior to the close of business on the third
Business Day preceding the Change of Control Payment Date;

(6) that Holders will be entitled to withdraw their tendered Notes and their election
to require the Issuers to purchase such Notes; provided that the Paying Agent receives, not
later than the expiration time of the Change of Control Offer, a telegram, telex, facsimile
transmission or letter setting forth the name of the Holder, the principal amount of Notes tendered for purchase, and a statement that such Holder is
withdrawing its election to have such Notes purchased;

 

-92-

 

(7) that if a Holder requests that only a portion of a Note held by it be purchased,
such Holder will be issued a new Note equal in principal amount to the unpurchased portion
of the Note surrendered. The unpurchased portion of the Note must be equal to $2,000 or an
integral multiple of $1,000 in excess thereof;

(8) if such notice is delivered prior to the occurrence of a Change of Control, stating
that the Change of Control Offer is conditional on the occurrence of such Change of Control;
and

(9) the other instructions, as determined by us, consistent with the covenant
hereunder, that a Holder must follow.

While the Notes are in global form and the Issuers make an offer to purchase all of the Notes
pursuant to the Change of Control Offer, a Holder may exercise its option to elect for the purchase
of the Notes through the facilities of DTC, subject to its rules and regulations.

The Issuers shall comply with the requirements of Rule 14e-1 under the Exchange Act and any
other securities laws and regulations thereunder to the extent those laws and regulations are
applicable in connection with the repurchase of the Notes as a result of a Change of Control. To
the extent that the provisions of any securities laws or regulations conflict with the provisions
of Sections 3.09 or 4.15 of this Indenture, the Company shall comply with the applicable securities
laws and regulations and shall not be deemed to have breached its obligations under Section 3.09 or
this Section 4.15 by virtue of such compliance.

(b) On the Change of Control Payment Date, the Issuers shall, to the extent lawful:

(1) accept for payment all Notes or portions of Notes properly tendered pursuant to the
Change of Control Offer;

(2) deposit with the Paying Agent an amount equal to the Change of Control Payment in
respect of all Notes or portions of Notes properly tendered; and

(3) deliver or cause to be delivered to the Trustee the Notes so accepted together with
an Officer’s Certificate stating the aggregate principal amount of Notes or portions of
Notes being purchased by the Issuers.

The Paying Agent shall promptly mail (but in any case not later than five days after the
Change of Control Payment Date) to each Holder of Notes properly tendered the Change of Control
Payment for such Notes, and the Trustee shall promptly authenticate and mail (or cause to be
transferred by book entry) to each Holder a new Note equal in principal
amount to any unpurchased portion of the Notes surrendered, if any. The Issuers shall
publicly announce the results of the Change of Control Offer on or as soon as practicable after the
Change of Control Payment Date.

 

-93-

 

(c) Notwithstanding anything to the contrary in this Section 4.15, the Issuers shall not be
required to make a Change of Control Offer upon a Change of Control if (1) a third party makes the
Change of Control Offer in the manner, at the times and otherwise in compliance with the
requirements set forth in this Section 4.15 hereof and purchases all Notes validly tendered and not
withdrawn under the Change of Control Offer, or (2) notice of redemption has been given pursuant to
Section 3.07 of this Indenture unless and until there is a Default in payment of the applicable
redemption price.

(d) Notwithstanding anything to the contrary in this Section 4.15, a Change of Control Offer
may be made in advance of a Change of Control, conditioned upon such Change of Control, if a
definitive agreement is in place for the Change of Control at the time of the making of such Change
of Control Offer.

Section 4.16 Specified Change of Control.

In connection with a Specified Change of Control, the Company may, by notice to the Trustee
identifying the Specified Change of Control Parent and the Specified Change of Control Parent
Assumption Date, elect to effect a Specified Change of Control Parent Assumption. If such election
is made, on the Specified Change of Control Assumption Date, the Specified Change of Control Parent
Assumption shall occur, and the Issuers shall be released from all of their obligations under this
Indenture. The Issuers and the Trustee shall execute a supplemental indenture effectuating such
assumption and release.

Section 4.17 Designation of Restricted and Unrestricted Subsidiaries.

The Board of Directors of the Company may designate any Restricted Subsidiary to be an
Unrestricted Subsidiary if that designation would not cause a Default. If a Restricted Subsidiary
is designated as an Unrestricted Subsidiary, the aggregate Fair Market Value of all outstanding
Investments owned by the Company and its Restricted Subsidiaries in the Subsidiary designated as an
Unrestricted Subsidiary shall be deemed to be an Investment made as of the time of the designation
and shall reduce the amount available for Restricted Payments under Section 4.07 or under one or
more clauses of the definition of Permitted Investments, as determined by the Company. That
designation shall only be permitted if the Investment would be permitted at that time and if the
Restricted Subsidiary otherwise meets the definition of an Unrestricted Subsidiary. The Board of
Directors of the Company may redesignate any Unrestricted Subsidiary to be a Restricted Subsidiary
if that redesignation would not cause a Default and either: (1) the Issuers could incur at least
$1.00 of additional Indebtedness pursuant to the Fixed Charge Coverage Ratio test described in
Section 4.09(a) or (2) the Fixed Charge Coverage Ratio for the Issuers and the Restricted
Subsidiaries would be greater than such ratio for the Issuers and the Restricted Subsidiaries
immediately
prior to such designation, in each case on a pro forma basis taking into account such
designation.

 

-94-

 

Any designation of a Subsidiary of the Company as an Unrestricted Subsidiary shall be
evidenced to the Trustee by filing with the Trustee a certified copy of a resolution of the Board
of Directors of the Company giving effect to such designation and an Officer’s Certificate
certifying that such designation complied with the preceding conditions and was permitted by
Section 4.07. If, at any time, any Unrestricted Subsidiary would fail to meet the preceding
requirements as an Unrestricted Subsidiary, it shall thereafter cease to be an Unrestricted
Subsidiary for purposes of this Indenture and any Indebtedness of such Subsidiary shall be deemed
to be incurred by a Restricted Subsidiary of the Company as of such date and, if such Indebtedness
is not permitted to be incurred as of such date under Section 4.09, the Company shall be in Default
of Section 4.09. The Board of Directors of the Company may at any time designate any Unrestricted
Subsidiary to be a Restricted Subsidiary of the Company; provided that such designation shall be
deemed to be an incurrence of Indebtedness by a Restricted Subsidiary of the Company of any
outstanding Indebtedness of such Unrestricted Subsidiary, and such designation shall only be
permitted if (1) such Indebtedness is permitted under Section 4.09 and (2) no Default or Event of
Default would be in existence following such designation.

Section 4.18 Existence of Corporate Co-Issuer.

The Company shall always maintain a Wholly Owned Subsidiary that is a Restricted Subsidiary of
the Company organized as a corporation under the laws of the United States of America, any State
thereof or the District of Columbia that will serve as a co-issuer of the Notes unless the Company
is itself a corporation under the laws of the United States of America, any State thereof or the
District of Columbia.

Section 4.19 Payments for Consent.

The Company shall not, and shall not permit any of its Restricted Subsidiaries to, directly or
indirectly, pay or cause to be paid any consideration to or for the benefit of any Holder for or as
an inducement to any consent, waiver or amendment of any of the terms or provisions of this
Indenture or the Notes unless such consideration is offered to be paid and is paid to all Holders
that consent, waive or agree to amend in the time frame set forth in the solicitation documents
relating to such consent, waiver or agreement.

 

-95-

 

Section 4.20 Additional Subsidiary Guarantees.

If the Company or any of its Restricted Subsidiaries, acquires or creates another Subsidiary,
other than a Non-Guarantor Subsidiary, after the Issue Date that guarantees Indebtedness under the
Credit Agreement, then that newly acquired or created Subsidiary shall become a Guarantor and
execute a Subsidiary Guarantee pursuant to a supplemental indenture in form and substance
satisfactory to the Trustee and deliver an Opinion of Counsel in form and substance satisfactory to
the Trustee within 30 Business Days of the date on which it was acquired or created. The form of
such Subsidiary Guarantee is attached as Exhibit E hereto

Section 4.21 Covenant Termination.

At any time after the Notes have received Investment Grade Ratings from both Rating Agencies
(a “Covenant Termination Event”), upon notice by the Company to the Trustee certifying that a
Covenant Termination Event has occurred and that at the time of the giving of such notice no
Default has occurred and is continuing under this Indenture (a “Covenant Termination Event
Notice”), the Issuers and the Restricted Subsidiaries will not thereafter be subject to the
following provisions of this Indenture:

(1) Section 4.07;

(2) Section 4.08;

(3) Section 4.09;

(4) Section 4.10;

(5) Section 4.11;

(6) any provision contained in Section 4.17 requiring compliance with any test for the
incurrence of Indebtedness; and

(7) Section 5.01(a)(4).

Upon delivery of a Covenant Termination Event Notice, the Guarantees of the Guarantors will
also be released.

 

-96-

 

ARTICLE 5.

SUCCESSORS

Section 5.01 Merger, Consolidation, or Sale of Assets.

(a) The Company shall not, directly or indirectly: (1) consolidate or merge with or into
another Person (whether or not the Company is the surviving corporation); or (2) sell, assign,
transfer, convey or otherwise dispose of all or substantially all of the properties or assets of
the Company and its Restricted Subsidiaries taken as a whole, in one or more related transactions,
to another Person, unless:

(1) either:

(A) the Company is the surviving entity; or

(B) the Person formed by or surviving any such consolidation or merger (if
other than the Company) or to which such sale, assignment, transfer, conveyance or
other disposition has been made is an entity organized or existing under the laws of
the United States, any state of the United States or the District of Columbia;

(2) the Person formed by or surviving any such consolidation or merger (if other than
the Company) or the Person to which such sale, assignment, transfer, conveyance or other
disposition has been made assumes all the obligations of the Company under the Notes, this
Indenture and the Registration Rights Agreement pursuant to agreements reasonably
satisfactory to the Trustee; provided, however, that at all times, a corporation organized
and existing under the laws of the United States of America, any State thereof or the
District of Columbia must be a co-issuer or the issuer of the Notes;

(3) immediately after such transaction, no Default or Event of Default exists; and

(4) the Company or the Person formed by or surviving any such consolidation or merger
(if other than the Company), or to which such sale, assignment, transfer, conveyance or
other disposition has been made would, on the date of such transaction after giving pro
forma effect thereto and any related financing transactions as if the same had occurred at
the beginning of the applicable four-quarter period:

(A) be permitted to incur at least $1.00 of additional Indebtedness pursuant to
the Fixed Charge Coverage Ratio test set forth in Section 4.09(a) herein or

 

-97-

 

(B) have a Fixed Charge Coverage Ratio that is greater than the actual Fixed
Charge Coverage Ratio of the Company immediately prior to such transaction.

In addition, the Company shall not, directly or indirectly, lease all or substantially all of
the properties and assets of it and its Restricted Subsidiaries taken as a whole, in one or more
related transactions, to any other Person.

(b) The provisions of Section 5.01(a) shall not apply to:

(1) a merger of the Company with an Affiliate solely for the purpose of reincorporating
the Company in another jurisdiction or any other transaction the sole purpose of which is to
reorganize the Company as a corporation;

(2) any consolidation or merger, or any sale, assignment, transfer, conveyance, lease
or other disposition of assets between or among the Company and its Restricted Subsidiaries;
and

(3) transfers of accounts receivable and related assets of the type specified in the
definition of Qualified Receivables Transaction (or a fractional undivided interest therein)
by a Receivables Subsidiary in a Qualified Receivables Transaction.

Section 5.02 Successor Corporation Substituted.

Upon any consolidation or merger, or any sale, assignment, transfer, lease, conveyance or
other disposition of all or substantially all of the assets of the Company in a transaction that is
subject to, and that complies with the provisions of, Section 5.01 hereof, the successor Person
formed by such consolidation or into or with which the Company is merged or to which such sale,
assignment, transfer, lease, conveyance or other disposition is made shall succeed to, and be
substituted for (so that from and after the date of such consolidation, merger, sale, assignment,
transfer, lease, conveyance or other disposition, the provisions of this Indenture referring to the
“Company” shall refer instead to the successor Person and not to the Company), and may exercise
every right and power of the Company under this Indenture with the same effect as if such successor
Person had been named as the Company herein; provided, however, that the predecessor Company, if
any, shall not be relieved from the obligation to pay the principal of and interest on the Notes
except in the case of a sale of all or substantially all of the properties or assets of the Company
and its Restricted Subsidiaries taken as whole in a transaction that is subject to, and that
complies with the provisions of, Section 5.01 hereof.

 

-98-

 

ARTICLE 6.

DEFAULTS AND REMEDIES

Section 6.01 Events of Default.

Each of the following is an “Event of Default”:

(1) default for 30 days in the payment when due of interest on, or Special Interest, if
any, with respect to, the Notes;

(2) default in the payment when due (at maturity, upon redemption, acceleration or
otherwise) of the principal of, or premium, if any, on, the Notes;

(3) failure by the Company or any of its Restricted Subsidiaries to comply with the
provisions of Section 5.01 hereof;

(4) failure by the Company or any of its Restricted Subsidiaries for 60 days after
notice to the Company by the Trustee or the Holders of at least 25% in aggregate principal
amount of the Notes then outstanding voting as a single class to comply with any of the
other agreements in this Indenture;

(5) default under any mortgage, indenture or instrument under which there may be issued
or by which there may be secured or evidenced any Indebtedness for money borrowed by the
Company or any of its Significant Subsidiaries (or the payment of which is guaranteed by the
Company or any of its Significant Subsidiaries), whether such Indebtedness or Guarantee now
exists, or is created after the Issue Date, if that default:

(A) is caused by a failure to pay principal at the final Stated Maturity of
such Indebtedness (a “Payment Default”); or

(B) results in the acceleration of such Indebtedness prior to its express
maturity,

and, in each case, the principal amount of such Indebtedness, together with the
principal amount of any other such Indebtedness under which there has been a Payment
Default or the maturity of which has been so accelerated, aggregates $30.0 million
or more;

(6) with respect to any judgment or decree for the payment of money (net of any amount
covered by insurance issued by a reputable and creditworthy insurer that has not contested
coverage or reserved rights with respect to an underlying claim) in excess of $30.0 million
or its foreign currency equivalent against the Company or any Restricted Subsidiary of the
Company, the failure by the Company or such Restricted Subsidiary, as applicable, to pay
such judgment or decree, which judgment or
decree has remained outstanding for a period of 60 days after such judgment or decree
became final and nonappealable without being paid, discharged, waived or stayed;

 

-99-

 

(7) except as permitted by this Indenture, any Subsidiary Guarantee of any Significant
Subsidiary is declared to be unenforceable or invalid by any final and nonappealable
judgment or decree or ceases for any reason to be in full force and effect, or any
Guarantor, that is a Significant Subsidiary or any Person acting on behalf of any Guarantor
that is a Significant Subsidiary denies or disaffirms its obligations in writing under its
Subsidiary Guarantee and such Default continues for 10 days after receipt of the notice
specified in this Indenture;

(8) either of the Issuers or any of the Company’s Restricted Subsidiaries that is a
Significant Subsidiary pursuant to or within the meaning of Bankruptcy Law:

(A) commences a voluntary case,

(B) consents to the entry of an order for relief against it in an involuntary
case,

(C) consents to the appointment of a custodian of it or for all or
substantially all of its property,

(D) makes a general assignment for the benefit of its creditors, or

(E) generally is not paying its debts as they become due; and

(9) a court of competent jurisdiction enters an order or decree under any Bankruptcy
Law that:

(A) is for relief against either of the Issuers or any of the Company’s
Restricted Subsidiaries that is a Significant Subsidiary in an involuntary case;

(B) appoints a custodian of either of the Issuers or any of the Company’s
Restricted Subsidiaries that is a Significant Subsidiary for all or substantially
all of the property of either of the Issuers or any of the Company’s Restricted
Subsidiaries that is a Significant Subsidiary; or

(C) orders the liquidation of either of the Issuers or any of the Company’s
Restricted Subsidiaries that is a Significant Subsidiary;

and the order or decree remains unstayed and in effect for 60 consecutive days.

 

-100-

 

Section 6.02 Acceleration.

In the case of an Event of Default specified in clause (8) or (9) of Section 6.01 hereof, all
outstanding Notes shall become due and payable immediately without further action or notice. If any
other Event of Default occurs and is continuing, the Trustee or the Holders of at least 25% in
aggregate principal amount of the then outstanding Notes may declare all the Notes to be due and
payable immediately.

Upon any such declaration, the Notes shall become due and payable immediately. The Holders of
a majority in aggregate principal amount of the then outstanding Notes by written notice to the
Trustee may, on behalf of all of the Holders, rescind an acceleration or waive any existing Default
or Event of Default and its consequences under this Indenture except a continuing Default or Event
of Default in the payment of interest or premium or Special Interest, if any, on, or the principal
of, the Notes.

Section 6.03 Other Remedies.

If an Event of Default occurs and is continuing, the Trustee may pursue any available remedy
to collect the payment of principal, premium and Special Interest, if any, and interest on the
Notes or to enforce the performance of any provision of the Notes or this Indenture.

The Trustee may maintain a proceeding even if it does not possess any of the Notes or does not
produce any of them in the proceeding. A delay or omission by the Trustee or any Holder of a Note
in exercising any right or remedy accruing upon an Event of Default shall not impair the right or
remedy or constitute a waiver of or acquiescence in the Event of Default. All remedies are
cumulative to the extent permitted by law.

Section 6.04 Waiver of Past Defaults.

Holders of a majority in aggregate principal amount of the then outstanding Notes by notice to
the Trustee may on behalf of the Holders of all of the Notes waive an existing Default or Event of
Default and its consequences hereunder, except a continuing Default or Event of Default in the
payment of the principal of, premium and Special Interest, if any, or interest on, the Notes
(including in connection with an offer to purchase); provided, however, that the Holders of a
majority in aggregate principal amount of the then outstanding Notes may rescind an acceleration
and its consequences, including any related payment default that resulted from such acceleration.
Upon any such waiver, such Default shall cease to exist, and any Event of Default arising therefrom
shall be deemed to have been cured for every purpose of this Indenture; but no such waiver shall
extend to any subsequent or other Default or impair any right consequent thereon.

 

-101-

 

Section 6.05 Control by Majority.

Holders of a majority in principal amount of the then outstanding Notes may direct the time,
method and place of conducting any proceeding for exercising any remedy available to the Trustee or
exercising any trust or power conferred on it. However, the Trustee may refuse to follow any
direction that conflicts with law or this Indenture that the Trustee determines may be unduly
prejudicial to the rights of other Holders or that may involve the Trustee in personal liability.

Section 6.06 Limitation on Suits.

A Holder may pursue a remedy with respect to this Indenture or the Notes only if:

(1) such Holder has previously given the Trustee notice that an Event of Default is
continuing;

(2) Holders of at least 25% in aggregate principal amount of the then outstanding Notes
have requested the Trustee to pursue the remedy;

(3) such Holders have offered the Trustee reasonable security or indemnity reasonably
satisfactory to it against any loss, liability or expense;

(4) the Trustee has not complied with such request within 60 days after the receipt of
the request and the offer of security or indemnity; and

(5) Holders of a majority in aggregate principal amount of the then-outstanding Notes
have not given the Trustee a direction inconsistent with such request within such 60-day
period.

Section 6.07 Rights of Holders to Receive Payment.

Notwithstanding any other provision of this Indenture, the right of any Holder of a Note to
receive payment of principal, premium and Special Interest, if any, and interest on the Note, on or
after the respective due dates expressed in the Note (including in connection with an offer to
purchase), or to bring suit for the enforcement of any such payment on or after such respective
dates, shall not be impaired or affected without the consent of such Holder.

Section 6.08 Collection Suit by Trustee.

If an Event of Default specified in Section 6.01(1) or (2) occurs and is continuing, the
Trustee is authorized to recover judgment in its own name and as trustee of an express trust
against the Company and each Guarantor for the whole amount of principal of, premium and Special
Interest, if any, and interest remaining unpaid on the Notes and interest on overdue principal and,
to the extent lawful, interest and such further amount as shall be sufficient
to cover the costs and expenses of collection, including the reasonable compensation,
expenses, disbursements and advances of the Trustee, its agents and counsel.

 

-102-

 

Section 6.09 Trustee May File Proofs of Claim.

The Trustee is authorized to file such proofs of claim and other papers or documents as may be
necessary or advisable in order to have the claims of the Trustee (including any claim for the
reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and
counsel) and the Holders of the Notes allowed in any judicial proceedings relative to the Company
(or any other obligor upon the Notes), its creditors or its property and shall be entitled and
empowered to collect, receive and distribute any money or other property payable or deliverable on
any such claims and any custodian in any such judicial proceeding is hereby authorized by each
Holder to make such payments to the Trustee, and in the event that the Trustee shall consent to the
making of such payments directly to the Holders, to pay to the Trustee any amount due to it for the
reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and
counsel, and any other amounts due to the Trustee under Section 7.07 hereof. To the extent that
the payment of any such compensation, expenses, disbursements and advances of the Trustee, its
agents and counsel, and any other amounts due the Trustee under Section 7.07 hereof out of the
estate in any such proceeding, shall be denied for any reason, payment of the same shall be secured
by a Lien on, and shall be paid out of, any and all distributions, dividends, money, securities and
other properties that the Holders may be entitled to receive in such proceeding whether in
liquidation or under any plan of reorganization or arrangement or otherwise. Nothing herein
contained shall be deemed to authorize the Trustee to authorize or consent to or accept or adopt on
behalf of any Holder any plan of reorganization, arrangement, adjustment or composition affecting
the Notes or the rights of any Holder, or to authorize the Trustee to vote in respect of the claim
of any Holder in any such proceeding.

Section 6.10 Priorities.

If the Trustee collects any money pursuant to this Article 6, it shall pay out the money in
the following order:

First: to the Trustee, its agents and attorneys for amounts due under Section 7.07
hereof, including payment of all compensation, expenses and liabilities incurred, and all
advances made, by the Trustee and the costs and expenses of collection;

Second: to Holders for amounts due and unpaid on the Notes for principal, premium and
Special Interest, if any, and interest, ratably, without preference or priority of any kind,
according to the amounts due and payable on the Notes for principal, premium and Special
Interest, if any, and interest, respectively; and

Third: to the Company or to such party as a court of competent jurisdiction shall
direct.

The Trustee may fix a record date and payment date for any payment to Holders pursuant to this
Section 6.10.

 

-103-

 

Section 6.11 Undertaking for Costs.

In any suit for the enforcement of any right or remedy under this Indenture or in any suit
against the Trustee for any action taken or omitted by it as a Trustee, a court in its discretion
may require the filing by any party litigant in the suit of an undertaking to pay the costs of the
suit, and the court in its discretion may assess reasonable costs, including reasonable attorneys’
fees and expenses, against any party litigant in the suit, having due regard to the merits and good
faith of the claims or defenses made by the party litigant. This Section 6.11 does not apply to a
suit by the Trustee, a suit by a Holder of a Note pursuant to Section 6.07 hereof, or a suit by
Holders of more than 10% in principal amount of the then outstanding Notes.

ARTICLE 7.

TRUSTEE

Section 7.01 Duties of Trustee.

(a) If an Event of Default has occurred and is continuing, the Trustee shall exercise such of
the rights and powers vested in it by this Indenture, and use the same degree of care and skill in
its exercise, as a prudent person would exercise or use under the circumstances in the conduct of
such person’s own affairs.

(b) Except during the continuance of an Event of Default:

(1) the duties of the Trustee shall be determined solely by the express provisions of
this Indenture and the Trustee need perform only those duties that are specifically set
forth in this Indenture and no others, and no implied covenants or obligations shall be read
into this Indenture against the Trustee; and

(2) in the absence of bad faith on its part, the Trustee may conclusively rely, as to
the truth of the statements and the correctness of the opinions expressed therein, upon
certificates or opinions furnished to the Trustee and conforming to the requirements of this
Indenture. However, in the case of certificates or opinions specifically required by any
provision hereof to be furnished to it, the Trustee shall examine the certificates and
opinions to determine whether or not they conform to the requirements of this Indenture (but
need not to confirm or investigate the accuracy of mathematical calculations or other facts
stated therein).

 

-104-

 

(c) The Trustee may not be relieved from liabilities for its own negligent action, its own
negligent failure to act, or its own willful misconduct, except that:

(1) this paragraph does not limit the effect of paragraph (b) of this Section 7.01;

(2) the Trustee shall not be liable for any error of judgment made in good faith by a
Responsible Officer, unless it is proved that the Trustee was negligent in ascertaining the
pertinent facts; and

(3) the Trustee shall not be liable with respect to any action it takes or omits to
take in good faith in accordance with a direction received by it pursuant to Section 6.05
hereof.

(d) Whether or not therein expressly so provided, every provision of this Indenture that in
any way relates to the Trustee is subject to paragraphs (a), (b), and (c) of this Section 7.01.

(e) No provision of this Indenture shall require the Trustee to expend or risk its own funds
or incur any liability.

(f) The Trustee shall not be liable for interest on any money received by it except as the
Trustee may agree in writing with the Company. Money held in trust by the Trustee need not be
segregated from other funds except to the extent required by law.

Section 7.02 Rights of Trustee.

(a) The Trustee may conclusively rely upon any document believed by it to be genuine and to
have been signed or presented by the proper Person. The Trustee need not investigate any fact or
matter stated in the document.

(b) Before the Trustee acts or refrains from acting, it may require an Officer’s Certificate
or an Opinion of Counsel or both. The Trustee shall not be liable for any action it takes or omits
to take in good faith in reliance on such Officer’s Certificate or Opinion of Counsel. The Trustee
may consult with counsel of its own selection and the advice of such counsel or any Opinion of
Counsel shall be full and complete authorization and protection from liability in respect of any
action taken, suffered or omitted by it hereunder in good faith and in reliance thereon.

(c) The Trustee may act through its attorneys and agents and shall not be responsible for the
misconduct or negligence of any agent appointed with due care.

(d) The Trustee shall not be liable for any action it takes or omits to take in good faith
that it believes to be authorized or within the rights or powers conferred upon it by this
Indenture provided, however, that the Trustee’s conduct does not constitute willful misconduct or
negligence.

 

-105-

 

(e) Unless otherwise specifically provided in this Indenture, any demand, request, direction
or notice from the Company shall be sufficient if signed by an Officer of the Company.

(f) The Trustee shall be under no obligation to exercise any of the rights or powers vested in
it by this Indenture at the request or direction of any of the Holders unless such Holders have
offered to the Trustee security or indemnity reasonably satisfactory to it against the costs,
expenses and liabilities that might be incurred by it in compliance with such request or direction.

(g) The Trustee shall not be deemed to have notice of any Default or Event of Default unless a
Responsible Officer of the Trustee has actual knowledge thereof or unless written notice of any
event which is in fact such a default is received by the Trustee at the Corporate Trust Office of
the Trustee, and such notice references the Notes and this Indenture.

(h) The rights, privileges, protections, immunities and benefits given to the Trustee,
including, without limitation, its right to be indemnified, are extended to, and shall be
enforceable by, the Trustee in each of its capacities hereunder.

(i) The Trustee may request that the Company deliver an Officer’s Certificate setting forth
the names of individuals and/or titles of officers authorized at such time to take specified
actions pursuant to this Indenture, which Officer’s Certificate may be signed by any person
authorized to sign an Officer’s Certificate, including any person specified as so authorized in any
such certificate previously delivered and not superseded.

(j) In no event shall the Trustee be responsible or liable for special, indirect, or
consequential loss or damage of any kind whatsoever (including, but not limited to, loss of profit)
irrespective of whether the Trustee has been advised of the likelihood of such loss or damage and
regardless of the form of action.

Section 7.03 Individual Rights of Trustee.

The Trustee in its individual or any other capacity may become the owner or pledgee of Notes
and may otherwise deal with the Company or any Affiliate of the Company with the same rights it
would have if it were not Trustee. However, in the event that the Trustee acquires any conflicting
interest it must eliminate such conflict within 90 days, apply to the SEC for permission to
continue as Trustee (if this Indenture has been qualified under the TIA) or resign. Any Agent may
do the same with like rights and duties. The Trustee is also subject to Sections 7.10 and 7.11
hereof.

 

-106-

 

Section 7.04 Trustee’s Disclaimer.

The Trustee shall not be responsible for and makes no representation as to the validity or
adequacy of this Indenture or the Notes, it shall not be accountable for the Company’s use of the proceeds from the Notes or any money paid to the Issuers or upon the
Issuers’ direction under any provision of this Indenture, it shall not be responsible for the use
or application of any money received by any Paying Agent other than the Trustee, and it shall not
be responsible for any statement or recital herein or any statement in the Notes or any other
document in connection with the sale of the Notes or pursuant to this Indenture other than its
certificate of authentication.

Section 7.05 Notice of Defaults.

If a Default or Event of Default occurs and is continuing and if it is known to the Trustee,
the Trustee shall mail to Holders a notice of the Default or Event of Default within 90 days after
it occurs. Except in the case of a Default or Event of Default in payment of principal of, premium
or Special Interest, if any, or interest on, any Note, the Trustee may withhold the notice if and
so long as a committee of its Responsible Officers in good faith determines that withholding the
notice is in the interests of the Holders of the Notes.

Section 7.06 Reports by Trustee to Holders of the Notes.

(a) Within 60 days after each May 15 beginning with the May 15 following the Issue Date, and
for so long as Notes remain outstanding, the Trustee shall mail to the Holders of the Notes a brief
report dated as of such reporting date that complies with TIA § 313(a) (but if no event described
in TIA § 313(a) has occurred within the twelve months preceding the reporting date, no report need
be transmitted). The Trustee also shall comply with TIA § 313(b)(2). The Trustee shall also
transmit by mail all reports as required by TIA § 313(c).

(b) A copy of each report at the time of its mailing to the Holders shall be mailed by the
Trustee to the Issuers and filed by the Trustee with the SEC and each stock exchange on which the
Notes are listed in accordance with TIA § 313(d). The Issuers shall promptly notify the Trustee
when the Notes are listed on any stock exchange or delisted therefrom.

Section 7.07 Compensation and Indemnity.

(a) The Issuers shall pay to the Trustee from time to time reasonable compensation for its
acceptance of this Indenture and services hereunder. The Trustee’s compensation shall not be
limited by any law on compensation of a trustee of an express trust. The Company shall reimburse
the Trustee promptly upon request for all disbursements, advances and expenses incurred or made by
it in addition to the compensation for its services. Such expenses shall include the reasonable
compensation, disbursements and expenses of the Trustee’s agents and counsel.

 

-107-

 

(b) The Issuers and the Guarantors, jointly and severally, shall indemnify the Trustee against
any and all losses, liabilities, claims, damages or expenses incurred by it arising out of or in
connection with the acceptance or administration of its duties under this
Indenture, including the costs and expenses of enforcing this Indenture against the Issuers
and the Guarantors (including this Section 7.07) and defending itself against any claim (whether
asserted by the Issuers, the Guarantors, any Holder or any other Person) or liability in connection
with the exercise or performance of any of its powers or duties hereunder, except to the extent any
such loss, liability or expense shall be determined to have been caused by its own negligence or
willful misconduct. The Trustee shall notify the Issuers promptly of any claim of which a
Responsible Officer has received written notice for which it may seek indemnity. Failure by the
Trustee to so notify the Issuers shall not relieve the Issuers or any of the Guarantors of their
obligations hereunder. The Issuers or such Guarantor shall defend the claim and the Trustee shall
cooperate in the defense. The Trustee may have separate counsel and the Issuers shall pay the
reasonable fees and expenses of such counsel. Neither the Issuers nor any Guarantor need pay for
any settlement made without its consent, which consent shall not be unreasonably withheld.

(c) The obligations of the Issuers and the Guarantors under this Section 7.07 shall survive
the satisfaction and discharge of this Indenture.

(d) To secure the Issuers’ and the Guarantors’ payment obligations in this Section 7.07, the
Trustee shall have a Lien prior to the Notes on all money or property held or collected by the
Trustee, except that held in trust to pay principal and interest on particular Notes. Such Lien
shall survive the satisfaction and discharge of this Indenture.

(e) When the Trustee incurs expenses or renders services after an Event of Default specified
in Section 6.01(8) or (9) hereof occurs, the expenses and the compensation for the services
(including the fees and expenses of its agents and counsel) are intended to constitute expenses of
administration under any Bankruptcy Law.

(f) The Trustee shall comply with the provisions of TIA § 313(b)(2) to the extent applicable.

Section 7.08 Replacement of Trustee.

(a) A resignation or removal of the Trustee and appointment of a successor Trustee shall
become effective only upon the successor Trustee’s acceptance of appointment as provided in this
Section 7.08.

(b) The Trustee may resign in writing at any time and be discharged from the trust hereby
created by so notifying the Issuers. The Holders of a majority in principal amount of the then
outstanding Notes may remove the Trustee by so notifying the Trustee and the Issuers in writing.
The Issuers may remove the Trustee if:

(1) the Trustee fails to comply with Section 7.10 hereof;

(2) the Trustee is adjudged bankrupt or insolvent or an order for relief is entered
with respect to the Trustee under any Bankruptcy Law;

 

-108-

 

(3) a custodian or public officer takes charge of the Trustee or its property; or

(4) the Trustee becomes incapable of acting.

(c) If the Trustee resigns or is removed or if a vacancy exists in the office of the Trustee
for any reason, the Issuers shall promptly appoint a successor Trustee. Within one year after the
successor Trustee takes office, the Holders of a majority in principal amount of the then
outstanding Notes may appoint a successor Trustee to replace the successor Trustee appointed by the
Issuers.

(d) If a successor Trustee does not take office within 60 days after the retiring Trustee
resigns or is removed, the retiring Trustee, the Issuers, or the Holders of at least 10% in
principal amount of the then outstanding Notes may petition, at the expense of the Issuers, any
court of competent jurisdiction for the appointment of a successor Trustee.

(e) If the Trustee, after written request by any Holder who has been a Holder for at least six
months, fails to comply with Section 7.10 hereof, such Holder may petition any court of competent
jurisdiction for the removal of the Trustee and the appointment of a successor Trustee.

(f) A successor Trustee shall deliver a written acceptance of its appointment to the retiring
Trustee and to the Issuers. Thereupon, the resignation or removal of the retiring Trustee shall
become effective, and the successor Trustee shall have all the rights, powers and duties of the
Trustee under this Indenture. The successor Trustee shall mail a notice of its succession to the
Holders. The retiring Trustee shall promptly transfer all property held by it as Trustee to the
successor Trustee, provided all sums owing to the Trustee hereunder have been paid and subject to
the Lien provided for in Section 7.07 hereof. Notwithstanding replacement of the Trustee pursuant
to this Section 7.08, the Company’s obligations under Section 7.07 hereof shall continue for the
benefit of the retiring Trustee.

Section 7.09 Successor Trustee by Merger, etc.

If the Trustee consolidates, merges or converts into, or transfers all or substantially all of
its corporate trust business to, another corporation, the successor corporation without any further
act shall be the successor Trustee.

Section 7.10 Eligibility; Disqualification.

There shall at all times be a Trustee hereunder that is a corporation organized and doing
business under the laws of the United States of America or of any state thereof that is authorized
under such laws to exercise corporate trustee power, that is subject to supervision or examination
by federal or state authorities and that together with its affiliates has a combined capital and
surplus of at least $100.0 million as set forth in its most recent published annual report of
condition.

This Indenture shall always have a Trustee who satisfies the requirements of TIA § 310(a)(1),
(2) and (5). The Trustee is subject to TIA § 310(b).

 

-109-

 

Section 7.11 Preferential Collection of Claims Against Company.

The Trustee is subject to TIA § 311(a), excluding any creditor relationship listed in TIA §
311(b). A Trustee who has resigned or been removed shall be subject to TIA § 311(a) to the extent
indicated therein.

ARTICLE 8.

LEGAL DEFEASANCE AND COVENANT DEFEASANCE

Section 8.01 Option to Effect Legal Defeasance or Covenant Defeasance.

The Issuers may, at any time, elect to have either Section 8.02 or 8.03 hereof be applied to
all outstanding Notes and all obligations of the Guarantors with respect to the Subsidiary
Guarantees upon compliance with the conditions set forth below in this Article 8.

Section 8.02 Legal Defeasance and Discharge.

Upon the Issuers’ exercise under Section 8.01 hereof of the option applicable to this Section
8.02, the Issuers and each of the Guarantors shall, subject to the satisfaction of the conditions
set forth in Section 8.04 hereof, be deemed to have been discharged from their obligations with
respect to all outstanding Notes (including the Subsidiary Guarantees) on the date the conditions
set forth in Section 8.04 hereof are satisfied (hereinafter, “Legal Defeasance”). For this
purpose, Legal Defeasance means that the Issuers and the Guarantors shall be deemed to have paid
and discharged the entire Indebtedness represented by the outstanding Notes (including the
Subsidiary Guarantees), which shall thereafter be deemed to be “outstanding” only for the purposes
of Section 8.05 hereof and the other Sections of this Indenture referred to in clauses (1) and (2)
below, and to have satisfied all their other obligations under such Notes, the Subsidiary
Guarantees and this Indenture (and the Trustee, on demand of and at the expense of the Issuers,
shall execute proper instruments acknowledging the same), except for the following provisions which
shall survive until otherwise terminated or discharged hereunder:

(1) the rights of Holders of outstanding Notes to receive payments in respect of the
principal of, or interest or premium and Special Interest, if any, on such Notes when such
payments are due from the trust referred to in Section 8.04 hereof;

(2) the Issuers’ obligations with respect to such Notes under Article 2 and Section
4.02 hereof;

(3) the rights, powers, trusts, duties and immunities of the Trustee hereunder and the
Issuers’ and the Guarantors’ obligations in connection therewith; and

 

-110-

 

(4) this Article 8.

Subject to compliance with this Section 8.02, the Issuers may exercise their option under this
Section 8.02 notwithstanding the prior exercise of their option under Section 8.03 hereof.

Section 8.03 Covenant Defeasance.

Upon the Issuers’ exercise under Section 8.01 hereof of the option applicable to this Section
8.03, the Issuers and the Guarantors shall, subject to the satisfaction of the conditions set forth
in Section 8.04 hereof, be released from each of their obligations under the covenants contained in
Sections 4.05, 4.07, 4.08, 4.09, 4.10, 4.11, 4.12, 4.13, 4.15, 4.16, 4.17, 4.18, 4.19, 4.20 hereof
and Section 5.01(a)(4) hereof with respect to the outstanding Notes on and after the date the
conditions set forth in Section 8.04 hereof are satisfied (hereinafter, “Covenant Defeasance”), and
the Notes shall thereafter be deemed not “outstanding” for the purposes of any direction, waiver,
consent or declaration or act of Holders (and the consequences of any thereof) in connection with
such covenants, but shall continue to be deemed “outstanding” for all other purposes hereunder (it
being understood that such Notes shall not be deemed outstanding for accounting purposes). For
this purpose, Covenant Defeasance means that, with respect to the outstanding Notes and the
Subsidiary Guarantees, the Issuers and the Guarantors may omit to comply with and shall have no
liability in respect of any term, condition or limitation set forth in any such covenant, whether
directly or indirectly, by reason of any reference elsewhere herein to any such covenant or by
reason of any reference in any such covenant to any other provision herein or in any other document
and such omission to comply shall not constitute a Default or an Event of Default under Section
6.01 hereof, but, except as specified above, the remainder of this Indenture and such Notes and
Subsidiary Guarantees shall be unaffected thereby. In addition, upon the Issuers’ exercise under
Section 8.01 hereof of the option applicable to this Section 8.03 subject to the satisfaction of
the conditions set forth in Section 8.04 hereof, Sections 6.01(3) through 6.01(6) and, to the
extent relating to a Significant Subsidiary, 6.01(8) and 6.01(9) hereof shall not constitute Events
of Default.

Section 8.04 Conditions to Legal or Covenant Defeasance.

In order to exercise either Legal Defeasance or Covenant Defeasance under either Section 8.02
or 8.03 hereof:

(1) the Issuers must irrevocably deposit with the Trustee, in trust, for the benefit of
the Holders of the Notes, cash in U.S. dollars, non-callable Government Securities, or a
combination of cash in U.S. dollars and non-callable Government Securities, in amounts as
shall be sufficient, in the opinion of a nationally recognized investment bank, appraisal
firm or firm of independent public accountants, to pay the principal of, or interest and
premium and Special Interest, if any, on, the outstanding Notes on the stated date for
payment thereof or on the applicable redemption date, as
the case may be, and the Issuers must specify whether the Notes are being defeased to
such stated date for payment or to a particular redemption date;

 

-111-

 

(2) in the case of Legal Defeasance, the Issuers must deliver to the Trustee an Opinion
of Counsel reasonably acceptable to the Trustee confirming that (a) the Issuers have
received from, or there has been published by, the Internal Revenue Service a ruling or (b)
since the Issue Date, there has been a change in the applicable federal income tax law, in
either case to the effect that, and based thereon such Opinion of Counsel shall confirm
that, the Holders of the outstanding Notes shall not recognize income, gain or loss for
federal income tax purposes as a result of such Legal Defeasance and shall be subject to
federal income tax on the same amounts, in the same manner and at the same times as would
have been the case if such Legal Defeasance had not occurred;

(3) in the case of Covenant Defeasance, the Issuers must deliver to the Trustee an
Opinion of Counsel reasonably acceptable to the Trustee confirming that the Holders of the
outstanding Notes shall not recognize income, gain or loss for federal income tax purposes
as a result of such Covenant Defeasance and shall be subject to federal income tax on the
same amounts, in the same manner and at the same times as would have been the case if such
Covenant Defeasance had not occurred;

(4) such Legal Defeasance or Covenant Defeasance shall not result in a breach or
violation of, or constitute a default under, any material agreement (including, without
limitation, the Credit Agreement) or instrument (other than this Indenture) to which the
Company or any of its Subsidiaries is a party or by which the Company or any of its
Subsidiaries is bound;

(5) the Issuers must deliver to the Trustee an Officer’s Certificate stating that the
deposit was not made by the Issuers with the intent of preferring the Holders over the other
creditors of the Issuers with the intent of defeating, hindering, delaying or defrauding any
creditors of the Issuers or others; and

(6) the Issuers must deliver to the Trustee an Officer’s Certificate and an Opinion of
Counsel, each stating that all conditions precedent relating to the Legal Defeasance or the
Covenant Defeasance have been complied with.

Section 8.05 Deposited Money and Government Securities to be Held in Trust; Other
Miscellaneous Provisions.

Subject to Section 8.06 hereof, all money and non-callable Government Securities (including
the proceeds thereof) deposited with the Trustee (or other qualifying trustee, collectively for
purposes of this Section 8.05, the “Trustee”) pursuant to Section 8.04 hereof in respect of the
outstanding Notes shall be held in trust and applied by the Trustee, in accordance with the
provisions of such Notes and this Indenture, to the payment, either directly or through any Paying
Agent (including the Company acting as Paying Agent) as the Trustee
may determine, to the Holders of such Notes of all sums due and to become due thereon in
respect of principal, premium and Special Interest, if any, and interest, but such money need not
be segregated from other funds except to the extent required by law.

 

-112-

 

The Issuers shall pay and indemnify the Trustee against any tax, fee or other charge imposed
on or assessed against the cash or non-callable Government Securities deposited pursuant to Section
8.04 hereof or the principal and interest received in respect thereof other than any such tax, fee
or other charge which by law is for the account of the Holders of the outstanding Notes.

Notwithstanding anything in this Article 8 to the contrary, the Trustee shall deliver or pay
to the Issuers from time to time upon the request of the Issuers any money or non-callable
Government Securities held by it as provided in Section 8.04 hereof which, in the opinion of a
nationally recognized firm of independent public accountants expressed in a written certification
thereof delivered to the Trustee (which may be the opinion delivered under Section 8.04(1) hereof),
are in excess of the amount thereof that would then be required to be deposited to effect an
equivalent Legal Defeasance or Covenant Defeasance.

Section 8.06 Repayment to Issuers.

Any money deposited with the Trustee or any Paying Agent, or then held by the Issuers, in
trust for the payment of the principal of, premium or Special Interest, if any, or interest on any
Note and remaining unclaimed for two years after such principal, premium or Special Interest, if
any, or interest has become due and payable shall be paid to the Issuers on their request or (if
then held by the Issuers) shall be discharged from such trust; and the Holder of such Note shall
thereafter be permitted to look only to the Issuers for payment thereof, and all liability of the
Trustee or such Paying Agent with respect to such trust money, and all liability of the Issuers as
trustee thereof, shall thereupon cease; provided, however, that the Trustee or such Paying Agent,
before being required to make any such repayment, may at the expense of the Issuers cause to be
published once, in the New York Times and The Wall Street Journal (national edition), notice that
such money remains unclaimed and that, after a date specified therein, which shall not be less than
30 days from the date of such notification or publication, any unclaimed balance of such money then
remaining shall be repaid to the Issuers.

Section 8.07 Reinstatement.

If the Trustee or Paying Agent is unable to apply any United States dollars or non-callable
Government Securities in accordance with Section 8.02 or 8.03 hereof, as the case may be, by reason
of any order or judgment of any court or governmental authority enjoining, restraining or otherwise
prohibiting such application, then the Issuers’ and the Guarantors’ obligations under this
Indenture and the Notes and the Subsidiary Guarantees shall be revived and reinstated as though no
deposit had occurred pursuant to Section 8.02 or 8.03 hereof until such time as the Trustee or
Paying Agent is permitted to apply all such money in accordance with Section 8.02 or 8.03 hereof,
as the case may be; provided, however, that, if
the Issuers make any payment of principal of, premium or Special Interest, if any, or interest
on any Note following the reinstatement of their obligations, the Issuers shall be subrogated to
the rights of the Holders of such Notes to receive such payment from the cash or Government
Securities held by the Trustee or Paying Agent.

 

-113-

 

ARTICLE 9.

AMENDMENT, SUPPLEMENT AND WAIVER

Section 9.01 Without Consent of Holders.

(a) Notwithstanding Section 9.02 of this Indenture, the Issuers, the Guarantors and the
Trustee may amend or supplement this Indenture, the Subsidiary Guarantees or the Notes without the
consent of any Holder of a Note:

(1) to cure any ambiguity, defect or inconsistency;

(2) to provide for uncertificated Notes in addition to or in place of certificated
Notes;

(3) to provide for the assumption of the Company’s or a Guarantor’s obligations to the
Holders and Subsidiary Guarantees by a successor to the Company or such Guarantor pursuant
to Article 5 or Section 10.05, respectively, hereof, or a Specified Change of Control, as
applicable and the corresponding release of the Issuers’ Obligations under this Indenture;

(4) to make any change that would provide any additional rights or benefits (including
the addition of collateral) to the Holders or that does not adversely affect the legal
rights hereunder of any such Holder;

(5) to comply with requirements of the SEC in order to effect or maintain the
qualification of this Indenture under the TIA;

(6) to conform the text of this Indenture, the Subsidiary Guarantees or the Notes to
any provision of the “Description of Notes” section of the Offering Memorandum;

(7) to provide for the issuance of Additional Notes in accordance with the limitations
set forth in this Indenture as of the Issue Date;

(8) to allow any Guarantor to execute a supplemental indenture and/or a Subsidiary
Guarantee with respect to the Notes; or

(9) to issue the Exchange Notes.

(b) Upon the request of the Company accompanied by a resolution of its Board of Directors
authorizing the execution of any such amended or supplemental indenture,
and upon receipt by the Trustee of the documents described in Section 7.02(b) hereof, the
Trustee shall join with the Company and the Guarantors in the execution of any amended or
supplemental indenture authorized or permitted by the terms of this Indenture and to make any
further appropriate agreements and stipulations that may be therein contained, but the Trustee
shall not be obligated to enter into such amended or supplemental indenture that affects its own
rights, duties or immunities under this Indenture or otherwise.

 

-114-

 

Section 9.02 With Consent of Holders.

(a) Except as provided below in this Section 9.02, the Company and the Trustee may amend or
supplement this Indenture (including, without limitation, Section 3.09, 4.10 and 4.15 hereof), the
Subsidiary Guarantees and the Notes with the consent of the Holders of at least a majority in
aggregate principal amount of the Notes (including, without limitation, consents obtained in
connection with a tender offer or exchange offer for, or purchase of, the Notes), and, subject to
Sections 6.04 and 6.07 hereof, any existing Default or Event of Default (other than a Default or
Event of Default in the payment of the principal of, premium or Special Interest, if any, or
interest on the Notes, except a payment default resulting from an acceleration that has been
rescinded) or compliance with any provision of this Indenture, the Subsidiary Guarantees or the
Notes may be waived with the consent of the Holders of a majority in aggregate principal amount of
the then outstanding Notes (including consents obtained in connection with a tender offer or
exchange offer for, or purchase of, the Notes).

(b) Upon the request of the Company accompanied by a resolution of its Board of Directors
authorizing the execution of any such amended or supplemental indenture, and upon the filing with
the Trustee of evidence satisfactory to the Trustee of the consent of the Holders as aforesaid, and
upon receipt by the Trustee of the documents described in Section 7.02(b) hereof, the Trustee shall
join with the Company and the Guarantors in the execution of such amended or supplemental indenture
unless such amended or supplemental indenture directly affects the Trustee’s own rights, duties or
immunities under this Indenture or otherwise, in which case the Trustee may in its discretion, but
shall not be obligated to, enter into such amended or supplemental indenture.

(c) It is not be necessary for the consent of the Holders under this Section 9.02 to approve
the particular form of any proposed amendment or waiver, but it is sufficient if such consent
approves the substance thereof.

(d) After an amendment, supplement or waiver under this Section 9.02 becomes effective, the
Issuers shall mail to the Holders affected thereby a notice briefly describing the amendment,
supplement or waiver. Any failure of the Issuers to mail such notice, or any defect therein, shall
not, however, in any way impair or affect the validity of any such amended or supplemental
indenture or waiver. Subject to Sections 6.04 and 6.07 hereof, the Holders of a majority in
aggregate principal amount of the Notes then outstanding, voting as a single class, may waive
compliance in a particular instance by the Issuers and the Guarantors with any provision of this
Indenture, the Notes, or the Subsidiary Guarantees. However,
without the consent of each Holder affected, an amendment, supplement or waiver under this
Section 9.02 may not (with respect to any Notes held by a non-consenting Holder):

(1) reduce the principal amount of Notes whose Holders must consent to an amendment,
supplement or waiver;

(2) reduce the principal of or change the fixed maturity of any Note or alter the
provisions with respect to the redemption of the Notes except as provided above with respect
to Sections 3.09, 4.10 and 4.15 hereof;

 

-115-

 

(3) reduce the rate of or change the time for payment of interest, including default
interest, on any Note;

(4) waive a Default or Event of Default in the payment of principal of, or interest or
premium, or Special Interest, if any, on, the Notes (except a rescission of acceleration of
the Notes by the Holders of at least a majority in aggregate principal amount of the then
outstanding Notes and a waiver of the payment default that resulted from such acceleration);

(5) make any Note payable in money other than that stated in the Notes;

(6) make any change in the provisions of this Indenture relating to waivers of past
Defaults or the rights of Holders to receive payments of principal of, or interest or
premium or Special Interest, if any, on, the Notes;

(7) waive a redemption payment with respect to any Note (other than a payment required
by Sections 3.09, 4.10 or 4.15 hereof);

(8) release any Guarantor from any of its obligations under its Subsidiary Guarantee or
this Indenture, except in accordance with the terms of this Indenture;

(9) impair the right of any Holder of the Notes to receive payment of principal of, or
interest on such Holder’s Notes on or after the due dates therefor or to institute suit for
the enforcement of any payment on or with respect to such Holder’s Notes;

(10) make any change to or modify the ranking of any such Note or related Guarantee
that would adversely affect the Holders; or

(11) make any change in the preceding amendment and waiver provisions.

Section 9.03 Compliance with Trust Indenture Act.

Every amendment or supplement to this Indenture or the Notes shall be set forth in an amended
or supplemental indenture that complies with the TIA as then in effect.

 

-116-

 

Section 9.04 Revocation and Effect of Consents.

Until an amendment, supplement or waiver becomes effective, a consent to it by a Holder of a
Note is a continuing consent by the Holder of a Note and every subsequent Holder of a Note or
portion of a Note that evidences the same debt as the consenting Holder’s Note, even if notation of
the consent is not made on any Note. However, any such Holder of a Note or subsequent Holder of a
Note may revoke the consent as to its Note if the Trustee receives written notice of revocation
before the date the waiver, supplement or amendment becomes effective. An amendment, supplement or
waiver becomes effective in accordance with its terms and thereafter binds every Holder.

Section 9.05 Notation on or Exchange of Notes.

The Trustee may place an appropriate notation about an amendment, supplement or waiver on any
Note thereafter authenticated. The Issuers in exchange for all Notes may issue and the Trustee
shall, upon receipt of an Authentication Order, authenticate new Notes that reflect the amendment,
supplement or waiver.

Failure to make the appropriate notation or issue a new Note shall not affect the validity and
effect of such amendment, supplement or waiver.

Section 9.06 Trustee to Sign Amendments, etc.

The Trustee shall sign any amended or supplemental indenture authorized pursuant to this
Article 9 if the amendment or supplement does not adversely affect the rights, duties, liabilities
or immunities of the Trustee. The Issuers may not sign an amended or supplemental indenture until
the Board of Directors approves it. In executing any amended or supplemental indenture, the
Trustee shall be provided with and (subject to Section 7.01 hereof) shall be fully protected in
relying upon, in addition to the documents required by Section 12.04 hereof, an Officer’s
Certificate and an Opinion of Counsel stating that the execution of such amended or supplemental
indenture is authorized or permitted by this Indenture.

ARTICLE 10.

SUBSIDIARY GUARANTEES

Section 10.01 Guarantee.

(a) Subject to this Article 10, each of the Guarantors hereby, jointly and severally,
unconditionally guarantees to each Holder of a Note authenticated and delivered by the Trustee and
to the Trustee and its successors and assigns, irrespective of the validity and enforceability of
this Indenture, the Notes or the obligations of the Issuers hereunder or thereunder, that:

(1) the principal of, premium and Special Interest, if any, and interest on the Notes
shall be promptly paid in full when due, whether at maturity, by acceleration, redemption or otherwise, and interest on the overdue principal of and interest on
the Notes, if any, if lawful, and all other Obligations of the Issuers to the Holders or the
Trustee hereunder or thereunder shall be promptly paid in full or performed, all in
accordance with the terms hereof and thereof; and

 

-117-

 

(2) in case of any extension of time of payment or renewal of any Notes or any of such
other Obligations, that same shall be promptly paid in full when due or performed in
accordance with the terms of the extension or renewal, whether at stated maturity, by
acceleration or otherwise.

Failing payment when due of any amount so guaranteed or any performance so guaranteed for
whatever reason, the Guarantors shall be jointly and severally obligated to pay the same
immediately. Each Guarantor agrees that this is a guarantee of payment and not a guarantee of
collection.

(b) The Guarantors hereby agree that their obligations hereunder are unconditional,
irrespective of the validity, regularity or enforceability of the Notes or this Indenture, the
absence of any action to enforce the same, any waiver or consent by any Holder of the Notes with
respect to any provisions hereof or thereof, the recovery of any judgment against the Company, any
action to enforce the same or any other circumstance which might otherwise constitute a legal or
equitable discharge or defense of a guarantor. Each Guarantor hereby waives diligence,
presentment, demand of payment, filing of claims with a court in the event of insolvency or
bankruptcy of the Issuers, any right to require a proceeding first against the Issuers, protest,
notice and all demands whatsoever and covenant that this Subsidiary Guarantee shall not be
discharged except by complete performance of the obligations contained in the Notes and this
Indenture or by release in accordance with the provisions of this Indenture.

(c) If any Holder or the Trustee is required by any court or otherwise to return to the
Issuers, the Guarantors or any custodian, trustee, liquidator or other similar official acting in
relation to either the Issuers or the Guarantors, any amount paid by either the Issuers or the
Guarantors to the Trustee or such Holder, this Subsidiary Guarantee, to the extent theretofore
discharged, shall be reinstated in full force and effect.

(d) Each Guarantor agrees that it shall not be entitled to any right of subrogation in
relation to the Holders in respect of any obligations guaranteed hereby until payment in full of
all Obligations guaranteed hereby. Each Guarantor further agrees that, as between the Guarantors,
on the one hand, and the Holders and the Trustee, on the other hand, (1) the maturity of the
Obligations guaranteed hereby may be accelerated as provided in Article 6 hereof for the purposes
of this Subsidiary Guarantee, notwithstanding any stay, injunction or other prohibition preventing
such acceleration in respect of the Obligations guaranteed hereby, and (2) in the event of any
declaration of acceleration of such Obligations as provided in Article 6 hereof, such Obligations
(whether or not due and payable) shall forthwith become due and payable by the Guarantors for the
purpose of this Subsidiary Guarantee. The Guarantors shall have the right to seek contribution
from any non-paying Guarantor so long as the
exercise of such right does not impair the rights of the Holders under the Subsidiary
Guarantee.

 

-118-

 

Section 10.02 Limitation on Guarantor Liability.

Each Guarantor, and by its acceptance of Notes, each Holder, hereby confirms that it is the
intention of all such parties that the Subsidiary Guarantee of such Guarantor not constitute a
fraudulent transfer or conveyance for purposes of Bankruptcy Law, the Uniform Fraudulent Conveyance
Act, the Uniform Fraudulent Transfer Act or any similar federal or state law to the extent
applicable to any Subsidiary Guarantee. To effectuate the foregoing intention, the Trustee, the
Holders and the Guarantors hereby irrevocably agree that the obligations of such Guarantor shall be
limited to the maximum amount that shall, after giving effect to such maximum amount and all other
contingent and fixed liabilities of such Guarantor that are relevant under such laws, and after
giving effect to any collections from, rights to receive contribution from or payments made by or
on behalf of any other Guarantor in respect of the obligations of such other Guarantor under this
Article 10, result in the obligations of such Guarantor under its Subsidiary Guarantee not
constituting a fraudulent transfer or conveyance.

Section 10.03 Execution and Delivery of Subsidiary Guarantee.

To evidence its Subsidiary Guarantee set forth in Section 10.01 hereof, each Guarantor hereby
agrees that a notation of such Subsidiary Guarantee substantially in the form attached as Exhibit E
hereto shall be endorsed by an Officer of such Guarantor on each Note authenticated and delivered
by the Trustee and that this Indenture shall be executed on behalf of such Guarantor by one of its
Officers.

Each Guarantor hereby agrees that its Subsidiary Guarantee set forth in Section 10.01 hereof
shall remain in full force and effect notwithstanding any failure to endorse on each Note a
notation of such Subsidiary Guarantee.

If an Officer whose signature is on this Indenture or on the Subsidiary Guarantee no longer
holds that office at the time the Trustee authenticates the Note on which a Subsidiary Guarantee is
endorsed, the Subsidiary Guarantee shall be valid nevertheless.

The delivery of any Note by the Trustee, after the authentication thereof hereunder, shall
constitute due delivery of the Subsidiary Guarantee set forth in this Indenture on behalf of the
Guarantors.

In the event that the Company or any of its Restricted Subsidiaries creates or acquires any
Subsidiary after the Issue Date, if required by Section 4.20 hereof, the Company shall cause such
Subsidiary to comply with the provisions of Section 4.20 hereof and this Article 10, to the extent
applicable.

 

-119-

 

Section 10.04 Guarantors May Consolidate, etc., on Certain Terms.

Except as otherwise provided in this Section 10.04, no Guarantor may sell or otherwise dispose
of all or substantially all of its assets to, or consolidate with or merge with or into (whether or
not such Guarantor is the surviving Person) another Person, other than either of the Issuers or
another Guarantor, unless:

(1) immediately after giving effect to such transaction, no Default or Event of Default
exists; and

(2) either:

(a) the Person (if other than either of the Issuers or a Guarantor) acquiring
the property in any such sale or disposition or the Person (if other than either of
the Issuers or a Guarantor) formed by or surviving any such consolidation or merger
unconditionally assumes all the obligations of that Guarantor, pursuant to a
supplemental indenture in form and substance reasonably satisfactory to the Trustee,
under this Indenture, the Subsidiary Guarantee and the Registration Rights Agreement
on the terms set forth herein or therein; or

(b) the Net Proceeds of such sale or other disposition are applied in
accordance with the applicable provisions of this Indenture, including without
limitation, Section 4.10 hereof.

In case of any such consolidation, merger, sale or conveyance and upon the assumption by the
successor Person, by supplemental indenture, executed and delivered to the Trustee and satisfactory
in form to the Trustee, of the Subsidiary Guarantee endorsed upon the Notes and the due and
punctual performance of all of the covenants and conditions of this Indenture to be performed by
the Guarantor, such successor Person shall succeed to and be substituted for the Guarantor with the
same effect as if it had been named herein as a Guarantor. Such successor Person thereupon may
cause to be signed any or all of the Subsidiary Guarantees to be endorsed upon all of the Notes
issuable hereunder which theretofore shall not have been signed by the Issuers and delivered to the
Trustee. All the Subsidiary Guarantees so issued shall in all respects have the same legal rank
and benefit under this Indenture as the Subsidiary Guarantees theretofore and thereafter issued in
accordance with the terms of this Indenture as though all of such Subsidiary Guarantees had been
issued at the date of the execution hereof.

Except as set forth in Articles 4 and 5 hereof, and notwithstanding clauses (a) and (b) above,
nothing contained in this Indenture or in any of the Notes shall prevent any consolidation or
merger of a Guarantor with or into either of the Issuers or another Guarantor, or shall prevent any
sale or conveyance of the property of a Guarantor as an entirety or substantially as an entirety to
the Company or another Guarantor.

 

-120-

 

Section 10.05 Releases.

The Subsidiary Guarantee of a Guarantor will be released:

(a) in connection with any sale or other disposition of all or substantially all of the assets
of that Guarantor (including by way of merger or consolidation) to a Person that is not (either
before or after giving effect to such transaction) the Company or a Restricted Subsidiary of the
Company, if the sale or other disposition does not violate Section 4.10 hereof;

(b) in connection with any sale or other disposition of all of the Capital Stock of that
Guarantor to a Person that is not (either before or after giving effect to such transaction) the
Company or a Restricted Subsidiary of the Company, if the sale or other disposition does not
violate Section 4.10 hereof;

(c) if the Company designates any Restricted Subsidiary that is a Guarantor to be an
Unrestricted Subsidiary in accordance with Section 4.17 hereof;

(d) if that Guarantor is released from its guarantee under the Credit Agreement;

(e) if that Guarantor is designated as a Non-Guarantor Subsidiary in accordance with the
definition of Non-Guarantor Subsidiary;

(f) upon legal defeasance in accordance with Article 8 hereof or satisfaction and discharge in
accordance with Article 11 hereof; or

(g) upon delivery of a Covenant Termination Event Notice pursuant to a Covenant Termination
Event.

If any Guarantor is released from its Subsidiary Guarantee, any of its Subsidiaries that are
Guarantors will be released from their Subsidiary Guarantees, if any.

Any Guarantor not released from its obligations under its Subsidiary Guarantee as provided in
this Section 10.05 shall remain liable for the full amount of principal of and interest on the
Notes and for the other obligations of any Guarantor under this Indenture as provided in this
Article 10.

ARTICLE 11.

SATISFACTION AND DISCHARGE

Section 11.01 Satisfaction and Discharge.

This Indenture shall be discharged and shall cease to be of further effect as to all Notes
issued hereunder, when:

(1) either:

(a) all Notes that have been authenticated, except lost, stolen or destroyed
Notes that have been replaced or paid and Notes for whose payment money has
theretofore been deposited in trust and thereafter repaid to the Issuers, have been
delivered to the Trustee for cancellation; or

 

-121-

 

(b) all Notes that have not been delivered to the Trustee for cancellation have
become due and payable by reason of the mailing of a notice of redemption or
otherwise or shall become due and payable within one year and the Issuers or any
Guarantor has irrevocably deposited or caused to be deposited with the Trustee as
trust funds in trust solely for the benefit of the Holders, cash in U.S. dollars,
non-callable Government Securities, or a combination of cash in U.S. dollars and
non-callable Government Securities, in amounts as shall be sufficient, without
consideration of any reinvestment of interest, to pay and discharge the entire
Indebtedness on the Notes not delivered to the Trustee for cancellation for
principal, premium and Special Interest, if any, and accrued interest to the date of
maturity or redemption;

(2) no Default or Event of Default has occurred and is continuing on the date of the
deposit (other than a Default or Event of Default resulting from the borrowing of funds to
be applied to such deposit) and the deposit shall not result in a breach or violation of, or
constitute a default under, any other instrument to which the Issuers or any Guarantor is a
party or by which the Issuers or any Guarantor is bound;

(3) the Issuers or any Guarantor has paid or caused to be paid all sums payable by it
under this Indenture; and

(4) the Issuers have delivered irrevocable instructions to the Trustee under this
Indenture to apply the deposited money toward the payment of the Notes at maturity or on the
redemption date, as the case may be.

In addition, the Issuers must deliver an Officer’s Certificate and an Opinion of Counsel to
the Trustee stating that all conditions precedent to satisfaction and discharge have been
satisfied.

Notwithstanding the satisfaction and discharge of this Indenture, if money has been deposited
with the Trustee pursuant to sub-clause (b) of clause (1) of this Section, the provisions of
Sections 12.02 and 8.06 shall survive. In addition, nothing in this Section 11.01 shall be deemed
to discharge those provisions of Section 7.07 hereof, that, by their terms, survive the
satisfaction and discharge of this Indenture.

 

-122-

 

Section 11.02 Application of Trust Money.

Subject to the provisions of Section 8.06 hereof, all money deposited with the Trustee
pursuant to Section 11.01 hereof shall be held in trust and applied by it, in accordance with the
provisions of the Notes and this Indenture, to the payment, either directly or through any Paying
Agent (including the Company acting as its own Paying Agent) as the Trustee may determine, to the
Persons entitled thereto, of the principal (and premium, if any) and interest for whose payment
such money has been deposited with the Trustee; but such money need not be segregated from other
funds except to the extent required by law.

To the extent that and so long as the Trustee or Paying Agent is unable to apply any money or
Government Securities in accordance with Section 11.01 hereof by reason of any legal proceeding or
by reason of any order or judgment of any court or governmental authority enjoining, restraining or
otherwise prohibiting such application, the Issuers’ and any Guarantor’s obligations under this
Indenture and the Notes shall be revived and reinstated as though no deposit had occurred pursuant
to Section 11.01 hereof; provided, however, that if the Issuers have made any payment of principal
of, premium, if any, or interest on any Notes following the reinstatement of their obligations, the
Issuers shall be subrogated to the rights of the Holders of such Notes to receive such payment from
the money or Government Securities held by the Trustee or Paying Agent.

ARTICLE 12.

MISCELLANEOUS

Section 12.01 Trust Indenture Act Controls.

If any provision of this Indenture limits, qualifies or conflicts with the duties imposed by
TIA § 318(c), the imposed duties shall control.

Section 12.02 Notices.

Any notice or communication by either of the Issuers, any Guarantor or the Trustee to the
others is duly given if in writing and delivered in Person or mailed by first class mail
(registered or certified, return receipt requested), telex, telecopier or overnight air courier
guaranteeing next day delivery, to the others’ address:

If to either of the Issuers and/or any Guarantor:

IASIS Healthcare LLC

117 Seaboard Lane

Building E

Franklin, Tennessee 37067

Facsimile No.: (615) 846-3006

Attention: General Counsel

 

-123-

 

If to the Trustee:

The Bank of New York Mellon Trust Company, N.A.

900 Ashford Parkway, Suite 425

Atlanta, Georgia 30338

Facsimile No.: (770) 698-5195

Attention: Corporate Trust Administration

The Company, any Guarantor or the Trustee, by notice to the others, may designate additional
or different addresses for subsequent notices or communications.

All notices and communications (other than those sent to Holders) shall be deemed to have been
duly given: at the time delivered by hand, if personally delivered; five Business Days after being
deposited in the mail, postage prepaid, if mailed; when answered back, if telexed; when receipt
acknowledged, if telecopied; and the next Business Day after timely delivery to the courier, if
sent by overnight air courier guaranteeing next day delivery.

Any notice or communication to a Holder shall be mailed by first class mail, certified or
registered, return receipt requested, or by overnight air courier guaranteeing next day delivery to
its address shown on the register kept by the Registrar. Any notice or communication shall also be
so mailed to any Person described in TIA § 313(c), to the extent required by the TIA. Failure to
mail a notice or communication to a Holder or any defect in it shall not affect its sufficiency
with respect to other Holders.

If a notice or communication is mailed in the manner provided above within the time
prescribed, it is duly given, whether or not the addressee receives it.

If the Company mails a notice or communication to Holders, it shall mail a copy to the Trustee
and each Agent at the same time.

Section 12.03 Communication by Holders with Other Holders.

Holders may communicate pursuant to TIA § 312(b) with other Holders with respect to their
rights under this Indenture or the Notes. The Company, the Trustee, the Registrar and anyone else
shall have the protection of TIA § 312(c).

Section 12.04 Certificate and Opinion as to Conditions Precedent.

Upon any request or application by the Company to the Trustee to take any action under this
Indenture, the Company shall furnish to the Trustee:

(1) an Officer’s Certificate in form and substance reasonably satisfactory to the
Trustee (which must include the statements set forth in Section 12.05 hereof) stating that,
in the opinion of the signers, all conditions precedent and covenants, if any, provided for
in this Indenture relating to the proposed action have been satisfied; and

 

-124-

 

(2) an Opinion of Counsel in form and substance reasonably satisfactory to the Trustee
(which must include the statements set forth in Section 12.05 hereof) stating that, in the
opinion of such counsel, all such conditions precedent and covenants have been satisfied.

Section 12.05 Statements Required in Certificate or Opinion.

Each certificate or opinion with respect to compliance with a condition or covenant provided
for in this Indenture (other than a certificate provided pursuant to TIA § 314(a)(4)) must comply
with the provisions of TIA § 314(e) and must include:

(1) a statement that the Person making such certificate or opinion has read such
covenant or condition;

(2) a brief statement as to the nature and scope of the examination or investigation
upon which the statements or opinions contained in such certificate or opinion are based;

(3) a statement that, in the opinion of such Person, he or she has made such
examination or investigation as is necessary to enable him or her to express an informed
opinion as to whether or not such covenant or condition has been satisfied; and

(4) a statement as to whether or not, in the opinion of such Person, such condition or
covenant has been satisfied.

Section 12.06 Rules by Trustee and Agents.

The Trustee may make reasonable rules for action by or at a meeting of Holders. The Registrar
or Paying Agent may make reasonable rules and set reasonable requirements for its functions.

Section 12.07 No Personal Liability of Directors, Officers, Employees and Stockholders.

No director, officer, employee, incorporator, stockholder, member or other holder of Equity
Interests of the Issuers or any Guarantor, as such, shall have any liability for any obligations of
the Issuers or the Guarantors under the Notes, this Indenture, the Subsidiary Guarantees or for any
claim based on, in respect of, or by reason of, such obligations or their creation. Each Holder by
accepting a Note waives and releases all such liability. The waiver and release are part of the
consideration for issuance of the Notes. The waiver may not be effective to waive liabilities under
the federal securities laws.

Section 12.08 Governing Law.

THE INTERNAL LAW OF THE STATE OF NEW YORK WILL GOVERN AND BE USED TO CONSTRUE THIS INDENTURE,
THE NOTES AND THE
SUBSIDIARY GUARANTEES WITHOUT GIVING EFFECT TO APPLICABLE PRINCIPLES OF CONFLICTS OF LAW TO
THE EXTENT THAT THE APPLICATION OF THE LAWS OF ANOTHER JURISDICTION WOULD BE REQUIRED THEREBY.

 

-125-

 

Section 12.09 No Adverse Interpretation of Other Agreements.

This Indenture may not be used to interpret any other indenture, loan or debt agreement of the
Company or its Subsidiaries or of any other Person. Any such indenture, loan or debt agreement may
not be used to interpret this Indenture.

Section 12.10 Successors.

All agreements of the Company in this Indenture and the Notes shall bind its successors. All
agreements of the Trustee in this Indenture shall bind its successors. All agreements of each
Guarantor in this Indenture shall bind its successors, except as otherwise provided in Section
10.05.

Section 12.11 Severability.

In case any provision in this Indenture or in the Notes is invalid, illegal or unenforceable,
the validity, legality and enforceability of the remaining provisions shall not in any way be
affected or impaired thereby.

Section 12.12 Counterpart Originals.

The parties may sign any number of copies of this Indenture. Each signed copy shall be an
original, but all of them together represent the same agreement.

Section 12.13 Table of Contents, Headings, etc.

The Table of Contents, Cross-Reference Table and Headings of the Articles and Sections of this
Indenture have been inserted for convenience of reference only, are not to be considered a part of
this Indenture and shall in no way modify or restrict any of the terms or provisions hereof.

Section 12.14 Waiver of Jury Trial.

EACH OF THE ISSUERS, THE GUARANTORS AND THE TRUSTEE HEREBY IRREVOCABLY WAIVES, TO THE FULLEST
EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING
ARISING OUT OF OR RELATING TO THIS INDENTURE, THE NOTES OR THE TRANSACTION CONTEMPLATED HEREBY.

 

-126-

 

Section 12.15 Force Majeure.

In no event shall the Trustee be responsible or liable for any failure or delay in the
performance of its obligations hereunder arising out of or caused by, directly or indirectly,
forces beyond its control, including, without limitation, strikes, work stoppages, accidents, acts
of war or terrorism, civil or military disturbances, nuclear or natural catastrophes or acts of
God, and interruptions, loss or malfunctions of utilities, communications or computer (software and
hardware) services; it being understood that the Trustee shall use reasonable efforts which are
consistent with accepted practices in the banking industry to resume performance as soon as
practicable under the circumstances.

(Signature Pages Follow)

 

-127-

 

SIGNATURES

Dated as of May 3, 2011

	 	 	 	 	 
	 	IASIS HEALTHCARE LLC

 	 
	 	By:  	/s/ John M. Doyle
 	 
	 	 	Name:  	John M. Doyle 	 
	 	 	Title:  	Chief Financial Officer 	 
	 
	 	IASIS CAPITAL CORPORATION

 	 
	 	By:  	/s/ John M. Doyle
 	 
	 	 	Name:  	John M. Doyle 	 
	 	 	Title:  	Chief Financial Officer 	 
	 
	 	ARIZONA DIAGNOSTIC &SURGICAL CENTER, INC.

BAPTIST JOINT VENTURE HOLDINGS, INC.

BEAUMONT HOSPITAL HOLDINGS, INC.

BILTMORE SURGERY CENTER HOLDINGS, INC.

BILTMORE SURGERY CENTER, INC.

BRIM HOLDING COMPANY, INC.

DAVIS HOSPITAL HOLDINGS, INC.

DECISIONPOINT SERVICES, INC.

FIRST CHOICE PHYSICIANS NETWORK HOLDINGS, INC.

HEART AND LUNG INSTITUTE OF UTAH, INC.

IASIS FINANCE, INC.

IASIS HEALTHCARE HOLDINGS, INC.

IASIS HOSPITAL NURSE STAFFING COMPANY

IASIS MANAGEMENT COMPANY

IASIS PHYSICIAN SERVICES, INC.

IASIS PORT ARTHUR ASC, INC.

IASIS TRANSCO, INC.

JORDAN VALLEY HOSPITAL HOLDINGS, INC.

MCS/AZ, INC.

NORTH VISTA HOSPITAL, INC.

PALMS OF PASADENA HOMECARE, INC.

PHYSICIAN GROUP OF ARIZONA, INC.

PHYSICIAN GROUP OF FLORIDA, INC.

PHYSICIAN GROUP OF LOUISIANA, INC.

 	 
	 	 	 
	 	 	 
	 	 	 

 

S-1

 

	 	 	 	 	 

	 	 	 	 	 
	 	PHYSICIAN GROUP OF UTAH, INC.

ROCKY MOUNTAIN MEDICAL CENTER, INC.

SALT LAKE REGIONAL PHYSICIANS, INC.

TAMPA BAY STAFFING SOLUTIONS, INC.

UTAH TRANSCRIPTION SERVICES, INC.

 	 
	 	By:  	/s/ John M. Doyle
 	 
	 	 	Name:  	John M. Doyle 	 
	 	 	Title:  	Chief Financial Officer 	 
	 
	 	IASIS GLENWOOD REGIONAL MEDICAL CENTER, LP

MEMORIAL HOSPITAL OF TAMPA, LP

MESA GENERAL HOSPITAL, LP

PALMS OF PASADENA HOSPITAL, LP

ST. LUKE’S BEHAVIORAL HOSPITAL, LP

ST. LUKE’S MEDICAL CENTER, LP

TOWN &COUNTRY HOSPITAL, LP

By: IASIS Healthcare Holdings, Inc.

       as General Partner

 	 
	 	 	By:  	/s/ John M. Doyle 
	 
	 	 	Name:  	John M. Doyle 	 
	 	 	Title:  	Chief Financial Officer 	 
	 
	 	BRIM HEALTHCARE OF COLORADO, LLC

BRIM PHYSICIANS GROUP OF COLORADO, LLC

BRIM PHYSICIANS GROUP OF TEXAS, LLC

By: Brim Holding Company, Inc.

       as Sole Member

 	 
	 	 	By:  	/s/ John M. Doyle
 	 
	 	 	Name:  	John M. Doyle 	 
	 	 	Title:  	Chief Financial Officer 	 
	 
	 	IASIS Finance Texas Holdings, LLC

Seaboard Development LLC

 	 
	 	By:  	/s/ John M. Doyle
 	 
	 	 	Name:  	John M. Doyle 	 
	 	 	Title:  	Chief Financial Officer 	 

 

S-2

 

	 	 	 	 	 

	 	 	 	 	 
	 	THE BANK OF NEW YORK MELLON TRUST 

COMPANY, N.A., as Trustee

 	 
	 	By:  	/s/ Kristine Prall
 	 
	 	 	Name:  	Kristine Prall 	 
	 	 	Title:  	Vice President 	 
	 

 

S-3

 

EXHIBIT A1

[Face of Note]

CUSIP/CINS ____________

8.375% Senior Notes due 2019

	 	 	 
	No.                     

	 	$                    

IASIS HEALTHCARE LLC

IASIS CAPITAL CORPORATION

promises
to pay to ____________________ or registered assigns,

the principal sum of
 _____ 

DOLLARS on May 15, 2019.

Interest Payment Dates: May 15 and November 15

Record Dates: May 1 and November 1

Dated: _______________, 2011

	 	 	 	 	 
	 	IASIS HEALTHCARE LLC

 	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 
	 	IASIS CAPITAL CORPORATION

 	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 

 

A1-1

 

This is one of the Notes referred to

in the within-mentioned Indenture:

THE BANK OF NEW YORK MELLON TRUST

COMPANY, N.A., as Trustee

	 	 	 	 	 
	By:
	 	 	 	 
	

	 	 

Authorized Signatory
	 	 

 

A1-2

 

[Back of Note]

8.375% Senior Notes due 2019

[Insert the Global Note Legend, if applicable pursuant to the provisions of the Indenture]

[Insert the Private Placement Legend, if applicable pursuant to the provisions of the Indenture]

Capitalized terms used herein have the meanings assigned to them in the Indenture referred to
below unless otherwise indicated.

(1) INTEREST. IASIS Healthcare LLC, a Delaware limited liability company (the
“Company”), and IASIS Capital Corporation, a Delaware corporation (“IASIS Capital” and
together with the Company, the “Issuers”), promise to pay interest on the principal amount
of this Note at 8.375% per annum from May 3, 2011 until maturity and shall pay the Special
Interest, if any, payable pursuant to the Registration Rights Agreement referred to below.
The Issuers shall pay interest and Special Interest, if any, semi-annually in arrears on May
15 and November 15 of each year, or if any such day is not a Business Day, on the next
succeeding Business Day (each, an “Interest Payment Date”). Interest on the Notes shall
accrue from the most recent date to which interest has been paid or, if no interest has been
paid, from the date of issuance; provided that if there is no existing Default in the
payment of interest, and if this Note is authenticated between a record date referred to on
the face hereof and the next succeeding Interest Payment Date, interest shall accrue from
such next succeeding Interest Payment Date; provided, further, that the first Interest
Payment Date shall be November 15, 2011. The Issuers shall pay interest (including
post-petition interest in any proceeding under any Bankruptcy Law) on overdue principal and
premium, if any, from time to time on demand at a rate that is 1% per annum in excess of the
rate then in effect; it shall pay interest (including post-petition interest in any
proceeding under any Bankruptcy Law) on overdue installments of interest and Special
Interest, if any, (without regard to any applicable grace periods) from time to time on
demand at the same rate to the extent lawful. Interest shall be computed on the basis of a
360-day year of twelve 30-day months.

(2) METHOD OF PAYMENT. The Issuers shall pay interest on the Notes (except defaulted
interest) and Special Interest, if any, to the Persons who are registered Holders at the
close of business on the May 1 or November 1 next preceding the Interest Payment Date, even
if such Notes are canceled after such record date and on or before such Interest Payment
Date, except as provided in Section 2.12 of the Indenture with respect to defaulted
interest. The Notes shall be payable as to principal, interest and premium and Special
Interest, if any, at the office or agency of the Paying Agent within the City and State of
New York, or, at the option of the Issuers, payment of interest and Special Interest, if
any, may be made by check mailed to the Holders at their addresses set forth in the register
of Holders; provided that payment by wire transfer of immediately available funds shall be
required with respect to principal of and interest, premium and Special Interest, if any,
on, all Global Notes and all other Notes the Holders of which shall have provided wire
transfer instructions to the Issuers or the Paying Agent. Such payment shall be in such
coin or currency of the United States of America as at the time of payment is legal tender
for payment of public and private debts.

 

A1-3

 

(3) PAYING AGENT AND REGISTRAR. Initially, The Bank of New York Mellon Trust Company,
N.A., the Trustee under the Indenture, shall act as Paying Agent and Registrar. The Issuers
may change any Paying Agent or Registrar without notice to any Holder. The Company or any
of its Subsidiaries may act in any such capacity.

(4) INDENTURE. The Issuers issued the Notes under an Indenture dated as of May 3, 2011
(the “Indenture”), among the Issuers, the Guarantors and the Trustee. The terms of the
Notes include those stated in the Indenture and those made part of the Indenture by
reference to the TIA (15 U.S. Code §§ 77aaa-77bbbb). The Notes are subject to all such
terms, and Holders are referred to the Indenture and such Act for a statement of such terms.
To the extent any provision of this Note conflicts with the express provisions of the
Indenture, the provisions of the Indenture shall govern and be controlling. The Notes are
general unsecured obligations of the Issuers. Subject to the conditions set forth in the
Indenture, the Issuers may issue Additional Notes.

(5) OPTIONAL REDEMPTION.

(a) Except as set forth in subparagraph (b) of this Paragraph 5, the Issuers shall not
have the option to redeem the Notes prior to May 15, 2014. On or after May 15, 2014, the
Issuers may redeem all or part of the Notes upon not less than 30 nor more than 60 days’
notice, at the redemption prices (expressed as percentages of principal amount) set forth
below plus accrued and unpaid interest and Special Interest, if any, thereon to the
applicable redemption date, if redeemed during the twelve-month period beginning on May 15
of the years indicated below, subject to the rights of Holders on the relevant record date
to receive interest on the relevant interest payment date:

	 	 	 	 	 
	Year	 	Percentage	 
	2014 
	 	 	106.281	%
	2015 
	 	 	104.188	%
	2016 
	 	 	102.094	%
	2017 and thereafter 
	 	 	100.000	%

(b) Notwithstanding the provisions of subparagraph (a) of this Paragraph 5, at any time
prior to May 15, 2014, the Issuers may, on any one or more occasions, redeem up to 35% of
the aggregate principal amount of Notes issued under the Indenture at a redemption price of
108.375% of the principal amount thereof, plus accrued and unpaid interest and Special
Interest, if any, to the redemption date with the net cash proceeds of one or more Equity
Offerings by the Issuers or a contribution to the common equity capital of the Company from
the net proceeds of one or more Equity Offerings by a direct or indirect parent of the
Company (in each case, other than Excluded Contributions and the net proceeds of a sale of
Designated Preferred Stock); provided that (i) at least 65% in aggregate principal amount of
the Notes originally issued under the Indenture (excluding Notes held by the Company and its
Subsidiaries) remains outstanding immediately after the occurrence of such redemption; and
(ii) the redemption occurs within 90 days of the date of the closing of such Equity Offering
or equity contribution.

 

A1-4

 

(c) At any time prior to May 15, 2014, the Issuers may redeem all or a part of the
Notes, at a redemption price equal to 100% of the principal amount of the Notes redeemed
plus the Applicable Premium as of, and accrued and unpaid interest and Special Interest, if
any to, but excluding, the Redemption Date, subject to the rights of Holders on the relevant
record date to receive interest due on the relevant interest payment date.

(6) MANDATORY REDEMPTION. The Issuers shall not be required to make mandatory
redemption or sinking fund payments with respect to the Notes.

(7) REPURCHASE AT THE OPTION OF HOLDER.

(a) If there is a Change of Control, unless the Issuers have previously or concurrently
mailed a redemption notice with respect to all the outstanding Notes as described under
Sections 3.07 or 12.01 of the Indenture, the Issuers will make an offer to purchase all of
the Notes pursuant to the offer described below (the “Change of Control Offer”) at a price
in cash (the “Change of Control Payment”) equal to 101% of the aggregate principal amount
thereof plus accrued and unpaid interest and Special Interest, if any, on the Notes
repurchased, if any, to, but excluding, the date of purchase subject to the rights of
Holders on the relevant record date to receive interest due on the relevant Interest Payment
Date. Within 30 days following any Change of Control, the Issuers will send notice of such
Change of Control Offer by first class mail, with a copy to the Trustee, to each Holder of
Notes to the address of such Holder appearing in the security register with a copy to the
Trustee or otherwise in accordance with the procedures of DTC.

(b) If the Company or a Restricted Subsidiary of the Company consummates any Asset
Sales, within 10 Business Days of each date on which the aggregate amount of Excess Proceeds
exceeds $25.0 million, the Company shall commence an Asset Sale Offer to all Holders and if
the Company elects (or is required by the terms of such other pari passu Indebtedness) all
holders of other Indebtedness that is pari passu with the Notes pursuant to Section 3.09 of
the Indenture to purchase the maximum aggregate principal amount of Notes and such pari
passu Indebtedness, in denominations of $2,000 initial principal amount and multiples of
$1,000 thereafter, that may be purchased out of the Excess Proceeds at an offer price in
cash in an amount equal to 100% of the principal amount thereof, or, in the case of Pari
Passu Indebtedness represented by securities sold at a discount, the amount of the accreted
value thereof at such time, plus accrued and unpaid interest and Special Interest, if any,
to the date fixed for the closing of such offer, in accordance with the procedures set forth
in the Indenture. To the extent that the aggregate amount of Notes and other pari passu
Indebtedness tendered pursuant to an Asset Sale Offer is less than the Excess Proceeds, the
Company may use the remaining Excess Proceeds for any purpose not otherwise prohibited by
the Indenture. If the aggregate principal amount of Notes and other pari passu Indebtedness
surrendered by holders thereof exceeds the amount of Excess Proceeds, the Trustee shall
select the Notes and other pari passu Indebtedness to be purchased on a pro rata basis.
Holders to whom an Asset Sale Offer is addressed shall receive an Asset Sale Offer from the
Company prior to the related Purchase Date and may elect to have such Notes purchased by
completing the form entitled “Option of Holder to Elect Purchase” attached to the Notes.

 

A1-5

 

(8) NOTICE OF REDEMPTION. Notice of redemption shall be mailed at least 30 days but
not more than 60 days before the redemption date to each Holder whose Notes are to be
redeemed at its registered address, except that redemption notices may be mailed more than
60 days prior to a redemption date if the notice is issued in connection with a defeasance
of the Notes or a satisfaction and discharge of the Indenture. Notes in denominations
larger than $2,000 may be redeemed in part but only in whole multiples of $1,000, unless all
of the Notes held by a Holder are to be redeemed. On and after the redemption date interest
ceases to accrue on Notes or portions thereof called for redemption.

(9) DENOMINATIONS, TRANSFER, EXCHANGE. The Notes are in registered form without
coupons in denominations of $2,000 and integral multiples of $1,000. The transfer of Notes
may be registered and Notes may be exchanged as provided in the Indenture. The Registrar
and the Trustee may require a Holder, among other things, to furnish appropriate
endorsements and transfer documents and the Issuers may require a Holder to pay any taxes
and fees required by law or permitted by the Indenture. The Issuers need not exchange or
register the transfer of any Note or portion of a Note selected for redemption, except for
the unredeemed portion of any Note being redeemed in part. Also, the Issuers need not
exchange or register the transfer of any Notes for a period of 15 days before a selection of
Notes to be redeemed or during the period between a record date and the corresponding
Interest Payment Date.

(10) PERSONS DEEMED OWNERS. The registered Holder of a Note may be treated as its
owner for all purposes.

(11) AMENDMENT, SUPPLEMENT AND WAIVER. Subject to certain exceptions, the Indenture,
the Subsidiary Guarantees or the Notes may be amended or supplemented with the consent of
the Holders of at least a majority in aggregate principal amount of the then outstanding
Notes, including without limitation, consents obtained in connection with a purchase of, or
tender offer or exchange offer for, Notes, and any existing Default or Event of Default or
compliance with any provision of the Indenture, the Subsidiary Guarantees or the Notes may
be waived with the consent of the Holders of a majority in aggregate principal amount of the
then outstanding Notes, including without limitation, consents obtained in connection with a
purchase of, or tender offer or exchange offer for, Notes. Without the consent of any
Holder, the Indenture, the Subsidiary Guarantees or the Notes may be amended or supplemented
(i) to cure any ambiguity, defect or inconsistency, (ii) to provide for uncertificated Notes
in addition to or in place of certificated Notes, (iii) to provide for the assumption of the
Company’s or any Guarantor’s obligations to Holders of the Notes in case of a merger or
consolidation or a Specified Change of Control, as applicable, (iv) to make any change that
would provide any additional rights or benefits (including the addition of collateral) to
the Holders or that does not adversely affect the legal rights under the Indenture of any
such Holder, (v) to comply with the requirements of the SEC in order to effect or maintain
the qualification of the Indenture under the TIA, (vi) to conform the text of the Indenture,
the Subsidiary Guarantees or the Notes to any provision of the “Description of Notes”
section of the Offering Memorandum, (vii) to provide for the issuance of Additional Notes in
accordance with the limitations set forth in the Indenture as of the Issue Date, (viii) to
allow any Guarantor to execute a supplemental indenture and/or a Subsidiary Guarantee with respect
to the Notes, or (ix) to issue the Exchange Notes.

 

A1-6

 

(12) DEFAULTS AND REMEDIES. Events of Default include: (i) default for 30 days in the
payment when due of interest on or Special Interest, if any, with respect to, the Notes;
(ii) default in payment when due (at maturity, upon redemption or otherwise) of the
principal of, or premium, if any, on the Notes; (iii) failure by the Company to comply with
Section 5.01 of the Indenture; (iv) failure by the Company or any of its Restricted
Subsidiaries for 60 days after notice to the Company by the Trustee or the Holders of at
least 25% in aggregate principal amount of Notes then outstanding voting as a single class
to comply with any of the other agreements in the Indenture; (v) default under any mortgage,
indenture or instrument under which there may be issued or by which there may be secured or
evidenced any Indebtedness for money borrowed by the Company or any of its Significant
Subsidiaries (or the payment of which is guaranteed by the Company or any of its Significant
Subsidiaries), whether such Indebtedness or Guarantee now exists, or is created after the
date of the Indenture, if that default: (a) is caused by a failure to pay principal at the
final Stated Maturity of such Indebtedness (a “Payment Default”) or (b) results in the
acceleration of such Indebtedness prior to its express maturity, and, in each case, the
principal amount of such Indebtedness, together with the principal amount of any other such
Indebtedness under which there has been a Payment Default or the maturity of which has been
so accelerated, aggregates $30.0 million or more; (vi) certain final judgments and decrees
for the payment of money that remain undischarged for a period of 60 days after such
judgment has become final and nonappealable; (vii) except as permitted by the Indenture, any
Subsidiary Guarantee of any Significant Subsidiary is declared to be unenforceable or
invalid by any final and nonappealable judgment or decree or ceases for any reason to be in
full force and effect, or any Guarantor, that is a Significant Subsidiary or any Person
acting on behalf of any Guarantor that is a Significant Subsidiary denies or disaffirms its
obligations in writing under its Subsidiary Guarantee and such Default continues for 10 days
after receipt of the notice specified in the Indenture and (viii) certain events of
bankruptcy or insolvency with respect to the Issuers or any of the Company’s Restricted
Subsidiaries that is a Significant Subsidiary. If any Event of Default occurs and is
continuing, the Trustee or the Holders of at least 25% in aggregate principal amount of the
then outstanding Notes may declare all the Notes to be due and payable. Notwithstanding the
foregoing, in the case of an Event of Default arising from certain events of bankruptcy or
insolvency, all outstanding Notes shall become due and payable without further action or
notice. Holders may not enforce the Indenture or the Notes except as provided in the
Indenture. Subject to certain limitations, Holders of a majority in principal amount of the
then outstanding Notes may direct the Trustee in its exercise of any trust or power. The
Trustee may withhold from Holders notice of any continuing Default or Event of Default
(except a Default or Event of Default relating to the payment of principal or interest) if
it determines that withholding notice is in their interest. The Holders of a majority in
aggregate principal amount of the Notes then outstanding by notice to the Trustee may on
behalf of the Holders of all of the Notes waive any existing Default or Event of Default and
its consequences under the Indenture except a continuing Default or Event of Default in the
payment of the principal of, premium and Special Interest, if any, or interest on, the Notes
(including in connection with an offer to purchase). The Company is required to deliver to
the Trustee annually a statement regarding compliance with the Indenture, and the Company is required upon becoming aware
of any Default or Event of Default, to deliver to the Trustee a statement specifying such
Default or Event of Default.

 

A1-7

 

(13) TRUSTEE DEALINGS WITH COMPANY. The Trustee, in its individual or any other
capacity, may make loans to, accept deposits from, and perform services for the Company or
its Affiliates, and may otherwise deal with the Company or its Affiliates, as if it were not
the Trustee.

(14) NO RECOURSE AGAINST OTHERS. A director, officer, employee, incorporator,
stockholder or member of the Issuers or any of the Guarantors, as such, shall not have any
liability for any obligations of the Issuers or such Guarantor under the Notes, the
Subsidiary Guarantees or the Indenture or for any claim based on, in respect of, or by
reason of, such obligations or their creation. Each Holder by accepting a Note waives and
releases all such liability. The waiver and release are part of the consideration for the
issuance of the Notes.

(15) AUTHENTICATION. This Note shall not be valid until authenticated by the manual
signature of the Trustee or an authenticating agent.

(16) ABBREVIATIONS. Customary abbreviations may be used in the name of a Holder or an
assignee, such as: TEN COM (= tenants in common), TEN ENT (= tenants by the entireties), JT
TEN (= joint tenants with right of survivorship and not as tenants in common), CUST (=
Custodian), and U/G/M/A (= Uniform Gifts to Minors Act).

(17) ADDITIONAL RIGHTS OF HOLDERS OF RESTRICTED GLOBAL NOTES AND RESTRICTED DEFINITIVE
NOTES. In addition to the rights provided to Holders under the Indenture, Holders of
Restricted Global Notes and Restricted Definitive Notes shall have all the rights set forth
in the Registration Rights Agreement dated as of May 3, 2011, among the Company, IASIS
Capital, the Guarantors and the other parties named on the signature pages thereof (the
“Registration Rights Agreement”).

(18) CUSIP NUMBERS. Pursuant to a recommendation promulgated by the Committee on
Uniform Security Identification Procedures, the Company has caused CUSIP numbers to be
printed on the Notes and the Trustee may use CUSIP numbers in notices of redemption as a
convenience to Holders. No representation is made as to the accuracy of such numbers either
as printed on the Notes or as contained in any notice of redemption and reliance may be
placed only on the other identification numbers placed thereon.

The Company shall furnish to any Holder upon written request and without charge a copy of the
Indenture and/or the Registration Rights Agreement. Requests may be made to:

IASIS Healthcare LLC

IASIS Capital Corporation

117 Seaboard Lane, Building E

Franklin, Tennessee 37067

Facsimile No.: (615) 846-3006

Attention: General Counsel

 

A1-8

 

ASSIGNMENT FORM

To assign this Note, fill in the form below:

(I) or (we) assign and transfer this Note to:
 ______________________________________ 

(Insert assignee’s legal name)

 

(Insert assignee’s soc. sec. or tax I.D. no.)

 

 

 

 

(Print or type assignee’s name, address and zip code)

and irrevocably appoint
_____________________________________________
to transfer this Note on the books of the Company. The agent may substitute another
to act for him.

Date: _______________

	 	 	 	 	 	 	 
	 

	 	Your Signature:	 	 	 	 
	 

	 	 	 	 

(Sign exactly as your name appears on the face of this Note)
	 	 

Signature Guarantee*: _________________________

	*	 	Participant in a recognized Signature Guarantee Medallion Program (or other signature
guarantor acceptable to the Trustee).

 

A1-9

 

OPTION OF HOLDER TO ELECT PURCHASE

If you want to elect to have this Note purchased by the Company pursuant to Section 4.10 or
4.15 of the Indenture, check the appropriate box below:

o Section 4.10       o Section 4.15

If you want to elect to have only part of the Note purchased by the Company pursuant to
Section 4.10 or Section 4.15 of the Indenture, state the amount you elect to have purchased:

$_______________

Date: _______________

	 	 	 	 	 	 	 
	 

	 	Your Signature:	 	 	 	 
	 

	 	 	 	 

(Sign exactly as your name appears on the face of this Note)
	 	 
	 
	 	 	 	 	 	 
	 	 	Tax Identification No.:

Signature Guarantee*: _________________________

	*	 	Participant in a recognized Signature Guarantee Medallion Program (or other signature
guarantor acceptable to the Trustee).

 

A1-10

 

SCHEDULE OF EXCHANGES OF INTERESTS IN THE GLOBAL NOTE*

The following exchanges of a part of this Global Note for an interest in another Global Note
or for a Definitive Note, or exchanges of a part of another Global Note or Definitive Note for an
interest in this Global Note, have been made:

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	 	Amount of	 	 	Amount of	 	 	Principal Amount 	 	 	Signature of	 
	 	 	decrease in	 	 	increase in	 	 	of this Global 	 	 	
 authorized	 
	 	 	Principal	 	 	Principal	 	 	Note following 	 	 	 officer of 	 
	 	 	Amount of	 	 	Amount of	 	 	such decrease	 	 	Trustee or	 
	Date of Exchange	 	this Global Note	 	 	this Global Note	 	 	(or increase)	 	 	Custodian	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 

	 	 	 
	*	 	This schedule should be included only if the Note is issued in global form.

 

A1-11

 

EXHIBIT A2

[Face of Regulation S Temporary Global Note]

CUSIP/CINS __________

8.375% Senior Notes due 2019

	 	 	 
	No.                     

	 	$                    

IASIS HEALTHCARE LLC

IASIS CAPITAL CORPORATION

promises to pay to CEDE & CO. or registered assigns,

the principal sum of
 _____ 

DOLLARS on May 15, 2019.

Interest Payment Dates: May 15 and November 15

Record Dates: May 1 and November 1

Dated: _______________, 2011

	 	 	 	 	 
	 	IASIS HEALTHCARE LLC

 	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 
	 	IASIS CAPITAL CORPORATION

 	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 

 

A2-1

 

This is one of the Notes referred to

in the within-mentioned Indenture:

THE BANK OF NEW YORK MELLON

TRUST COMPANY, N.A., as Trustee

	 	 	 	 	 
	By:
	 	 	 	 
	 

	 	 

Authorized Signatory
	 	 

 

A2-2

 

[Back of Regulation S Temporary Global Note]

8.375% Senior Notes due 2019

THE RIGHTS ATTACHING TO THIS REGULATION S TEMPORARY GLOBAL NOTE, AND THE CONDITIONS AND PROCEDURES
GOVERNING ITS EXCHANGE FOR CERTIFICATED NOTES, ARE AS SPECIFIED IN THE INDENTURE (AS DEFINED
HEREIN). NEITHER THE HOLDER NOR THE BENEFICIAL OWNERS OF THIS REGULATION S TEMPORARY GLOBAL NOTE
SHALL BE ENTITLED TO RECEIVE PAYMENT OF PRINCIPAL HEREOF OR INTEREST HEREON.

THIS GLOBAL NOTE IS HELD BY THE DEPOSITARY (AS DEFINED IN THE INDENTURE GOVERNING THIS NOTE) OR ITS
NOMINEE IN CUSTODY FOR THE BENEFIT OF THE BENEFICIAL OWNERS HEREOF, AND IS NOT TRANSFERABLE TO ANY
PERSON UNDER ANY CIRCUMSTANCES EXCEPT THAT (1) THE TRUSTEE MAY MAKE SUCH NOTATIONS HEREON AS MAY BE
REQUIRED PURSUANT TO SECTION 2.01 AND SECTION 2.06 OF THE INDENTURE, (2) THIS GLOBAL NOTE MAY BE
EXCHANGED IN WHOLE BUT NOT IN PART PURSUANT TO SECTION 2.06(a) OF THE INDENTURE, (3) THIS GLOBAL
NOTE MAY BE DELIVERED TO THE TRUSTEE FOR CANCELLATION PURSUANT TO SECTION 2.11 OF THE INDENTURE AND
(4) THIS GLOBAL NOTE MAY BE TRANSFERRED TO A SUCCESSOR DEPOSITARY WITH THE PRIOR WRITTEN CONSENT OF
THE ISSUERS.

UNLESS AND UNTIL IT IS EXCHANGED IN WHOLE OR IN PART FOR NOTES IN DEFINITIVE FORM, THIS NOTE MAY
NOT BE TRANSFERRED EXCEPT AS A WHOLE BY THE DEPOSITARY TO A NOMINEE OF THE DEPOSITARY OR BY A
NOMINEE OF THE DEPOSITARY TO THE DEPOSITARY OR ANOTHER NOMINEE OF THE DEPOSITARY OR BY THE
DEPOSITARY OR ANY SUCH NOMINEE TO A SUCCESSOR DEPOSITARY OR A NOMINEE OF SUCH SUCCESSOR DEPOSITARY.
UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST
COMPANY (55 WATER STREET, NEW YORK, NEW YORK) (“DTC”), TO THE COMPANY OR ITS AGENT FOR REGISTRATION
OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE &
CO. OR SUCH OTHER NAME AS MAY BE REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT
IS MADE TO CEDE & CO. OR SUCH OTHER ENTITY AS MAY BE REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF
DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS
WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN.

 

A2-3

 

THIS NOTE AND THE GUARANTEES ENDORSED HEREON HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF
1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY STATE SECURITIES LAWS. NEITHER THIS NOTE NOR THE
GUARANTEES ENDORSED HEREON NOR ANY INTEREST OR PARTICIPATION HEREIN MAY BE OFFERED, SOLD, ASSIGNED,
TRANSFERRED, PLEDGED, ENCUMBERED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF SUCH REGISTRATION OR
UNLESS SUCH TRANSACTION IS EXEMPT FROM, OR NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE
SECURITIES ACT. THE

HOLDER OF THIS NOTE AND THE GUARANTEES ENDORSED HEREON BY ITS ACCEPTANCE HEREOF AGREES TO OFFER,
SELL OR OTHERWISE TRANSFER SUCH SECURITY, PRIOR TO THE DATE WHICH IS ONE YEAR AFTER THE LATER OF
THE ORIGINAL ISSUE DATE HEREOF AND THE LAST DATE ON WHICH AN ISSUER OR ANY AFFILIATE OF AN ISSUER
WAS THE OWNER OF THIS NOTE AND THE GUARANTEES ENDORSED HEREON (OR ANY PREDECESSOR OF THIS NOTE AND
THE GUARANTEES ENDORSED HEREON) (THE “RESALE RESTRICTION TERMINATION DATE”) ONLY (A)(1) TO IASIS
HEALTHCARE LLC OR ANY SUBSIDIARY THEREOF, (2) PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER
THE SECURITIES ACT, (3) FOR SO LONG AS THE NOTES ARE ELIGIBLE FOR RESALE PURSUANT TO RULE 144A
UNDER THE SECURITIES ACT (“RULE 144A”), TO A PERSON IT REASONABLY BELIEVES IS A “QUALIFIED
INSTITUTIONAL BUYER” AS DEFINED IN RULE 144A THAT PURCHASES FOR ITS OWN ACCOUNT OR FOR THE ACCOUNT
OF A QUALIFIED INSTITUTIONAL BUYER TO WHOM NOTICE IS GIVEN THAT THE TRANSFER IS BEING MADE IN
RELIANCE ON RULE 144A IN A TRANSACTION MEETING THE REQUIREMENTS OF RULE 144A, (4) PURSUANT TO
OFFERS AND SALES TO NON-U.S. PERSONS THAT OCCUR OUTSIDE THE UNITED STATES WITHIN THE MEANING OF
REGULATION S UNDER THE SECURITIES ACT (“REGULATION S”) IN AN OFFSHORE TRANSACTION COMPLYING WITH
REGULATION S OR (5) PURSUANT TO ANOTHER AVAILABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF
THE SECURITIES ACT, SUBJECT TO THE ISSUERS’ AND THE TRUSTEE’S RIGHT PRIOR TO ANY SUCH OFFER, SALE
OR TRANSFER (i) PURSUANT TO CLAUSE (A)(4) PRIOR TO THE END OF THE 40-DAY DISTRIBUTION COMPLIANCE
PERIOD WITHIN THE MEANING OF REGULATION S OR PURSUANT TO CLAUSE (A)(5) PRIOR TO THE RESALE
RESTRICTION TERMINATION DATE, TO REQUIRE THE DELIVERY OF AN OPINION OF COUNSEL, CERTIFICATION
AND/OR OTHER INFORMATION SATISFACTORY TO EACH OF THEM, AND (ii) IN EACH OF THE FOREGOING CASES, TO
REQUIRE THAT A CERTIFICATE OF TRANSFER IN THE FORM APPEARING ON THIS NOTE IS COMPLETED AND
DELIVERED BY THE TRANSFEROR TO THE TRUSTEE AND (B) IN ACCORDANCE WITH ALL APPLICABLE SECURITIES
LAWS OF THE STATES OF THE UNITED STATES AND OTHER APPLICABLE JURISDICTIONS. THIS LEGEND WILL BE
REMOVED UPON THE REQUEST OF A HOLDER AFTER THE RESALE RESTRICTION TERMINATION DATE.

Capitalized terms used herein have the meanings assigned to them in the Indenture referred to
below unless otherwise indicated.

(1) INTEREST. IASIS Healthcare LLC, a Delaware limited liability company (the
“Company”), and IASIS Capital Corporation, a Delaware corporation (“IASIS Capital” and
together with the Company, the “Issuers”), promise to pay interest on the principal amount
of this Note at 8.375% per annum from May 3, 2011 until maturity and shall pay the Special
Interest, if any, payable pursuant to the Registration Rights Agreement referred to below.
The Issuers shall pay interest and Special Interest, if any, semi-annually in arrears on May
15 and November 15 of each year, or if any such day is not a Business Day, on the next
succeeding Business Day (each, an “Interest Payment Date”). Interest on the Notes shall
accrue from the most recent date

 

A2-4

 

to
which interest has been paid or, if no interest has been paid, from the date of issuance; provided that if
there is no existing Default in the payment of interest, and if this Note is authenticated
between a record date referred to on the face hereof and the next succeeding Interest
Payment Date, interest shall accrue from such next succeeding Interest Payment Date;
provided, further, that the first Interest Payment Date shall be November 15, 2011. The
Issuers shall pay interest (including post-petition interest in any proceeding under any
Bankruptcy Law) on overdue principal and premium, if any, from time to time on demand at a
rate that is 1% per annum in excess of the rate then in effect; it shall pay interest
(including post-petition interest in any proceeding under any Bankruptcy Law) on overdue
installments of interest and Special Interest, if any, (without regard to any applicable
grace periods) from time to time on demand at the same rate to the extent lawful. Interest
shall be computed on the basis of a 360-day year of twelve 30-day months.

(2) METHOD OF PAYMENT. The Issuers shall pay interest on the Notes (except defaulted
interest) and Special Interest, if any, to the Persons who are registered Holders at the
close of business on the May 1 or November 1 next preceding the Interest Payment Date, even
if such Notes are canceled after such record date and on or before such Interest Payment
Date, except as provided in Section 2.12 of the Indenture with respect to defaulted
interest. The Notes shall be payable as to principal, interest and premium and Special
Interest, if any, at the office or agency of the Paying Agent within the City and State of
New York, or, at the option of the Issuers, payment of interest and Special Interest, if
any, may be made by check mailed to the Holders at their addresses set forth in the register
of Holders; provided that payment by wire transfer of immediately available funds shall be
required with respect to principal of and interest, premium and Special Interest, if any,
on, all Global Notes and all other Notes the Holders of which shall have provided wire
transfer instructions to the Issuers or the Paying Agent. Such payment shall be in such
coin or currency of the United States of America as at the time of payment is legal tender
for payment of public and private debts.

(3) PAYING AGENT AND REGISTRAR. Initially, The Bank of New York Mellon Trust Company,
N.A., the Trustee under the Indenture, shall act as Paying Agent and Registrar. The Issuers
may change any Paying Agent or Registrar without notice to any Holder. The Company or any
of its Subsidiaries may act in any such capacity.

(4) INDENTURE. The Issuers issued the Notes under an Indenture dated as of May 3, 2011
(the “Indenture”), among the Issuers, the Guarantors and the Trustee. The terms of the
Notes include those stated in the Indenture and those made part of the Indenture by
reference to the TIA (15 U.S. Code §§ 77aaa-77bbbb). The Notes are subject to all such
terms, and Holders are referred to the Indenture and such Act for a statement of such terms.
To the extent any provision of this Note conflicts with the express provisions of the
Indenture, the provisions of the Indenture shall govern and be controlling. The Notes are
general unsecured obligations of the Issuers. Subject to the conditions set forth in the
Indenture, the Issuers may issue Additional Notes.

 

A2-5

 

(5) OPTIONAL REDEMPTION.

(a) Except as set forth in subparagraph (b) of this Paragraph 5, the Issuers shall not
have the option to redeem the Notes prior to May 15, 2014. On or after May 15, 2014, the
Issuers may redeem all or part of the Notes upon not less than 30 nor more than 60 days’
notice, at the redemption prices (expressed as percentages of principal amount) set forth
below plus accrued and unpaid interest and Special Interest, if any, thereon to the
applicable redemption date, if redeemed during the twelve-month period beginning on May 15
of the years indicated below, subject to the rights of Holders on the relevant record date
to receive interest on the relevant interest payment date:

	 	 	 	 	 
	Year	 	Percentage	 
	2014 
	 	 	106.281	%
	2015 
	 	 	104.188	%
	2016 
	 	 	102.094	%
	2017 and thereafter 
	 	 	100.000	%

(b) Notwithstanding the provisions of subparagraph (a) of this Paragraph 5, at any time
prior to May 15, 2014, the Issuers may, on any one or more occasions, redeem up to 35% of
the aggregate principal amount of Notes issued under the Indenture at a redemption price of
108.375% of the principal amount thereof, plus accrued and unpaid interest and Special
Interest, if any, to the redemption date with the net cash proceeds of one or more Equity
Offerings by the Issuers or a contribution to the common equity capital of the Company from
the net proceeds of one or more Equity Offerings by a direct or indirect parent of the
Company (in each case, other than Excluded Contributions and the net proceeds of a sale of
Designated Preferred Stock); provided that (i) at least 65% in aggregate principal amount of
the Notes originally issued under the Indenture (excluding Notes held by the Company and its
Subsidiaries) remains outstanding immediately after the occurrence of such redemption; and
(ii) the redemption occurs within 90 days of the date of the closing of such Equity Offering
or equity contribution.

(c) At any time prior to May 15, 2014, the Issuers may redeem all or a part of the
Notes, at a redemption price equal to 100% of the principal amount of the Notes redeemed
plus the Applicable Premium as of, and accrued and unpaid interest and Special Interest, if
any to, but excluding, the Redemption Date, subject to the rights of Holder on the relevant
record date to receive interest due on the relevant interest payment date.

(6) MANDATORY REDEMPTION. The Issuers shall not be required to make mandatory
redemption or sinking fund payments with respect to the Notes.

(7) REPURCHASE AT THE OPTION OF HOLDER.

(a) If there is a Change of Control, unless the Issuers have previously or concurrently
mailed a redemption notice with respect to all the outstanding Notes as described under
Sections 3.07 or 12.01 of the Indenture, the Issuers will make an offer to purchase all of
the Notes pursuant to the offer described below (the “Change of Control Offer”) at a price
in cash (the “Change of Control Payment”) equal to 101% of the aggregate principal amount thereof plus accrued and unpaid interest and Special Interest, if
any, on the Notes repurchased, if any, to, but excluding, the date of purchase subject to
the rights of Holders on the relevant record date to receive interest due on the relevant
Interest Payment Date. Within 30 days following any Change of Control, the Issuers will
send notice of such Change of Control Offer by first class mail, with a copy to the Trustee,
to each Holder of Notes to the address of such Holder appearing in the security register
with a copy to the Trustee or otherwise in accordance with the procedures of DTC.

 

A2-6

 

(b) If the Company or a Restricted Subsidiary of the Company consummates any Asset
Sales, within 10 Business Days of each date on which the aggregate amount of Excess Proceeds
exceeds $25.0 million, the Company shall commence an Asset Sale Offer to all Holders and if
the Company elects (or is required by the terms of such other pari passu Indebtedness) all
holders of other Indebtedness that is pari passu with the Notes pursuant to Section 3.09 of
the Indenture to purchase the maximum aggregate principal amount of Notes and such pari
passu Indebtedness, in denominations of $2,000 initial principal amount and multiples of
$1,000 thereafter, that may be purchased out of the Excess Proceeds at an offer price in
cash in an amount equal to 100% of the principal amount thereof, or, in the case of Pari
Passu Indebtedness represented by securities sold at a discount, the amount of the accreted
value thereof at such time, plus accrued and unpaid interest and Special Interest, if any,
to the date fixed for the closing of such offer, in accordance with the procedures set forth
in the Indenture. To the extent that the aggregate amount of Notes and other pari passu
Indebtedness tendered pursuant to an Asset Sale Offer is less than the Excess Proceeds, the
Company may use the remaining Excess Proceeds for any purpose not otherwise prohibited by
the Indenture. If the aggregate principal amount of Notes and other pari passu Indebtedness
surrendered by holders thereof exceeds the amount of Excess Proceeds, the Trustee shall
select the Notes and other pari passu Indebtedness to be purchased on a pro rata basis.
Holders to whom an Asset Sale Offer is addressed shall receive an Asset Sale Offer from the
Company prior to the related Purchase Date and may elect to have such Notes purchased by
completing the form entitled “Option of Holder to Elect Purchase” attached to the Notes.

(8) NOTICE OF REDEMPTION. Notice of redemption shall be mailed at least 30 days but
not more than 60 days before the redemption date to each Holder whose Notes are to be
redeemed at its registered address, except that redemption notices may be mailed more than
60 days prior to a redemption date if the notice is issued in connection with a defeasance
of the Notes or a satisfaction and discharge of the Indenture. Notes in denominations
larger than $2,000 may be redeemed in part but only in whole multiples of $1,000, unless all
of the Notes held by a Holder are to be redeemed. On and after the redemption date interest
ceases to accrue on Notes or portions thereof called for redemption.

(9) DENOMINATIONS, TRANSFER, EXCHANGE. The Notes are in registered form without
coupons in denominations of $2,000 and integral multiples of $1,000. The transfer of Notes
may be registered and Notes may be exchanged as provided in the Indenture. The Registrar
and the Trustee may require a Holder, among other things, to furnish appropriate
endorsements and transfer documents and the Issuers may require a Holder to pay any taxes
and fees required by law or permitted by the Indenture. The Issuers need not exchange or register the transfer of any Note or portion of a Note
selected for redemption, except for the unredeemed portion of any Note being redeemed in
part. Also, the Issuers need not exchange or register the transfer of any Notes for a
period of 15 days before a selection of Notes to be redeemed or during the period between a
record date and the corresponding Interest Payment Date.

 

A2-7

 

(10) PERSONS DEEMED OWNERS. The registered Holder of a Note may be treated as its
owner for all purposes.

(11) AMENDMENT, SUPPLEMENT AND WAIVER. Subject to certain exceptions, the Indenture,
the Subsidiary Guarantees or the Notes may be amended or supplemented with the consent of
the Holders of at least a majority in aggregate principal amount of the then outstanding
Notes, including without limitation, consents obtained in connection with a purchase of, or
tender offer or exchange offer for, Notes, and any existing Default or Event of Default or
compliance with any provision of the Indenture, the Subsidiary Guarantees or the Notes may
be waived with the consent of the Holders of a majority in aggregate principal amount of the
then outstanding Notes, including without limitation, consents obtained in connection with a
purchase of, or tender offer or exchange offer for, Notes. Without the consent of any
Holder, the Indenture, the Subsidiary Guarantees or the Notes may be amended or supplemented
(i) to cure any ambiguity, defect or inconsistency, (ii) to provide for uncertificated Notes
in addition to or in place of certificated Notes, (iii) to provide for the assumption of the
Company’s or any Guarantor’s obligations to Holders of the Notes in case of a merger or
consolidation or a Specified Change of Control, as applicable, (iv) to make any change that
would provide any additional rights or benefits (including the addition of collateral) to
the Holders or that does not adversely affect the legal rights under the Indenture of any
such Holder, (v) to comply with the requirements of the SEC in order to effect or maintain
the qualification of the Indenture under the TIA, (vi) to conform the text of the Indenture,
the Subsidiary Guarantees or the Notes to any provision of the “Description of Notes”
section of the Offering Memorandum, (vii) to provide for the issuance of Additional Notes in
accordance with the limitations set forth in the Indenture as of the Issue Date, (viii) to
allow any Guarantor to execute a supplemental indenture and/or a Subsidiary Guarantee with
respect to the Notes, or (ix) to issue the Exchange Notes.

(12) DEFAULTS AND REMEDIES. Events of Default include: (i) default for 30 days in the
payment when due of interest on or Special Interest, if any, with respect to, the Notes;
(ii) default in payment when due (at maturity, upon redemption or otherwise) of the
principal of, or premium, if any, on the Notes; (iii) failure by the Company to comply with
Section 5.01 of the Indenture; (iv) failure by the Company or any of its Restricted
Subsidiaries for 60 days after notice to the Company by the Trustee or the Holders of at
least 25% in aggregate principal amount of Notes then-outstanding voting as a single class
to comply with any of the other agreements in the Indenture; (v) default under any mortgage,
indenture or instrument under which there may be issued or by which there may be secured or
evidenced any Indebtedness for money borrowed by the Company or any of its Significant
Subsidiaries (or the payment of which is guaranteed by the Company or any of its Significant
Subsidiaries), whether such Indebtedness or Guarantee now exists, or is created after the
date of the Indenture, if that default: (a) is caused by a

 

A2-8

 

failure to pay principal at the final Stated Maturity of such Indebtedness (a “Payment
Default”) or (b) results in the acceleration of such Indebtedness prior to its express
maturity, and, in each case, the principal amount of such Indebtedness, together with the
principal amount of any other such Indebtedness under which there has been a Payment Default
or the maturity of which has been so accelerated, aggregates $30.0 million or more; (vi)
certain final judgments and decrees for the payment of money that remain undischarged for a
period of 60 days after such judgment has become final and nonappealable; (vii) except as
permitted by the Indenture, any Subsidiary Guarantee of any Significant Subsidiary is
declared to be unenforceable or invalid by any final and nonappealable judgment or decree or
ceases for any reason to be in full force and effect, or any Guarantor, that is a
Significant Subsidiary or any Person acting on behalf of any Guarantor that is a Significant
Subsidiary denies or disaffirms its obligations in writing under its Subsidiary Guarantee
and such Default continues for 10 days after receipt of the notice specified in the
Indenture and (viii) certain events of bankruptcy or insolvency with respect to the Issuers
or any of the Company’s Restricted Subsidiaries that is a Significant Subsidiary. If any
Event of Default occurs and is continuing, the Trustee or the Holders of at least 25% in
aggregate principal amount of the then-outstanding Notes may declare all the Notes to be due
and payable. Notwithstanding the foregoing, in the case of an Event of Default arising from
certain events of bankruptcy or insolvency, all outstanding Notes shall become due and
payable without further action or notice. Holders may not enforce the Indenture or the
Notes except as provided in the Indenture. Subject to certain limitations, Holders of a
majority in principal amount of the then-outstanding Notes may direct the Trustee in its
exercise of any trust or power. The Trustee may withhold from Holders notice of any
continuing Default or Event of Default (except a Default or Event of Default relating to the
payment of principal or interest) if it determines that withholding notice is in their
interest. The Holders of a majority in aggregate principal amount of the Notes
then-outstanding by notice to the Trustee may on behalf of the Holders of all of the Notes
waive any existing Default or Event of Default and its consequences under the Indenture
except a continuing Default or Event of Default in the payment of the principal of, premium
and Special Interest, if any, or interest on, the Notes (including in connection with an
offer to purchase). The Company is required to deliver to the Trustee annually a statement
regarding compliance with the Indenture, and the Company is required upon becoming aware of
any Default or Event of Default, to deliver to the Trustee a statement specifying such
Default or Event of Default.

(13) TRUSTEE DEALINGS WITH COMPANY. The Trustee, in its individual or any other
capacity, may make loans to, accept deposits from, and perform services for the Company or
its Affiliates, and may otherwise deal with the Company or its Affiliates, as if it were not
the Trustee.

(14) NO RECOURSE AGAINST OTHERS. A director, officer, employee, incorporator,
stockholder or member of the Issuers or any of the Guarantors, as such, shall not have any
liability for any obligations of the Issuers or such Guarantor under the Notes, the
Subsidiary Guarantees or the Indenture or for any claim based on, in respect of, or by
reason of, such obligations or their creation. Each Holder by accepting a Note waives and
releases all such liability. The waiver and release are part of the consideration for the
issuance of the Notes.

 

A2-9

 

(15) AUTHENTICATION. This Note shall not be valid until authenticated by the manual
signature of the Trustee or an authenticating agent.

(16) ABBREVIATIONS. Customary abbreviations may be used in the name of a Holder or an
assignee, such as: TEN COM (= tenants in common), TEN ENT (= tenants by the entireties), JT
TEN (= joint tenants with right of survivorship and not as tenants in common), CUST (=
Custodian), and U/G/M/A (= Uniform Gifts to Minors Act).

(17) ADDITIONAL RIGHTS OF HOLDERS OF RESTRICTED GLOBAL NOTES AND RESTRICTED DEFINITIVE
NOTES. In addition to the rights provided to Holders under the Indenture, Holders of
Restricted Global Notes and Restricted Definitive Notes shall have all the rights set forth
in the Registration Rights Agreement dated as of May 3, 2011, among the Company, IASIS
Capital, the Guarantors and the other parties named on the signature pages thereof (the
“Registration Rights Agreement”).

(18) CUSIP NUMBERS. Pursuant to a recommendation promulgated by the Committee on
Uniform Security Identification Procedures, the Company has caused CUSIP numbers to be
printed on the Notes and the Trustee may use CUSIP numbers in notices of redemption as a
convenience to Holders. No representation is made as to the accuracy of such numbers either
as printed on the Notes or as contained in any notice of redemption and reliance may be
placed only on the other identification numbers placed thereon.

The Company shall furnish to any Holder upon written request and without charge a copy of the
Indenture and/or the Registration Rights Agreement. Requests may be made to:

IASIS Healthcare LLC

IASIS Capital Corporation

117 Seaboard Lane, Building E

Franklin, Tennessee 37067

Facsimile No.: (615) 846-3006

Attention: General Counsel

ASSIGNMENT FORM

To assign this Note, fill in the form below:

(I) or (we) assign and transfer this Note to:
 _______________________________________

(Insert assignee’s legal name)

 

(Insert assignee’s soc. sec. or tax I.D. no.)

 

 

 

 

 

A2-10

 

(Print or type assignee’s name, address and zip code)

and irrevocably appoint
 ____________________________ 
to transfer this Note on the books of the Company. The agent may substitute another
to act for him.

Date: _______________

	 	 	 	 	 	 	 
	 

	 	Your Signature:	 	 	 	 
	 

	 	 	 	 

(Sign exactly as your name appears on the face of this Note)
	 	 

Signature Guarantee*: _________________________

	*	 	Participant in a recognized Signature Guarantee Medallion Program (or other signature
guarantor acceptable to the Trustee).

 

A2-11

 

OPTION OF HOLDER TO ELECT PURCHASE

If you want to elect to have this Note purchased by the Company pursuant to Section 4.10 or
4.15 of the Indenture, check the appropriate box below:

o Section 4.10       o Section 4.15

If you want to elect to have only part of the Note purchased by the Company pursuant to
Section 4.10 or Section 4.15 of the Indenture, state the amount you elect to have purchased:

$_______________

Date: _______________

	 	 	 	 	 	 	 
	 

	 	Your Signature:	 	 	 	 
	 

	 	 	 	 

(Sign exactly as your name appears on the face of this Note)
	 	 
	 
	 	 	 	 	 	 
	 	 	Tax Identification No.:

Signature Guarantee*: _________________________

	*	 	Participant in a recognized Signature Guarantee Medallion Program (or other signature
guarantor acceptable to the Trustee).

 

A2-12

 

SCHEDULE OF EXCHANGES OF INTERESTS IN THE GLOBAL NOTE*

The following exchanges of a part of this Global Note for an interest in another Global Note
or for a Definitive Note, or exchanges of a part of another Global Note or Definitive Note for an
interest in this Global Note, have been made:

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	 	Amount of	 	 	Amount of	 	 	Principal Amount	 	 	Signature of	 
	 	 	decrease in	 	 	increase in	 	 	of this Global	 	 	authorized	 
	 	 	Principal	 	 	Principal	 	 	Note following	 	 	officer of	 
	Date of	 	Amount of	 	 	Amount of	 	 	such decrease	 	 	Trustee or	 
	Exchange	 	this Global Note	 	 	this Global Note	 	 	(or Increase)	 	 	Custodian	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 

	 	 	 
	*	 	This schedule should be included only if the Note is issued in global form.

 

A2-13

 

EXHIBIT B

FORM OF CERTIFICATE OF TRANSFER

IASIS Healthcare LLC

IASIS Capital Corporation

117 Seaboard Lane, Building E

Franklin, Tennessee 37067

The Bank of New York Mellon Trust Company, N.A.

900 Ashford Parkway, Suite 425

Atlanta, Georgia 30338

Re: 8.375% Senior Notes due 2019

Reference is hereby made to the Indenture, dated as of May 3, 2011 (the “Indenture”), among
IASIS Healthcare LLC, (the “Company”), IASIS Capital Corporation (“IASIS Capital” and together with
the Company, the “Issuers”), the Guarantors party thereto and The Bank of New York Mellon Trust
Company, N.A., as trustee. Capitalized terms used but not defined herein shall have the meanings
given to them in the Indenture.

 _____, (the “Transferor”) owns and proposes to transfer the Note[s] or interest
in such Note[s] specified in Annex A hereto, in the principal amount of $_____
in such
Note[s] or interests (the “Transfer”), to
 _____ 

(the “Transferee”), as
further specified in Annex A hereto. In connection with the Transfer, the Transferor hereby
certifies that:

[CHECK ALL THAT APPLY]

1. o Check if Transferee shall take delivery of a beneficial interest in the 144A Global
Note or a Restricted Definitive Note pursuant to Rule 144A. The Transfer is being effected
pursuant to and in accordance with Rule 144A under the Securities Act of 1933, as amended (the
“Securities Act”), and, accordingly, the Transferor hereby further certifies that the beneficial
interest or Definitive Note is being transferred to a Person that the Transferor reasonably
believes is purchasing the beneficial interest or Definitive Note for its own account, or for one
or more accounts with respect to which such Person exercises sole investment discretion, and such
Person and each such account is a “qualified institutional buyer” within the meaning of Rule 144A
in a transaction meeting the requirements of Rule 144A, and such Transfer is in compliance with any
applicable blue sky securities laws of any state of the United States. Upon consummation of the
proposed Transfer in accordance with the terms of the Indenture, the transferred beneficial
interest or Definitive Note shall be subject to the restrictions on transfer enumerated in the
Private Placement Legend printed on the 144A Global Note and/or the Restricted Definitive Note and
in the Indenture and the Securities Act.

2. o Check if Transferee shall take delivery of a beneficial interest in the Regulation
S Global Note or a Restricted Definitive Note pursuant to Regulation S. The Transfer is being
effected pursuant to and in accordance with Rule 903 or Rule 904 under the
Securities Act and, accordingly, the Transferor hereby further certifies that (i) the Transfer
is not being made to a Person in the United States and (x) at the time the buy order was
originated, the Transferee was outside the United States or such Transferor and any Person acting
on its behalf reasonably believed and believes that the Transferee was outside the United States or
(y) the transaction was executed in, on or through the facilities of a designated offshore
securities market and neither such Transferor nor any Person acting on its behalf knows that the
transaction was prearranged with a buyer in the United States, (ii) no directed selling efforts
have been made in contravention of the requirements of Rule 903(b) or Rule 904(b) of Regulation S
under the Securities Act, (iii) the transaction is not part of a plan or scheme to evade the
registration requirements of the Securities Act and (iv) if the proposed transfer is being made
prior to the expiration of the Restricted Period, the transfer is not being made to a U.S. Person
or for the account or benefit of a U.S. Person (other than an Initial Purchaser). Upon consummation
of the proposed transfer in accordance with the terms of the Indenture, the transferred beneficial
interest or Definitive Note shall be subject to the restrictions on Transfer enumerated in the
Private Placement Legend printed on the Regulation S Global Note and/or the Restricted Definitive
Note and in the Indenture and the Securities Act.

 

B-1

 

3. o Check and complete if Transferee will take delivery of a beneficial interest in a
Restricted Global Note or a Restricted Definitive Note pursuant to any provision of the Securities
Act other than Rule 144A or Regulation S. The Transfer is being effected in compliance with
the transfer restrictions applicable to beneficial interests in Restricted Global Notes and
Restricted Definitive Notes and pursuant to and in accordance with the Securities Act and any
applicable blue sky securities laws of any state of the United States, and accordingly the
Transferor hereby further certifies that (check one):

(a) o such Transfer is being effected pursuant to and in accordance with Rule 144
under the Securities Act;

or

(b) o such Transfer is being effected to the Company or a subsidiary thereof;

or

(c) o such Transfer is being effected pursuant to an effective registration statement
under the Securities Act.

4. o Check if Transferee shall take delivery of a beneficial interest in an Unrestricted
Global Note or of an Unrestricted Definitive Note.

(a) o Check if Transfer is pursuant to Rule 144. (i) The Transfer is being effected
pursuant to and in accordance with Rule 144 under the Securities Act and in compliance with
the transfer restrictions contained in the Indenture and any applicable blue sky securities
laws of any state of the United States and (ii) the restrictions on transfer contained in
the Indenture and the Private Placement Legend are not required in order to
maintain compliance with the Securities Act. Upon consummation of the proposed
Transfer in accordance with the terms of the Indenture, the transferred beneficial interest
or Definitive Note shall no longer be subject to the restrictions on transfer enumerated in
the Private Placement Legend printed on the Restricted Global Notes, on Restricted
Definitive Notes and in the Indenture.

 

B-2

 

(b) o Check if Transfer is Pursuant to Regulation S. (i) The Transfer is being
effected pursuant to and in accordance with Rule 903 or Rule 904 under the Securities Act
and in compliance with the transfer restrictions contained in the Indenture and any
applicable blue sky securities laws of any state of the United States and (ii) the
restrictions on transfer contained in the Indenture and the Private Placement Legend are not
required in order to maintain compliance with the Securities Act. Upon consummation of the
proposed Transfer in accordance with the terms of the Indenture, the transferred beneficial
interest or Definitive Note shall no longer be subject to the restrictions on transfer
enumerated in the Private Placement Legend printed on the Restricted Global Notes, on
Restricted Definitive Notes and in the Indenture.

(c) o Check if Transfer is Pursuant to Other Exemption. (i) The Transfer is being
effected pursuant to and in compliance with an exemption from the registration requirements
of the Securities Act other than Rule 144, Rule 903 or Rule 904 and in compliance with the
transfer restrictions contained in the Indenture and any applicable blue sky securities laws
of any State of the United States and (ii) the restrictions on transfer contained in the
Indenture and the Private Placement Legend are not required in order to maintain compliance
with the Securities Act. Upon consummation of the proposed Transfer in accordance with the
terms of the Indenture, the transferred beneficial interest or Definitive Note shall not be
subject to the restrictions on transfer enumerated in the Private Placement Legend printed
on the Restricted Global Notes or Restricted Definitive Notes and in the Indenture.

This certificate and the statements contained herein are made for your benefit and the benefit
of the Company.

	 	 	 	 	 
	 

	 

[Insert Name of Transferor]
	 	 
	 	 	 	 	 
	 	 	 
	 	By:  	
 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 

Dated:
 _____ 

 

B-3

 

ANNEX A TO CERTIFICATE OF TRANSFER

	1.	 	The Transferor owns and proposes to transfer the following:

[CHECK ONE OF (a) OR (b)]

	 	(a)	 	o a beneficial interest in the:

	 	(i)	 	o 144A Global Note (CUSIP
 _____), or
	 
	 	(ii)	 	o Regulation S Global Note (CUSIP
 _____), or

	 	(b)	 	o a Restricted Definitive Note.

	2.	 	After the Transfer the Transferee shall hold:

[CHECK ONE]

	 	(a)	 	o a beneficial interest in the:

	 	(i)	 	o 144A Global Note (CUSIP
 _____), or
	 
	 	(ii)	 	o Regulation S Global Note (CUSIP
 _____), or
	 
	 	(iii)	 	o Unrestricted Global Note (CUSIP
 _____); or

	 	(b)	 	o a Restricted Definitive Note; or
	 
	 	(c)	 	o an Unrestricted Definitive Note,

in accordance with the terms of the Indenture.

 

B-4

 

EXHIBIT C

FORM OF CERTIFICATE OF EXCHANGE

IASIS Healthcare LLC

IASIS Capital Corporation

117 Seaboard Lane, Building E

Franklin, Tennessee 37067

The Bank of New York Mellon Trust Company, N.A.

900 Ashford Parkway, Suite 425

Atlanta, Georgia 30338

Re: 8.375% Senior Notes due 2019

(CUSIP
 _____)

Reference is hereby made to the Indenture, dated as of May 3, 2011 (the “Indenture”), among
IASIS Healthcare LLC (the “Company”), IASIS Capital Corporation (“IASIS Capital” and together with
the Company, the “Issuers”), the Guarantors party thereto and The Bank of New York Mellon Trust
Company, N.A., as trustee. Capitalized terms used but not defined herein shall have the meanings
given to them in the Indenture.

 _____, (the “Owner”) owns and proposes to exchange the Note[s] or
interest in such Note[s] specified herein, in the principal amount of $_____ 

in such Note[s]
or interests (the “Exchange”). In connection with the Exchange, the Owner hereby certifies that:

1. Exchange of Restricted Definitive Notes or Beneficial Interests in a Restricted Global
Note for Unrestricted Definitive Notes or Beneficial Interests in an Unrestricted Global Note

(a) o Check if Exchange is from beneficial interest in a Restricted Global Note to beneficial
interest in an Unrestricted Global Note. In connection with the Exchange of the Owner’s beneficial
interest in a Restricted Global Note for a beneficial interest in an Unrestricted Global Note in an
equal principal amount, the Owner hereby certifies (i) the beneficial interest is being acquired
for the Owner’s own account without transfer, (ii) such Exchange has been effected in compliance
with the transfer restrictions applicable to the Global Notes and pursuant to and in accordance
with the Securities Act of 1933, as amended (the “Securities Act”), (iii) the restrictions on
transfer contained in the Indenture and the Private Placement Legend are not required in order to
maintain compliance with the Securities Act and (iv) the beneficial interest in an Unrestricted
Global Note is being acquired in compliance with any applicable blue sky securities laws of any
state of the United States.

 

C-1

 

(b) o Check if Exchange is from beneficial interest in a Restricted Global Note to
Unrestricted Definitive Note. In connection with the Exchange of the Owner’s beneficial interest in a Restricted Global Note for an Unrestricted Definitive Note, the Owner
hereby certifies (i) the Definitive Note is being acquired for the Owner’s own account without
transfer, (ii) such Exchange has been effected in compliance with the transfer restrictions
applicable to the Restricted Global Notes and pursuant to and in accordance with the Securities
Act, (iii) the restrictions on transfer contained in the Indenture and the Private Placement Legend
are not required in order to maintain compliance with the Securities Act and (iv) the Definitive
Note is being acquired in compliance with any applicable blue sky securities laws of any state of
the United States.

(c) o Check if Exchange is from Restricted Definitive Note to beneficial interest in an
Unrestricted Global Note. In connection with the Owner’s Exchange of a Restricted Definitive Note
for a beneficial interest in an Unrestricted Global Note, the Owner hereby certifies (i) the
beneficial interest is being acquired for the Owner’s own account without transfer, (ii) such
Exchange has been effected in compliance with the transfer restrictions applicable to Restricted
Definitive Notes and pursuant to and in accordance with the Securities Act, (iii) the restrictions
on transfer contained in the Indenture and the Private Placement Legend are not required in order
to maintain compliance with the Securities Act and (iv) the beneficial interest is being acquired
in compliance with any applicable blue sky securities laws of any state of the United States.

(d) o Check if Exchange is from Restricted Definitive Note to Unrestricted Definitive Note.
In connection with the Owner’s Exchange of a Restricted Definitive Note for an Unrestricted
Definitive Note, the Owner hereby certifies (i) the Unrestricted Definitive Note is being acquired
for the Owner’s own account without transfer, (ii) such Exchange has been effected in compliance
with the transfer restrictions applicable to Restricted Definitive Notes and pursuant to and in
accordance with the Securities Act, (iii) the restrictions on transfer contained in the Indenture
and the Private Placement Legend are not required in order to maintain compliance with the
Securities Act and (iv) the Unrestricted Definitive Note is being acquired in compliance with any
applicable blue sky securities laws of any state of the United States.

2. Exchange of Restricted Definitive Notes or Beneficial Interests in Restricted Global
Notes for Restricted Definitive Notes or Beneficial Interests in Restricted Global Notes

(a) o Check if Exchange is from beneficial interest in a Restricted Global Note to Restricted
Definitive Note. In connection with the Exchange of the Owner’s beneficial interest in a
Restricted Global Note for a Restricted Definitive Note with an equal principal amount, the Owner
hereby certifies that the Restricted Definitive Note is being acquired for the Owner’s own account
without transfer. Upon consummation of the proposed Exchange in accordance with the terms of the
Indenture, the Restricted Definitive Note issued shall continue to be subject to the restrictions
on transfer enumerated in the Private Placement Legend printed on the Restricted Definitive Note
and in the Indenture and the Securities Act.

 

E-2

 

(b) o Check if Exchange is from Restricted Definitive Note to beneficial interest in a
Restricted Global Note. In connection with the Exchange of the Owner’s Restricted Definitive Note
for a beneficial interest in the [CHECK ONE]  ̈ 144A Global Note,  ̈ Regulation
S Global Note with an equal principal amount, the Owner hereby certifies (i) the beneficial
interest is being acquired for the Owner’s own account without transfer and (ii) such Exchange has
been effected in compliance with the transfer restrictions applicable to the Restricted Global
Notes and pursuant to and in accordance with the Securities Act, and in compliance with any
applicable blue sky securities laws of any state of the United States. Upon consummation of the
proposed Exchange in accordance with the terms of the Indenture, the beneficial interest issued
shall be subject to the restrictions on transfer enumerated in the Private Placement Legend printed
on the relevant Restricted Global Note and in the Indenture and the Securities Act.

This certificate and the statements contained herein are made for your benefit and the benefit
of the Company.

	 	 	 	 	 
	 

	 

[Insert Name of Transferor]
	 
	 	 	 	 	 
	 	 	 
	 	By:  	
 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 

Dated:
 _____ 

 

E-3

 

EXHIBIT D

[FORM OF NOTATION OF SUBSIDIARY GUARANTEE]

For value received, each Guarantor (which term includes any successor Person under the
Indenture) has, jointly and severally, unconditionally guaranteed, to the extent set forth in the
Indenture and subject to the provisions in the Indenture dated as of May 3, 2011 (the “Indenture”)
among IASIS Healthcare LLC, (the “Company”), IASIS Capital Corporation (“IASIS Capital,” and
together with the Company, the “Issuers”), the Guarantors party thereto and The Bank of New York
Mellon Trust Company, N.A., as trustee (the “Trustee”), (a) the due and punctual payment of the
principal of, premium and Special Interest, if any, and interest on, the Notes, whether at
maturity, by acceleration, redemption or otherwise, the due and punctual payment of interest on
overdue principal of and interest on the Notes, if any, if lawful, and the due and punctual
performance of all other Obligations of the Issuers to the Holders or the Trustee all in accordance
with the terms of the Indenture and (b) in case of any extension of time of payment or renewal of
any Notes or any of such other Obligations, that the same shall be promptly paid in full when due
or performed in accordance with the terms of the extension or renewal, whether at stated maturity,
by acceleration or otherwise. The obligations of the Guarantors to the Holders and to the Trustee
pursuant to the Subsidiary Guarantee and the Indenture are expressly set forth in Article 10 of the
Indenture and reference is hereby made to the Indenture for the precise terms of the Subsidiary
Guarantee. Each Holder of a Note, by accepting the same, (a) agrees to and shall be bound by such
provisions, (b) authorizes and directs the Trustee, on behalf of such Holder, to take such action
as may be necessary or appropriate to effectuate the subordination as provided in the Indenture and
(c) appoints the Trustee attorney-in-fact of such Holder for such purpose.

Capitalized terms used but not defined herein have the meanings given to them in the
Indenture.

	 	 	 	 	 
	 	[NAME OF GUARANTOR(S)]

 	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 

 

D-1

 

EXHIBIT E

FORM OF SUPPLEMENTAL INDENTURE

TO BE DELIVERED BY SUBSEQUENT GUARANTORS

SUPPLEMENTAL INDENTURE (this “Supplemental Indenture”), dated as of
 _____, 20_____, among  _____ (the “Guaranteeing Subsidiary”), a subsidiary of IASIS Healthcare LLC (or
its permitted successor), (the “Company”), the Company, IASIS Capital Corporation (or its permitted
successor), (“IASIS Capital,” and together with the Company, the “Issuers”), the other Guarantors
(as defined in the Indenture referred to herein) and The Bank of New York Mellon Trust Company,
N.A., as trustee under the Indenture referred to below (the “Trustee”).

W I T N E S S E T H

WHEREAS, the Issuers have heretofore executed and delivered to the Trustee an indenture (the
“Indenture”), dated as of May 3, 2011 providing for the issuance of 8.375% Senior Notes due 2019
(the “Notes”);

WHEREAS, the Indenture provides that under certain circumstances the Guaranteeing Subsidiary
shall execute and deliver to the Trustee a supplemental indenture pursuant to which the
Guaranteeing Subsidiary shall unconditionally guarantee all of the Company’s Obligations under the
Notes and the Indenture on the terms and conditions set forth herein (the “Subsidiary Guarantee”);
and

WHEREAS, pursuant to Section 9.01 of the Indenture, the Trustee is authorized to execute and
deliver this Supplemental Indenture.

NOW THEREFORE, in consideration of the foregoing and for other good and valuable
consideration, the receipt of which is hereby acknowledged, the Guaranteeing Subsidiary and the
Trustee mutually covenant and agree for the equal and ratable benefit of the Holders of the Notes
as follows:

1. CAPITALIZED TERMS. Capitalized terms used herein without definition shall have the
meanings assigned to them in the Indenture.

2. AGREEMENT TO GUARANTEE. The Guaranteeing Subsidiary hereby agrees to provide an
unconditional Guarantee on the terms and subject to the conditions set forth in the Subsidiary
Guarantee and in this Indenture including but not limited to Article 10 thereof.

3. NO RECOURSE AGAINST OTHERS. No past, present or future director, officer, employee,
incorporator, stockholder or agent of the Guaranteeing Subsidiary, as such, shall have any
liability for any obligations of the Issuers or any Guaranteeing Subsidiary under the Notes, any
Subsidiary Guarantees, the Indenture or this Supplemental Indenture or for any claim based on, in
respect of, or by reason of, such obligations or their creation. Each Holder of the Notes by
accepting a Note waives and releases all such liability. The waiver and release
are part of the consideration for issuance of the Notes. Such waiver may not be effective to
waive liabilities under the federal securities laws and it is the view of the SEC that such a
waiver is against public policy.

 

E-1

 

4. NEW YORK LAW TO GOVERN. THE INTERNAL LAW OF THE STATE OF NEW YORK SHALL GOVERN AND BE USED
TO CONSTRUE THIS SUPPLEMENTAL INDENTURE BUT WITHOUT GIVING EFFECT TO APPLICABLE PRINCIPLES OF
CONFLICTS OF LAW TO THE EXTENT THAT THE APPLICATION OF THE LAWS OF ANOTHER JURISDICTION WOULD BE
REQUIRED THEREBY.

5. COUNTERPARTS. The parties may sign any number of copies of this Supplemental Indenture.
Each signed copy shall be an original, but all of them together represent the same agreement.

6. EFFECT OF HEADINGS. The Section headings herein are for convenience only and shall not
affect the construction hereof.

7. THE TRUSTEE. The Trustee shall not be responsible in any manner whatsoever for or in
respect of the validity or sufficiency of this Supplemental Indenture or for or in respect of the
recitals contained herein, all of which recitals are made solely by the Guaranteeing Subsidiary and
the Issuers.

 

E-2

 

IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly
executed and attested, all as of the date first above written.

Dated:
 _____, 20 _____ 

	 	 	 	 	 
	 	[GUARANTEEING SUBSIDIARY]

 	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 
	 	IASIS Healthcare LLC

 	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 
	 	IASIS Capital Corporation

 	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 
	 	[EXISTING GUARANTORS]

 	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 
	 	The Bank of New York Mellon Trust 

Company, N.A., as Trustee

 	 
	 	By:  	 	 
	 	 	Authorized Signature 	 

 

E-3Exhibit 4.2

Exhibit 4.2

EXECUTION VERSION

REGISTRATION RIGHTS AGREEMENT

by and among

IASIS Healthcare LLC

IASIS Capital Corporation

and the Guarantors

and

Merrill Lynch, Pierce, Fenner & Smith Incorporated

Barclays Capital Inc.

Citigroup Global Markets Inc.

Goldman, Sachs & Co.

J.P. Morgan Securities LLC

Deutsche Bank Securities Inc.

SunTrust Robinson Humphrey, Inc.

Dated as of May 3, 2011

 

 

 

REGISTRATION RIGHTS AGREEMENT

This Registration Rights Agreement (this “Agreement”) is made and entered into as of May 3,
2011, by and among IASIS Healthcare LLC, a Delaware limited liability company (the “Company”),
IASIS Capital Corporation, a Delaware corporation (the “Co-Issuer” and together with the Company,
the “Issuers”), the guarantors that are listed on the signature page hereto (collectively, the
“Guarantors”), and Merrill Lynch, Pierce, Fenner & Smith Incorporated, Barclays Capital Inc.,
Citigroup Global Markets Inc., Goldman, Sachs & Co., J.P. Morgan Securities LLC, Deutsche Bank
Securities Inc. and SunTrust Robinson Humphrey, Inc. (collectively, the “Initial Purchasers”), each
of whom has agreed to purchase the Issuers’ 8.375% Senior Notes due 2019 (the “Initial Notes”)
fully and unconditionally guaranteed by the Guarantors (the “Guarantees”) pursuant to the Purchase
Agreement (as defined below). The Initial Notes and the Guarantees attached thereto are herein
collectively referred to as the “Initial Securities.”

This Agreement is made pursuant to the Purchase Agreement, dated April 27, 2011 (the “Purchase
Agreement”), among the Issuers, the Guarantors and the Initial Purchasers (i) for the benefit of
the Initial Purchasers and (ii) for the benefit of the holders from time to time of the Initial
Securities, including the Initial Purchasers. In order to induce the Initial Purchasers to
purchase the Initial Securities, the Issuers have agreed to provide the registration rights set
forth in this Agreement. The execution and delivery of this Agreement is a condition to the
obligations of the Initial Purchasers under the Purchase Agreement, as set forth in Section 6(l)
thereof.

The parties hereby agree as follows:

SECTION 1. Definitions. As used in this Agreement, the following capitalized terms shall have
the following meanings:

Additional Interest Payment Date: With respect to the Initial Securities, each Interest
Payment Date.

Broker-Dealer: Any broker or dealer registered under the Exchange Act.

Business Day: Any day other than a Saturday, Sunday or U.S. federal holiday or a day on which
banking institutions or trust companies located in New York, New York are authorized or obligated
to be closed.

Closing Date: The date of this Agreement.

Commission: The Securities and Exchange Commission.

Consummate: A registered Exchange Offer shall be deemed “Consummated” for purposes of this
Agreement upon the occurrence of (i) the filing and effectiveness under the Securities Act of the
Exchange Offer Registration Statement relating to the Exchange Securities to be issued in the
Exchange Offer, (ii) the maintenance of such Registration Statement continuously effective and the
keeping of the Exchange Offer open for a period not less than the minimum period required pursuant
to Section 3(b) hereof, and (iii) the delivery by the Issuers to the Registrar under the Indenture
of Exchange Securities in the same aggregate principal amount as the aggregate principal amount of Initial Securities that were validly tendered by Holders thereof
pursuant to the terms of the Exchange Offer.

 

 

 

Effectiveness Target Date: As defined in Section 5 hereof.

Exchange Act: The Securities Exchange Act of 1934, as amended.

Exchange Offer: The registration by the Issuers under the Securities Act of the Exchange
Securities pursuant to a Registration Statement pursuant to which the Issuers offer the Holders of
all outstanding Transfer Restricted Securities the opportunity to exchange all such outstanding
Transfer Restricted Securities held by such Holders for Exchange Securities in an aggregate
principal amount equal to the aggregate principal amount of the Transfer Restricted Securities
tendered in such exchange offer by such Holders.

Exchange Offer Registration Statement: The Registration Statement relating to the Exchange
Offer, including the related Prospectus.

Exempt Resales: The transactions in which the Initial Purchasers propose to sell the Initial
Securities to certain “qualified institutional buyers,” as such term is defined in Rule 144A under
the Securities Act, to certain institutional “accredited investors,” as such term is defined in
Rule 501(a)(1), (2), (3) and (7) of Regulation D under the Securities Act and to certain non-U.S.
persons pursuant to Regulation S under the Securities Act.

Exchange Securities: The 8.375% Senior Notes due 2019, of the same series under the Indenture
as the Initial Notes and the Guarantees attached thereto, to be issued to Holders in exchange for
Transfer Restricted Securities pursuant to this Agreement.

FINRA: Financial Industry Regulatory Authority, Inc.

Holders: As defined in Section 2(b) hereof.

Indemnified Holder: As defined in Section 8(a) hereof.

Indenture: The Indenture, dated as of May 3, 2011, by and among the Issuers, the Guarantors
and The Bank of New York Mellon Trust Company, N.A., as trustee (the “Trustee”), pursuant to which
the Initial Securities are to be issued, as such Indenture is amended or supplemented from time to
time in accordance with the terms thereof.

Initial Purchasers: As defined in the preamble hereto.

Initial Notes: As defined in the preamble hereto.

Initial Placement: The issuance and sale by the Issuers of the Initial Securities to the
Initial Purchasers pursuant to the Purchase Agreement.

Initial Securities: As defined in the preamble hereto.

Interest Payment Date: As defined in the Indenture.

 

-2-

 

Person: An individual, partnership, corporation, trust or unincorporated organization, or a
government or agency or political subdivision thereof.

Prospectus: The prospectus included in a Registration Statement, as amended or supplemented
by any prospectus supplement and by all other amendments thereto, including post-effective
amendments, and all exhibits and material incorporated by reference into such Prospectus.

Registration Default: As defined in Section 5 hereof.

Registration Statement: Any registration statement of the Issuers relating to (a) an offering
of Exchange Securities pursuant to an Exchange Offer or (b) the registration for resale of the
Transfer Restricted Securities pursuant to the Shelf Registration Statement, which is filed
pursuant to the provisions of this Agreement, in each case, including the Prospectus included
therein, all amendments and supplements thereto (including post-effective amendments) and all
exhibits and material incorporated by reference therein.

Securities Act: The Securities Act of 1933, as amended.

Shelf Filing Deadline: As defined in Section 4(a) hereof.

Shelf Registration Statement: As defined in Section 4(a) hereof.

Shelf Suspension Period: As defined in Section 6(d) hereof.

Transfer Restricted Securities: Each Initial Security, until the earliest to occur of (a) the
date on which such Initial Security is exchanged in the Exchange Offer for an Exchange Security
entitled to be resold to the public by the Holder thereof without complying with the prospectus
delivery requirements of the Securities Act, (b) the date on which such Initial Security has been
effectively registered under the Securities Act and disposed of in accordance with a Shelf
Registration Statement, (c) the date on which such Initial Security has been effectively registered
under the Securities Act and is distributed to the public by a Broker-Dealer pursuant to the “Plan
of Distribution” contemplated by the Exchange Offer Registration Statement (including delivery of
the Prospectus contained therein), (d) the date on which such Initial Security has been distributed
to the public pursuant to Rule 144 under the Securities Act and (e) the date on which such Initial
Security ceases to be outstanding for purposes of the Indenture.

Trust Indenture Act: The Trust Indenture Act of 1939, as amended.

Underwritten Registration or Underwritten Offering: A registration in which securities of the
Issuers are sold to an underwriter for reoffering to the public.

SECTION 2. Securities Subject to this Agreement.

(a) Transfer Restricted Securities. The securities entitled to the benefits of this Agreement
are the Transfer Restricted Securities.

 

-3-

 

(b) Holders of Transfer Restricted Securities. A Person is deemed to be a holder of Transfer
Restricted Securities (each, a “Holder”) whenever such Person owns Transfer Restricted Securities.

SECTION 3. Registered Exchange Offer.

(a) Unless the Exchange Offer shall not be permissible under applicable law or Commission
policy (after the procedures set forth in Section 6(a) hereof have been complied with), each of the
Issuers and the Guarantors shall (i) cause to be filed with the Commission as soon as practicable
after the Closing Date, but in no event later than 180 days after the Closing Date (or if such
180th day is not a Business Day, the next succeeding Business Day), a Registration Statement under
the Securities Act relating to the Exchange Securities and the Exchange Offer, (ii) use its
commercially reasonable efforts to cause such Registration Statement to become effective at the
earliest possible time, but in no event later than 270 days after the Closing Date (or if such
270th day is not a Business Day, the next succeeding Business Day), (iii) in connection with the
foregoing, file (A) all pre-effective amendments to such Registration Statement as may be necessary
in order to cause such Registration Statement to become effective, (B) if applicable, a
post-effective amendment to such Registration Statement pursuant to Rule 430A under the Securities
Act and (C) cause all necessary filings in connection with the registration and qualification of
the Exchange Securities to be made under the state securities or blue sky laws of such
jurisdictions as are necessary to permit Consummation of the Exchange Offer, and (iv) upon the
effectiveness of such Registration Statement, commence the Exchange Offer. The Exchange Offer
Registration Statement shall be on the appropriate form permitting registration of the Exchange
Securities to be offered in exchange for the Transfer Restricted Securities and to permit resales
of Transfer Restricted Securities held by Broker-Dealers as contemplated by Section 3(c) hereof.

(b) The Issuers and the Guarantors shall cause the Exchange Offer Registration Statement to be
effective continuously and shall use their commercially reasonable efforts to issue on or prior to
30 Business Days, or longer, if required by the federal securities laws, after the date on which
the Exchange Offer Registration Statement was declared effective by the SEC, Exchange Securities in
exchange for all Transfer Restricted Securities tendered prior thereto in the Exchange Offer. The
Issuers and the Guarantors shall cause the Exchange Offer to comply with all applicable federal and
state securities laws. No securities other than the Exchange Securities shall be included in the
Exchange Offer Registration Statement.

(c) The Issuers shall indicate in a “Plan of Distribution” section contained in the Prospectus
forming a part of the Exchange Offer Registration Statement that any Broker-Dealer who holds
Transfer Restricted Securities that were acquired for its own account as a result of market-making
activities or other trading activities (other than Transfer Restricted Securities acquired directly
from the Issuers), may exchange such Transfer Restricted Securities pursuant to the Exchange Offer;
however, such Broker-Dealer may be deemed to be an “underwriter” within the meaning of the
Securities Act and must, therefore, deliver a prospectus meeting the requirements of the Securities
Act in connection with any resales of the Exchange Securities received by such Broker-Dealer in the
Exchange Offer, which prospectus delivery requirement may be satisfied by the delivery by such
Broker-Dealer of the Prospectus contained in the Exchange Offer Registration Statement. Such “Plan of Distribution” section shall also contain all other information
with respect to such resales by Broker-Dealers that the Commission may require in order to permit
such resales pursuant thereto, but such “Plan of Distribution” shall not name any such
Broker-Dealer or disclose the amount of Initial Securities held by any such Broker-Dealer except to
the extent required by the Commission as a result of a change in policy after the date of this
Agreement.

 

-4-

 

Each of the Issuers shall use commercially reasonable efforts to cause the Guarantors to use
their commercially reasonable efforts to keep the Exchange Offer Registration Statement
continuously effective, supplemented and amended as required by the provisions of Section 6(c)
hereof to the extent necessary to ensure that it is available for resales of Initial Securities
acquired by Broker-Dealers for their own accounts as a result of market-making activities or other
trading activities, and to ensure that it conforms with the requirements of this Agreement, the
Securities Act and the policies, rules and regulations of the Commission as announced from time to
time, for a period ending on the earlier of (i) 180 days from the date on which the Exchange Offer
Registration Statement is declared effective and (ii) the date on which a Broker-Dealer is no
longer required to deliver a prospectus in connection with market-making or other trading
activities.

The Issuers shall provide sufficient copies of the latest version of such Prospectus to
Broker-Dealers promptly upon request at any time during such 180-day (or shorter as provided in the
foregoing sentence) period in order to facilitate such resales.

SECTION 4. Shelf Registration.

(a) Shelf Registration. If (i) the Issuers and the Guarantors are not required to file an
Exchange Offer Registration Statement or to consummate the Exchange Offer because the Exchange
Offer is not permitted by applicable law or Commission policy (after the procedures set forth in
Section 6(a) hereof have been complied with) on or prior to the 180th day after the Closing Date,
(ii) for any reason the Exchange Offer is not Consummated within 270 days after the Closing Date
(or if such 270th day is not a Business Day, the next succeeding Business Day), or (iii) with
respect to any Holder of Transfer Restricted Securities that notifies the Issuers prior to the 20th
Business Day following the consummation of the Exchange Offer (A) such Holder is prohibited by
applicable law or Commission policy from participating in the Exchange Offer, (B) in the case of
any Holder that participates in the Exchange Offer, such Holder may not resell the Exchange
Securities acquired by it in the Exchange Offer to the public without delivering a prospectus and
that the Prospectus contained in the Exchange Offer Registration Statement is not appropriate or
available for such resales by such Holder or (C) such Holder is a Broker-Dealer and holds Initial
Securities acquired directly from the Issuers or one of their affiliates, then, upon such Holder’s
request, the Issuers and the Guarantors shall

(x) promptly file a shelf registration statement pursuant to Rule 415 under the
Securities Act, which may be an amendment to the Exchange Offer Registration Statement (in
either event, the “Shelf Registration Statement”) on or prior to the earliest to occur of
(1) the 180th day after the date on which the Company determines that it is not required to
file the Exchange Offer Registration Statement, (2) the 180th day after the date on which
the Company receives notice of a request from a Holder of Transfer Restricted
Securities as contemplated by clause (iii) above, and (3) the 270th day after the
Closing Date (or if such 270th day is not a Business Day, the next succeeding Business Day)
(such earliest date being the “Shelf Filing Deadline”), which Shelf Registration Statement
shall provide for resales of all Transfer Restricted Securities the Holders of which shall
have provided the information required pursuant to Section 4(b) hereof; and

 

-5-

 

(y) use their commercially reasonable efforts to cause such Shelf Registration
Statement to be declared effective by the Commission on or before the 270th day after the
Closing Date (or if such 270th day is not a Business Day, the next succeeding Business Day).

Each of the Issuers and the Guarantors shall use their commercially reasonable efforts to keep
such Shelf Registration Statement continuously effective, supplemented and amended as required by
the provisions of Sections 6(b) and (c) hereof to the extent necessary to ensure that it is
available for resales of Initial Securities by the Holders of Transfer Restricted Securities
entitled to the benefit of this Section 4(a), and to ensure that it conforms with the requirements
of this Agreement, the Securities Act and the policies, rules and regulations of the Commission as
announced from time to time, until the earliest of (i) two years after the Closing Date, (ii) such
time as all of the applicable notes have been sold pursuant to such Shelf Registration Statement or
(iii) the date upon which all Notes covered by such Shelf Registration Statement are distributed to
the public pursuant to Rule 144 (such period, the “Shelf Registration Period”).

(b) Provision by Holders of Certain Information in Connection with the Shelf Registration
Statement. No Holder of Transfer Restricted Securities may include any of its Transfer Restricted
Securities in any Shelf Registration Statement pursuant to this Agreement unless and until such
Holder furnishes to the Issuers in writing, within 30 Business Days after receipt of a request
therefor, such information as the Issuers may reasonably request for use in connection with any
Shelf Registration Statement or Prospectus or preliminary Prospectus included therein. Each Holder
as to which any Shelf Registration Statement is being effected agrees to furnish promptly to the
Issuers all information required to be disclosed in order to make the information previously
furnished to the Issuers by such Holder not materially misleading.

SECTION 5. Additional Interest. If (i) any of the Registration Statements required by this
Agreement is not filed with the Commission on or prior to the date specified for such filing in
this Agreement, (ii) any of such Registration Statements has not been declared effective by the
Commission on or prior to the date specified for such effectiveness in this Agreement (the
“Effectiveness Target Date”), (iii) the Exchange Offer has not been Consummated within 30 Business
Days after the Effectiveness Target Date with respect to the Exchange Offer Registration Statement
or (iv) any Registration Statement required by this Agreement is filed and declared effective but
shall thereafter cease to be effective or fail to be usable for its intended purpose without being
succeeded immediately by a post-effective amendment to such Registration Statement that cures such
failure and that is itself immediately declared effective (each such event referred to in clauses
(i) through (iv), a “Registration Default”), the Issuers hereby agree that the interest rate borne
by the Transfer Restricted Securities shall be increased by 0.25% per annum during the 90-day
period immediately following the occurrence of any Registration Default and shall increase by 0.25%
per annum at the end of each subsequent 90-day period, but in
no event shall such increase exceed 1.00% per annum (such increase, “Additional Interest”)
commencing on (x) the 270th day after the Closing Date, in the case of clause (i) above, or (y) the
day such Shelf Registration Statement cease to be effective, in the case of clause (ii) above.
Following the cure of all Registration Defaults relating to any particular Transfer Restricted
Securities, the interest rate borne by the relevant Transfer Restricted Securities will be reduced
to the original interest rate borne by such Transfer Restricted Securities; provided, however,
that, if after any such reduction in interest rate, a different Registration Default occurs, the
interest rate borne by the relevant Transfer Restricted Securities shall again be increased
pursuant to the foregoing provisions.

 

-6-

 

All obligations of the Issuers and the Guarantors set forth in the preceding paragraph that
are outstanding with respect to any Transfer Restricted Security at the time such security ceases
to be a Transfer Restricted Security shall survive until such time as all such obligations with
respect to such security shall have been satisfied in full.

Any amounts of Additional Interest accrued pursuant to this Section 5 will be paid in arrears
in cash semiannually by wire transfer of immediately available funds or by federal funds check on
the Additional Interest Payment Dates applicable to the Holders of record specified in the
Indenture, commencing with the first such Additional Interest Payment Date occurring after any
Additional Interest commences to accrue.

SECTION 6. Registration Procedures.

(a) Exchange Offer Registration Statement. In connection with the Exchange Offer, the Issuers
and the Guarantors shall comply with all of the provisions of Section 6(c) hereof, shall use their
commercially reasonable efforts to effect such exchange to permit the sale of Transfer Restricted
Securities being sold in accordance with the intended method or methods of distribution thereof,
and shall comply with all of the following provisions:

(i) If in the reasonable opinion of counsel to the Issuers there is a question as to
whether the Exchange Offer is permitted by applicable law, each of the Issuers and the
Guarantors hereby agrees to seek a no-action letter or other favorable decision from the
Commission allowing the Issuers and the Guarantors to Consummate an Exchange Offer for such
Transfer Restricted Securities. Each of the Issuers and the Guarantors hereby agrees to
pursue the issuance of such a decision to the Commission staff level but shall not be
required to take commercially unreasonable action to effect a change of Commission policy.
Each of the Issuers and the Guarantors hereby agrees, however, to (A) participate in
telephonic conferences with the Commission, (B) deliver to the Commission staff an analysis
prepared by counsel to the Issuers setting forth the legal bases, if any, upon which such
counsel has concluded that such an Exchange Offer should be permitted and (C) diligently
pursue a favorable resolution by the Commission staff of such submission.

 

-7-

 

(ii) As a condition to its participation in the Exchange Offer pursuant to the terms of
this Agreement, each Holder of Transfer Restricted Securities shall furnish, upon the
request of the Issuers, prior to the Consummation thereof, a written representation to the
Issuers (which may be contained in the letter of transmittal contemplated by the Exchange Offer Registration Statement) to the effect that (A) it is acquiring the
Exchange Securities in its ordinary course of business, (B) that, at the time of the
commencement of the Exchange Offer, it has no arrangement or understanding with any Person
to participate in a distribution (within the meaning of the Securities Act) of the Exchange
Securities to be issued in the Exchange Offer in violation of the Securities Act, (C) it is
not an “affiliate” (as defined in Rule 405 under the Securities Act) of the Issuers, (D) if
such holder is not a Broker-Dealer, that it is not engaged in, and does not intend to engage
in, the distribution of the Exchange Securities to be issued in the Exchange Offer, and (E)
if such Holder is a Broker-Dealer that will receive the Exchange Securities that are
Transfer Restricted Securities for its own account in exchange for Transfer Restricted
Securities that were acquired as a result of market-making activities or other trading
activities, that it will deliver a prospectus in connection with any resale of such Exchange
Notes. In addition, all such Holders of Transfer Restricted Securities shall otherwise
cooperate in the Issuers’ preparations for the Exchange Offer. Each Holder hereby
acknowledges and agrees that any Broker-Dealer and any such Holder using the Exchange Offer
to participate in a distribution of the securities to be acquired in the Exchange Offer (1)
could not under Commission policy as in effect on the date of this Agreement rely on the
position of the Commission enunciated in Morgan Stanley and Co., Inc. (available
June 5, 1991) and Exxon Capital Holdings Corporation (available May 13, 1988), as
interpreted in the Commission’s letter to Shearman & Sterling dated July 2, 1993, and
similar no-action letters (which may include any no-action letter obtained pursuant to
clause (i) above), and (2) must comply with the registration and prospectus delivery
requirements of the Securities Act in connection with a secondary resale transaction and
that such a secondary resale transaction should be covered by an effective registration
statement containing the selling security holder information required by Item 507 or 508, as
applicable, of Regulation S-K if the resales are of Exchange Securities obtained by such
Holder in exchange for Initial Securities acquired by such Holder directly from the Issuers.

(b) Shelf Registration Statement. In connection with the Shelf Registration Statement, each
of the Issuers and the Guarantors shall comply with all the provisions of Section 6(c) hereof and
shall use their commercially reasonable efforts to effect such registration to permit the sale of
the Transfer Restricted Securities being sold in accordance with the intended method or methods of
distribution thereof, and pursuant thereto each of the Issuers and the Guarantors will in
accordance with Section 4 above, prepare and file with the Commission a Registration Statement
relating to the registration on any appropriate form under the Securities Act, which form shall be
available for the sale of the Transfer Restricted Securities in accordance with the intended method
or methods of distribution thereof.

 

-8-

 

(c) General Provisions. In connection with any Registration Statement and any Prospectus
required by this Agreement to permit the sale or resale of Transfer Restricted Securities
(including, without limitation, any Registration Statement and the related Prospectus required to
permit resales of Initial Securities by Broker-Dealers), each of the Issuers and the Guarantors
shall:

(i) use its commercially reasonable efforts to keep such Registration Statement
continuously effective (subject to any Shelf Suspension Period) and provide all requisite financial statements (including, if required by the Securities Act or any
regulation thereunder, financial statements of the Guarantors for the period specified in
Section 3 or 4 hereof, as applicable; upon the occurrence of any event that would cause any
such Registration Statement or the Prospectus contained therein (A) to contain a material
misstatement or omission or (B) not to be effective and usable for resale of Transfer
Restricted Securities during the period required by this Agreement, the Issuers shall
(subject to any Shelf Suspension Period) file promptly an appropriate amendment to such
Registration Statement, in the case of clause (A), correcting any such misstatement or
omission, and, in the case of either clause (A) or (B), use its commercially reasonable
efforts to cause such amendment to be declared effective and such Registration Statement and
the related Prospectus to become usable for their intended purpose(s) as soon as practicable
thereafter;

(ii) prepare and file with the Commission such amendments and post-effective amendments
to the applicable Registration Statement as may be necessary to keep the Registration
Statement effective for the applicable period set forth in Section 3 or 4 hereof, as
applicable, or such shorter period as will terminate when all Transfer Restricted Securities
covered by such Registration Statement have been sold; cause the Prospectus to be
supplemented by any required Prospectus supplement, and as so supplemented to be filed
pursuant to Rule 424 under the Securities Act, and to comply fully with the applicable
provisions of Rules 424 and 430A under the Securities Act in a timely manner; and comply
with the provisions of the Securities Act with respect to the disposition of all securities
covered by such Registration Statement during the applicable period in accordance with the
intended method or methods of distribution by the sellers thereof set forth in such
Registration Statement or supplement to the Prospectus;

(iii) advise the underwriter(s), if any, and selling Holders promptly and, if requested
by such Persons, to confirm such advice in writing, (A) when the Prospectus or any
prospectus supplement or post-effective amendment has been filed, and, with respect to any
Registration Statement or any post-effective amendment thereto, when the same has become
effective under the Securities Act, (B) of any request by the Commission for amendments to
the Registration Statement or amendments or supplements to the Prospectus or for additional
information relating thereto, (C) of the issuance by the Commission of any stop order
suspending the effectiveness of the Registration Statement under the Securities Act or of
the suspension by any state securities commission of the qualification of the Transfer
Restricted Securities for offering or sale in any jurisdiction, or the initiation of any
proceeding for any of the preceding purposes, (D) of the existence of any fact or the
happening of any event that makes any statement of a material fact made in the Registration
Statement, the Prospectus, any amendment or supplement thereto, or any document incorporated
by reference therein untrue, or that requires the making of any additions to or changes in
the Registration Statement or the Prospectus in order to make the statements therein not
misleading. If at any time the Commission shall issue any stop order suspending the
effectiveness of the Registration Statement, or any state securities commission or other
regulatory authority shall issue an order suspending the qualification or exemption from
qualification of the Transfer Restricted Securities under state securities or blue sky laws,
each of the Issuers and the Guarantors shall use their commercially
reasonable efforts to obtain the withdrawal or lifting of such order at the earliest
possible time;

 

-9-

 

(iv) furnish without charge to each of the Initial Purchasers, each selling Holder
named in any Registration Statement, and each of the underwriter(s), if any, before filing
with the Commission, copies of any Registration Statement or any Prospectus included therein
or any amendments or supplements to any such Registration Statement or Prospectus (including
all documents incorporated by reference after the initial filing of such Registration
Statement), which documents will be subject to the review and comment of such Holders and
underwriter(s) in connection with such sale, if any, for a period of at least five Business
Days, and the Issuers will not file any such Registration Statement or Prospectus or any
amendment or supplement to any such Registration Statement or Prospectus (including all such
documents incorporated by reference) to which an Initial Purchaser of Transfer Restricted
Securities covered by such Registration Statement or the underwriter(s), if any, shall
reasonably object in writing within five Business Days after the receipt thereof (such
objection to be deemed timely made upon confirmation of facsimile transmission within such
period). The objection of an Initial Purchaser or underwriter, if any, shall be deemed to
be reasonable if such Registration Statement, amendment, Prospectus or supplement, as
applicable, as proposed to be filed, contains a material misstatement or omission;

(v) promptly prior to the filing of any document that is to be incorporated by
reference into a Registration Statement or Prospectus, provide copies of such document to
the Initial Purchasers, subject to execution of customary agreements regarding
confidentiality and use of such information, in the form reasonably satisfactory to the
Issuers and the Guarantors and in compliance with Regulation FD, and to the underwriter(s),
if any, make the Issuers’ and the Guarantors’ representatives available for discussion of
such document and other customary due diligence matters, and give reasonable consideration
to any comments provided by the Initial Purchasers, each Selling Holder named in any
Registration Statement and the underwriter(s), if any, on such documents prior to the filing
thereof;

(vi) make available at reasonable times for inspection by the Initial Purchasers, the
managing underwriter(s), if any, participating in any disposition pursuant to such
Registration Statement, subject to execution of customary agreements regarding
confidentiality and use of such information, in the form reasonably satisfactory to the
Issuers and the Guarantors and in compliance with Regulation FD, and any attorney or
accountant retained by such Initial Purchasers or any of the underwriter(s), all financial
and other records, pertinent corporate documents and properties of each of the Issuers and
the Guarantors and cause the Issuers’ and the Guarantors’ officers, directors and employees
to supply all information reasonably requested by the Initial Purchasers, underwriter,
attorney or accountant in connection with such Registration Statement or any post-effective
amendment thereto subsequent to the filing thereof and prior to its effectiveness and to
participate in meetings with investors to the extent requested by the managing
underwriter(s), if any;

 

-10-

 

(vii) if requested by any selling Holders or the underwriter(s), if any, promptly
incorporate in any Registration Statement or Prospectus, pursuant to a supplement or
post-effective amendment if necessary, such information as such selling Holders and
underwriter(s), if any, may reasonably request to have included therein, including, without
limitation, information relating to the “Plan of Distribution” of the Transfer Restricted
Securities, information with respect to the principal amount of Transfer Restricted
Securities being sold to such underwriter(s), the purchase price being paid therefor and any
other terms of the offering of the Transfer Restricted Securities to be sold in such
offering; and make all required filings of such prospectus supplement or post-effective
amendment as soon as practicable after the Issuers are notified of the matters to be
incorporated in such prospectus supplement or post-effective amendment;

(viii) cause the Transfer Restricted Securities covered by the Registration Statement
to be rated with the appropriate rating agencies, if so requested by the Holders of a
majority in aggregate principal amount of Transfer Restricted Securities covered thereby or
the underwriter(s), if any;

(ix) furnish to each Initial Purchaser, each selling Holder and each of the
underwriter(s), if any, without charge, at least one copy of the Registration Statement, as
first filed with the Commission, and of each amendment thereto, including financial
statements and schedules, all documents incorporated by reference therein and all exhibits
(including exhibits incorporated therein by reference);

(x) deliver to each selling Holder and each of the underwriter(s), if any, without
charge, as many copies of the Prospectus (including each preliminary prospectus) and any
amendment or supplement thereto as such Persons reasonably may request; each of the Issuers
and the Guarantors hereby consents to the use of the Prospectus and any amendment or
supplement thereto by each of the selling Holders and each of the underwriter(s), if any, in
connection with the offering and the sale of the Transfer Restricted Securities covered by
the Prospectus or any amendment or supplement thereto;

(xi) enter into such customary agreements (including an underwriting agreement), and
make such representations and warranties, and take all such other reasonable actions in
connection therewith in order to expedite or facilitate the disposition of the Transfer
Restricted Securities pursuant to any Registration Statement contemplated by this Agreement,
all to such extent as may be requested by any Initial Purchaser or by any Holder of Transfer
Restricted Securities or underwriter in connection with any sale or resale pursuant to any
Registration Statement contemplated by this Agreement; and whether or not an underwriting
agreement is entered into and whether or not the registration is an Underwritten
Registration, each of the Issuers and the Guarantors shall:

(A) furnish to each Initial Purchaser, each selling Holder and each
underwriter, if any, in such substance and scope as they may reasonably request and
as are customarily made by issuers to underwriters in primary underwritten
offerings, upon the date of the Consummation of the Exchange Offer or, if
applicable, the effectiveness of the Shelf Registration Statement:

(1) a certificate, dated the date of Consummation of the Exchange Offer
or the date of effectiveness of the Shelf Registration Statement, as the
case may be, signed by (y) an executive officer and (z) a principal
financial or accounting officer of each of the Issuers and the Guarantors,
confirming, as of the date thereof, the matters set forth in Section 6(d) of
the Purchase Agreement and such other matters as such parties may reasonably
request;

 

-11-

 

(2) an opinion, dated the date of Consummation of the Exchange Offer or
the date of effectiveness of the Shelf Registration Statement, as the case
may be, of counsel for the Issuers and the Guarantors, covering the matters
set forth in Section 6(c) of the Purchase Agreement, and in any event
including a statement to the effect that such counsel has participated in
conferences with officers and other representatives of the Issuers and the
Guarantors, representatives of the independent public accountants for the
Issuers and the Guarantors, representatives of the underwriter(s), if any,
and counsel to the underwriter(s), if any, in connection with the
preparation of such Registration Statement and the related Prospectus and
have considered the matters required to be stated therein and the statements
contained therein, although such counsel has not independently verified the
accuracy, completeness or fairness of such statements; and that such counsel
advises that, on the basis of the foregoing, no facts came to such counsel’s
attention that caused such counsel to believe that the applicable
Registration Statement, at the time such Registration Statement or any
post-effective amendment thereto became effective, and, in the case of the
Exchange Offer Registration Statement, as of the date of Consummation,
contained an untrue statement of a material fact or omitted to state a
material fact required to be stated therein or necessary to make the
statements therein not misleading, or that the Prospectus contained in such
Registration Statement as of its date and, in the case of the opinion dated
the date of Consummation of the Exchange Offer, as of the date of
Consummation, contained an untrue statement of a material fact or omitted to
state a material fact necessary in order to make the statements therein not
misleading. Without limiting the foregoing, such counsel may state further
that such counsel assumes no responsibility for, and has not independently
verified, the accuracy, completeness or fairness of the financial
statements, notes and schedules and other financial data included in any
Registration Statement contemplated by this Agreement or the related
Prospectus; and

(3) a customary comfort letter, dated the date of effectiveness of the
Shelf Registration Statement, from the Issuers’ independent accountants, in
the customary form and covering matters of the type customarily requested to
be covered in comfort letters by underwriters in connection with primary
underwritten offerings, and covering or affirming the
matters set forth in the comfort letters delivered pursuant to Section
6(f) of the Purchase Agreement, without exception;

 

-12-

 

(B) set forth in full or incorporate by reference in the underwriting
agreement, if any, the indemnification provisions and procedures of Section 8 hereof
with respect to all parties to be indemnified pursuant to said Section; and

(C) deliver such other documents and certificates as may be reasonably
requested by such parties to evidence compliance with Section 6(c)(xi)(A) hereof and
with any customary conditions contained in the underwriting agreement or other
agreement entered into by the Issuers or any of the Guarantors pursuant to this
Section 6(c)(xi), if any.

If at any time the representations and warranties of the Issuers and the Guarantors
contemplated in Section 6(c)(xi)(A)(1) hereof cease to be true and correct, the Issuers or
the Guarantors shall so advise the Initial Purchasers and the underwriter(s), if any, and
each selling Holder promptly and, if requested by such Persons, shall confirm such advice in
writing;

(xii) prior to any public offering of Transfer Restricted Securities, cooperate with
the selling Holders, the underwriter(s), if any, and their respective counsel in connection
with the registration and qualification of the Transfer Restricted Securities under the
state securities or blue sky laws of such jurisdictions as the selling Holders or
underwriter(s), if any, may request and do any and all other acts or things necessary or
advisable to enable the disposition in such jurisdictions of the Transfer Restricted
Securities covered by the Shelf Registration Statement; provided, however, that none of the
Issuers or the Guarantors shall be required to register or qualify as a foreign corporation
where it is not then so qualified or to take any action that would subject it to the service
of process in suits or to taxation, other than as to matters and transactions relating to
the Registration Statement, in any jurisdiction where it is not then so subject;

(xiii) shall issue, upon the request of any Holder of Initial Securities covered by the
Shelf Registration Statement, Exchange Securities having an aggregate principal amount equal
to the aggregate principal amount of Initial Securities surrendered to the Issuers by such
Holder in exchange therefor or being sold by such Holder; such Exchange Securities to be
registered in the name of such Holder or in the name of the purchaser(s) of such Securities,
as the case may be; in return, the Initial Securities held by such Holder shall be
surrendered to the Issuers for cancellation;

(xiv) cooperate with the selling Holders and the underwriter(s), if any, to facilitate
the timely preparation and delivery of certificates representing Transfer Restricted
Securities to be sold and not bearing any restrictive legends; and enable such Transfer
Restricted Securities to be in such denominations and registered in such names as the
Holders or the underwriter(s), if any, may request at least two Business Days prior to any
sale of Transfer Restricted Securities made by such Holders or underwriter(s);

 

-13-

 

(xv) use their commercially reasonable efforts to cause the Transfer Restricted
Securities covered by the Registration Statement to be registered with or approved by such
other governmental agencies or authorities as may be necessary to enable the seller or
sellers thereof or the underwriter(s), if any, to consummate the disposition of such
Transfer Restricted Securities, subject to the proviso contained in Section 6(c)(xii)
hereof;

(xvi) if any fact or event contemplated by Section 6(c)(iii)(D) hereof shall exist or
have occurred, prepare a supplement or post-effective amendment to such Registration
Statement or related Prospectus or any document incorporated therein by reference or file
any other required document so that, as thereafter delivered to the purchasers of Transfer
Restricted Securities, the Prospectus will not contain an untrue statement of a material
fact or omit to state any material fact necessary in order to make the statements therein,
in light of the circumstances under which they were made, not misleading;

(xvii) provide a CUSIP number for all Initial Securities not later than the effective
date of the Registration Statement covering such Initial Securities and provide the Trustee
under the Indenture with printed certificates for such Initial Securities which are in a
form eligible for deposit with the Depository Trust Company and take all other action
necessary to ensure that all such Initial Securities are eligible for deposit with the
Depository Trust Company;

(xviii) cooperate and assist in any filings required to be made with FINRA and in the
performance of any due diligence investigation by any underwriter (including any “qualified
independent underwriter”) that is required to be retained in accordance with the rules and
regulations of FINRA;

(xix) otherwise use their commercially reasonable efforts to comply with all applicable
rules and regulations of the Commission, and make generally available to its security
holders, as soon as practicable, a consolidated earnings statement meeting the requirements
of Rule 158 (which need not be audited) for the twelve-month period (A) commencing at the
end of any fiscal quarter in which Transfer Restricted Securities are sold to underwriters
in a firm commitment or commercially reasonable efforts Underwritten Offering or (B) if not
sold to underwriters in such an offering, beginning with the first month of the Issuers’
first fiscal quarter commencing after the effective date of the Registration Statement;

(xx) cause the Indenture to be qualified under the Trust Indenture Act not later than
the effective date of the first Registration Statement required by this Agreement, and, in
connection therewith, cooperate with the Trustee and the Holders of Initial Securities to
effect such changes to the Indenture as may be required for such Indenture to be so
qualified in accordance with the terms of the Trust Indenture Act; and to execute and use
their commercially reasonable efforts to cause the Trustee to execute, all documents that
may be required to effect such changes and all other forms and documents required to be
filed with the Commission to enable such Indenture to be so qualified in a timely manner;

 

-14-

 

(xxi) cause all Securities covered by the Registration Statement to be listed on each
securities exchange or automated quotation system on which similar debt securities issued by
the Issuers are then listed if requested by the Holders of a majority in aggregate principal
amount of Initial Securities or the managing underwriter(s), if any; and

(xxii) if not otherwise available on EDGAR, provide promptly to each Holder upon
request each document filed with the Commission pursuant to the requirements of Section 13
and Section 15 of the Exchange Act.

Each Holder agrees by acquisition of a Transfer Restricted Security that, upon receipt of any
notice from the Issuers of the existence of any fact of the kind described in Section 6(c)(iii)(D)
hereof, such Holder will forthwith discontinue disposition of Transfer Restricted Securities
pursuant to the applicable Registration Statement until such Holder’s receipt of the copies of the
supplemented or amended Prospectus contemplated by Section 6(c)(xvi) hereof, or until it is advised
in writing (the “Advice”) by the Issuers that the use of the Prospectus may be resumed, and has
received copies of any additional or supplemental filings that are incorporated by reference in the
Prospectus. If so directed by the Issuers, each Holder will deliver to the Issuers (at the
Issuers’ expense) all copies, other than permanent file copies then in such Holder’s possession, of
the Prospectus covering such Transfer Restricted Securities that was current at the time of receipt
of such notice. In the event the Issuers shall give any such notice, the time period regarding the
effectiveness of such Registration Statement set forth in Section 3 or 4 hereof, as applicable,
shall be extended by the number of days during the period from and including the date of the giving
of such notice pursuant to Section 6(c)(iii)(D) hereof to and including the date when each selling
Holder covered by such Registration Statement shall have received the copies of the supplemented or
amended Prospectus contemplated by Section 6(c)(xvi) hereof or shall have received the Advice;
provided, however, that no such extension shall be taken into account in determining whether
Additional Interest is due pursuant to Section 5 hereof or the amount of such Additional Interest,
it being agreed that the Issuers’ option to suspend use of a Registration Statement pursuant to
this paragraph shall be treated as a Registration Default for purposes of Section 5 hereof.

(d) The Issuers and the Guarantors will have the ability to suspend the use of a Shelf
Registration Statement (a “Shelf Suspension Period”) for a period not to exceed 30 consecutive
calendar days or an aggregate of 60 calendar days in any twelve-month period, if the Issuers’ Board
of Directors determines, in its reasonable business judgment, upon advice of counsel, that the
continued effectiveness and use of the Shelf Registration Statement would require the disclosure of
material non-public information of the Issuers or Guarantors. A Shelf Suspension Period shall
commence on and include the date that the Issuers give notice that the Shelf Registration Statement
is no longer effective or the Prospectus included therein is no longer usable for offers and sales
of the Transfer Restricted Securities covered by such Registration Statement and continue until
Holders of such Transfer Restricted Securities either receive the copies of the supplemented or
amended Prospectus contemplated by Section 6(c) above or are advised in writing by the Issuers that
use of the Prospectus may be resumed; provided, that as promptly as practicable following the
Issuers’ Board of Directors’ determination, in their reasonable business judgment, that the event
causing the Shelf Suspension Period no longer exists, the Issuers shall terminate the Shelf
Suspension Period and notify each Holder of such termination.

 

-15-

 

SECTION 7. Registration Expenses.

(a) All expenses incident to the Issuers’ and the Guarantors’ performance of or compliance
with this Agreement will be borne by the Issuers and the Guarantors, jointly and severally,
regardless of whether a Registration Statement becomes effective, including, without limitation:
(i) all registration and filing fees and expenses (including filings made by any Initial Purchaser
or Holder with FINRA (and, if applicable, the fees and expenses of any “qualified independent
underwriter” and its counsel that may be required by the rules and regulations of FINRA)); (ii) all
fees and expenses of compliance with federal securities and state securities or blue sky laws;
(iii) all expenses of printing (including printing certificates for the Exchange Securities to be
issued in the Exchange Offer and printing of Prospectuses), messenger and delivery services and
telephone; (iv) all fees and disbursements of counsel for the Issuers, the Guarantors and, subject
to Section 7(b) hereof, the Holders of Transfer Restricted Securities; (v) all application and
filing fees in connection with listing the Exchange Securities on a securities exchange or
automated quotation system pursuant to the requirements thereof; and (vi) all fees and
disbursements of independent certified public accountants of the Issuers and the Guarantors
(including the expenses of any special audit and comfort letters required by or incident to such
performance).

Each of the Issuers and the Guarantors will, in any event, bear its internal expenses
(including, without limitation, all salaries and expenses of its officers and employees performing
legal or accounting duties), the expenses of any annual audit and the fees and expenses of any
Person, including special experts, retained by the Issuers or the Guarantors.

(b) In connection with any Registration Statement required by this Agreement (including,
without limitation, the Exchange Offer Registration Statement and the Shelf Registration
Statement), the Issuers and the Guarantors, jointly and severally, will reimburse the Initial
Purchasers and the Holders of Transfer Restricted Securities being tendered in the Exchange Offer
and/or resold pursuant to the “Plan of Distribution” contained in the Exchange Offer Registration
Statement or registered pursuant to the Shelf Registration Statement, as applicable, for the
reasonable fees and disbursements of not more than one counsel, who shall be Cahill Gordon &
Reindel LLP or such other counsel as may be chosen by the Holders of a majority in
principal amount of the Transfer Restricted Securities for whose benefit such Registration
Statement is being prepared.

SECTION 8. Indemnification.

(a) The Issuers and the Guarantors, jointly and severally, agree to indemnify and hold
harmless (i) each Holder and (ii) each Person, if any, who controls (within the meaning of Section
15 of the Securities Act or Section 20 of the Exchange Act) any Holder (any of the Persons referred
to in this clause (ii) being hereinafter referred to as a “controlling person”) and (iii) the
respective officers, directors, partners, employees, representatives and agents of any Holder or
any controlling person (any Person referred to in clause (i), (ii) or (iii) may hereinafter be
referred to as an “Indemnified Holder”), to the fullest extent lawful, from and against any and all
losses, claims, damages, liabilities, judgments, actions and expenses (including, without
limitation, and as incurred, reimbursement of all reasonable costs of investigating, preparing,
pursuing, settling, compromising, paying or defending any claim or action, or any

 

-16-

 

investigation or
proceeding by any governmental agency or body, commenced or threatened, including the reasonable fees
and expenses of counsel to any Indemnified Holder), joint or several, directly or indirectly caused
by, related to, based upon, arising out of or in connection with any untrue statement or alleged
untrue statement of a material fact contained in any Registration Statement or Prospectus (or any
amendment or supplement thereto), or any omission or alleged omission to state therein a material
fact required to be stated therein or necessary to make the statements therein (in the case of any
Prospectus, in light of the circumstances under which they were made) not misleading, except
insofar as such losses, claims, damages, liabilities or expenses are caused by an untrue statement
or omission or alleged untrue statement or omission that is made in reliance upon and in conformity
with information relating to any of the Holders furnished in writing to the Issuers by any of the
Holders expressly for use therein. This indemnity agreement shall be in addition to any liability
which the Issuer or any of the Guarantors may otherwise have.

In case any action or proceeding (including any governmental or regulatory investigation or
proceeding) shall be brought or asserted against any of the Indemnified Holders with respect to
which indemnity may be sought against the Issuers or the Guarantors, such Indemnified Holder (or
the Indemnified Holder controlled by such controlling person) shall promptly notify the Issuers and
the Guarantors in writing; provided, however, that the failure to give such notice shall not
relieve any of the Issuers or the Guarantors of its obligations pursuant to this Agreement. Such
Indemnified Holder shall have the right to employ its own counsel in any such action and the fees
and expenses of such counsel shall be paid, as incurred, by the Issuers and the Guarantors
(regardless of whether it is ultimately determined that an Indemnified Holder is not entitled to
indemnification hereunder). The Issuers and the Guarantors shall not, in connection with any one
such action or proceeding or separate but substantially similar or related actions or proceedings
in the same jurisdiction arising out of the same general allegations or circumstances, be liable
for the reasonable fees and expenses of more than one separate firm of attorneys (in addition to
any local counsel) at any time for such Indemnified Holders, which firm shall be designated by the
Holders. The Issuers and the Guarantors shall be liable for any settlement of any such action or
proceeding effected with the Issuers’ and the Guarantors’ prior written consent, which consent
shall not be withheld unreasonably, and each of the Issuers and the Guarantors agrees to indemnify
and hold harmless any Indemnified Holder from and against any loss, claim, damage, liability or
expense by reason of any settlement of any action effected with the written consent of the Issuers
and the Guarantors. The Issuers and the Guarantors shall not, without the prior written consent of
each Indemnified Holder, settle or compromise or consent to the entry of judgment in or otherwise
seek to terminate any pending or threatened action, claim, litigation or proceeding in respect of
which indemnification or contribution may be sought hereunder (whether or not any Indemnified
Holder is a party thereto), unless such settlement, compromise, consent or termination includes an
unconditional release of each Indemnified Holder from all liability arising out of such action,
claim, litigation or proceeding.

 

-17-

 

(b) Each Holder of Transfer Restricted Securities agrees, severally and not jointly, to
indemnify and hold harmless the Issuers, the Guarantors and their respective directors, officers of
the Issuers and the Guarantors who sign a Registration Statement, and any Person controlling
(within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act) the
Issuer or any of the Guarantors, and the respective officers, directors, partners, employees,
representatives and agents of each such Person, to the same extent as the foregoing indemnity from
the Issuers and the Guarantors to each of the Indemnified Holders, but only with respect to
claims and actions based solely on information relating to such Holder furnished in writing by such
Holder expressly for use in any Registration Statement or prospectus (or any amendment or
supplement thereto). In case any action or proceeding shall be brought against the Issuers, the
Guarantors or their respective directors or officers or any such controlling person in respect of
which indemnity may be sought against a Holder of Transfer Restricted Securities, such Holder shall
have the rights and duties given the Issuers and the Guarantors, and the Issuers, the Guarantors,
their respective directors and officers and such controlling person shall have the rights and
duties given to each Holder by the preceding paragraph.

(c) If the indemnification provided for in this Section 8 is unavailable to an indemnified
party under Section 8(a) or (b) hereof (other than by reason of exceptions provided in those
Sections) in respect of any losses, claims, damages, liabilities, judgments, actions or expenses
referred to therein, then each applicable indemnifying party, in lieu of indemnifying such
indemnified party, shall contribute to the amount paid or payable by such indemnified party as a
result of such losses, claims, damages, liabilities or expenses in such proportion as is
appropriate to reflect the relative benefits received by the Issuers and the Guarantors, on the one
hand, and by the Holders, on the other hand, from the Initial Placement (which in the case of the
Issuers and the Guarantors shall be deemed to be equal to the total net proceeds to the Issuers and
the Guarantors from the Initial Placement (before deducting expenses)), the amount of Additional
Interest which did not become payable as a result of the filing of the Registration Statement
resulting in such losses, claims, damages, liabilities, judgments actions or expenses, and such
Registration Statement, or if such allocation is not permitted by applicable law, in such
proportion as is appropriate to reflect not only the relative benefits referred to above but also
the relative fault of the Issuers and the Guarantors, on the one hand, and the Holders, on the
other hand, in connection with the statements or omissions that resulted in such losses, claims,
damages, liabilities or expenses, as well as any other relevant equitable considerations. The
relative fault of the Issuers and the Guarantors on the one hand and of the Indemnified Holder on
the other shall be determined by reference to, among other things, whether the untrue or alleged
untrue statement of a material fact or the omission or alleged omission to state a material fact
relates to information supplied by the Issuers or any of the Guarantors, on the one hand, or the
Indemnified Holders, on the other hand, and the parties’ relative intent, knowledge, access to
information and opportunity to correct or prevent such statement or omission. The amount paid or
payable by a party as a result of the losses, claims, damages, liabilities and expenses referred to
above shall be deemed to include, subject to the limitations set forth in the second paragraph of
Section 8(a) hereof, any legal or other fees or expenses reasonably incurred by such party in
connection with investigating or defending any action or claim.

 

-18-

 

The Issuers, the Guarantors and each Holder of Transfer Restricted Securities agree that it
would not be just and equitable if contribution pursuant to this Section 8(c) were determined by
pro rata allocation (even if the Holders were treated as one entity for such purpose) or by any
other method of allocation which does not take account of the equitable considerations referred to
in the immediately preceding paragraph. The amount paid or payable by an indemnified party as a
result of the losses, claims, damages, liabilities or expenses referred to in the immediately
preceding paragraph shall be deemed to include, subject to the limitations set forth above, any
legal or other expenses reasonably incurred by such indemnified party in connection with investigating or defending any such action or claim. Notwithstanding the provisions of this
Section 8, none of the Holders (and its related Indemnified Holders) shall be required to
contribute, in the aggregate, any amount in excess of the amount by which the total discount
received by such Holder with respect to the Initial Securities exceeds the amount of any damages
which such Holder has otherwise been required to pay by reason of such untrue or alleged untrue
statement or omission or alleged omission. No Person guilty of fraudulent misrepresentation
(within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from
any Person who was not guilty of such fraudulent misrepresentation. The Holders’ obligations to
contribute pursuant to this Section 8(c) are several in proportion to the respective principal
amount of Initial Securities held by each of the Holders hereunder and not joint.

SECTION 9. Rule 144A. Each of the Issuers and the Guarantors hereby agrees with each Holder,
for so long as any Transfer Restricted Securities remain outstanding, to make available to any
Holder or beneficial owner of Transfer Restricted Securities in connection with any sale thereof
and any prospective purchaser of such Transfer Restricted Securities from such Holder or beneficial
owner, the information required by Rule 144A(d)(4) under the Securities Act in order to permit
resales of such Transfer Restricted Securities pursuant to Rule 144A under the Securities Act.

SECTION 10. Participation in Underwritten Registrations. No Holder may participate in any
Underwritten Registration hereunder unless such Holder (a) agrees to sell such Holder’s Transfer
Restricted Securities on the basis provided in any underwriting arrangements approved by the
Persons entitled hereunder to approve such arrangements and (b) completes and executes all
reasonable questionnaires, powers of attorney, indemnities, underwriting agreements, lock-up
letters and other documents required under the terms of such underwriting arrangements.

SECTION 11. Selection of Underwriters. The Holders of Transfer Restricted Securities covered
by the Shelf Registration Statement who desire to do so may sell such Transfer Restricted
Securities in an Underwritten Offering only upon the prior consent of the Issuers, such consent not
to be unreasonably withheld. In any such Underwritten Offering so consented to by the Issuers, the
investment banker(s) and managing underwriter(s) that will administer such offering will be
selected by the Holders of a majority in aggregate principal amount of the Transfer Restricted
Securities included in such offering; provided, however, that such investment banker(s) and
managing underwriter(s) must be reasonably satisfactory to the Issuers.

SECTION 12. Miscellaneous.

(a) Remedies. Each of the Issuers and the Guarantors hereby agrees that monetary damages
would not be adequate compensation for any loss incurred by reason of a breach by it of the
provisions of this Agreement and hereby agree to waive the defense in any action for specific
performance that a remedy at law would be adequate.

(b) No Inconsistent Agreements. Each of the Issuers and the Guarantors will not on or after
the date of this Agreement enter into any agreement with respect to its securities that is
inconsistent with the rights granted to the Holders in this Agreement or otherwise conflicts with
the provisions hereof. Neither the Company nor any Guarantor has previously entered into any
agreement granting any registration rights with respect to the Initial Notes to any Person. The
rights granted to the Holders hereunder do not in any way conflict with and are not
inconsistent with the rights granted to the holders of the Issuers’ or any of the Guarantors’
securities under any agreement in effect on the date hereof.

 

-19-

 

(c) Adjustments Affecting the Initial Securities. The Issuers will not take any action, or
agree to any change, with respect to the Initial Securities that would materially and adversely
affect the Consummation of the Exchange Offer on the terms specified herein.

(d) Amendments and Waivers. The provisions of this Agreement may not be amended, modified or
supplemented, and waivers or consents to or departures from the provisions hereof may not be given
unless the Issuers have (i) in the case of Section 5 hereof and this Section 12(d)(i), obtained the
written consent of Holders of all outstanding Transfer Restricted Securities and (ii) in the case
of all other provisions hereof, obtained the written consent of Holders of a majority of the
outstanding principal amount of Transfer Restricted Securities (excluding any Transfer Restricted
Securities held by the Issuers or its Affiliates). Notwithstanding the foregoing, a waiver or
consent to departure from the provisions hereof that relates exclusively to the rights of Holders
whose securities are being tendered pursuant to the Exchange Offer and that does not affect
directly or indirectly the rights of other Holders whose securities are not being tendered pursuant
to such Exchange Offer may be given by the Holders of a majority of the outstanding principal
amount of Transfer Restricted Securities being tendered or registered; provided, however, that,
with respect to any matter that directly or indirectly affects the rights of any Initial Purchaser
hereunder, the Issuers shall obtain the written consent of each such Initial Purchaser with respect
to which such amendment, qualification, supplement, waiver, consent or departure is to be
effective.

(e) Notices. All notices and other communications provided for or permitted hereunder shall
be made in writing by hand-delivery, first-class mail (registered or certified, return receipt
requested), facsimile or air courier guaranteeing overnight delivery:

(i) if to a Holder, at the address set forth on the records of the Registrar under the
Indenture, with a copy to the Registrar under the Indenture; and

(ii) if to the Issuers:

IASIS Healthcare LLC

117 Seaboard Lane

Building E

Franklin, Tennessee 37067

Facsimile: (615) 846-3006

Attention: General Counsel

With a copy to:

Cleary Gottlieb Steen & Hamilton LLP

One Liberty Plaza

New York, New York 10006

Facsimile No.: (212) 225-3999

Attention: Michael Ryan

 

-20-

 

All such notices and communications shall be deemed to have been duly given: at the time
delivered by hand, if personally delivered; five Business Days after being deposited in the mail,
postage prepaid, if mailed; when receipt acknowledged, if sent by facsimile; and on the next
Business Day, if timely delivered to an air courier guaranteeing overnight delivery.

Copies of all such notices, demands or other communications shall be concurrently delivered by
the Person giving the same to the Trustee at the address specified in the Indenture.

(f) Successors and Assigns. This Agreement shall inure to the benefit of and be binding upon
the successors and assigns of each of the parties, including, without limitation, and without the
need for an express assignment, subsequent Holders of Transfer Restricted Securities; provided,
however, that this Agreement shall not inure to the benefit of or be binding upon a successor or
assign of a Holder unless and to the extent such successor or assign acquired Transfer Restricted
Securities from such Holder.

(g) Counterparts. This Agreement may be executed in any number of counterparts and by the
parties hereto in separate counterparts, each of which when so executed shall be deemed to be an
original and all of which taken together shall constitute one and the same agreement.

(h) Headings. The headings in this Agreement are for convenience of reference only and shall
not limit or otherwise affect the meaning hereof.

(i) Governing Law. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE
LAWS OF THE STATE OF NEW YORK, WITHOUT REGARD TO THE CONFLICTS OF LAW RULES THEREOF.

(j) Severability. In the event that any one or more of the provisions contained herein, or
the application thereof in any circumstance, is held invalid, illegal or unenforceable, the
validity, legality and enforceability of any such provision in every other respect and of the
remaining provisions contained herein shall not be affected or impaired thereby.

(k) Entire Agreement. This Agreement is intended by the parties as a final expression of
their agreement and intended to be a complete and exclusive statement of the agreement and
understanding of the parties hereto in respect of the subject matter contained herein. There are
no restrictions, promises, warranties or undertakings, other than those set forth or referred to
herein with respect to the registration rights granted by the Issuers and the Guarantors with
respect to the Transfer Restricted Securities. This Agreement supersedes all prior agreements and
understandings between the parties with respect to such subject matter.

 

-21-

 

IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written
above.

	 	 	 	 	 
	 	IASIS HEALTHCARE LLC

 	 
	 	By:  	/s/ John M. Doyle
 	 
	 	 	Name:  	John M. Doyle 	 
	 	 	Title:  	Chief Financial Officer 	 
	 
	 	IASIS CAPITAL CORPORATION

 	 
	 	By:  	/s/ John M. Doyle
 	 
	 	 	Name:  	John M. Doyle 	 
	 	 	Title:  	Chief Financial Officer 	 
	 

 

-22-

 

	 	 	 	 	 
	 	ARIZONA DIAGNOSTIC &SURGICAL CENTER, INC.

BAPTIST JOINT VENTURE HOLDINGS, INC.

BEAUMONT HOSPITAL HOLDINGS, INC.

BILTMORE SURGERY CENTER HOLDINGS, INC.

BILTMORE SURGERY CENTER, INC.

BRIM HOLDING COMPANY, INC.

DAVIS HOSPITAL HOLDINGS, INC.

DECISIONPOINT SERVICES, INC.

FIRST CHOICE PHYSICIANS NETWORK HOLDINGS, INC.

HEART AND LUNG INSTITUTE OF UTAH, INC.

IASIS FINANCE, INC.

IASIS HEALTHCARE HOLDINGS, INC.

IASIS HOSPITAL NURSE STAFFING COMPANY

IASIS MANAGEMENT COMPANY

IASIS PHYSICIAN SERVICES, INC.

IASIS PORT ARTHUR ASC, INC.

IASIS TRANSCO, INC.

JORDAN VALLEY HOSPITAL HOLDINGS, INC.

MCS/AZ, INC.

NORTH VISTA HOSPITAL, INC.

PALMS OF PASADENA HOMECARE, INC.

PHYSICIAN GROUP OF ARIZONA, INC.

PHYSICIAN GROUP OF FLORIDA, INC.

PHYSICIAN GROUP OF LOUISIANA, INC.

PHYSICIAN GROUP OF UTAH, INC.

ROCKY MOUNTAIN MEDICAL CENTER, INC.

SALT LAKE REGIONAL PHYSICIANS, INC.

TAMPA BAY STAFFING SOLUTIONS, INC.

UTAH TRANSCRIPTION SERVICES, INC.

 	 
	 	By:  	/s/ John M. Doyle
 	 
	 	 	Name:  	John M. Doyle 	 
	 	 	Title:  	Chief Financial Officer 	 
	 

 

-23-

 

	 	 	 	 	 
	 	IASIS GLENWOOD REGIONAL MEDICAL CENTER, LP

MEMORIAL HOSPITAL OF TAMPA, LP

MESA GENERAL HOSPITAL, LP

PALMS OF PASADENA HOSPITAL, LP

ST. LUKE’S BEHAVIORAL HOSPITAL, LP

ST. LUKE’S MEDICAL CENTER, LP

TOWN &COUNTRY HOSPITAL, LP

 	 
	 	By:  	IASIS Healthcare Holdings, Inc.
 	 
	 	 	as General Partner 	 

	 	 	 	 	 
	 	By:  	                            /s/ John M. Doyle
 	 
	 	 	Name:  	John M. Doyle 	 
	 	 	Title:  	Chief Financial Officer 	 

	 	 	 	 	 
	 	BRIM HEALTHCARE OF COLORADO, LLC

BRIM PHYSICIANS GROUP OF COLORADO, LLC

BRIM PHYSICIANS GROUP OF TEXAS, LLC

 	 
	 	By:  	                                              Brim Holding Company, Inc.
 	 
	 	 	as Sole Member 	 

	 	 	 	 	 
	 	 	 
	 	By:  	                            /s/ John M. Doyle
 	 
	 	 	Name:  	John M. Doyle 	 
	 	 	Title:  	Chief Financial Officer 	 
	 

	 	 	 	 	 
	 	IASIS Finance Texas Holdings, LLC

Seaboard Development LLC

 	 
	 	By:  	/s/ John M. Doyle
 	 
	 	 	Name:  	John M. Doyle 	 
	 	 	Title:  	Chief Financial Officer 	 

 

-24-

 

	 	 	 	 	 

The foregoing Registration Rights Agreement is hereby confirmed and accepted as of the date
first above written:

	 	 	 	 	 
	MERRILL LYNCH, PIERCE, FENNER & SMITH	 	 
	 

	 	INCORPORATED	 	 
	 

	 	Acting on behalf of itself	 	 
	 

	 	and as the Representative of	 	 
	 

	 	the several Initial Purchasers	 	 
	 
	 	 	 	 
	By:

	 	Merrill Lynch, Pierce, Fenner & Smith	 	 
	 

	 	Incorporated	 	 
	 
	 	 	 	 
	By:

	 	/s/ Sam Baruch
 

Name: Sam Baruch
	 	 
	 

	 	Title: Director	 	 

 

-25-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00189-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00189-of-00352.parquet"}]]